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Abstract 
Abstract 
Analysis of gene expression during the macrophage to foam cell transformation 
using high-density eDNA arrays 
By Assum Guizar 
Coronary heart disease (CHD) is the leading cause of death in most industrialised 
countries. Atherosclerosis is the major underlying cause of CHD. Atherosclerosis is a 
disease process in which monocyte derived macrophages enter the subendothelial space, 
accumulate excess amounts of cholesterol to form lipid filled foam cells. These foam 
cells have been found contribute significantly to the aetiology of the fatty streak and 
subsequent lesions involved in atherosclerosis. 
The aim of this study was to gain a further understanding of the foam cell 
formation process by studying gene expression during the macrophage to foam cell 
transformation. Human THP-1 monocytic cells were differentiated into macrophages 
using a phorbol ester. Macrophages were subsequently exposed to either acetylated LDL 
or oxidised LDL to induce foam cell formation. Foam cell formation was assessed using 
the techniques of flow cytometry, Oil Red 0 staining, fluorescence microscopy and 
cholesteryl oleate loading. 
Gene expression was examined using high density eDNA array technology. RNA 
was isolated from cells exposed to native or modified LDL. First strand eDNA probes 
were subsequently generated and applied to high-density eDNA arrays. Two different 
arrays were probed; an array representative of the Human I.M.A.G.E collection and a 
custom array containing known genes thought to be involved in the cardiovascular 
disease process. 
The results of this study showed increased expression in CD36, a known receptor 
for OxLDL. In addition other genes were also identified including ILl~ and fibronectin. 
Cluster analysis of a time series experiment showed the existence of nine distinct clusters 
of genes with different expression patterns. In particular two genes IL-l~ and TIMP-1 
were shown to have a highly correlated pattern of expression. 
Declaration and Copyright 
Declaration 
I declare that the work contained within this thesis submitted by me for the degree of 
Master of Philosophy has not been previously submitted for a degree at this or any other 
University. 
The work presented within this thesis is my own except where stated. Where others have 
contributed to this work, their contribution is clearly stated. 
The thesis conforms to the word limit set out in the University Degree of Regulations. 
Copyright 
The copyright of this thesis rests with the author. No quotation from it should be 
published without their prior written consent and information derived from it should be 
acknowledged. 
This thesis has been approved by Glaxo SmithKline Intellectual Property Department for 
publication. 
Correspondence 
Correspondence regarding this thesis may be addressed to the author via email to 
Assum_ Gulzar@ yahoo.co. uk. 
Contents 
List of Contents 
Chapter 1: Introduction 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
1.7 
1.8 
Atherosclerosis 
Lipoproteins 
Lipoprotein receptors 
1.3.1 The LDL receptor 
1.3.2 LDL receptor related protein 
1.3.3 The VLDL receptor 
1.3.4 The macrophage scavenger receptors 
Structure of the normal artery wall 
Lesions of atherosclerosis 
1.5.1 Fatty streaks 
1.5.2 Fibrous plaques 
1.5.3 The complicated lesion 
1.5.4 Detection of atherosclerotic lesions 
1.5.5 Initiation of atherosclerotic lesions 
The response to injury hypothesis 
Properties of the components of the arterial wall 
1. 7.1 Endothelial cells 
1.7.2 Smooth muscle cells 
1.7.3 Macrophages 
I. 7.4 Extracellular matrix 
1.7.5 T-cells 
Foam cell formation 
1.8.1 The role of the monocyte-derived macrophage 
1.8.2 Monocyte attachment 
1.8.2.1 Endothelial selectins 
1.8.2.2 Immunoglobulin superfamily of adhesion molecules 
1.8.3 Monocyte migration and accumulation in the intima 
__ ,~ _ L8.4 Lipoprotein-uptake 
page 1 
page2 
page3 
page6 
pageS 
page 10 
page 11 
page 14 
Conte11ts 
1.8.5 Retention of LDL 
1.9 Intracellular cholesterol regulation in the macrophage 
1.9.1 Enzymes involved in intracellular cholesterol regulation 
1.10 Oxidative modification of LDL 
1.1 0.1 Evidence for LDL oxidation 
1.10.2 Mechanisms of LDL oxidation 
1.10.2.1 
1.10.2.2 
1.10.2.3 
1.10.2.4 
1.10.2.5 
Metal ions 
Cell induced oxidation of LDL 
Lipoxygenases 
Myeloperoxidase 
Role of nitric oxide 
1.10.3 Susceptibility of LDL to oxidation 
1.10.4 Components of OxLDL 
1.1 0.5 The role of antioxidants 
1.10.6 Effects and atherogenicity of OxLDL 
page 18 
page 20 
1.10.7 Role of OxLDL in the expression of cytokines and growth factors 
1.11 The role of perixosome proliferator activator receptors and the nuclear LXR 
receptors page 27 
1.12 The role of the macrophage derived foam cell in advanced lesions 
1.12.1 Composition of vulnerable plaques 
1.12.2 The fibrous cap 
1.12.3 Role of lipids 
1.12.4 Role of apoptosis 
1.12.5 Effects of lipid lowering on plaque stability 
1.13 The matrix metalloproteinases 
1.13.1 Biochemistry of the MMPs 
1.13.2 MMP and TIMP expression 
page 28 
page 32 
1.13 .3 Effects of statins and antioxidants on MMP and TIMP expression 
1.14 Inflammatory markers page 36 
1.15 Aims and objectives page 37 
-h-150'1 Background"to this study-" 
Colltents 
1.15.2 Experimental considerations 
1.15.2.1 The THP-1 cell line 
1.15.2.2 Use of AcLDL and OxLDL 
1.15.2.3 Analysing gene expression 
1.15.3 Aims 
1.15.4 Objectives 
Chapter 2: Methods 
2.1 
2.2 
Human THP-1 cell line 
2.1.1 Culture of human THP-1 cells 
2.1.2 Differentiation 
2.1.3 Freezing/thawing 
2.1.4 Cell Counting 
2.1.5 Oil Red 0 staining 
2.1.6 Nile red staining 
2.1.7 Flow cytometry 
2.1.8 Estimation of cholesterol uptake 
2.1.8.1 Preparation of 14C-oleate label 
page 41 
2.1.8.2 Preparation of 3H-cholesterol oleate internal standard 
2.1.8.3 Lipid extraction and thin layer chromatography 
2.1.9 MTT assay for cell viability 
2.1.10 Statistical Analysis of results 
Isolation of Low-density lipoprotein 
2.2.1 Preparation of density solutions 
2.2.2 Collection of blood and separation of plasma 
2.2.3 Separation of LDL 
2.2.4 Concentration of LDL 
2.2.5 Bradford assay 
2.2.6 Modification of LDL 
2.2.6.1 Oxidation 
page 47 
2.3 
2.4 
Contents 
2.2.6.2 Acetylation 
2.2.7 Agarose gel electrophoresis of LDL 
General molecular biology 
2.3.1 DNA extraction 
2.3.1.1 Extraction of DNA from human blood 
2.3.1.2 Quantitative estimation of DNA 
2.3.2 RNA extraction 
2.3.2.1 Isolation of white blood cells from human blood 
2.3.2.2 Isolation of total RNA using TRizol reagent 
2.3.3 Reverse transcription of total RNA 
2.3.4 PCR 
2.3.4.1 Polymerase chain reaction 
2.3.4.2 PCR primer sequences 
2.3.4.3 PCR product sizes 
2.3.4.4 PCR programmes 
2.3.5 Agarose gel electrophoresis of PCR products 
2.3.6 Purification of DNA from agarose gels 
2.3.7 Quantitative RT-PCR 
page 51 
2.3.7 .1 Oligonucleotide end labelling using gamma 32P- ATP 
2.3.7.2 Denaturing gel electrophoresis 
Differential gene expression page 62 
2.4.1 Isolation of mRNA for differential gene expression 
2.4.1.1 Isolation of total RNA 
2.4.1.2 Isolation of messenger RNA 
2.4.1.3 Quantitation of RNA 
2.4.1.4 Determining RNA integrity 
2.4.1.4.1 Agarose/formaldehyde gel electrophoresis of RNA 
2.4.1.4.2 Glyoxal gel electrophoresis of RNA 
2.4.2 Preparation of high-density eDNA arrays 
2.4.3 Quantitation of PCR products on arrays 
2.4.3.1 Five prime radiolabelling of M 13F oligonucleotide 
Contents 
2.4.3.3 Hybridisation of radio labelled M 13F oligonucleotide probe to 
2.5 
arrays. 
2.4.4 Complex probe preparation from RNA 
2.4.5 Complex probe quality control 
2.4.6 Hybridisation of complex probes to arrays 
2.4.7 Data analysis 
2.4.7.1 DGE data analysis 
2.4.7.2 Temporal gene expression data analysis 
Hierarchical Clustering page 71 
2.5.1 Steps involved in correlating gene expression data and performing 
hierarchical clustering 
2.6 
2.7 
2.5.2 Cluster analysis 
Composition of solutions 
Materials 
Chapter 3: Foam cell formation 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
3.7 
Introduction 
3.1.1 The cholesterol ester cycle 
3.1.2 The THP-1 cell line 
Experimental design 
Modification of LDL 
Differentiation of THP-1 cells 
Oil Red 0 staining 
Fluorescence microscopy of nile red stained cells 
Flow Cytometry 
3. 7 .l Confirmation of THP-1 differentiation 
3.7.2 Nile red fluorescence staining 
3.7.3 Nile red staining in response modified LDL 
3.8 14C-oleate loading of differentiated THP-1 cells 
3.9 Assay for assessing cell viability 
3.10 Discussion 
page 74 
page 78 
page 79 
page 81 
page 83 
page 85 
page 87 
page 89 
page 93 
page 100 
page 103 
page 105 
Contents 
Chapter 4: Differential Gene Expression Technology 
4.1 
4.2 
4.3 
4.4 
4.5 
4.6 
4.7 
4.8 
4.9 
Introduction to the concept of gene expression page 108 
Introduction to array technology and differential gene expression 
Designing eDNA arrays 
Experimental probe preparation and hybridisation 
Detection 
page 110 
page 110 
page 111 
page 111 
Overview of Differential Gene Expression page 112 
4.6.1 Preparation of eDNA arrays 
4.6.2 The human I.M.A.G.E collection and the custom atheroma array 
4.6.3 Checking for amount of PCR products on the arrays 
4.6.4 Isolation of mRNA 
4.6.5 Experimental probe preparation 
4.6.6 Hybridisation 
4.6.6 Data Analysis 
Analysing DGE results 
DGE database access and features 
Discussion 
page 125 
page 129 
page 130 
Chapter 5: Gene Regulation in response to native and modified LDL 
5.1 
5.2 
5.3 
5.4 
5.5 
5.6 
Introduction 
Experimental design 
Reproducibility of results 
Sensitivity of detection 
Results from custom atheroma array comparisons 
5.5.1 Total number of regulated genes 
Genes regulated on exposure to lipoprotein 
5.6.1 Native LDL versus control 
5.6.2 AcLDL (24) versus control 
page 131 
page 131 
page 134 
page 135 
page 136 
page 139 
5.7 
Contents 
5.6.3 OxLDL (24) and OxLDL (4) versus control 
5.6.4 Genes regulated specifically by AcLDL 
5.6.5 Genes regulated specifically by OxLDL 
5.6.6 Genes regulated specifically by AcLDL and OxLDL 
5.6.7 Genes regulated after early and late exposure to OxLDL 
5.6.8 Discussion of results from the custom atheroma arrays 
Genes regulated by native and modified LDL 
5.7.1 Genes regulated by native LDL 
5.7.2 Genes regulated by modified LDL 
5.7.3 Genes regulated specifically by AcLDL 
5.7.4 Genes regulated specifically by OxLDL 
5.7.5 Genes regulated by both OxLDL and AcLDL 
5.7.6 Conclusions from atheroma array results 
page 148 
5.8 Results from the human I.M.A.G.E arrays page 158 
5.8.1 Discussion of results from human I.M.A.G.E arrays 
5.8.2 Genes regulated by native LDL using human I.M.A.G.E arrays 
5.8.3 Genes regulated by AcLDL using human I.M.A.G.E arrays 
5.8.4 Genes regulated by OxLDL using human I.M.A.G.E arrays 
5.9 Conclusions from results of human I.M.A.G.E arrays page 169 
5.10 Discussion of array technology page 170 
Chapter 6: Temporal Gene Expression 
6.1 Introduction page 171 
6.1.1 Temporal gene expression 
6.1.2 Initial work on temporal gene expression 
6.1.3 Introduction to clustering methodologies for analysing large data sets 
6.1.3.1 Supervised Methods 
6.1.3.1.1 Nearest Neighbours 
6.1.3.1.2 Support Vector Machines 
6.1.3.2 Unsupervised Methods 
6.1.3.2.1 Hierarchical clustering 
6.1.3.2.2 
6.1.3.2.3 
6.1.3.2.4 
6.1.3.2.5 
Contents 
k-means clustering 
Self-organising maps (SOMs) 
Relevance networks 
Principle Component Analysis 
6.2 Temporal gene expression in macrophages exposed to OxLDL 
6.3 
6.2.1 Experimental design 
6.2.2 Data collection 
6.2.3 Data analysis 
Results 
page 179 
page 180 
6.3.1 Qualitative and quantitative analysis of genes showing temporal 
expression 
6.3.2 Analysis of genes of interest showing temporal expression 
6.3.3 Conclusion from expression patterns of gene families 
6.3.4 Data analysis of genes of interest 
6.3.5 Conclusion from expression patterns of genes of interest 
6.4 Hierarchical cluster analysis page 203 
6.4.1 Data correlation 
6.4.2 Results of clusters obtained 
6.5 Discussion 
Chapter 7: Quantitative RT-PCR 
7.1 Introduction 
7 .l.l Current methods for analysing mRNA expression 
7 .1.1.1 Northern Blots 
7.1.1.2 
7.1.1.3 
7.1.1.4 
7.1.1.5 
AtTay technology 
Ribonuclease protection assays 
RNA Interference 
RT-PCR 
page 211 
page 214 
7.1.1.5.1 
7.1.1.5.2 
7. I. 2 Use of standards 
Contems 
Differential Display 
Quantitative RT-PCR 
7 .1.2.1 Use of housekeeping controls 
7 .1.2.2 Use of Internal Standards 
7.1.3 Competitive PCR 
7.2 Experimental Design page 220 
7.3 
7.4 
7 .2.1 Steps involved in performing quantitative RT -PCR 
Results 
7 .2.1.1 Isolation of RNA 
7.2.1.2 
7.2.1.3 
7.2.1.4 
7.2.1.5 
Internal standard preparation 
eDNA synthesis 
PCR 
Quantitation 
7 .3.1 Internal standard preparation 
page 224 
7.3.2 Initial quantitation of internal standards using ethidium bromide 
staining 
7.3.3 Quantitation using phosphorimaging 
Discussion 
7 .4.1 Problems associated with RT -PCR 
7.4.2 Discussion of results 
7.4.3 Future Experiments 
7.4.4 The future of RT-PCR 
page 234 
Chapter 8: Discussion 
8.1 
8.2 
Background page 239 
Experimental design page 240 
8.2.1 THP-1 cells -use of an in vitro model for foam cell formation 
8.2.2 Use of acetylated and oxidised LDL 
Contents 
8.2.3 Choice of technology to examine differentially regulated genes 
8.3 
8.4 
8.5 
8.6 
Results 
8.3.1 Foam cell formation 
8.3.2 Array Technology 
8.3.3 Differential gene expression 
8.3.4 Temporal gene expression 
Problems associated with array technology 
8.4.1 Reverse transcription bias 
8.4.2 Oligonucleotide versus eDNA arrays 
8.4.3 Controls for array experiments 
8.4.4 Background 
8.4.5 Glass slides versus nylon membranes 
8.4.6 Single versus Dual labelling 
8.4.7 Technical versus Biological Replicates 
8.4.8 Array technology for the identification of novel genes 
8.4.9 Data Storage, Sharing and Interpretation 
Future work 
Conclusion 
Chapter 9: Bibliography 
Appendixes 1-8 
Attached CD 
page 242 
page 251 
page 256 
page 258 
page 259 
ACAT 
AcLDL 
AP-I 
BSA 
bp 
~-actin 
CHD 
cpm 
dpm 
DEPC 
DGE 
DMSO 
dNTP's 
OTT 
ECM 
ECs 
EF-1 
FBS 
FH 
GAPDH 
HDL 
HOC I 
HSL 
IL 
I.M.A.G.E 
LDL 
LpL 
MCSF 
MCP-1 
Abbreviations 
Abbreviations used in the text 
Acyl-coenzyme A cholesterol acyl transferase 
Acetylated low-density lipoprotein 
Activator protein I 
Bovine serum albumin 
Base pairs 
beta actin 
Coronary heart disease 
Counts per minute 
Disintegrations per minute 
Diethyl pyrocarbonate 
Differential Gene Expression 
Dimethyl sulphoxide 
Dideoxy nucleoside triphosphates 
Dithiothreitol 
Extracellular matrix 
Endothelial cells 
Elongation factor-! 
Foetal bovine serum 
Familial Hypercholesteorlemia 
glycealdehyde 3-phosphate dehydrogenase 
High density lipoprotein 
Hypochlorous acid 
Hormone sensitive lipase 
Interleukin 
Integrated molecular analysis of Genomes and their 
Expression 
Low density lipoprotein 
Lipoprotein Lipase 
Macrophage colony stimulating factor 
Macrophage chemoattractant protein I 
MMPs 
MOPS 
MPO 
NO 
NF-KB 
OxLDL 
PBS 
PDGF 
PCA 
PCR 
PMA 
PPARs 
SDS 
SMCs 
SMase 
SRs 
STATs 
TAE 
TBE 
TIMPs 
TLC 
TNF-a 
TGF-~ 
TGE 
Abbreviations 
Matrix metalloproteinases 
3-N-morpholinopropane sulfonic acid 
Myeloperoxidase 
Nitric oxide 
Nuclear factor kappa b 
Oxidised low-density lipoprotein 
Phosphate buffered saline 
Platelet derived growth factor 
Principle component analyis 
Polymerase Chain Reaction 
Phorbol 12-myristate 13-acetate 
Peroxisome proliferator activator receptors 
Sodium dodecyl sulphate 
Smooth muscle cells 
Sphingomyelinase 
Scavenger receptors 
Signal transducers and activators of transcription 
Tris acetate buffer 
Tris borate buffer 
Tissue inhibitors of metalloproteinases 
Thin layer Chromatography 
Tumour necrosis factor alpha 
Transforming growth factor beta 
Temporal gene expression 
Chapter I Introduction 
Chapter 1: Introduction 
1.1 Atherosclerosis 
Despite many advances in cardiovascular medicine over the last few decades, 
coronary heart disease (CHD) still remains one of the leading cause of mortality in 
most industrialised nations [ 1]. The major underlying cause of CHD is the disease 
process of atherosclerosis. The term 'arteriosclerosis' was introduced in 1829 to 
describe the scarring and calcification seen in post-mortem arteries. Atherosclerosis 
was subsequently used as a term used to describe lipid-rich deposits seen in 
arteriosclerosis [2]. The term atherosclerosis comes from the Greek words "athero" 
meaning gruel and "sclerosis" meaning hard, describing the process in which the 
coronary arteries become narrowed with deposits of fat and these deposits of fat 
develop into plaques filled with cholesterol [2]. 
Initially atherosclerosis was thought to be a lipid related disease, however in 
recent years the role of inflammation has gained has gained as much importance as the 
lipid aspect [3,4]. The major clinical symptoms of atherosclerosis include myocardial 
infarction and stroke [5]. Disease progressesion occurs for many years before 
symptoms develop, making it difficult to follow the early development of the disease 
in humans. Knowledge of early atherosclerosis has thus been obtained mainly from 
post mortem examinations and animal studies. Plaque formation is thought to begin in 
early life and advanced plaques are common by the time people are in the third decade 
of life [6]. 
The earliest lesion of atherosclerosis is the fatty streak, which is characterised 
by the accumulation of monocyte-derived macrophages containing large amounts of 
lipids [7]. These cells are known as "foam cells" and are characteristic of both early 
and advanced lesions of atherosclerosis [8]. 
Atherosclerosis is a multifactorial disease with a wide range of risk factors 
associated with it. The major risk factors include dyslipidemia, hypertension, diabetes 
and the use of tobacco products [9]. Other risk factors include, raised plasma 
cholesterol concentrations, increasing age, the male gender, the postmenopausal state 
in woman, obesity, alcohol consumption, homocysteinemia and a family history of 
premature atherosclerosis [9]. 
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1.2 Lipoproteins 
Lipids are insoluble in aqueous solution and are therefore transported in the 
plasma in the form of lipoproteins. Lipoproteins are complex water-soluble molecules 
containing a core of cholesteryl ester and triglyceride covered by a surface monolayer 
of phospholipids, free cholesterol and apolipoproteins [5]. The major classes of 
lipoprotein found in the plasma are chylomicrons, very low-density lipoprotein 
(VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL) and 
high-density lipoprotein (HDL) [14]. Lipoproteins are synthesised in the liver or the 
intestine with a corresponding structural apoprotein. Table 1.1 below lists the major 
properties of the different lipoproteins. 
Table 1.1 
Properties of the plasma lipoproteins (from reference 5) 
Name of 
lipoprotein 
chylomicrons 
very low density 
lipoproteins (VLDL) 
intermediate density 
lipoproteins (IDL) 
low density 
lipoprotein (LDL) 
high density 
lipoprotein (HDL) 
I 
II 
III 
2 
3 
Density 
(d; g/ml) 
<0.95 
<1.006 
1.006-1 .009 
1.02-1.03 
1.03-1.04 
1.04-1.06 
1.063-1.125 
1.125-1.21 
Electrophoretic 
mobility 
origin 
pre-~ 
broad~ 
a 
Source 
intestine 
liver 
catabolism of VLDL 
& chylomicrons 
catabolism of VLDL 
catabolism of chylo-
microns&VLDL; liver 
& intestine 
Lipoproteins can be distinguished from one another by a variety of methods 
including lipid content, density, size, electrophoretic mobility and the proteins on their 
surfaces [5]. The different classes of lipoproteins vary in their contribution to 
atheorsclerotic risk. LDL, chylomicron remnants and IDL are known to be pro-
atherogenic, whereas HDL levels are thought to be inversely related to risk of CHD 
2 
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[10]. The mam cholesterol carrying lipoproteins are LDL and HDL. In a normal 
individual, LDL contains approximately 70% and HDL 20% of the total plasma 
cholesterol flO). 
1.3 Lipoprotein receptors 
1.3.1 The WL receptor 
LDL is a spherical particle containing a hydrophobic core surrounded by a 
polar phospholipid coat. The apolipoprotein of LDL is apo Bum. Apo 8 100 on the 
surface of the LDL allows recognition binding and removal of the lipoprotein by the 
LDL receptor [II]. The LDL receptor was first elucidated by the experiments of 
Goldstein and Brown in the 1970s using cultured human fibroblasts [12]. They 
demonstrated that the underlying defect in the genetic disease Familial 
Hypercholesterolemia (FH) was an absence or impairment of function in the LDL 
receptor [ 12]. 
The LDL receptor can bind apoB 100 or a poE containing ligands including 
chylomicron remnants, IDL and LDL (hence is also referred to as the apoB/E receptor 
[ 13]). The LDL receptor is responsible for removing approximately 75% of LDL 
particles from the circulation [ 13]. The LDL receptor pathway is a tightly regulated 
pathway, in which expression of the LDL receptor decreases as intracellular 
cholesterol levels increase. 
1.3.2 WL receptor related protein (LRP) 
LRP is a receptor that has homology to the LDL receptor, however it differs 
from the LDL receptor in that it does not recognise apoB [14]. LRP has been found to 
be highly expressed in the liver, brain and placenta [14]. It is able to mediate uptake of 
apoE containing lipoproteins including chylomicrons and IDL [14]. LRP has has been 
implicated in atherosclerosis as it allows macrophages to take up lipoproteins. 
3 
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1.3.3 The VLDL receptor 
The VLDL receptor is a more recently discovered member of the lipoprotein 
receptor family [15]. The VLDL receptor is also highly homologous to the LDL 
receptor and like the LRP it also binds apoE but not apoB containing lipoproteins. The 
VLDL receptor differs from the LDL receptor in its expression pattern [ 15]. It is found 
highly expressed in heart, skeletal muscle and adipose tissue [2]. Although the exact 
function of the VLDL receptor remains to be determined, it is thought to be involved 
in the binding of triglyceride-rich lipoproteins thereby helping deliver fatty acids to 
tissues [2]. 
1.3.4 The macrophage scavellger receptors 
Since LDL is the major atherogenic lipoprotein found in atherosclerotic 
lesions, it would be expected that incubation of macrophages with LDL would lead to 
foam cell formation. However this proved not to be the case, as reported by Goldstein 
and Brown [ 16]. This lead to a search for an explanation for the paradox. Again it was 
Goldstein and Brown who provided the answer. They reported the existence of a 
receptor for modified LDL using acetylated LDL as a ligand [ 16]. Macrophage 
scavenger receptors (SRs) have been found to mediate the uptake of large amounts of 
modified LDL in an uncontrolled fashion [ 17]. This occurs because unlike the LDL 
receptor pathway, scavenger receptor expression is not down-regulated. 
In addition to binding modified LDL such as oxidised and aggregated LDL, 
SRs also act as binding sites for polyribonucleases and some polysaccharides (such as 
dextran sulphate) and anionic phospholipids such as phosphotidylserine. Six different 
classes of SRs have been described [ 18] and they have been classified as shown in 
table 1.2. 
SR classes A and B are expressed in atherosclerotic plaques and are involved 
in the development of lipid laden foam cells [ 19, 20]. However since expression of 
SRs is not restricted to the cells within the arterial wall, preventing foam cell 
formation in atherosclerotic plaques by inhibition of SRs may not be very effective. 
4 
Chapter I Introduction 
Table 1.2 
Table showing classification of the scavenger receptors (From reference 18) 
Scavenger Receptor Class 
Class A 
Class B 
Class C 
The scavenger receptors 
Members of Class 
SR-AI, SR-AII, SR-AIII 
and MARCO (the macrophage 
receptor with collagenous structure) 
SR-B I and CD36 
Drosophilia SR-C 
Class D, E and F receptors are the most recently identified and none of them show any 
structural similarity with class A, B or C receptors 
Class A SRs include macrophage SR types AI, All and AID (SR-AI, SR-AII 
and SR-AIII). SR-AI and II are homotrimeric membrane proteins [ 19], found 
predominantly in macrophages and activated smooth muscle cells. Ligands for class A 
scavenger receptors include acetylated LDL, oxidised LDL, fucoidan and caragenan 
[ 19]. An increase in SR activity has been observed during differentiation of 
monocytes to macrophages. This has been attributed to an increase in the expression 
of the SR-AI isoforrn [211. Furthermore this increased macrophage SR-AI expression 
is thought to be important for the transformation of macrophages into foam cells [21 ]. 
Class B scavenger receptors include CD36, and SR-B I, which are found in 
adipose tissue, lung, liver and macrophages [22]. These receptors bind OxLDL, 
apoptotic cells and anionic phospholipids. CD36 has been found to be significantly 
expressed in atherosclerotic foam cells in human coronary arteries [231 and has been 
implicated to be a major receptor for OxLDL [22]. 
SR-BI has also been reported to be major a receptor for HDL [24]. SR-BI has 
been found to bind HDL with high affinity and subsequently mediate the selective 
uptake of cholesteryl ester [24]. Thus it is possible that SR-BI may be involved in the 
initial steps of cholesterol efflux from foam cells in the arterial wall [25 ]. A third class 
s 
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of scavenger receptors has also been reported as CD68/macrosialin, a family of 
endosomal proteins that have a sequence homology similar to lysosomal associated 
membrane proteins [26]. 
A more recent receptor for OxLDL has also been reported. Lectin-like 
oxidised LDL receptor-! (LOX-I) was found to be present on bovine vascular 
endothelial cells [27]. In addition to being expressed on ECs, LOX-I has also been 
found to be present on smooth muscle cells (SMCs) and macrophages [28]. 
1.4 Structure of the normal artery wall 
The main types of arteries found to have plaques leading to clinical symptoms 
are the coronary arteries, although lesions can also be found in other arteries [5]. 
Normal muscular and elastic arteries have been found to consist of three 
morphologically distinct layers [29], the intima, the media and the adventitia (figure 
1.1 ). 
The intima is the innermost layer and consists of a narrow region bounded on 
one side by a single continuous layer of endothelial cells and bound peripherally by a 
sheet of elastic fibres, which is known as the internal elastic lamina (shown in figure 
1.2 below). The media is the middle layer. It consists of diagonally orientated smooth 
muscle cells, surrounded by collagen, small elastic fibres and proteoglycans. 
Figure 1.1 
Diagrammatic cross-sectional representation of the artery wall 
media 
\+--- adventita 
intima 
lumen 
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The adventitia is the outermost layer of the artery. It consists mainly of 
fibroblasts intermixed with SMC loosely arranged between bundles of collagen and 
surrounded by proteoglycan. It also contains vaso vasorum and innervation. It is 
separated from the media by a discontinuous sheet of elastic tissue, the external elastic 
lamina [29]. 
The intima is the initial cell layer that is involved in atherosclerosis (figure 
1.2) although changes can also be found in the media during the later stages of 
atherosclerosis [29]. The intima itself consists of two regions. Beneath the endothelial 
cells is the proteoglycan layer that contains non-fibrous connective tissue, 
proteoglycans and a few elastic fibres. Proteoglycans interact with other matrix 
proteins such as collagens, elastin and fibronectin [30]. In normal human coronary 
arteries the content of these proteoglycans increases with age, but levels are also found 
to increase in atherosclerosis [30]. Below the proteoglycan layer is the musculoelastic 
layer that consists of SMC s of the contractile phenotype. The major component of the 
intima however is the extracellular matrix, which comprises around 60% of the 
volume of the intima [31]. It contains molecules synthesized and secreted by both ECs 
and SMCs. 
Figure 1.2 
Diagrammatic representation of the intima (adapted from reference 2) 
Endothelial cells 
------··-Extracellular matrix 
Intima 
Macrophage 
Smooth muscle cells 
1.5 Lesions of atherosclerosis 
Stary and other investigators [29, 32, 33] have reported the main types of 
lesion that are found during the progression of atherosclerosis, the fatty streak, the 
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fibrous plaque and the advanced complicated lesion (types 1-Vb ). The progression of 
lesions in experimental animals is the development of fatty streaks and later the 
development of fibrous plaques and more complicated lesions [34]. Studies of human 
disease have indicated similar patterns of lesion evolution (although it should be noted 
they are not identical [33]). 
1.5.1 Fatty streaks 
The first atherosclerotic lesions that appear are fatty streaks. Post mortem 
studies have shown that fatty streaks are commonly found in young children [35]. The 
fatty streak causes no obstruction and does not result in any clinical symptoms [35]. 
Fatty streaks are characterised by the accumulation of lipid filled foam cells [35]. 
Most of the foam cells arise from circulating monocytes that enter the subendothelial 
space, transforn1 into macrophages and then take up and accumulate excess lipid and 
reside within the endothelium [36]. The fatty streak is found to be a yellowish colour 
which is associated with the presence of lipid deposits (mainly cholesterol and 
cholesteryl ester) found in macrophages and smooth muscle cells [29]. 
1.5.2 Fibrous plaques 
The fibrous plaque is the most characteristic lesion of advancing 
atherosclerosis [29]. It is found to protude out into the vessel wall and has found to be 
whitish in appearance [29]. It consists of an accumulation of intimal smooth muscle 
cells surrounded by connective tissue matrix and containing variable amounts of 
intracellular and extracellular lipid. 
1.5.3 Complicated lesions 
The third type of lesion is the advanced complicated lesion. These advanced 
lesions are thought to result from fibrous plaques that become altered as a result of 
haemorrhage, calcification, cell necrosis and thrombosis [33]. One of the 
characteristics of the complicated lesion is the presence of calcification. Studies by 
Stary [32] indicate that a fully developed plaque can take up to 10-15 years to 
develop. 
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Advanced plaques have been found to have a very characteristic anatomy [32]. 
They contain a core of extracellular lipid separated from the media by SMCs and 
separated from the lumen by a thick cap of collagen rich fibrous tissue containing 
SMC. Lipid filled foam cells are found to surround the lipid core. The lipid core is 
thought to be largely derived from the death of macrophage foam cells and the release 
of their cytoplasmic content [38]. The advanced plaque is the stage at which plaque 
complications develop and clinical symptoms appear. Advanced plaques can be of 
two types, stable or unstable. Unlike the stable plaque, unstable plaques have a thin 
fibrous cap separating the lipid core from the lumen of the artery [39]. This thin 
fibrous cap is more prone to rupture leading to thrombotic events [39] (discussed 
below). 
1.5.4 Detection of atherosclerotic lesions 
Atherosclerosis is a progressive disease that takes many years to develop to the 
point where clinical symptoms are evident. It is not possible to determine the early 
stages of atherosclerosis in humans due to the fact that most atherosclerotic lesions are 
found in vital arteries. A number of methods are however available to examine lesions 
that have already formed. These include angiography and intravascular ultrasound 
[40]. 
Angiography involves the injection of an opaque dye and then subsequently X-
raying the vascular system. Intravascular ultrasound involves introduction of small 
catheter delivered ultrasound probes (ranging from 20-SOMHz), which enables 
visualisation of the full 360° circumference of the vessel wall, rather than the 2-
dimensional projection of the lumen seen by angiography. Both these techniques 
however, pose a certain degree of risk, as they are both invasive techniques. However 
non-invasive techniques such as Magnetic Resonance Imaging (MRI) and Electron-
beam computed tomography (EBCT) have also been reported [41 ,42]. More recently 
Brindle and colleagues [43] reported the use of NMR-based metabnomics, (a 
technique in which metabolites within patients serum/plasma can be studied) as a 
novel, more rapid and non invasive technique for diagnosis of CHD. 
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l.S.Slnitiation of atherosclerosis 
As discussed in section 1.2, various factors are known to predispose to the 
development of atherosclerosis with clinical symptoms. Elevated plasma lipoprotein 
concentration has been associated with increased concentrations in the intima. At such 
regions (referred to as as lesion prone sites) mechanical forces may favour the entry of 
LDL into the subendothelial space. [ 44 ]. In addition advanced lesions are more 
commoly found at such lesion prone sites [44]. Furthermore continued exposure to 
risk factors such as hyperlipidemia, cigarette smoke, high blood pressure, 
homocysteine, increased PAI-l and C-reactive protein (CRP) results in a progressive 
endothelial dysfunction during atherosclerosis [9]. 
1.6 The response to injury hypothesis 
The normal function of the endothelium is to form a barrier from the passage 
of blood constituents into the artery wall. The response to injury hypothesis of 
atherogenesis put forward by Russel Ross [45] proposes that injury to the endothelium 
is the initiating event in atherogenesis [45]. Factors such as hyperlipidemia, increased 
sheer stress and hypertension have been proposed to 'injure' the endothelium [45]. 
According to the response to injury hypothesis, restoration of the endothelial barrier 
eventually occurs and the lesions regress if both the injury and the tissue responses to 
it are limited. However further proliferation of SMC and accumulation of connective 
tissue and lipid occur if injury to the endothelium is continuous or repeated [ 45 j. 
Loss of endothelial cells from the fatty streaks has been observed, first by 
Gerrity [46] in swine and then by Faggiotto [47] in primates. Studies with monkeys 
that were fed dietary cholesterol to induce hypercholesterolemia showed that they lose 
approximately 7% of their arterial endothelial surface [47]. Injury to the endothelium 
is though to alter endothelial cell to cell or endothelial cell to connective tissue 
interactions or both, resulting in the possible detachment of endothelial cells from the 
artery wall [45]. Detachment of endothelial cells is known as desquamation. Focal 
desquamation of the endothelium exposes the underlying subendothelial connective 
tissue to components in the circulation including platelets, macrophages and 
lipoproteins. 
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Although endothelial dysfunction has been found to be an early occurrence in 
atherosclerotic lesions, the appearance of actual physical damage is a later process. 
Thus the endothelium may be injured without actual loss of cells, yet altered enough 
to elicit a response that triggers the release of growth factors initiating a sequence of 
events that leads to the formation of an atherosclerotic lesion [45]. The injury could be 
mechanical or induced by immune complexes, toxins, viruses or other factors [48]. 
1. 7 Properties of the components of the arterial wall 
1.7.1 Endothelial cells (ECs) 
ECs of normal arteries have a flattened and elongated structure [49]. The most 
characteristic feature of endothelial cells is the presence of Weibel-Palade bodies 
which are rod shaped inclusions that contain factor VIII related antigen and Von 
Williebrand factor. ECs have number of physiological functions in the normal artery 
wall which include [50]: -
[a] Acting as a permeability barrier 
One of the most important features of the normal endothelium is to regulate 
the traffic of plasma proteins and lipoproteins. Transport across the 
endothelium can occur by transcytosis in plasmalemmal vesicles and through 
intracellular junctions [50]. 
[b] Providing a non-thrombogenic surface. 
Normally cells do not adhere to the endothelial surface since ECs do not 
contain receptors for cells to bind. The EC membrane also contains 
thrombomodulin that binds thrombin and prevents clot formation [50]. 
[ c] Synthesis of basement membrane components. 
ECs are involved in the synthesis and secretion of extracellular matrix 
components including fibronectin, type IV and type V collagen, laminin and 
proteoglycans. 
[d) Maintenance of vascular tone. 
ECs are also involved in maintaining the vascular tone by the release of 
prostacyclin, nitric oxide and endothelin. 
II 
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[ e] Formation and secretion of growth regulatory molecules and cytokines. 
Dysfunction of the endothelium is thought to result in the secretion of growth 
molecules and cytokines 
1.7.2 Smooth muscle cells (SMCs) 
In vitro studies have attributed the following functions to SMCs in the normal 
endothelium [51]:-
[a] Synthesis of extracellular matrix components. 
SMC can synthesise collagen, elastin, and proteoglycans and thus contribute to 
intimal growth. 
[b] Ability to proliferate. 
SMC will proliferate in response to growth factors released during injury to 
the endothelium, since they express various growth factor receptors [45] 
Jn addition SMCs are found in two distinct phenotypes, the synthetic 
phenotype and the contractile phenotype [52]. The synthetic phenotypes are rich in 
rough endoplasmic reticulum while the contractile phenotypes are rich in myofibrils. 
During atherosclerosis, SMCs are present in varying degrees in early fatty streaks, in 
which macrophages are the principal cell type [35]. However as fatty streaks progress 
to fibro fatty lesions, SMCs become more abundant. In fibrous plaques, SMCs are the 
predominant cell type. The role of SMC in fibrous plaques is important since their 
accumulation and proliferation are critical in determining the extent and 
characteristics of advanced lesions and whether they will lead to clinical symptoms 
[53]. 
I. 7.3 Macrophages 
Macrophages are present in the normal intima in very low numbers. Their 
function in normal intima is thought to include the following [54] : 
[a] Remodelling of the intima. 
Macrophages can synthesise and secrete the metalloproteinases (MMPs) 
collagenase and elastase and other components that can play a role in 
modifying the extracellular matrix [54]. 
lb] Inflammatory response and scavenger function. 
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Macrophages are responsible for the phagocytosis of bacteria and tumour cells. 
In the intima, macrophages are responsible for the phagocytosis and removal 
of dead cells and immune complexes, removal of plasma proteins and 
lipoproteins. Macrophages also secrete cytokines that attract lymphocytes to 
the sites of injury [54]. 
[ c] Immune response. 
Macrophages are involved in binding and presentation of antigens, cytokines 
and growth factor production related to the immune respons 
1.7.4 Extracellular matrix (ECM) 
The ECM is composed of mainly of proteoglycans, collagen, elastin, 
fibronectin and laminin [29]. The four major types of proteoglycans present in the 
ECM of the vessel wall are chondroitin sulphate, heparin sulphate, dermatin sulphate 
and keratin [29]. During atherosclerosis, there is a significant increase in the content 
of chrondoitin sulphate and dermatin sulphate proteoglycans. Both these molecules 
can bind plasma LDL and thus enhance its retention in the intima [55]. The amount of 
chondroitin sulphate has been shown to be positively correlated with the intimal 
accumulation of apoB [55]. 
In the normal artery wall most of the collagen exists in the form of two 
interstitial collagens, types I and Ill [7]. In children, type III collagen is the 
predominant form in the subendothelial space of the intima. With ageing, there is a 
change in the ratio of the two types of collagen in favour of type I [56]. Other types of 
collagen are present; but account for only 0.5-l% of the total arterial collagen content. 
Both collagen types I and III increase significantly in advanced lesions [29]. SMC are 
the major cell type responsible for collagen generation in the vessel wall [39]. 
Elastin is the main component of the elastic fibres, which give blood vessels 
their elasticity [2]. In the normal vessel, elastin is mainly located in the media and the 
musculoelastic layer of the intima and very little change in the elastin content in early 
atherosclerosis [7]. In contrast advanced lesions contain an increased amount of 
subendothelial, medial and adventitial elastin [29]. 
Fibronectin is an adhesive glycoprotein present on cell surfaces in extracellular 
matrix and in blood. It plays important roles in cell-cell adhesion, cell-substrate 
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adhesion and cell-matrix interactions [57]. Laminin is another major non-collagenous 
glycoprotein found in the ECM. Along with heparin sulphate proteoglycan and type 
IV collagen, laminin is a major component of the basement membrane that underlies 
the endothelium and surrounds each SMC [58]. Both fibronectin and laminin are 
found to be increased in atherosclerotic lesions [57, 58]. Fibronectin may promote 
SMC migration as well as monocyte and T-lymphocyte infiltration. 
Together the components of the extracellular matrix have a number of 
important physiological functions. These include [2]:-
[a] Arterial Permeability. 
The extracellular matrix is involved in the transfer of essential nutrients across 
the intima to cells within the intima and the underlying media. 
[b] Maintaining the structural integrity of the intima. 
The chondroitin sulphate proteoglycans provides the intima with its strength 
and compression properties [55]. The collagen and elastin fibres provide 
further structural strengthening. Cells within the intima are held in the 
intracellular matrix by cell associated heparin sulphate proteoglycans. 
1. 7.5 T-cells 
Although T-cells are not normally present within the arterial wall, they are 
present in early lesions as part of fatty streaks [48]. In advanced atherosclerotic 
plaques, T-lymphocytes make up about 20% of the cells in the fibrous cap [29]. B-
lymphocytes and natural killer cells are normally sparse [48] 
1.8 Foam cell formation 
The sequence of events leading to fatty streak formation can be summarised as 
follows (schematically represented in figure 1.3 below). Damage to the endothelium 
caused by factors such as hyperlipidemia or infectious agents results in increased 
adherence of blood monocytes to endothelial cells and the release of cytokines such as 
macrophage chemoattractant protein I (MCP-1) and macrophage colony-stimulating 
factor (M-CSF) [58,59]. It is thought that in the presence of a high level of plasma 
LDL, the concentration of LDL in the intima is increased where it becomes oxidised 
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[601 . This oxidised LDL contributes to the subsequent recruitment of circulating 
monocytes [611 . Once within the arterial wall , the monocyte differentiates into a 
macrophage [611 . OxLDL subsequently inhibits it from returning to the plasma [86] . 
As resident macrophages these cells express scavenger receptors, take up OxLDL and 
become foam cell s [61]. These foam cells accumulate beneath the endothelial cell 
layer forming the precursor lesion of atherosclerosis, the fatty streak [35] 
Figure 1.3 
Schematic diagram showing formation of the fatt y streak 
LDL 
• 
• 
• 
MEDIA 
BLOOD FLOW 
-
O MmHw.:yte 
0 S11 c of e ndothe li al mjur)' c.:aucU hy factor-. .. uch a" hyperl ipidemia. ' ' re'' and 
.. mokin £: 
I 
'I' 
0 
... Differentia tion 
.. 
Mac rophage 
~bt~k~i~fa1~1:~~~;~l a tcd "-.._ 
proce .. ~ lead !> to foa m 
~o:e ll forma tion 
--------------------· 
1.8.1 The role of the monocyte derived macrophage 
FormatiOn of F<tll ) Streak. , the earl ie\t 
les io n o f <Ltherm d ero' i" wh i,: h j, the 
prec ur .. or of suho.equent more 
compli cated J c-,i~Jfl \ givi ng n~ 10 
chn icaJ ,) mpto rn' 
I 
'I' 
····--
Foam Cell 
Although smooth muscle cells can also take up lipid, monocyte derived 
macrophages are the major source of foam cells in all stages of human and 
experimental atherosclerosis [29, 33]. The macrophage derived foam cell has been 
implicated in multiple aspects of atherosclerotic plaque development [38, 61]. The 
monocyte-derived macrophage is also capable of producing growth factors for 
vascular smooth muscle cell s thus it can also contribute to the proliferative stages of 
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plaque development [9]. It can also generate cytotoxic factors for neighbouring cells, 
leading to smooth muscle cell and endothelial cell damage and death 138]. 
1.8.2 Monocyte attachment 
Damage to the endothelium is thought to be the initiating event that leads to 
monocyte adherence [45]. The recruitment of leukocytes (monocytes and T-cells) is a 
process that includes cell rolling, cell adhesion to the endothelium and cell migration 
in response to chemotactic gradients [8]. 
The activated endothelium expresses several proteins on its surface that 
attracts some of the cellular components of the bloodstream particularly leukocytes. 
These cellular components in turn have receptors that bind to the proteins expressed 
on the endothelium. These adhesion proteins expressed on the endothelial cell surface 
can be of two classes. 
[I] The selectins. 
[2] The immunoglobulin superfamily. 
1.8.2.1 Endothelial selectins 
The selectins are a family of glycoproteins with specific structural motifs in 
common. They all have an amino terminal lectin-like domain followed by an EGF-
Iike domain, numerous cysteine rich tandem motifs, a transmembrane region and a 
short cytoplasmic tail [62]. These molecules are not present on unstimulated 
endothelial cells but appear on the surface of the endothelium after activation by 
several biological modifiers such as interleukin-l (IL-l), bacterial lipopolysaccharide, 
thrombin, phorbol esters and TNF [62]. Two selectins have been identified on the 
activated endothelium, E selectin and P selectin. E selectin is thought to be involved 
in the adhesion of monocytes to endothelial cells [62]. Platelet selectin (P- selectin) 
was first shown to be present on the surface of activated platelets. It has subsequently 
also been shown to be present on the surface of activated endothelial cells [62]. The 
ligand for both P selectin and E selectin is the monocyte. 
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1.8.2.2 Immunoglobulin supe!family of adhesion molecules 
These adhesion molecules derive their name from the fact that they contain 
several immunoglobulin-like domains. Three members of this family have been 
characterised in ECs, vascular cell adhesion molecule I (VCAM-1) and intracellular 
adhesion molecules I and 2 (ICAM I and ICAM 2) [63]. VCAM I is a glycoprotein 
expressed on the surface of activated endothelial cells. Its ligand on leukocytes has 
been shown to be VLA 4 (very late antigen 4), which is present on lymphocytes and 
monocytes but not neutrophils [63]. The ligands for VCAM-1 are monocytes and 
lymphocytes [63]. VCAM-1 has recently gainied importance as the molecule having 
the major role in recruiting monocytes in early atherosclerosis [64]. 
1.8.3 Monocyte migration and accumulation in the intima 
Once monocytes attache to ECs, chemoattractant stimuli are thought to 
promote their migration and entry into the intima. The chemoattractant thought to be 
involved in monocyte migration is MCP-1 [65]. This cytokine has been shown to be a 
specific chemoattractant for monocytes and is found to potently stimulate directed 
migration of monocytes in vitro [65]. ECs, SMCs and leukocytes have all been shown 
to inducibly express MCP-1 in vitro [66]. Transgenic mice deficient in MCP-1 or its 
receptor CCR-2 have been shown to have significantly reduced lesions, implying that 
the MCP-1 /CCR-2 have an important role in monocyte recruitment in atherosclerosis 
[66]. 
1.8.4 Lipoprotein uptake 
The accumulation of cholesteryl esters by macrophages occurs by the uptake 
of modified lipoprotein particles via specific membrane receptors most notably the 
scavenger receptors. Macrophages can thus become heavily loaded with lipid droplets 
in the subendothelial space. Macrophages within human atherosclerotic lesions have 
been found to express scavenger receptors [67], whilst circulating monocytes do not 
express scavenger receptors. Differentiation of monocytes into macrophages has been 
found to induce expression of SRAI [22]. Macrophage colony stimulating factor (M-
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CSF) can stimulate the expression of scavenger receptors whereas a-interferon can 
suppress expression of scavenger receptors [ 18]. 
It is now recognised that LDL must undergo some form of modification in its 
structural and biological properties before it can be taken up by macrophages at a rate 
sufficient to generate foam cells [68]. A number of chemical modifications have been 
shown to have this effect including acetylated LDL (AcLDL) and oxidised LDL 
(OxLDL). Experimentally AcLDL is used as the standard form of modified LDL to 
induce foam cell formation (as used by Goldstein and Brown in the discovery of the 
scavenger receptor [16]). In vivo however, the main modification of LDL is thought to 
be oxidation [68] (discussed below). Other forms of modified LDL also exist 
including aggregated LDL and glycated LDL (found in patients with diabetes). The 
rapid uptake of modified LDL particles leads to foam cell formation and foam cells 
accumulate beneath the endothelial cell layer. 
1.8.5 Retention of WL 
The subendothelial aggregation and retention of LDL are key events in 
atherogenesis. As noted above, components of the extracellular matrix such as the 
proteoglycans can bind and retain LDL [60]. Specifically chondroitin sulphate and 
dermatin sulphate can bind plasma LDL and thus enhance its retention in the intima 
[60]. Studies have also shown that treatment of LDL with sphingomyelinase in vitro 
leads to formation of lesion-like aggregates that become retained by the extracellular 
matrix and stimulate foam cell formation [69]. Although the mechanism of lipoprotein 
aggregation in lesions is not known, it has been suggested that the enzyme 
sphingomyelinase (SMase) plays a major role [69]. 
1.9 Intracellular cholesterol regulation in macrophages 
Once atherogenic lipoproteins have been taken up via unregulated scavenger 
pathways, post-receptor events that affect intracellular cholesterol metabolism are 
thought to play a major role in whether or not foam cell formation occurs [ 17]. For 
cholesteryl ester accumulation to occur, intracellular metabolism has to favour 
cholesterol esterification. The cholesterol esterification process in macrophages is a 
regulated process, although the nature of this regulation is still not fully understood. 
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The process appears to be a balance between cholesterol esterification by acyl-
coenzyme A cholesterol acyl transferase (ACAT is also known as SOAT) and 
hydrolysis by neutral cholesteryl ester hydrolase (nCEH) [70]. 
Macrophages internalise LDL via receptor-mediated endocytosis [ 17]. These 
endocytic vesicles are then passed to the lysosome, where the cholesteryl esters are 
degraded by an acid hydrolase [71]. The free cholesterol leaves the lysosome and 
enters the cytoplasm where it has two fates; it can be excreted and is taken up by HDL 
which acts as an acceptor or it can be re-esterified by the enzyme ACAT and stored as 
cholesteryl ester droplets [71]. Stored cholesteryl ester droplets can be subsequently 
hydrolysed by a cytoplasmic enzyme (nCEH) and passed on to HDL through ABC-
AI. In the absence of HDL or another acceptor for cholesterol the free cholesterol is 
retained in the cell and re-esterified by ACAT [72]. In addition macrophages actively 
secrete apoE. This may promote cholesterol efflux to HDL and thereby inhibit the 
transformation of macrophages to foam cells. This role of apoE has been 
demonstrated in apoE null mice that have been found to develop much larger lesions 
when compared to normal mice [ 113]. 
Thus stored cho1esteryl esters are not inert; they are in a dynamic state 
continually undergoing a cycle of hydrolysis and re-esterification (dependent on the 
availability of an acceptor for free cholesterol). This cycle has been termed the 
cholesteryl ester cycle [73]. 
1.9.1 Enzymes involved in intracellular cholesterol regulation 
NCEH is an enzyme which works best at a pH in the neutral range (6.5-7 .5) 
hence its name. It has been found to be located in the cytosolic compartment part of 
the cell. It can be activated by a cAMP-dependent protein kinase [72]. NCEH is 
responsible for mobilisation of stored cholesteryl esters. ACA T is a microsomal 
enzyme that is responsible for esterifying intracellular free cholesterol to cholesteryl 
esters and promoting storage of lipid in arterial macrophages. ACA T uses long chain 
fatty acyl coenzyme A and cholesterol as substrates [75]. It has been shown that 
increased ACAT activity is responsible for the cholesteryl ester accumulation in 
cytoplasmic lipid droplets [76]. ACA T' s role in re-esterification is of particular 
importance in controlling the concentration of membrane free cholesterol, which in 
excess can be toxic to cells. 
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Two separate ACAT enzymes have been identified: ACAT! and ACAT2 [75]. 
ACAT 1 is widely distributed in tissues and plays a central role in cholesterol 
metabolism in steroidogenic tissues and macrophages [75]. ACAT 2 acts in the 
intestine and the liver synthesizing cholesteryl ester that are then incorporated into 
lipoprotein particles [75]. The role of ACAT in foam cell formation has led to the 
development of ACA T inhibitors that work by acting directly in the cells that form the 
atherosclerotic plaque [77]. 
Hormone sensitive lipase (HSL) is a key enzyme involved in lipolysis in 
adipose tissue and catalyses the rate limiting step in the breakdown of triacylglycerol. 
[78]. The activity of HSL is regulated by phosphorylation via a cyclic-AMP dependent 
protein kinase [78]. HSL has been shown to be present in macrophages where 
immunological studies have suggested that it is responsible for the neutral hydrolysis 
of cholesteryl esters [79]. This has been further supported by the fact HSL and nCEH 
are products of the same gene [80]. It has been shown that an increase in the cellular 
concentration of cholesterol in macrophages inhibits HSL activity and reduces HSL 
expression [81]. This loss of HSL activity leads to an imbalance in the cholesteryl 
ester cycle, resulting in cholesteryl ester accumulation. Thus whether a foam cell will 
increase or decrease its stores of cholesteryl esters depends on the relative activities of 
nCEH and ACAT within the cell. HSL expression has been demonstrated in both 
human monocyte-derived macrophages and human THP-1 cells [71]. 
Lipoprotein lipase (LpL) is an enzyme that plays a central role in lipid 
metabolism and transport by catalysing the hydrolysis of triacylglycerol rich 
lipoproteins [82]. LpL hydrolyses the triacylglycerol component of chylomicrons and 
VLDL, thereby providing non-esterified fatty acids and 2-monoacylglycerols for tissue 
utilisation [82]. Macrophage derived foam cells are the primary source of the LpL 
enzyme within atherosclerotic lesions [83]. Studies with transgenic mice have shown 
that macrophages isolated from atherosclerotic susceptible mice showed a higher LpL 
activity and mRNA levels than those from atherosclerotic resistant mice, thereby 
suggesting a contributive role for LpL in the progression of atherosclerosis [84]. 
Paradoxically evidence also exists in support of an anti-atherogenic role for 
LpL. LpL deficient patients and patients heterozygous for LpL mutations still develop 
relatively advanced atherosclerosis [83]. It is likely that the role of LpL in 
atherosclerosis may depend on the tissue in which it is expressed. In the arterial wall, 
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LpL may be pro-atherogenic whereas in muscles and adipose tissue, it may function 
protectively [83 ]. 
1.10 Oxidative modification of LDL 
The hypothesis that oxidative stress plays an important role in the 
atherosclerosis process has now been well established [85]. In particular oxidation of 
lipoproteins by activated macrophages in the subintimal space has been postulated to 
be an important early step in the atherosclerosis process [61 ]. Lipoprotein oxidation is 
critically important in allowing macrophages and other cells to remove lipid from the 
interstitial space, as modified lipoproteins are more readily cleared by macrophage 
scavenger receptors. Lipoprotein oxidation could therefore also be considered a 
normal adaptive process to remove excess lipid. Oxidation of LDL however, has been 
shown to result in a modified LDL particle that is taken up rapidly by scavenger 
receptors on macrophages, leading to foam cell formation resulting in atherosclerosis 
[86]. Thus LDL oxidation is considered to be an initial and important step in 
atherogenesis and this has initiated interest in the mechanisms by which the LDL 
oxidation may occur and interventions to slow the rate of oxidation. 
Oxidative modification of LDL is primarily though to occur in intima of the 
artery wall [87]. Significant amounts of LDL oxidation are not thought to occur in the 
plasma because of the presence of antioxidants such as vitamin C and E. Furthermore 
were sufficient oxidation to occur in the plasma, that oxidised LDL would be rapidly 
removed from the plasma by scavenger receptors present on hepatic Kupfer sinusoidal 
cells [87]. 
1.10.1 Evidence for WL oxidation 
Several lines of evidence support the role of oxidatively modified LDL in 
atherogenesis. These include 
(a) Cells in the subendothelial space of a developing lesion can oxidise LDL in 
vitro in the presence of transition metals [881. 
(b) A large proportion of the lipids in lesions is oxidised [87]. 
(c) Lesion-derived LDL particles have increased electrophoretic mobility [871. 
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(d) Epitopes of OxLDL have been found in plasma and atherosclerotic lesions of 
animals and humans [87]. 
(e) The presence of antibodies against OxLDL [89]. 
(f) Dietary supplementation with antioxidants reduces the development of 
atherosclerosis in experimental animals [89]. 
(g) Lysine-aldehyde adducts (markers of OxLDL) have been demonstrated in the 
macrophage rich lesions of human and rabbit aorta [87]. 
1.10.2 Mechanisms of WL oxidation 
The oxidation of LDL has been proposed to occur in three phases [88]. 
(a) An initial lag phase when endogenous LDL antioxidants are consumed. 
(b) A propagation phase with rapid oxidation of unsaturated fatty acids to lipid 
hydroperoxides. 
(c) A decomposition phase when hydroperoxides are converted to reactive 
aldehydes. 
Results of in vitro experiments have proposed that there are a variety of potential 
mechanisms for cell mediated LDL oxidation [88] (see table 1.3). 
Table 1.3 
Table showing proposed mechanisms of LDL oxidation (from reference 88) 
Proposed mechanisms of WL oxidation 
(I) Extracellular iron or copper 
Free or low molecular weight complexes 
Ceruplasmin bound copper 
(2) Superoxide 
(3) Thiols 
(4) Lipoxygenase 
(5) Reactive Nitrogen Species 
(6) Myeloperoxidase 
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1.10.2.1 Metal ions 
LDL oxidation has been found to require trace amounts of redox active metals 
(copper or iron) [91 ]. Evidence suggests that copper binding histidine residues on 
apolipoprotein 8 l 00 promote lipid peroxidation [911. 
1.10.2.2 Cell induced oxidation of LDL 
All three of the major cell types of the arterial lesion, ECs, SMCs and 
macrophages can oxidise LDL in cell culture [92]. Cells in the subendothelial space 
are thought to oxidise LDL by different methods. Release of superoxide anion is 
thought to be the major pathway in cultured fibroblasts and SMCs [92]. Generation of 
lipoperoxides by the action of 15-lipoxygenase is thought to be the major pathway of 
oxidation catalysed by macrophages and by endothelial cells [92]. 
Macrophages have the potential to oxidise LDL because they produce large 
amounts of highly reactive oxidants when they generate an inflammatory response or 
kill invading microorganisms and tumour cells [93]. They generate superoxide that 
can subsequently be broken down to form hydrogen peroxide [94]. They also secrete 
myeloperoxidase, which amplifies the oxidative potential of hydrogen peroxide by 
generating cytotoxic oxidants [95]. 
/. 10.2.3 Lipoxygenases 
Lipoxygenases are intracellular enzymes that can peroxidise polyunsaturated 
fatty acids [96]. There appears to be differences among the lipoxygenases with respect 
to their involvement in the oxidation of LDL. In humans, 5-lipoxygenase does not 
appear to be involved whereas 12- lipoxygenase and 15-lipoxygenase do, particularly 
in macrophages and endothelial cells [97, 98]. The role of lipoxygenases has been 
shown in mice where disruption of the 12115 lipoxygenase gene has been shown to 
dramatically reduce atherosclerotic lesions [99]. 
23 
Chapter/ Introduction 
1. 10.2.4 Myeloperoxidase 
Myeloperoxidase (MPO) is a haem-containing enzyme secreted by human 
phagocytes [95] which has two major activities, halogenation and peroxidation. 
Myeloperoxidase and MPO-derived hypochlorous acid (HOC!) have been implicated 
in vivo in LDL modification and atherogenesis [95]. Reaction of MPO derived HOC! 
with LDL results primarily in the modification of apoB [ 1001. HOC! reacts rapidly 
with the E amino groups of apoB lysine residues resulting in the formation of N-
chloroamines [ 100]. Catalytically active MPO has been detected in human 
atherosclerotic lesions and co-localises with macrophages [I 0 1]. 
1. 10.2.5. Role of nitric oxide 
Nitric oxide (NO) released by endothelial cells of the artery wall plays an 
important role in normal physiology [ 102]. The major stimulus of nitric oxide 
synthesis, in vivo is thought to be shear stress that occurs on the surface of the 
endothelium by the flow of blood [ 102]. NO is also thought to have several functions 
in the normal intima including vasometric relaxation, promotion of SMC relaxation, 
inhibition of platelet adherence and aggregation, action as an antioxidant and as an 
inhibitor of smooth muscle cell proliferation [ 102]. NO produced by inducible nitric 
oxide synthases in activated macrophages is cytotoxic and is normally involved in 
antiviral, anti-protozoal and anti-microbial activities [93]. NO has also been shown to 
react with superoxide. This may represent a protective effect since superoxide can 
oxidise lipids [103]. However it may also be atherogenic. When NO reacts with 
superoxide it generates peroxynitrite, a powerful oxidising intermediate [ 103]. 
Peroxynitrite oxidises LDL lipids and converts the lipoprotein into a form recognised 
by the scavenger receptor. Studies using cultured cells have suggested that NO 
protects LDL from oxidation [ 104]. However the evidence is conflicting; a reduction 
in fatty streak formation has been reported in mice lacking nitrix oxide synthase [105]. 
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1.10.3 Susceptibility of WL to oxidation 
The susceptibility of LDL to oxidation appears to depend on the abundance of 
unsaturated fatty acids in the particle [88]. Other factors may also affect the 
susceptibility of LDL to in vitro oxidation. These include variations in LDL particle 
size, lipid composition and the presence of Lp (a) [88]. In particular; small dense LDL 
particles are thought to be more atherogenic and prone to oxidation than the larger 
species. 
1.10.4 Components ofOxWL 
The components of OxLDL that results in its biological activities have still not 
been fully elucidated. However LDL oxidation does result in oxysterol formation 
which contribute to the cytotoxicity of OxLDL [ 106]. Several oxysterols including 7a 
and 7~ hydroxycholesterol, 7-ketocholesterol and 2-hydroxycholesterol have been 
identified. [ 106]. Oxysterols can alter membrane permeability; inhibit cholesterol 
biosynthesis and suppress LDL receptor expression [I 06]. 
1.10.5 The role of antioxidants 
Blood concentrations of antioxidants may affect the susceptibility of LDL and 
Lp(a) to oxidation [I 03]. The last decade has seen a number of studies performed on 
the hypothesis that antioxidants (such as Vitamin E, Vitamin C and ~-carotene) may 
have a role in prevention of atherosclerosis [ 107]. One of the strongest lines of 
evidence for the oxidation hypothesis is the ability antioxidants to inhibit 
atherogenesis in animal models of hypercholesterolemia [I 08]. Thus it can be 
postulated that interventions inhibiting the oxidation of LDL within the artery in vivo 
wall should also inhibit the atherogenic process. 
Results from human studies however, have not as yet provided clear evidence 
that antioxidants play a role in reducing the risk of CHD [I 09, 110]. A recent meta-
study by Topol et a{ [II 0] looked at seven randomised trials of vi taman E treatment 
and eight trials of ~-carotene treatment. Their analysis concluded that vitamin E and 
~-carotene should not be used in patients at high risk of CHD. 
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1.10.6 Effects and atherogenicity of OxLD 
OxLDL is not a single defined chemical entity. Depending on the extent of oxidation 
and on various oxidised products generated, it may show a broad range of biological 
effects including;-
(a) Uptake 
One of the most important effects of OxLDL is that it is taken up by 
macrophages at a rate many times faster than native LDL [86]. Oxidatively 
modified LDL has been shown to be taken up by macrophages 3-10 times more 
rapidly than is native LDL and can therefore generate foam cells [86]. Oxidation 
of the lipid moiety of LDL causes modification of apoB10o [88]. Scavenger 
receptors on macrophages subsequently recognise and bind OxLDL and are not 
down-regulated as intracellular cholesterol accumulates. As uptake continues, the 
macrophages become lipid laden foam cells. 
(b) Chemotactic activity 
OxLDL has chemotactic activity and is involved in the recruitment of blood 
monocytes [61]. Studies by Quinn et al [61] have shown that oxidatively modified 
LDL, but not native LDL is a potent chemoattractant for circulating human 
monocytes. This chemotactic activity has been attributeted to lysolecithin that is 
generated during oxidation of LDL [ 61]. Once oxidised, LDL is thought to build 
up in a given area of an artery and it may contribute to the further accumulation of 
monocytes in the same area. 
(c) Cytotoxicity 
Oxidised LDL is cytotoxic [ 106], and therefore could contribute to 
atherogenesis by causing cell injury and death. It also interacts with platelets, 
which promotes their aggregation [88]. 
(d) Inhibition of motility 
Oxidised LDL has also been found to inhibit the mobility of tissue 
macrophages [ 61 ]. 
(e) Resistance to cathepsins 
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OxLDL has been shown to be more resistant than native LDL to cathepsins 
and can cause partial inactivation of macrophage lysosomal proteases [Ill]. 
OxLDL has been shown to inactivate cathepsin B but up-regulate cathepsin D 
[ 112]. High cathepsin D expression has been reported in human macrophage 
derived foam cells [ 112]. 
It has been speculated that uptake of OxLDL by macrophages in early stages of 
atherosclerosis may be beneficial rather than harmful [ 113]. By taking up OxLDL it 
may actually protect cells, including endothelial cells from its cytotoxic effects. Later 
when the macrophages have become excessively loaded with lipid and die, the effect 
may be harmful because of the release of cytotoxic components from lipid-laden 
macrophages [ 113]. 
1.10.7 Role ofOxWL in the expression ofcytokines and growth factors 
Cytokines, chemokines and growth factors are a set of multi-functional 
signalling molecules involved in regulating several cellular functions, including 
chemotaxis, proliferation, accumulation of lipid and synthesis of matrix components. 
Cytokines are thought to regulate immune function whereas growth factors are 
stimulators and inhibitors of cell proliferation [ 114]. Cytokines and growth factors can 
be induced by a variety of processes including damage to the endothelium and uptake 
ofOxLDL. 
Uptake of OxLDL by macrophages induces the expression of a wide range of 
growth factors and cytokines many of which have been localised within 
atherosclerotic lesions. These include transforming growth factor beta (TGF-~), 
fibroblast growth factor (FGF), macrophage chemotactic protein-1 (MCP-1) 
macrophage colony stimulating factor (M-CSF), interleukin-1 (IL-l), interleukin-8 
(IL-8), tumour necrosis factor alpha (TNF-a) and platelet derived growth factor 
(PDGF) [ 115]. In addition, a number of chemokine receptors such as chemokine motif 
receptor 2 (CCR2), chemokine motif receptor 5 (CCR5) and the Chemokine CX3C 
receptor (CX3CR I) are thought to be important in the development of CHD [I]. 
IL-l can sustain the inflammatory process and is a chemoattractant for T -ce1Is 
[116]. Both OxLDL and 9-hydroxyoctadecadienoic acid, a breakdown product of 
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OxLDL can induce the expression of IL-l. IFN-y down-regulates the expression of 
scavenger receptors for modified LDL on macrophages [117]. The secretion of MCP-
1 (a chemoattractant for monocyes) from the endothelium has been shown to be 
induced by IL-l~, IL-4, TNF and IFN-y [65]. OxLDL also induces the production of 
JL-8 from macrophages [ 118]. JL-8 is chemotactic for neutrophils and lymphocytes 
[ 119]. M-CSF stimulates the proliferation and differentiation of macrophages [ 120]. 
Many cytokines and growth factors mediate their effects via the activation of a 
common signal transduction pathway, the JAK/ STAT pathway Uanus kinases/ signal 
transducers and activators of transcription) [ 199]. Studies show that oxidised LDL 
activates ST A Tl and ST AT3, transcription factors that can mediate the effects of 
cytokines and growth factors [ 121 ]. 
It has been shown that interaction of CD40 with its ligand CD40L (CD I 54) 
has an important role in the development of advanced lesions [ 122]. The binding of 
CD 154 to CD40 particularly on macrophages results in the production of 
inflammatory cytokines, matrix degrading proteases and adhesion molecules [ 122]. 
1.11 The role of peroxisome proliferator activator receptors (PPARs) and the 
nuclear receptors LXRa and LXR~ 
Perixosome proliferator activator receptors (PPARs) are ligand activated 
transcription factors that belong to the nuclear receptor superfamily. Three different 
PPAR subtypes have been indentified; PPARa, PPAR o and PPARy [123]. Both 
PPARa and PPARy are present in human ECs, SMCs and macrophages in vivo [ 124]. 
In particular PPARy has been found to be highly expressed in foam cells and OxLDL 
has been demonstrated to activate macrophage gene expression through PPARy [124]. 
Upon activation PPARa and PPARy regulate genes involved in lipid and glucose 
metabolism, cellular differentiation and inflammation control [ 124]. 
PPARs regulate gene expression by binding with 9-cis retinoic-acid X-receptor 
(RXR) to specific DNA sequence elements known as PPAR response elements [ 123]. 
PPARs regulate gene expression by interfering with the transcriptional activities of 
activator protein I (AP-1) and nuclear factor kappa ~ (NF-KB) [123 ]. Fatty acids such 
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as linoleic and arachidonic acid have been identified as natural PPAR activators that 
bind and activate both PPARa and PPARy [124]. 
Activation of PPARy has been shown to enhance macrophage differentiation 
and induce expression of the scavenger receptor CD36 leading to increased 
intracellular cholesterol accumulation [ 125]. However this is counteracted by reduced 
expression of another scavenger receptor SR-A [125]. Thus the net effect of PPAR 
activation in foam cells may be anti-atherogenic. 
Both PPARy and PPARy activators have been found to induce the expression 
of the gene encoding ABC I, a transporter that controls apoA ]-mediated cholesterol 
efflux from macrophages [124]. In contrast PPARy activation does not affect 
cholesterol efflux from macrophages in patients with Tangiers disease which is caused 
by a genetic defect in the ABC I transporter [126]. 
The nuclear oxysterol receptors LRX-a and LRX-~ are involved in regulating 
the expression of proteins involved in the control of hepatic lipid metabolism and also 
in cellular cholesterol efflux [127]. The main activators of the LXR receptors are 
oxysterols. Activation of the macrophage LXR by free cholesterol induces the 
expression of the ABCA I and also of Apo E, therby leading to cholesterol efflux from 
the cell [128]. Recently it has been demonstrated that LXR's and their ligands are 
negative regulators of macrophage inflammatory gene expression [ 129]. 
1.12 The role of the macrophage derived foam cell in advanced lesions. 
Plaque rupture is the underlying cause of coronary syndromes, which include 
unstable angina and myocardial infarction [33]. Growth of atherosclerotic plaques can 
occur by outward luminal expansion and when coronary blood flow is decreased it 
presents itself clinically as stable angina [33]. 
During atherosclerosis there is a continuous dynamic balance between the 
influence of inflammatory cells including macrophages tending to destabilise the 
plaque and the influence of SMCs, which favour plaque stability [39]. Macrophage 
derived foam cells have been implicated in a number of processes which lead to 
plaque instability and subsequent acute coronary syndromes [39]. These include 
contributing to the lipid core, weakening the fibrous cap and being a source of tissue 
factor [39]. 
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1.12.1 Composition of vulnerable plaques 
The composition and vulnerability of a plaque rather than its volume is 
thought to be the most important determinant for the development of coronary 
syndromes [32]. Plaques that are vulnerable to rupture tend have thinner fibrous caps 
especially at the shoulder region [130]. In addition to an increased macrophage density 
they also have a reduced collagen and SMC content in their fibrous caps [ 130]. 
Increased macrophage density and decreased collagen content have been shown to be 
associated with a reduced tensile strength, which may weaken the fibrous cap [ 130]. 
Plaques less likely to lead to myocardial events tend to have thicker fibrous caps that 
protect the underlying thrombogenic lipid core from contact with the circulating 
bloodstream [32]. Although the thicker fibrous cap increases stenosis of the artery, it 
makes the plaque less likely to rupture. 
1.12.2 The fibrous cap 
The integrity of the fibrous cap overlying the lipid rich core is one of most 
important factors in determining the stability of an atherosclerotic plaque [131]. The 
fibrous cap consists of a dense fibrous extracellular matrix made up of collagens, 
elastins and other extracellular matrix materials like proteoglycans [ 131]. The SMC is 
the major cell type involved in the production of extracellular matrix. As would be 
expected, regions of the plaques fibrous cap particularly prone to disruption have been 
found to contain relatively few SMCs [131]. 
Cytokines and growth factors such as IL-l, TGF-~ and PDGF can significantly 
induce collagen synthesis in SMC [I 32]. In the unstable plaque, IFN-y secreted by 
activated T-cells has a number of effects on SMC [132]. It has been shown to inhibit 
collagen synthesis, suppress the proliferation of SMC in response to other growth 
factors and promote apoptosis of SMC [ 132]. In addition IFN-y secreted by the T-
lymphocytes can also activate the macrophage [ 132]. Activation of macrophages in 
the atherosclerotic plaque leads to the secretion of a variety of proteolytic enzymes 
capable of degrading the extracellular matrix [ 133]. Three major families of enzymes 
participate in extracellular matrix degradation [ 133]: the serine pro teases (urokinase 
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and plasmin), cystine proteases (such as cathepsins) and the matrix metalloproteinases 
(discussed below). 
Degradation of collagen and other matrix components contributes to the 
weakening of the fibrous cap, rendering it particularly susceptible to rupture. Rupture 
of the fibrous cap exposes the underlying core to circulating platelets in the blood 
[ 131 ]. Foam cells in the lesion area are subsequently capable of producing large 
quantities of tissue factor (a strong procoagulant), that potently stimulates thrombosis 
formation when in contact with blood [134]. In addition to tissue factor, the plaque 
core is rich in collagen and lipid, all of which are potent thrombogenic agents [ 131 ]. 
Thus a delicate balance exists in which SMC synthesize ECM components and 
macrophages break them down. When this balance is disrupted, then the plaque is 
more vulnerable to rupture and exposure to the bloodstream. 
1.12.3 Role of lipids 
The propensity of atherosclerotic plaques to rupture may also be influenced by 
their lipid content. Disrupted plaques have been shown to have a greater content of 
lipid (mainly free cholesterol and cholesteryl esters) than intact plaques [ 130] 
especially in the shoulder region. Lipid concentrations have been shown to be 
positively associated with macrophage accumulation in all plaque types [ 130 J. 
1.12.4 Role of apoptosis 
Apoptosis of both macrophages and SMC has been detected in atherosclerotic 
plaques [135]. Since macrophages are responsible for collagen breakdown in the 
plaque, loss of macrophages will lead to less MMP activity and subsequently 
decreased collagen breakdown [ 135]. This could lead to plaque stabilisation and 
therefore less risk of plaque rupture. This supports the idea that macrophage apoptosis 
may be a beneficial process, which leads to plaque stability. 
However the situation may be more complex. Uptake of dying cells is an 
important component of the apoptotic process since it prevents the release of toxic 
intracellular contents and the formation of an inflammatory infiltrate [ 135]. If 
apoptotic bodies are cleared quickly, a stable fibrous plaque will form with low 
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atherogenicity [ 132J. If apoptotic SMCs or macrophages are not engulfed, however, a 
necrotic core with high thrombogenicity forms [ 135]. Thus macrophage apoptosis 
may actually be a detrimental process since it reduces the number of cells available to 
scavenge apoptotic cells. Apoptosis of SMC in the fibrous cap is also thought to be 
detrimental since it will lead to a loss of collagen types I and II and a weakening of the 
fibrous plaque. This will subsequently lead to unstable plaques that are more prone to 
rupture [132]. 
1.12.5 Effects of lipid lowering on plaque stability 
Lipid lowering has been found to result in a decrease in clinical events without a 
substantial change in the degree of luminal stenosis [ 136]. This suggests that lipid 
lowering affects the composition of the plaque rather than its size. Lipid lowering by 
statin therapy is though to stabilize plaques through several mechanisms [ 137]: -
(a) Reduced lipid intake into the artery wall results in a less lipid-rich plaque with 
reduced macrophage foam cell formation. 
(b) Decreased MMP activity allows a higher collagen content m the 
atheorsclerotic plaque. 
(c) Reduced inflammatory cell proliferation appears to correlate with a reduction 
in apoptotic cell death in the plaque. 
(d) Statins may also have an inhibitory effect on tissue factor. 
1.13 The Matrix Metalloproteinases 
The matrix metalloproteinases (MMPs) have been implicated in tissue 
remodelling in both normal and pathological conditions [ 138]. Changes in MMP 
activity have been observed in menstruation, pregnancy, wound healing, inflammation 
and tumour metastasis [138]. There is also evidence that the MMPs are also involved 
in a number of events associated with the development and progression of 
atherosclerosis [ 133]. 
The ECM constitutes up to 60% of the volume of the intima and it is thought 
to undergo continuous remodelling during atherogenesis [139]. MMPs are secreted by 
a number of cells including fibroblasts, SMCs, ECs and macrophages. The MMPs 
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have been implicated as the major molecules involved in the breakdown of the fibrous 
cap and subsequently plaque instability [ 131 ]. The major source of MMPs in the 
plaque is the foam cell [ 140]. Macrophages release cytokines that can activate a range 
of MMPs and may also regulate MMP activation via release of reactive oxygen 
species [140,141]. 
1.13.1 Biochemistry of the MMPs 
The matrix metalloproteinase family in humans comprises of 22 enzymes. 
These are generally expressed at low levels in normal adult tissue but are up regulated 
during normal and pathological remodelling processes [138]. The general 
classification of MMP is based on substrate specificity, but several of the MMPs have 
overlapping substrate specificties. All MMPs share the following common features 
[ 138]: -
(a) Most are secreted as latent zymogens requiring activation for proteolytic 
activity. 
(b) They degrade ECM components but non-ECM molecules can also be 
substrates. 
(c) They function at neutral pH. 
(d) They contain zinc at their active sites and require calcium for stability. 
(e) They are inhibited by specific tissue inhibitors of metalloproteinases 
(TIMPs). 
The MMP family can been divided into four main subgroups, based on their substrate 
preferences (see table 1.4 Properties of the matrix metalloproteinases) [138]:-
(a) The interstitial collagens 
(b) The gelatinases 
(c) The stromelysins 
(d) The membrane-type MMPs (MT-MMPs) 
An important control point of MMP activity is the inhibition of the activated 
enzyme by the tissue inhibitors. To date, four TIMPs have been identified [ 142). All 
TIMPs inhibit MMP function by forming inhibitory non-covalent stiochiometric 
complexes with MMPs and blocking access to their substrate f 142]. The balance 
between degradations by MMPs and TIMPs may regulate plaque stability. 
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Table 1.4 
Classification of the matrix metalloproteinases (adapted from reference [ 138)) 
MMP subgroup 
Name 
Collagenases 
MMP number 
Interstitial collagenase MMP-1 
Nuetrophil collagenase MMP-8 
Collagenase- 3 MMP-13 
Gelatinases 
Gelatinase A MMP-2 
(72Kd type IV collagenase) 
Gelatinase B MMP-9 
(92kd type IV collagenase) 
Stromeiysins 
Stromelysin I 
Stromelysin 2 
Stromelysin 3 
Matrilysin 
Metalloelastase 
Membrane type MMPs 
MTI- MMP 
MT2 -MMP 
MT3- MMP 
MT4-MMP 
MT5- MMP 
MT6- MMP 
CA-MMP 
MMP-3 
MMP-10 
MMP-11 
MMP-7 
MMP-12 
MMP-14 
MMP-15 
MMP-16 
MMP-17 
MMP-24 
MMP-25 
MMP23A 
MMP23B 
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Substrate 
Collagen types I. II, III, V, X, gelatins and 
proteoglycans 
as above (for MMP-1) 
as above (for MMP-1) 
Gelatins, collagens types IV, V, VII, X and XI, 
elastin, fibronectin and proteoglycans 
Gelatins, collagen types IV, V, elastin and 
proteoglycans 
Proteoglycans, fibronectin and laminin 
Elastin, gelatin, collagen types II, IV, V, IX 
and X 
Gelatin, fibronectin and proteoglycans 
Gelatins, collagens types 1- IV and proteoglycans 
Elastin 
Collagen types I-III, gelatin 
Collagen type I-III, gelatin 
Collagen type I-III, gelatin 
Gelatin 
Gelatin 
Collagen type IV and gelatin 
Gelatin 
Chapter 1 
Others 
RASI-1 
Enamclysin 
Epilysin 
Matrilysin-2 
MMP-19 
MMP-20 
MMP-28 
MMP-26 
1.14.2 MMP and TJMP expression 
Introduction 
Collagen types I, IV and gelatin 
Casein 
Collagen type IV and gelatin 
A number of MMPs and TIMPs are expressed by SMCs and macrophages in 
atherosclerotic plaques where they may participate in vascular remodelling, SMC 
migration and plaque disruption [140,143]. 
MMP-1, MMP-9 and MMP-3 have been found to be expressed in the fibrous 
cap, shoulders of lesions and at the base of the lipid core, whereas MMP-7 is 
predominantly expressed in macrophages overlying the lipid core [144]. TIMP-1, 2 
and 3 have also been localised in all these areas, particularly in plaque shoulders and 
between the fibrous cap and the necrotic core [ 142]. In particular intense MMP-1 
expression has been detected in macrophages located at the borders of lipid cores next 
to fibrous caps and shoulder regions, which are critical to plaque integrity [ 145]. Thus 
MMP-1 could contribute to plaque rupture by degradation of the two of major 
structural proteins of the fibrous cap, collagen types I and III collagen [ 146]. Both 
MMP-2 and MMP-9 have been found to be expressed in isolated atherosclerotic 
lesions [147]. MMP-2 and MMP-9 have been associated with SMC migration and 
proliferation in vitro and in vivo [146]. MMP-2 can degrade type IV collagen, an 
important component of the basement membrane to which endothelial cells attach 
[ 146]. Unlike other secreted MMPs, MMP-2 activation does not occur through 
proteolysis by serine proteases but rather through MTl-MMP [ 148]. 
It has been demonstrated that MTI-MMP is expressed by SMCs and 
macrophages in lipid rich atherosclerotic plaques [ 148]. Proinflammatory molecules 
IL-l a, TNF-a and OxLDL have been found to augment MT 1-MMP expression, 
leading to increased activation of MMP-2 [148]. MMP-9 has emerged as one of the 
major members of the MMP family in the context of plaque events [ 149]. It has been 
found to be up-regulated in plaques vulnerable to rupture [ 149]. Several mechanisms 
exist for the up-regulation of expression of MMPs. TNF-a and IL-l have been shown 
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to up-regulate MMP activity by macrophages [144]. In addition the interaction of 
macrophages with T-lymphocytes, through the interaction of CD40 with its ligand 
CD 154 also up-regulate MMP expression [ 122]. 
TIMP-1 is synthesized and secreted by macrophages and its expression is 
regulated by a variety of agents including growth factors (EGF, TNF-a, IL-l and 
TGF-~), phorbol esters and retinoids [150]. IL-8 is thought to play a potentially 
atherogenic role by inhibiting local TIMP-1 expression [ 150]. TIMP-2 is frequently 
co-localised with MMP-2 and its expression is largely constitutive and down-
regulated by TGF-~ [133]. In vitro studies have also established the human 
macrophage as a novel source of TIMP-3 [151]. Extracts of atherosclerotic plaques 
have been found to have a 5 fold higher levels of TIMP3 than non-atherosclerotic 
tissue [ 151 ], where it has been found to be localised with macrophages [151 ]. 
1.13. 3 Effects ofstatins and antioxidants 011 MMP and TIMP expression 
Lipid lowering may produce clinical benefit by stabilising plaques against 
disruption. A study using pravastatin has shown that the drug decreases lipids, lipid 
oxidation, inflammation, MMP-2 and cell death and increases TIMP-1 and collagen 
content in plaques, confirming its plaque stabilizing effect in humans [ 137]. 
Plaques and foam cells taken from lesions of rabbits have showed a marked 
decrease in the expression of MMP-9, if the animal had been treated with the reactive 
oxygen species scavenger, n-acetyl cysteine [ 152]. Inhibition of MMP activity by 
antioxidants early in atherosclerotic lesion development may again contribute to 
plaque stability. 
1.14 Inflammatory markers 
Studies have indicated that levels of plasma markers of inflammation such as 
C-reactive protein, white cell count and fibrinogen levels are elevated in individuals at 
risk from CHD [153]. C-reactive protein is a liver derived protein (regulated by 
interleukin-6), which is produced by inflammatory cells. Data by Ridker et a! [!54] 
has indicated that patients with relatively low lipid levels but elevated CRP levels may 
benefit from statin therapy 
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Studies have also linked lipoprotein-associated phospholipase A2 (Lp-PLA2) 
with a risk of CHD [155]. A2 phospholipases are a family of enzymes that can 
hydrolyse phospholipids at the sn2 position to generate lysophospolipids and fatty 
acids. Plasma Lp-PLA2 levels have been found to be significantly elevated in patients 
with CHD, when compared with age-matched controls [ 153]. Furthermore a 
comparison of risk factors in CHD patients and normal groups has indicated that 
plasma Lp-PLA2 is a clearer marker of risk on a case control basis than either plasma 
cholesterol or LDL cholesterol. The majority of Lp-PLA2 has been found to be 
associated with LDL where it is involved in the oxidative modification of OxLDL 
[ 156]. In particular Lp-PLA2 has been found to be highly enriched in the atherogenic 
small dense LDL particles [ 156]. 
1.15 Aims and objectives 
1.15.1 Background to this study 
Even when an atherosclerotic lesion is well advanced and the risk of plaque 
rupture is high, lipid lowering may stabilise the plaque and reduce the risk of 
thrombotic events [ 137]. Results from animal experiments have indicated that 
macrophage foam cells may be a relatively reversible component in atherosclerotic 
lesions [ 157]. CHD is a multifactorial disease with both genetic and environmental 
factors having an input to its progrsssion [2]. Many of the genes responsible for single 
gene vascular disorders, such as FH and Tangiers Disease have been described [ 126]. 
Although genes that contribute to atherosclerosis have been identified, it is likely that 
more remain to be discovered. 
In an effort to identify other genes that are specifically induced in foam cell 
formation we examined genes in a human macrophage cell line (THP-1 cells) in 
response to native LDL (nLDL), AcLDL and OxLDL stimulation using high-density 
eDNA arrays. A comprehensive review of the use of gene expression profiling in 
cardiovascular disease has been reviewed by Henriksen et al [ 158]. A better 
knowledge of gene expression would be helpful in understanding the mechanisms 
behind foam cell formation. 
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1.15.2 Experimental Considerations 
1.15.2.1 The THP-1 eel/line 
The THP-1 cell line was used as a in vitro model for studying foam cell 
formation. Human THP-1 cells have been established as a cell line for studying the 
lipid metabolism of human macrophages and have been reported to represent a more 
differentiated and committed macrophage cell line than previously available human 
monocytic lines [ 159]. THP-1 cells can be differentiated to mature macrophages after 
stimulation with various factors including phorbol esters and retinoic acid [ 160]. 
THP-1 cells, like mature human primary macrophages, synthesize and secrete M-CSF, 
and apo E. IL-8 secretion has also been described in THP-1 cells [ 159]. Further 
properties of THP-1 cells, which make them a useful model for studying foam cell 
formation, are discussed in chapter 3. The main reason for using an in vitro rather than 
an in vivo model of macrophages in this study was to minimise variability. Compared 
to THP-1 cells, human monocyte derived macrophages show large variability between 
subjects. In addition compared to human monocyte derived macrophages, THP-1 cells 
are easier to grow in large batches. 
1.15.2.2 Use ofAcLDL and OxLDL 
Although AcLDL it is not a naturally occurring in vivo modification of LDL, 
Goldstein and Brown used it in their studies leading to the discovery of the scavenger 
receptor. Thus experimentally AcLDL is used as a modified form of LDL to induce 
foam cell formation as it represents a standardised particle for lipid loading. 
OxLDL is more likely to represent the in vivo situation, although it may not be 
a true representation since the degree of oxidation of LDL that occurs in vivo remains 
to be determined. Importantly OxLDL is a more heterogeneous entity composed of a 
variety of oxidation products and having a range of biological effects. Thus OxLDL 
formed by in vitro copper oxidation was used to try and induce large changes in 
expression of key genes. 
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1.15.2.3 Analysing gene expression 
Various molecular biology methodologies exist for the detection and 
quantitation of gene expression [ 161 ]. The most popular ones include RT-PCR, 
differential display and northern blots [ 161]. The last decade has seen the 
development of a new method for analysing gene expression namely DNA array 
technology [162]. The main advantage of DNA array technology is that it allows the 
expression levels of thousands of genes to be measured simultaneously ll62] (hence 
the reason for using this technology in this study). High-density eDNA arrays are 
nylon membranes or glass slides containing eDNA sequences corresponding to 
individual genes/transcripts arrayed at high density. 
Briefly messenger RNA was extracted from both differentiated THP-1 cells 
and THPI cells exposed to nLDL, AcLDL and OxLDL. Complementary DNA was 
subsequently prepared from the messenger RNA and radioactively labelled. The 
labelled cDNAs were then hybridised to identical arrays consisting of several 
thousand spotted gene fragments. Phosphorimaging of the arrays revealed the genes 
being expressed for each treatment and the differences between differentiated THP-1 
cells and differentiated THP-1 cells exposed to AcLDL or OxLDL were identified. 
The method is discussed in further detail in chapter 4. 
1.15.3 Aims of this study 
The aim of this study was to determine which genes are expressed during foam 
cell formation and, in particular, which genes are specifically regulated by the two 
forms of modified LDL used in this study, namely OxLDL and AcLDL. A number of 
genes have already been reported to be altered on exposure to these agents. Most of 
these genes have been found to be inflammatory molecules and cytokines. 
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1.15.4 Objectives 
[I] To establish an in vitro model of foam cells using THP-1 cells incubated with 
AcLDL/OxLDL 
[2] To differentiate the THP-1 monocytic cell line into macrophages using PMA 
and confirm this differentiation. 
[3] To establish eDNA array technology (in use at Glaxo SmithKiine) to compare 
acetylated and oxidised LDL induced changes in gene expression. 
[ 4] To perform a temporal study of gene expression in THP-1 cells exposed to 
OxLDL for up to 72 hours compared to zero. 
[5] To confirm these changes identified by independent means, namely 
quantitative RT-PCR. 
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Chapter 2: Methods 
2.1 Human THP-1 cell line 
2.1.1 Culture of human THP-1 cells 
Human THP-1 cells were kindly donated by Dr Steve Yeaman, Department of 
Biochemistry at the University of Newcastle (original source: American Type Culture 
Collection [ATCC 1080 I], Rockville, MD). THP-1 cells were grown continuously in 
culture in RPMI-1640 + L-glutamine + 25mM HEPES media supplemented with 10% 
foetal bovine serum (FBS), I% penicillin/streptomycin (lOmg/ml), I% L-glutamine 
(IOmg/ml) and IOJ..lM 2-mercaptoethanol as previously described [163]. (Media and 
all media components were obtained from GibcoBRL, Paisley. FBS was obtained 
from Sigma, Dorset). Cells were maintained in an incubator at 37°C in a humidified 
atmosphere containing 5% C02/95% air. Cells were grown in suspension to a density 
of I -2 xI 06 cells/ ml over seven days (with a media change every two days) before 
being split back to a level of I xI 05 cells/mi. Cells were counted as described in 2.1.4. 
2.1.2 Differentiation 
THP-1 cells in suspension were pelleted by centrifugation (Sigma 3-15) at 
400g for 10 minutes. Cells were resuspended in RPMI 1640 + L-glutamine media 
supplemented with l 0% FBS, l% penicillin/streptomycin (I Omg/ml), I% L-glutamine 
( 1 Omg/ml) and l OflM 2-mercaptoethanol at a concentration of 5x l 05 cells/mi. Cells 
were subsequently plated at a concentration of lxl06cells per well (2mls per well) in 
six-well plates (Falcon!Becton Dickinson, Oxford). Cells were differentiated using 
phorbol 12- myristate 13-acetate (PMA) [Sigma, Dorset] at a final concentration of 
250nM (5fll of a 50nM stock solution of PMA per well, prepared as described in 
section 2.5). Medium containing 250nM PMA was replaced every two days. 
After 7 days of differentiation, the media was removed and the cells were 
washed twice with 2ml of phosphate buffered saline (PBS). Cells were then exposed 
to RPMI 1640 + L-glutamine media supplemented with I% L-glutamine (lOmg/ml), 
l% penicillin/streptomycin [ IOmg/ml], 0.2% bovine serum albumin (BSA) 
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[essentially fatty acid free A6003, Sigma, Dorset], I011M 2-mercaptoethanol and 
250nM PMA. This media contained no FBS and cleared the cells of any exogenous 
lipoprotein. 
After 24 hours the media was replaced with RPMI 1640 + L-Glutamine media 
supplemented with I% L-glutamine [I Omg/ml], I% penicillin/streptomycin 
[I Omg/ml], 0.08 % BSA, IO!lM 2-mercaptoethanol and 250nM PMA. At this stage 
the cells were ready for addition of lipoproteins. 
2.1.3 Freezing/thawing 
Cultured THP-1 cells (SOx 106) were pelleted at 400g for 10 minutes (Sigma 3-
15) and resuspended in lml of freezing media (90% FBS, 10% dimethyl sulphoxide 
[DMSO]). Cells were immediately placed in a cryofreezing chamber (Nalgene) 
containing isopropanol (50ml) and placed at -70°C. After 24 hours cells were 
transferred to liquid nitrogen for long-term storage. 
Cells were thawed in warm water (3rC) and resuspended in 20ml of RPMI-
1640 + L-glutamine + 25mM HEPES media supplemented with 10% FBS, l% 
penicillin/streptomycin ( IOmg/ml), I% L-glutamine (I Omg/ml) and IOJlM 2-
mercaptoethanol. Cells were then pelleted by centrifugation at 400g for l 0 minutes 
and resuspended in fresh media to remove any remaining DMSO. Initially these 
thawed cells were grown at high density (one vial cells/per 20m! media) for one week 
to help their proliferation before being split and grown as described in section 2.1.1. 
2.1.4 Cell Counting 
To determine the numbers of cells in culture at any time during their growth, 
IOOJll of cell suspension was added to IOOJll 0.6% filtered trypan blue (trypan blue is 
excluded by live cells and stains dead cells blue). The cell suspension was placed on a 
counting chamber (Weber Scientific, depth 0.02mm, l/400mm2). The number of cells 
in the four quadrants was counted (using a standard laboratory light microscope [CK 
Olympus, Tokyo] at x40 magnification). The total number of cells in the four 
quadrants was divided by four to give an average number. This average was 
subsequently multiplied by two (to take account of the dilution with trypan blue) and 
by 104 to give the number of cells per millilitre. 
42 
Chapter 2 Methods 
2.1.5 Oil Red 0 staining 
Cells were stained with Oil Red 0 (lipid stain) as previously described [164]. 
THP-1 cells (I x 106) in suspension were pelleted at 400g for I 0 minutes and 
resuspended in lml of 40% FBS in PBS. A sample of the cells (200J.!l) was loaded 
into a cytocentrifuge chamber attached to a slide. Cells were subsequently pelleted 
onto the slide by spinning in a cytospin for 5 minutes at I OOg and allowed to air dry 
for a few minutes. 
Differentiated THP-1 cells were grown on culture slides (5ml; Falcon/ Becton 
Dickinson, Oxford) for 7 days as described in section 2.1.2 before being exposed to 
lipoprotein. Slides with cells were fixed in 40% calcium formal solution (see section 
2.6) for one hour. The slides were then placed in 60% isopropanol for 15 minutes and 
subsequently stained in a solution of Oil Red 0 (Sigma, Dorset; see 2.6) for 15 
minutes. After staining, the slides were dipped in 60% isopropanol for approximately 
15 seconds and washed in deionised water. Subsequently the slides were 
counterstained with haematoxylin solution (Sigma, Dorset) for 3 minutes to stain the 
nuclei. The slides were then rinsed well in deionised water and allowed to air dry. 
Finally a coverslip was mounted onto the slide using glycerine jelly (BDH, Dorset) 
and the slides were stored at 4°C. 
2.1.6 Nile red staining 
THP-1 cells were differentiated as described in section 2.1.2. The cells were 
then exposed to varying concentrations of native, acetylated or oxidised LDL for 
different time intervals. After exposure to lipoprotein, cells were washed twice in PBS 
and incubated in I ml of 0.27% EDT A for I 0 minutes at 37°C. The cells were 
subsequently lifted from the well with the single stroke of a cell scraper, transferred to 
a microfuge tube and pelleted by centrifugation for I 0 minutes at 400g. The 
supernatant was removed and the cells were fixed in I% paraformaldehyde solution 
(see section 2.6) for 10 minutes. An automatic pipette was used to mix the cells and to 
disrupt aggregates by gently sucking the cell solution up and down, gently in a pipette 
tip. The cells were then centrifuged at 400g for I 0 minutes to remove the 
paraformaldehyde, and the cell pellet was resuspended in I ml PBS. 
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Nile red [Sigma, Dorsetl (10!11 from a 10jJg/ml solution of nile red in acetone) 
was added to each sample to give a final concentration of 100ng/ml as previously 
described [165]. The samples were incubated with the dye for 5 minutes before 
running the samples on a flow cytometer. 
2.1.7 Flow Cytometry 
Using a flow cytometer (Coulter EPICs XL-HCL), cells (which are counted as 
events) were allowed to pass through the cytometer with the flow rate set to medium 
(around 100 cells counted per second) until 10,000 events had passed. The excitation 
wavelength was set to 488nm (since nile red has an excitation wavelength of 488nm). 
The data was subsequently expressed as a ratio of the side scatter (granularity 
of the cell) versus forward scatter (size of the cell). Emission spectra were collected 
using four different fluorescence (FL) channels, which had different emission spectra 
collection ranges. These were FLI (505-545nm), FL2 (560-590nm), FL3 (605-
635nm) and FL4 (660-700nm). Cholesteryl esters were detected using a 600nm long 
pass filter (FL3) and triglycerides were detected using a 580nm long pass filter (FL2). 
The data was expressed as number of cells versus log fluorescence. 
2.1.8 Estimation of cholesterol uptake 
Stimulation of cholesteryl [14C] oleate synthesis is commonly used as a 
functional assay to measure lipoprotein uptake. Loading of THP-1 cells with 14C-
oleate was performed as previously described [166]. 
2.1.8.1 Preparation of 14C-oleate label 
Four individual solutions were prepared as follows: Solution 1: - 150mM 
NaCl, 50mM Tris-HCl, pH 7.4. 
Solution 2 was prepared by dissolving 12 g of BSA (essentially fatty acid free 
A6003; Sigma, Dorset] in 2g aliquots to 35ml of solution I over a five-hour petiod 
with continuous stirring at room temperature. After five hours, the solution was 
adjusted to pH 7.4 with 5M NaOH and the volume made up to 50 ml using solution I. 
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For solution 3, 90mg of oleic acid (Sigma, Dorset) was dissolved in 2m! of 
ethanol and IOOJ..ll of 5M NaOH. This solution was then dried under gaseous nitrogen 
and re-dissolved in I Om I of solution I. The resulting solution was heated to 60°C for 5 
minutes, before the addition of 12.5ml of ice-cold solution 2. The solution was then 
stirred for 10 minutes before the volume was finally adjusted to 25m! with solution I. 
Solution 4 was prepared by drying 50J1Ci 14C oleic acid (I OOJ1Ci/ml) under 
nitrogen. The mixture was resuspended in 0.16ml solution I, 0.16ml solution 2 and 
0.87ml solution 3 and stirred gently at room temperature for 4-6 hours. 
After their preparation solution 1 was stored at room temperature, whilst 
solutions 2-4 were stored at -20°C until required. 
2.1.8.2 Preparation of3 H-cholestel}'l oleate internal standard 
To prepare the cholesteryl oleate internal standard 50mg cholesterol, 50mg 
oleic acid, 50mg triolein and 1 OJ..ll of 3H-cholesteryl oleate (I J1Ci/J..ll) were dissolved 
in I Oml of a mixture of chloroform: methanol ( 1 :2). 
2.1.8.3 Lipid extraction and thin layer chromatography 
To estimate cholesterol ester accumulation by THP-1 cells, amount of 
cholesterol esters was measured. THP-1 cells were differentiated as described in 
section 2.1.2. Differentiated THP-1 cells were exposed to varying concentrations of 
native, acetylated and oxidised LDL for varying time periods in the presence of IOJ..ll 
of IOmM 14C oleate (0.42J1Ci 14C oleate) in 12% BSA (final concentration O.lmM 
oleate in 0.12% BSA). 
After the cells had been exposed for the relevant time period, media 
containing lipoproteins and 14C oleate was removed. Cells were subsequently washed 
twice in 2m! of PBS per well and I ml of PBS was added per well. Cells were lifted 
into the PBS using a cell scraper and a pasteur pipette was used to transfer the mixture 
into a glass tube. 
To extract the lipid, 3.75ml of a solution of chloroform-methanol (l :2, v/v) 
was added to the cells/PBS mixture and mixed thoroughly by vortexing. This was 
followed by the addition of 1.25ml of chloroform and 0.25ml of water. At this stage 
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201-11 of 3H-cholesterol oleate internal standard (0.02!-lCi) was added to each sample to 
determine percentage recovery. Samples were subsequently centrifuged at 500g for 15 
minutes. The upper phase and denatured proteins were removed and the lower phase 
was transferred to 5ml-scintillation vial. Samples were dried down in a rotary 
evaporator (Jouan Rotary Evaporator RC I 0.22) at 50°C for 90 minutes before being 
redissolved in 50!-ll chloroform (containing lg/ml cholesterol oleate and lmg/ml 
cholesterol). 
Samples were applied in I 01-11 aliquots as spots onto a 20cm x 20cm plastic 
backed silica thin layer chromatography (TLC) plate (catalogue number 01511; 
Anachem, Luton) using a I 001-11 Hamilton syringe and needle and dried using a hair 
dryer. An additional 50!-ll of chloroform (containing l mg/ml cholesterol oleate and 
lmg/ml cholesterol) was added to each tube to remove any remaining sample and 
again spotted onto the TLC plate. Two standards, cholesterol (I mg/ml in chloroform) 
and cholesterol oleate ( 1 mg/ml) were also spotted onto the plate. The TLC plate was 
placed in a standard chromatography tank containing I OOml of petroleum 
spirit/diethyl ether (170:30, v/v) until the solvent front had reached three-quarters up 
the TLC plate (approximately 30 minutes). 
The TLC plate was subsequently placed in an enclosed chromatography tank 
containing a small amount of iodine crystals until the iodine vapours allowed 
visualisation of the cholesterol and cholesterol oleate spots. The TLC plate was 
removed and the position of the spots was marked using a pencil. 
Cholesterol oleate spots were subsequently cut out the TLC plate and placed in 
a scintillation vial containing lOml of scintillation fluid (Ecoscint A, National 
Diagnostics). The vial was left for twenty-four hours to allow leaching. Samples were 
then counted in a liquid scintillation counter (Packard tricarb liquid scintillation 
analyser 2200 CA) for I minute using a dual 3H and 14C program. Each reading was 
taken twice and the results obtained were averaged and converted from cpm into dpm. 
The results in dpm were corrected by using percentage recovery of the 3H cholesterol 
oleate internal standard. Amount of 14C incorporated into cholesterol esters was 
calculated (0.42!-lCi = 932400dpm = O.l11mol 14C cholesterol oleate) and the results 
were expressed as micromoles of cholesterol ester accumulation per I xI 06 cells. 
46 
Chapter 2 Methods 
2.1.9 MTT assay for cell viability 
Cells were seeded at a density of 3-5 xI 05 cells per well. After differentiation 
with PMA (as described in section 2.1.2) cells were exposed to native LDL, AcLDL 
or OxLDL at a concentration of 0.2mg/ml for 24, 48 and 72 hours respectively. After 
incubation with lipoprotein for the appropriate time period, lOOf.tl of 5mg.ml MTT 
was added to each well (in 900J1l media) to a give a final concentration of 0.5mg/ml. 
Cells were then incubated at 37°C for 3 hours. After 3 hours, water-insoluble 
formazan was solubilised by adding lml of HCI/Isopropanol (1:24) and mixed with a 
pipette. The OD value of the subsequent solution from each well was measured in a 
spectrophotometer using a test wavelength of 570nm and reference wavelength of 
630nm. The MTT assay was performed by Dr Wei, (Department of Obstetrics and 
Gynaecology, Glasgow Royal Infirmary) 
2.1.10 Statistical Analysis of Results 
Statistical Analysis was performed using a computer software package called Stastica 
with a function called multiple dependent measures analysis. This initially tests 
whether these are differences across the whole time course or concentration series 
being studied. A post-hoc test; Tukey Honest Significant Difference (THSD) was then 
used to test for specific differences between different time points or concentrations. A 
* is used in the graphed results to indicate a significant difference between groups 
being compared. 
2.2 Isolation of low-density lipoprotein 
LDL was isolated from human plasma by density ultracentrifugation as previously 
described [167, 168] and as described below. 
2.2.1 Preparation of density solutions 
A density solution at a density of 1.006g/ml was prepared by dissolving 57g 
NaCI, 0.5g NaEDT A and 5ml of I M NaOH in 5 litres of deionised water. The 
1.006g/ml density solution was subsequently used as a base solution to make a further 
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density solution of density 1.063g/ml by addition of 74g of potassium bromide to 
litre of 1.006g/ml density solution. 
The density of the solution was assessed using the refractive index of the 
solutions since refractive index is proportional to the refractive index of the solution 
(appendix one). Density solutions at density l.006g/ml and I.063g/ml have refractive 
indexes of 1.335 and 1.344 respectively [ 169]. 
2.2.2 Collection of blood and separation of plasma 
Blood was collected from laboratory volunteers at Dryburn General Hospital, 
Durham. Human blood was collected in tubes containing 50mM EDT A to prevent 
coagulation. Blood was centrifuged at 1900rpm for 10 minutes using a centrifuge with 
a swing out rotor to separate the plasma. The plasma layer was removed using a 
pasteur pipette and transferred to a new tube. The plasma was subsequently 
centrifuged at 3000rpm to pellet the white blood cells. Potassium bromide (43.75g) 
was subsequently dissolved per lOOm! of plasma to give a solution of density greater 
than 1.063g/ml 
2.2.3 Separation of LDL 
Beckman Quickseal centrifuge tubes were filled with 24ml of 1.0063g/ml 
solution. Potassium bromide adjusted plasma (ll.5ml) was placed below the density 
solution using a gradient former (Watson-Marlow 501). Tubes were filled to the top 
with 1.0063g/ml density solution, balanced to within 50mg of one another and sealed 
using a Beckman heat sealer. Tubes were placed in a Beckman VTi50 horizontal rotor 
and centrifuged at 50000g for 2.5 hours at l6°C using Beckman L-70 ultracentrifuge. 
Minimum deceleration, no acceleration and no brake controls were used so as not to 
disturb the gradient. After centrifugation the LDL layer was found to form a tight 
band in the middle of the tube (volume 6-!0ml). This LDL band was removed using a 
syringe and needle (21 gauge) by piercing the tube below the LDL band 
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2.2.4 Concentration of WL 
LDL was concentrated using CF50 centrifuge filter cones (Amicon, Bedford, 
USA). LDL was loaded into filter cones placed in collection tubes (Amicon, Bedford, 
USA). The tubes were centrifuged (in a centrifuge with a swing out rotor), three times 
at a maximum speed of IOOOg for 15 minutes or until the LDL volume was between 
2-4m!. 
To wash the LDL to ensure it was free of contaminants and other lipoproteins, 
2ml of LDL was placed in a 5ml polyallomer quick seal tube (Beckman). The LDL 
was overlaid with 1.063g/ml density solution, tubes were sealed using a heat sealer 
and placed in a TLAl00.4 rotor. Tubes were centrifuged at lOO,OOOrpm for l hour at 
l6°C in a Beckman Optima TLX ultracentrifuge. After centrifugation the LDL moved 
to the top of the tube. The LDL band was removed using a syringe and needle (21 
gauge) by piercing the tube above the LDL band. 
Subsequently the LDL was desalted on a PD I 0 column (Pharmacia, Little 
Chalfont) to remove the salt. PD lO Columns were equilibrated with PBS. LDL in a 
volume of 2.5ml was passed through the column and eluted with 3.5ml of PBS. 
Finally the LDL was dialysed extensively at 4°C in a volume of PBS that was at least 
l 000 times the volume of LDL. 
2.2.5 Bradford assay 
The concentration of LDL was expressed as mg/ml using the standard 
Bradford assay for protein measurement [ 170]. 
Bradford working reagent was prepared by adding l5ml of Bradford stock 
reagent (see section 2.6) to 85ml of deionised water. Bovine serum albumin [BSAJ 
(l mg/ml) was used to construct a standard protein curve. Dilutions of BSA (0.1-
1 mg/ml) were prepared in a total volume of l 00111 of deionised water. A blank sample 
containing no BSA was also prepared as a reagent blank. Dilutions of LDL were 
prepared in a range of I to 1110 in a total volume of lOOjll. Bradford working reagent 
(900j1l) was added to each sample whilst mixing on a vortex. Samples were allowed 
to stand at room temperature for 15 minutes before being read in a spectrophotometer 
at 595nm. The spectrophotometer was set to zero using the reagent blank. The 
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readings from the standard samples were used to construct a standard curve. The 
concentration of the LDL was determined using the BSA standard curve. 
2.2.6 Modification of LDL 
LDL was modified either by oxidation or acetylation. 
2.2.6. 1 Oxidation 
OxLDL was prepared as previously described [171] by incubating native LDL 
at a concentration of lmg/ml (diluted with PBS) with 20f..IM copper sulphate (1/IOOOth 
volume of 20mM solution) for 20 hours at 37°C. Transferring the reaction to 4°C was 
used to stop the oxidation reaction. 
2.2.6.2 Acetylation 
AcLDL was prepared as previously described [ 172] by adding 1 ml of a 
saturated solution of sodium acetate per ml of native LDL (irrespective of LDL 
concentration) in a glass beaker and stirring for I 0 minutes. Acetic anhydride was 
then added at a volume in micro litres equal to 1.5 times the total protein 
concentration of LDL (in mg/ml), in small aliquots over a one-hour period with 
continuous stirring at 4°C. After a further 30 minutes of stirring the AcLDL was 
dialysed overnight against PBS to remove the sodium acetate. 
Finally both Ox LDL and AcLDL were filter sterilised in a flow hood using 0.2f..lm 
filters and stored at 4°C until required. All preparations of LDL were used within two 
weeks of preparation. 
2.2. 7 Agarose gel electrophoresis of LDL 
Relative electrophoretic mobility on Beckman Paragon LIPO™ gels was used 
to check modification of LDL. 
The gel was prepared as per manufacturer's instructions; 5f..il of each LDL 
sample was applied to the gel slots and allowed to diffuse for 5-l 0 minutes. The gel 
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was placed in an electrophoresis cell containing 30m! barbital buffer (see section 2.6) 
and electrophoresis performed for 30 minutes at 100 volts in a Beckman Paragon 
Electrophoresis kit (kindly loaned from Glaxo Wellcome). After the electrophoresis 
the gel was placed in fixative solution (see section 2.6) for 5 minutes and dried using 
a hair dryer. The gel was then stained with lipoprotein stain (Sudan black B stain 
0.07% v/v; in deionised water) for 5 minutes before being placed in a destain solution 
(see section 2.6) for at least 5 minutes. The gel was finally washed well in de-ionised 
water before being dried with a hair dryer. 
2.3. General Molecular Biology 
2.3.1 DNA extraction 
DNA was extracted from blood using the method reported by Kunkel et a/ 
[173]. 
2.3.1.1 Extraction of DNA from human blood 
Blood was collected in tubes containing 50mM EDT A to prevent coagulation. 
Blood was centrifuged at 2800rpm to separate the blood cells and the plasma. The 
plasma layer was removed using a sterile pasteur pipette. 
Blood cells (4ml from !Om! of blood) were mixed with 80ml of lysis buffer 
(see section 2.6). This mixture was centrifuged at 10,500g for 10 min at 4°C using 
Beckman centrifuge J2-HC and rotor JA-20 to pellet the nuclei. The pellet was 
resuspended in 4.5ml of resuspension buffer (see section 2.6), 250!11 of I 0% SDS and 
250!11 of proteinase K (2mg/ml) and incubated overnight (18 hours) at 37°C. 
After incubation, 5ml of phenol was added. The tube was mixed by inversion 
and the mixture was centrifuged at 3000rpm for 5 mins. This separated the mixture 
into two phases. The upper phase was transferred to clean tube using a bent pasteur 
pipette. Chloroform: isoamylalchohol (24: I; 5ml) was added to the upper phase and 
the tube mixed by inversion. The mixture was centrifuged at 3000rpm for 5 mins. The 
upper phase was again removed and the chloroforrn/isoamylalcohol extraction step 
was repeated. The upper phase was finally transferred to a fresh tube. 
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Pure ethanol (99%; llmls) and 0.5ml of 3M sodium acetate solution (pH 7) 
were added to the upper phase and the mixture mixed gently by inversion several 
times. At this stage the DNA can be visualised and was hooked out using a sealed 
pasteur pipette and placed in a 1.5ml eppendorf tube. Excess ethanol was removed 
from the DNA by briefly centrifuging and removing the ethanol with an automatic 
pipette. The DNA was dissolved in 500).11 TE buffer (see section 2.6). Dissolving was 
aided by aspirating the solution gently with a sterile pipette tip. DNA, once dissolved, 
was stored at -20°C. Typical yield obtained was about 200-500ng of DNA per !Oml of 
blood. 
2.3.1.2 Quantitative estimation of DNA 
The optical density of a I in 50 dilution of DNA was measured at 260nm and 
280nm. The reading at 260nm is a measure of the amount of DNA present while the 
reading at 280nm is a measure of any protein that may be present. An optical density 
of I at 260nm corresponds to 50J.lg/ml of double stranded DNA. The ratio between 
the optical density at 260nm and 280nm gives an estimate of the purity of the DNA. A 
ratio of 1.8 was used as an indicator of a relatively pure preparation of DNA. 
2.3.2 RNA extraction 
2.3.2.llsolation ofwhite blood cells from human blood 
Blood was collected in tubes containing 50mM EDTA. Histopaque (4.5ml; 
Pharmacia, Little Chalfont) was added to a 15ml tube and overlaid with 6ml of blood. 
The tubes were centrifuged for 30 mins at 1500rpm. The plasma layer was aspirated 
to just above the cell layer using a sterile pasteur pipette. A 5ml sterile pipette was 
used to remove the white blood cell band to a fresh tube. The volume of the cell band 
was made up to 13.5ml with PBS. The tube was then centrifuged for I 0 mins at 
1900rpm to pellet the cells. After centrifugation the supernatant was removed leaving 
the white blood cell pellet. 
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2.3.2.2 Isolation of total RNA using TR/zol reagent 
Cells isolated as described above in section 2.3.2.1, pelleted THP-1 cells or 
differentiated THP-1 cells grown in six well plates were lysed in I ml TRizol reagent 
(GibcoBRL, Paisley) by repetitive pipetting (TRizol is a ready to use reagent for the 
isolation of total RNA from cells and tissues based on the method of Chomcyzynski 
and Sacchi [174]). Samples were processed according to the manufacturer's 
instructions. After the addition of TRizol, samples were incubated at room 
temperature for 5 minutes to allow complete dissociation of nucleoprotein complexes. 
After 5 minutes, 2001JI of chloroform were added to the tubes. The tubes were shaken 
vigorously by inversion and allowed to stand at room temperature for a further 2-3 
minutes. Samples were then centrifuged at 12000g for 15minutes at 4°C (Beckman 
Avanti 30 using rotor F2402). 
After centrifugation the mixture separated into a lower red phenol-chloroform 
phase, an interphase and a colourless upper aqueous phase. RNA remained in the 
upper aqueous phase. The aqueous phase was transferred to a fresh tube, 0.5ml of 
isopropanol were added and the sample was incubated at room temperature. After I 0 
minutes the samples were centrifuged at 12000 g for 10 mins at 4°C. After 
centrifugation the supernatant was carefully removed to avoid disturbing the RNA 
pellet. 
The RNA pellet was washed by adding I ml of 75% ethanol, vortexing and 
centrifuging at 7500g for 5 minutes at 4°C. The ethanol was removed and the RNA 
pellet was allowed to dry at room temperature for 15 minutes. The RNA was 
dissolved in IO!Jl of RNase-free water (Ambion, Texas, USA). 
2.3.3 Reverse transcription of total RNA 
RNA was transcribed into eDNA as previously described [ 175]. Total RNA 
(51Jg) was made up to ll!JI with DEPC treated water in a 200111 plastic thin-walled 
PCR tube (Scotlab). Oligo dT primer I!Jl (0.51Jgi!JI; GibcoBRL, Paisley) was added to 
the samples and the samples were heated at 70°C for I 0 minutes. The samples were 
then chilled on ice and centrifuged briefly. 
For eDNA synthesis, a master mix containing all the components required was 
prepared and subsequently aliquoted. The master mix contained the following 
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components per sample; 4111 of first strand eDNA buffer (supplied with reverse 
transcriptase enzyme), 1111 dNTPs (IOmM), 2111 OTT (O.lmM) and 1111 of MMLV 
reverse transcriptase (200units/111) [all GibcoBRL, Paisley]. After the addition of 
components required for eDNA synthesis, samples were incubated at room 
temperature for I 0 minutes. The samples were then incubated at 42°C for 50 minutes 
followed by 90°C for 10 minutes in a thermal cycler (MJ2; Roche, Lewis). After 
heating, samples were placed on ice for I 0 minutes and cent1ifuged briefly in a bench 
top micro centrifuge. Finally 1111 of RNase H (200U/111; GibcoBRL, Paisley) was 
added to the samples and the samples were incubated at 3rc for 20 minutes. 
Each time the reverse transcription reaction was performed two control 
samples were included to check for contamination. Control I contained RNA but no 
reverse transcriptase enzyme. Control 2 contained all reverse transcription 
components but no RNA template. All steps were carried out using procedures that 
minimised risk of RNase contamination. 
2.3.4PCR 
2.3.4.1 Polymerase chain reaction 
PCR was performed using the protocols of Innis et al [ 176]. For each PCR 
reaction 1111 of DNA (SOng) was dispensed into 0.2ml thin walled PCR tubes. To 
minimise pipetting errors a master mix was prepared and subsequently aliquoted. 
When n number of samples was being prepared, a master mix for n+ I samples was 
prepared. The master mix contained the following components per sample; I11l of !Ox 
Taq polymerase buffer, 0.5111 forward oligonucleotide (5pmol/111), 0.5111 reverse 
oligonucleotide (5pmo11111), I ul of dNTP's (IOmM), 5.9111 of sterile filtered water, 
O.I11I of Taq polymerase (SU/111) [Boehringer Mannheim; Lewis]. Master mix (10111) 
was dispensed into each tube and the samples were overlaid with 10111 silicon oil 
(Sigma, Dorset). The samples were briefly vortexed, centrifuged briefly in a bench 
top micro centrifuge and placed in PCR machine (MJ2; Roche, Lewis). The PCR 
primers being used determined the PCR programme subsequently used to run the 
samples. 
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2.3.4.2 PCR primer sequences 
Table 2.1 shows primer sequences used to amplify genes of interest. The 
forward primer sequence anneals to the DNA in the 5'-3'direction whereas the reverse 
primer anneals to DNA in the 3' -5' direction. The internal standard primer was used 
to generate a DNA fragment that was shorter in length than the fragment produced by 
the original forward and reverse primers, but had the same primer binding sites [ 177]. 
In addition the base pairs at the beginning of the internal primer sequence were 
designed to be identical to the base pairs at the end of the forward primer sequence. 
All primer sequences were designed from published sequences obtained from the 
Genbank database (at the internet site http://www.ncbi.nlm.nih.gov/Genbank). 
Oligonucleotide primers were synthesized by MWG Biotech, Germany or PE-Applied 
Biosystems, UK. 
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Table 2.1 
Table showing sequences of oligonucleotides used to amplify genes of interest. 
Gene Sequence of Sequence!>( re1•erse Sequence of Genhank 
forward primer primer internal standard accession 
primer number 
CETP 5'-CAC TAG CCC 5'-CTG AGC CCA From reference 
AGA GAG AGG GCC GCA CAC - [178] 
AGTGCC-3' TAAC- 3' 
HPRT 5 '-CCT GCT GGA 5' -GTC AAG GGC 5'-CAA AGC ACT M31642 
ITA CAT CAA ATA TCC TAC GAT CAG ACT 
AGC ACTG-3' AACAAAC-3' GAA GAG CTA 
GTG-3' 
ACAT 5'-CAC CTA GTA 5'- GTA GAC AGG 5'- GAA TTG L21934 
ATG GTC GAA AAC ATG ATC ACA TAA GTT 
TTG ACA-3' CAC CAG-3' GGC AGT CAC T-
3' 
IL-8 5'- GGA AGG 5'- AGT GTC CAC 5'- ACT GTG TGT 014283 
AAC CAT CTC TCT CAA TCA ACC TGA TIT 
ACT GTG TGT A CTC T- 3' CTGCAGC- 3' 
-3' 
~-actin 5'- TGT GAT 5'- TIT GAT GTC 5'- TGT GAT M31642 
GGT GGG AAT ACG CAC GAT GGT GGG AAT 
GGGTCAG-3' TIC C-3' GGG TCA GGC 
CAA CCG CGA 
GAA GAT GAC 
CCAG-3 
LpL 5'-ACA CAG CTG 5'- CAC TGG GTA 'i'- GGA CAC Ml5856 
AGG ACA CIT ATG CTC CTG TTG CTG GTG 
GC-3' AG-3' ATC CAT GGC T-
:r 
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2.3.4.3 PCR product sizes 
Table 2.2 shows the sizes of the products obtained after PCR and the names of the 
programs used for PCR. For those genes where an internal standard was prepared, the 
size of the internal standard and intermediate product obtained on preparing the 
internal standards are also given. 
Table 2.2 
Table showing product sizes in base pairs (bp) obtained after PCR for genes of 
interest and the name of the PCR programme used for their amplification 
Gene Product size Internal Product size - PCR 
(bp) standard internal programme 
forward and product size standard/reverse 
reverse primers (bp) primer(bp) 
CETP 535 - - 860 
HPRT 351 294 314 T65 
ACAT 475 392 407 T65 
IL-8 210 154 169 T65 
P-actin 511 318 318 860 
LpL 227 ISO 165 860 
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2.3.4.4 PCR programs 
Table 2.3 below shows the two PCR programs used for the amplification of genes of 
interest. 
Table 2.3 
Table showing the steps involved in the PCR programs used, with temperature in 
degrees Celsius and time in seconds 
PCR programme Step Number Temperature (C) Time (sec) 
860 94 15 
2 60 15 
3 72 30 
4 Go to step I, twenty-nine more times 
T65 94 15 
2 70 10 
3 72 10 
4 Go to step I, five more times 
5 94 15 
6 65 10 
7 72 10 
8 Go to step 5, five more time 
9 94 15 
10 60 10 
II 72 10 
12 Go to step 9, five more times 
13 94 15 
14 65 10 
15 72 10 
16 Go to step 13, twenty-five more times 
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2.3.5 Agarose gel electrophoresis of PCR products 
A I% agarose gel was prepared by dissolving I g of agarose in lOOm! of I x 
TBE buffer (see section 2.6). The mixture was heated to boiling and subsequently 
cooled. Ethidium bromide (I Of.! I of a !Omg/ml solution) was added to the gel solution 
before the gel was cast to set (gel size; 14cm x llcm). 
Loading buffer (!Ox; see section 2.6), 2J.il was added to each IOJ.il PCR 
product and Sf.! I of each sample was subsequently loaded per lane of the gel. A marker 
100 base pair ladder, (0.5ug; GibcoBRL, Paisley) was also loaded onto the gel to 
check the size of the PCR products. Electrophoresis was performed in 1 x TBE buffer 
at 100 volts for 60 minutes. Gels were visualised using a UV trans-illuminator and 
photographed (Polaroid type 667; size 314 x 414). 
2.3.6 Purification of DNA from agarose gels 
DNA was isolated from agarose gels using the Wizard PCR Preps DNA 
Purification Kit (Pro mega Corporation) according to the manufacturer's instructions. 
The PCR reaction products were separated in a 1 x T AE agarose gel (low 
melting point agarose; Sigma, Dorset) containing ethidium bromide and visualised by 
UV trans-illuminator. The band of interest was isolated from the gel using a sterile 
razor blade. The exercised band was transferred to a l.Sml micro centrifuge tube and 
incubated at 70°C with lml of DNA purification resin (supplied with the kit) until the 
gel had completely melted. 
For each PCR product, one Wizard mini-column (a column containing a filter 
to bind the DNA) was used. A disposable syringe (with the plunger removed) was 
attached to each mini-column (at the opening where the needle is attached). 
The DNA/resin mixture was pipetted into the syringe and pushed through the 
attached mini-column gently using the syringe plunger. The syringe was detached 
from the mini-column and the plunger removed. The syringe was reattached to the 
column and 2m! of 80% isopropanol were pipetted into the syringe and pushed 
through the column (using the plunger) so as to wash the column. The syringe was 
then removed and the minicolumn was transferred to a 1.5ml eppendorf tube. The 
mini-column was centrifuged in a bench top centrifuge for 2 minutes at I O,OOOg to 
dry the resin. 
59 
Chapter 2 Methods 
The mini-column was transferred to a fresh tube and TE buffer (50J.1l; see 
section 2.6) was added. The column was then left for two minutes and subsequently 
centrifuged for 20 seconds at IO,OOOg to elute the bound DNA fragment. 
2.3.7 Quantitative RT-PCR 
2.3.7.1 Oligonucleotide end labelling using gamma 32 P- ATP 
For each oligonucleotide, 41 J.ll water, I.5J.1l of oligonucleotide to be labelled 
(5pmoi/J.ll), lui of T4 polynucleotide kinase (GibcoBRL), 5J.1l "phosphorus all in one 
buffer"(supplied with the enzyme) and IJ.ll gamma-32P ATP (IOJ.1CiiJ.1l) were 
combined together. The mixture was incubated at 37°C for 30 minutes in a heating 
block. Incorporation was checked by paper chromatography. A small amount of each 
sample (I J.ll) was spotted onto 3MM paper (Whatman). The filter paper was placed 
veitically in a large beaker containing IOOml 0.25M ammonium formate for about 30 
mins or until the solution front had travelled three quarters up the filter paper. The 
filter paper was allowed to air dry and subsequently covered with Saran'" wrap (cling 
film). The film was then exposed to film (Kodak X-OMAT; 35 x 43 em) for 2 hours 
before the film was developed using a film developer (X-ograph Imaging Systems: -
Compact X4). 
The amount of radioactivity incorporated into the forward or reverse primer 
for any gene was visually compared by eye and the primer showing the most 
radioactive incorporation was identified. Subsequently for each PCR reaction, in 
addition to the normal volumes of both oligonucleotides, 0.5J.ll of this 32P-labelled 
oligonucleotide was also added as a tracer to each PCR reaction. 
2.3. 7.2 Denaturing gel electrophoresis 
For denaturing gel electrophoresis an acrylamide/urea gel was prepared by 
combining 42g urea, !Oml lOx TBE buffer (see section 2.6), 15m! 40% acrylamide 
(acrylamide: bisacrylamide; 40: I) and 37m! of water. The mixture was stirred until all 
the urea had dissolved. At this stage IOOJ.ll TEMED and I ml 5% ammonium 
persulphate were added to allow polymerisation. 
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Gel glass plates were prepared by washing the glass plates with ethanol (70%) 
and deionised water. One of the plates (back plate) was coated with Sigmacoten.• 
(water repellent; Sigma, Dorset) on the side that was going to be exposed to the gel 
and the plates were allowed to dry. Spacers (1.5 em width) were placed between the 
two plates and the plates were sealed tightly using electrical tape (BDH, Dorset). The 
gel solution was cast into the plates in a slanted vertical position avoiding the 
introduction of air bubbles. A 32-tooth comb was placed in the top, and the plates and 
comb were clipped together using bulldog clips. The gel was subsequently allowed to 
set for at least an hour in a horizontal position. After the gel had set, the comb was 
removed and the wells were washed with TBE buffer to remove any unpolymerised 
acrylamide. The tape from the bottom edge of the gel plates was removed. 
Radioactive PCR samples were prepared for loading onto the gel by the 
addition of 2J1l of formamide dye (see section 2.6) to each sample. Samples (IOJll) 
were subsequently loaded onto the gel. Electrophoresis was performed in a vertical 
electrophoresis gel tank (Gibco-BRL) containing TBE buffer for 2.5 hours at 1000 
volts. 
After electrophoresis the electrical tape and spacers were removed from the 
gel plates and the plates were carefully forced apart. The gel was found to stick to one 
of the glass plates as the other had been coated with Sigmacote'". A sheet of 3MM 
chromatography paper was placed on top of the gel and subsequently lifted slowly 
from one comer. This transferred the gel onto the chromatography paper. The gel was 
covered with Saran1M wrap and dried using a gel dryer [BioRad slab dryer model 483] 
at 80°C for one hour. The gel was then exposed to film (Kodak X-OMAT; 35 x 43 
em) overnight before the film was developed using a film developer (X-ograph 
Imaging Systems:- Compact X4) 
For quantitation of radioactive PCR products, the dried gel was placed next to 
a 20cm x 25cm phosphor beta-imaging screen (BioRad, Heme! Hempstead) for one 
hour. The screen was scanned using a Molecular Imager (BioRad model GS-525) and 
the data captured and analysed using Molecular Analyst software (BioRad, version 
2.1) according to the manufacturer's instructions. 
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2.4 Differential gene expression 
2.4.1. Isolation of RNA for differential gene expression 
For gene expression studies, cells were cultured in large numbers (7xl07 cells) 
so as to provide a greater yield of RNA. Cells were differentiated in 175cm2 flasks 
(Falcon) rather than 6 well plates. RNA was isolated in two steps. Firstly total RNA 
was isolated from the cells and then messenger RNA was subsequently isolated from 
the total RNA. All steps were carried out using procedures that minimised risk of 
RNase contamination. 
2.4.1.1 Isolation of total RNA 
Total RNA was isolated using an RNeasy Midikit (Qiagen, Crawley) according to the 
manufacturer's instructions. 
Cells were washed twice in PBS after exposure to lipoprotein. Cells were 
lysed by addition of 3.8ml of RLT buffer (supplied with kit) containing 38J.1l ~­
mercaptoethanol directly to the culture flask. Cells were collected using a cell scraper 
and the lysate was transferred to a sterile RNase free polypropylene tube. The lysate 
was vortexed for 10 seconds before being passed through a 1 Oml syringe and needle 
(21 gauge) between 5-l 0 times to homogenise the lysate. Then 3.8ml of 70% ethanol 
were added to the lysate and the mixture vortexed briefly. 
The vortexed sample was applied in maximum volumes of 3.8ml to an 
RNeasy midi spin column (a column containing a filter to bind the RNA) placed in a 
15m! centrifuge tube. The tube was centrifuged (Sigma 3-15) for 5 minutes at 
5000rpm and the flow through was discarded. This was repeated until the entire 
sample had been applied to the column. A buffer RWI (3.8mls; supplied with kit) was 
then applied to the column and the column was centrifuged for 5 minutes at 5000rpm, 
with the flow through being discarded. 
To wash the bound RNA, 2.5ml of buffer RPE (supplied with kit) was added 
to the column and the column was centrifuged for 2 minutes at 5000rpm. This was 
followed with a further 2.5ml of buffer RPE and centrifugation at 5000rpm for 5 
minutes. The RNA was eluted by adding 250J.1l of RNase free water to the spin 
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column membrane, allowing the column to stand for I minute before centrifugation 
for 3 minutes at 5000g. The elution step was repeated so as to maximise the yield of 
RNA. 
2.4.1.2 Isolation of messenger RNA 
Messenger RNA was subsequently isolated from the total RNA using an 
mRNA Midikit (Qiagen, Crawley) according to the manufacturer's instructions. Total 
mRNA (500f.JI) was mixed with 500f.JI of 2x binding buffer and 55f.JI oligotex 
suspension in a sterile eppendorf tube. The tube was initially incubated at 65°C for 5 
minutes to allow disruption of RNA secondary structure and then left at room 
temperature for at least 10 minutes to allow annealing of the oligo dT to the poly A tail 
of the mRNA. 
The tube was centrifuged for 2 minutes at 14000g in bench-top micro 
centrifuge to pellet the oligotex resin containing the mRNA. The supernatant was 
carefully removed by pipetting and the pellet was resuspended in 400f.JI of wash 
buffer by vortexing. This was applied to a spin column (a column containing a filter to 
capture the oligo dT resin bound to the mRNA) sitting in an eppendorf tube and the 
tube was centrifuged at 14000g for 30 seconds in a bench top micro centrifuge. The 
spin column was transferred to a fresh tube and 400f.JI wash buffer was applied to the 
column, followed by centrifugation for 30 seconds at 14000g. 
To elute the bound mRNA, the spin column (containing the mRNA) was 
transferred to a fresh tube. Elution buffer (75f.Jl), preheated to 70°C was applied to the 
column. The elution buffer was pipetted up and down several times using an 
automatic pipette to allow resuspension of the resin. The tube was then centrifuged for 
30 seconds at 14000g. The elution step was repeated with a further 75f.JI of elution 
buffer. The isolated mRN A was stored in elution buffer at -70°C after the addition of 
lf.JI of RNasin (40U/f.JI; Boehringer Mannheim, Lewis). 
To precipitate the RNA in a small volume, RNA in elution buffer was mixed 
with 2.5 volumes of 100% ethanol, 21-11 glycogen (20mg/ml; Boehringer Mannheim, 
Lewis) and 0.1 volumes of 3M sodium acetate. This mixture was stored overnight at-
20°C, before being centrifuged for 15 minutes at 13000g. After centrifugation the 
supernatant was removed and the pellet was re-suspended in 500f.JI of 75% ethanol. 
This was followed by centrifugation at 13000g for 15 minutes to wash the pellet. The 
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RNA pellet was subsequently dried at room temperature for I 0-15 minutes before 
being re-suspended in 9fll of DEPC treated water and lfll RNasin (40U/fll). 
2.4.1.3 Quantitation of RNA 
The concentration and purity of RNA was determined by measuring 
absorbance of RNA in a spectrophotometer at 260nm and 280nm. Cuvettes (IOOfll) 
were washed with a solution of 0.1M NaOH/ImM EDTA followed by RNase free 
water to ensure that they were RNase free. The RNA was diluted 1 in 20 and the 
absorbance readings at 260nm and 280nm were read in a spectrophotometer (Unicam 
UV NIS). The RNA concentration was calculated using the relationship that an 
absorbance of 1 at 260nm corresponds to 40flg of RNA per mi. The ratio between the 
absorbance readings at 260nm and 280nm indicated the purity of the RNA. A ratio of 
1.8 or above was used as an indication of a relatively pure preparation of RNA. 
2.4.1.4 Determining RNA integrity 
RNA integrity can be determined by examining ribosomal RNA bands (ISS 
and 28S) present in the RNA samples. For both total RNA and mRNA, two types of 
gels were prepared either an agarose/formaldehyde gel or a glyoxal gel. Initially 
agarose/formaldehyde gels were used however glyoxal gels were subsequently used 
since they represent a more advanced detection method in terms of sensitivity. 
2.4.1.4.1 Agarose !formaldehyde gel electrophoresis of RNA 
A I% agarose gel was prepared by combining the following, 20ml 5x MOPS 
buffer (see section 2.6), 62.1 ml DEPC-treated water and I g of agarose (Sigma, 
Dorset). The mixture was heated until boiling to dissolve the agarose and 
subsequently cooled to 55°C. This was followed by the addition of 17 .9m1 of 37% 
formaldehyde, mixing the solution and casting the gel (gel size; 14cm x llcm). 
RNA samples were prepared by adding one part RNA to two parts RNA 
sample buffer (see section 2.6) up to a volume of IOfll. The samples were heated to 
65°C for 5 minutes and cooled to room temperature. This was followed by the 
addition of 2fll of RNA loading buffer and lfll of ethidium bromide (lOmg/ml). 
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Before loading the samples on the gel, the gel was pre-run at I 00 volts for I 0 minutes 
in I x MOPS buffer (see section 2.6). The gel was run at I 00 volts for 90 minutes or 
until the bromophenol blue had migrated at least lOcm from the wells. The gel was 
visualised using a UV trans-illuminator and photographed (Polaroid type 667; size 31!1 
X 41/i). 
2.4.1.4.2 Glyoxal gel electrophoresis of RNA 
A 1% agarose/MOPS gel was prepared by dissolving lg agarose in lOOm! of 
I x MOPS buffer, heating until boiling and pouring the gel. RNA samples were 
prepared by combining 0.5Jll of RNA (0.06jlg) with 8.5Jll of RNase free water and 
9Jll of a Glyoxal!DMSO mixture (1.5ml Glyoxal I 2.5ml DMSO). The samples were 
then heated at 50°C for 60 minutes and chilled on ice for one minute. This was 
followed by the addition of 5Jll of gel loading buffer (Sigma, Dorset) before the 
samples were loaded onto the gel. Electrophoresis was performed for 45 minutes at 90 
volts in lx MOPS buffer. 
After electrophoresis the gel was stained in 1 x MOPS buffer with a 1:10000 
dilution SYBR gold stain (Sigma, Dorset) for 30 minutes with continuous shaking. 
The RNA was then detected using a Fluorimager (Molecular Dynamics) and the 
image file generated was saved. 
In both cases 18S and 28S RNA markers (Sigma, Dorset) were also loaded onto the 
gel. The integrity of the samples was confirmed by the presence of 18S and 28S 
ribosomal RNA bands. 
2.4.2 Preparation of high-density eDNA arrays 
High-density eDNA arrays were prepared by the DGE group, Department of 
Genetics at Glaxo Wellcome Medicines Research Centre (Stevenage). Briefly 
complementary DNA (eDNA) libraries were robotically picked from 96-well format 
into 384-well format using a picker/gridder (Genetix, UK). PCR was performed on 
the library eDNA cloned inserts using a high-throughput custom-built PCR robot. 
PCR conditions were 95°C for one minute followed by 29 cycles of 94°C for 30 
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seconds, 50°C for 2 minutes and 72°C for 2 minutes and a final incubation at 72°C for 
5 minutes. 
PCR products were subsequently gridded in duplicate onto 20cm x 30cm 
positively charged nylon membranes (Boehringer Mannheim, Lewis) using a 
picker/gridder (Genetix, UK). The libraries used in this study were the human re-
arrayed I.M.A.G.E (Integrated Molecular Analysis of Genomes and their Expression) 
library, and a custom atheroma library (prepared by the DGE group in collaboration 
with the Vascular Diseases Unit at Glaxo Wellcome). In addition luciferase eDNA 
and control genes were also gridded onto the arrays at set positions to be used in 
subsequent analysis. Gridded arrays were cut to size approximately 22.5cm by 16cm 
(so that they would fit into Techne Hybridisation bottles). Each grid was subsequently 
labelled (by pencil) with a unique experiment number and marked with a upward 
pointing arrow on the top left hand side of the grid (near to position I, 1 of gridding) to 
designate orientation 
2.4.3 Quantitation of PCR products on arrays 
To measure the amount of DNA per spot on the arrays, the arrays were 
annealed with a 33P -end labelled oligonucleotide. This end labelled oligonucleotide 
was designed to specifically anneal to all the spotted PCR products by virtue of 
complementarity to the plasmid vector polylinker sequence. For the both the re-
arrayed human I.M.A.G.E library and the custom atheroma, an oligonucleotide named 
M 13F was used. 
Ml3F sequence 5' ACG TTG TAA AAC GAC GGC CAG 3' 
2.4.3.1 5' radiolabel/ing of M 13F oligonucleotide 
To prepare the DNA loading oligonucleotide probe (M 13F), the following 
were combined together: 5111 lOx polynucleotide kinase buffer (supplied with the 
enzyme), 1111 DNA oligonucleotide MI3F (20pmol/111), 5111 Redivue gamma 33P-
dATP 0011Ci/11l), 2111 polynucleotide kinase (New England Biosciences) and 37111 of 
deionised water. The reaction mixture was incubated at 37°C for one hour in a water 
bath. 
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After one hour the probe was purified using a sephadex G25 spin column 
(Pharmacia, Little Chalfont). Total number of cpm were assessed before and after 
purification of the probe using a bench top counter (Bioscan QC-4000, Bioscan, 
Washington, USA) and the percentage incorporation calculated. Only probes showing 
percentage incorporation in the expected range of 20-50 % were used. 
2.4.3.2 Hybridisation of radio/abe/led M JJF oligonucleotide probe to arrays. 
Arrays were placed in a shallow tray containing a small volume (I Oml) of 
Digoxigenin Easy Hybridisation Buffer (DIG Easy Hyb; Boehringer Mannheim, 
Lewis). DIG Easy Hyb is a ready-to-use buffer for nucleic acid blot hybridisation. 
When more than one array was being used, a mesh was placed between the arrays and 
any resulting air bubbles were expelled. The sandwich of arrays and meshes (up to 
maximum of four arrays) were transferred to a Techne hybridisation bottle containing 
JOml of DIG Easy Hyb buffer and allowed to pre-hybridise in a Techne oven pre-set 
to 45°C for at least 30 minutes. 
After 30 minutes the pre-hybridisation solution in the Techne bottle was 
discarded and replaced with 10 ml of DIG Easy Hyb buffer pre-heated to 45°C. The 
labelled probe (M 13F) was then added and hybridisation was performed overnight in 
a Techne oven at 45°C. 
After overnight hybridisation, the hybridisation solution was discarded and the 
arrays were washed three times with a wash solution (preheated to 45°C; see section 
2.5) for 15 minutes per wash. Arrays were removed from the Techne bottle and 
mounted in a cassette between a layer of thin plastic sheeting and Saran1" wrap. The 
arrays were subsequently placed next to a phosphorimaging screen (Molecular 
Dynamics) for two days. The data from the screen was captured using a Storm 
Scanner (Molecular Dynamics). 
2.4.4 Complex probe preparation from mRNA 
Messenger RNA isolated from experimental samples as described in section 
2.4.1 was transcribed into radiolabelled ls1 strand eDNA probes. 
For first strand eDNA synthesis lfll dVN (T) ts (1.44g/ml; GibcoBRL) was 
added to 5f.JI RNA (containing IOflg total RNA or 2flg mRNA) and heated at 70°C for 
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lO minutes. This was followed by addition of 4f1l of 5x Superscript reaction buffer, 
2f1l O.IM OTT, lfll dNTP mix [lmM dATP, dGTP, dTTP, O.OimM dCTP), lf1l of 
RNasin [40U/f1l] and 4f1l of a 33 P dCTP (l0f1Ci/f1l) and 2f1l of Superscript II enzyme 
[200U/f1l] (GibcoBRL, Paisley). This mixture was incubated at 42°C for 90 minutes. 
After the incubation, 30f1l of distilled water was added to the reaction mixture. 
Total cpm were assessed before purification using a bench top counter (Bioscan QC-
4000, Bioscan, Washington, USA). The probe was then purified using a sephadex 
GSO column (Pharmacia, Little Chalfont). Total cpm were recounted after purification 
and percentage incorporation calculated. Only probes showing incorporation greater 
than 40% were subsequently used (the higher the percentage incorporation the better 
the probe). 
2.4.5 Complex probe quality control 
The length of each probe was determined by gel electrophoresis and 
comparing against a set of markers of known size (in the range of 500bp-1.5kb). Up 
to five labelled marker PCR product markers of size 500bp, 800bp, 900bp, 1.3kb and 
l.5Kb were used (prepared by the DGE group in the same way as the Ml3F 
oligonucleotide probe as described in section 2.4.3.1 ). 
Gel loading buffer II (2f1l; Ambion, Texas, USA) was added to prepared 
eDNA probes (2f1V0.08f1g mRNA) and to each standard (2f1l). The samples were 
heated at l 00°C for 5 minutes, allowed to cool and subsequently loaded onto a pre-
prepared 6% polyacrylamide: TBE gel (Novex). Electrophoresis was performed at 
120 volts for 90 minutes. The gel was removed from the plates, placed in an imaging 
cassette (with a thin plastic sheet backing). The gel was covered with Saran™ wrap 
and exposed to a phosphorimaging screen overnight. The image of the gel was 
subsequently captured using a Storm Scanner and the size of the probes in relation to 
the size of the markers was examined. Only probes whose length profile was between 
500bp and 2kb were subsequently used for hybridisation experiments. 
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2.4.6 Hybridisation of complex probes to arrays 
Pre-hybridisation of filters was carried out as for DNA loading as described in 
section 2.4.3.2. The complex probes (prepared as described in section 2.4.4) were 
prepared for hybridisation by combining the complex probe with 5J.1l poly (A) 80 
(GibcoBRL, Paisley), lJll Human COT-I DNA (GibcoBRL, Paisley) and 435J.1l Dig 
Easy Hyb. [COT-I DNA and poly (A) 80 were used to bind to alu sequences and T-
repeat sequences respectively that are present and may interfere with hybridisation]. 
Radiolabelled luciferase probe (5J.1l) was also added to each experimental probe 
prepared (the luciferase probe was prepared as per complex probes described in 
section 2.4.4 using 2J.1g Iuciferase mRNA). 
This complex probe mixture was heated at 100°C for 10 minutes followed by 
incubation at 45°C for 90 minutes and then added to IOml of DIG Easy Hyb pre-
equilibrated to 45°C. The DIG Easy Hyb containing the probe was subsequently 
added to the Techne bottle containing the pre-hybridised arrays. Hybridisation was 
performed in a Techne oven at 45°C for three days. 
After three days, the arrays were washed three times for 15 minutes in wash 
solution (50ml; see section 2.5) preheated to 68°C. Arrays were then mounted in 
cassette (between a layer of thin plastic sheeting and SaranTM wrap) and exposed to a 
phosphorimaging screen for two days. The image data from the screens was then 
captured using a Storm Scanner (Phosphorimager). 
2.4. 7 Data Analysis 
2.4.7.1. DGE data analysis 
A more detailed account of how data analysis was performed is given in 
Chapter 4. The image data collected using the Storm Scanner (from section 2.4.3.2 
and section 2.4.6) was subsequently processed using a software package called 
DGENT (developed by the DOE group, Glaxo Wellcome, Stevenage). 
Briefly, two images were obtained for each filter. A DNA loading image 
obtained after hybridisation with M l3F oligonucleotide (to assess for the amount of 
DNA present on the grid) and a probe hybridisation image obtained after 
hybridisation with the experimental probe. Images were firstly cropped to keep the 
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size of the image to a minimum (reduces the file size) and were labelled using the date 
of the experiment and the name of experimental probe. 
These images were subsequently processed using DGENT. (The positions at 
which PCR products are mTayed are referred here to as spots, due the fact that they 
show up as spots on the images). The position of the corner spots and luciferase 
marker spots of an image was marked using the software. The software then detected 
the position of the remaining spots using the luciferase marker spots. In addition the 
position of the control spots were also marked. Once spots had been detected the 
software was used to find the intensity of the actual spot hybridisation. 
To perform a comparison experiment the image data for the hybridisations to 
be compared were opened (both the DNA loading data and the experimental 
hybridisation data for two different experiments, four sets of data). The DNA loading 
data was associated with the relevant experimental hybridisation data to take into 
account any discrepancies in DNA loading (automatically done by the DGENT 
software). The expression level on each array was corrected using the expression 
levels of the control genes on the array. The comparison was designated a comparison 
identification number and the two images were compared using the DGENT software 
and the differences listed. 
Each difference was inspected by eye to omit any false positives. Real 
differences were sent to the DGE database (a database containing all the gridding 
data). The position of spot on the array was used as a means to identify the gridded 
eDNA sequence from the database. 
2.4. 7.2 Temporal gene expression data analysis 
The data generated from the temporal gene expression experiments was 
coloured using the tools function of Microsoft Excel. Under the tools menu, add-in 
was selected and the Excel data analysis tool-pack was loaded. Firstly the data was 
analysed using the histogram tool to get a feel for sensible minimum and maximum 
values for the data. These values were then used to colour the data accordingly. 
Colour differentiation was selected under the tools menu of Excel; this brings up the 
colour differentiation wizard. The minimum and maximum values of the data were 
entered so that at least 95% of the data was represented (these values were determined 
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using the Histogram too l), then sharp colour was chosen to colour the data (other 
options were grey and colour). 
2.5 Hierarchical Clustering 
2.5.1 Steps involved in correlating gene expression data and perfonning 
hierarchical clustering. 
The initial gene expression data correlation in this study was performed by Dr 
Steve Blakemore, DGE group, Glaxo Wellcome. Figure 2.1 shows the steps in 
correlati ng gene expression data, applying hierarchical clustering and analys ing the 
resul ts. 
Figure 2.1. Steps involved m correlating gene expression data and performing 
hierarchical clustering 
This gives a matrix of distances and correlations, where each gene is related to one 
another. The data is exported to Excel and analysed to confirm that a significant degree 
of correlation exists in the data set 
To analyse the results, the data is transferred back into Excel 
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The first step in the procedure involved transferring the corrected data of 
expression levels (table 6.1) from Microsoft Excel into SPSS version 8.0. Next, the 
data was transposed so that column heading were gene names and rows were time 
points (this is because SPSS will only derive gene correlations if the gene names are 
column headings). Then from the statistics pull down menu, correlate, distances was 
selected. The distances were then calculated by SPSS and displayed in SPSS viewer 
as a correlation matrix, where each of the genes is related to one another by a 
similarity distance. The correlations were then calculated by SPSS and the results 
were displayed as correlation matrix where each gene was related to one another by a 
correlation coefficient. 
The correlation steps were performed so as to demonstrate that the number of 
positive correlations observed in the data set were greater than would expected by 
chance alone. It would be useless to apply hierarchical cluster analysis (HCA) to a 
data set in which there was no significant degree of correlation especially since 
clustering algorithms can generate clusters even when applied to random data. 
2.5.2 Cluster analysis 
The cluster analysis on the temporal gene expression data set was again 
performed in SPSS. The corrected raw hybridisation intensity data was imported from 
Excel into SPSS. Under the statistics pull down menu, classify was selected followed 
by hierarchical clustering. This brings up the HCA processing window. Time points 
were then selected as the variables to cluster. Clicking on statistics brings up the 
statistics window from which agglomerative schedule was selected (agglomeration 
schedule displays the clusters joined at each stage, the distances between the clusters 
and the last cluster level at which a variable joined the cluster; it starts with the two 
most related samples and links them forming an initial cluster, the process is then 
repeated until all the samples have been linked). 
Clicking the methods button on the hierarchical cluster analysis window 
brings up the methods window, from which between-groups linkage was used 
followed by Pearson correlation. This means that the procedure will operate an 
average cluster linkage clustering using a correlation matrix based on the appropriate 
correlation formula. Finally the data needs to be visualised graphically so the plot 
button from the hierarchical cluster analysis window was selected and dendogram was 
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selected. This completed setting the parameters involved in the clustering procedure. 
The results were subsequently displayed in SPSS viewer as an agglomeration 
schedule, which gave information on the clustering process and a dendogram plot that 
showed how the genes were linked into clusters. 
Using the dendogram plot the appropriate cluster solution can be chosen. The 
clustering procedure was then repeated to take account of the clustering solution 
generated. In the hierarchical cluster analysis window, the save button was selected, 
this brings up the save new variable window under which single solution was selected 
and the number of clusters (cluster solution from dendogram plot) was entered. This 
saves the individual clusters for subsequent analysis. At this stage SPSS data editor 
displays the original data (genes with expression levels at each time point) with an 
extra variable (column) that gives the cluster membership (the cluster assigned to each 
gene). To analyse the results, the first step involves looking at the time course plots 
for the different clusters. This can be easily done in Excel so the data matrix with the 
new variable (cluster membership) was exported to Excel. 
Once the data has been exported to Excel, plots of each of the different 
clusters were created. To do this a Macro called Separator was activated (this is a 
function of Microsoft Excel). Once activated the separator macro was chosen under 
the tools menu of Excel. This brings up the row separator wizard that allows you to 
select the area on the worksheet that you wish to analyse. Next the column containing 
the cluster solution was selected as the variable (to separate the plots). Finally the 
number of genes to plot in each chart was chosen (all the genes in the cluster were 
chosen so that all genes in the cluster were displayed on one graph). Separator then 
created a new worksheet for each cluster in Excel, into which each cluster has been 
copied and graphs had been created. 
The worksheets were then edited to presentable form so that genes were listed 
alphabetically, variable names were replaced with the experimental time points and 
the graphs were edited to show each gene in a different colour on the graph. These 
worksheets showing the genes in each cluster and their plots are shown in appendix 8. 
Each worksheet shows a separate cluster with a table showing the genes in the 
cluster (listed alphabetically) and their expression levels. A graph of the genes in the 
cluster is then given below the expression level table. Graph legends (gene names) are 
only given when there are less than 10 genes in the cluster. Where there are more than 
10 genes per cluster, graph legends are not given due to the size of the graphs 
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generated. In this case one may determine the identity of a line on the graph by simply 
placing the mouse cursor on the line of interest, this will provide the gene name. 
2.6 Composition of solutions 
Standard solutions were prepared according to Sambrook eta! [ 179]. 
Barbital Buffer 
Barbital buffer was composed of IOmM 5,5-diethylbarbituric acid and 50mM 
5,5-diethylbarbituric acid sodium salt. 
Bradford stock reagent 
Bradford stock reagent was prepared by dissolving I OOmg Commassie 
Brilliant Blue G in 95% ethanol and I OOml of 85% (w/v) phosphoric acid. The 
stock reagent was subsequently stored at 4°C and filtered before use. 
Calcium formal solution 
Calcium formal solution was prepared by combining !Oml 40% formaldehyde, 
I Oml I 0% calcium chloride and 90ml distilled water. 
DEPC treated water 
DEPC was added to deionised water at a final concentration of 0.0 I %(v/v). 
The resulting solution was stirred overnight before being autoclaved. 
Destain solution 
45ml of reagent alcohol (95% methanol, 5% methanol) was mixed with 55ml 
of de-ionised water. 
DNA lysis buffer 
DNA lysis buffer was composed of 0.32M sucrose, IOmM Tris-HCI, 5mM 
MgCh and l% Triton X -100. The resulting solution was adjusted to pH 7.5 
and autoclaved. 
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DNA resuspension buffer 
DNA resuspension buffer consisted of 0.075M NaCI and 0.024M EDT A. The 
pH of the final solution was adjusted to pH 8.0 and the solution was 
autoclaved. 
Fixative solution 
180m) reagent alcohol [95% ethanol, 5% methanol] was combined with 90ml 
de-ionised water and 30ml glacial acetic acid. 
Formamide dye 
Formamide dye was prepared by combining 24.5ml formamide, 0.5ml EDT A 
(0.5M), 12.5mg bromophenol blue and 12.5mg xylene cyanole FF. 
Hybridisation wash solution 
Hybridisation wash solution consisted of 0.1% SDS and 0.1 x SSC. 
Loading buffer for agarose gel electrophoresis of PCR products 
Loading buffer was prepared by combining 5ml glycerol, 0.37g 
Naz.EDTA.2H20, O.lg SDS, O.Oig bromophenol blue and O.Oig xylene 
cyanole FF. The resulting solution was made up to lOml in deionised water 
Membrane wash solution 
6 x SSC and 0.5% SDS 
Messenger RNA binding buffer (supplied with kit) 
20M Tris-HCI, lOOOmM NaCl, 2mM EDTA, 0.2% SDS 
Messenger RNA wash buffer (supplied with kit) 
IOmM Tris-HCl (pH 7.5), 150mM NaCI and lmM EDTA 
Messenger RNA Elution buffer (supplied with kit) 
5mM Tris-HCI at pH 7.5 
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5X MOPS buffer 
A 5x MOPS solution was prepared consisting of 0.2M MOPS, 0.05M sodium 
acetate and 0.05M EDT A. The final solution was adjusted to pH 7 with I M 
NaOH. 
Oil Red 0 working solution 
Oil Red 0 working solution was prepared by taking three parts of a stock 
solution of Oil Red 0 (Oil Red 0 saturated in 99% isopropanol) and mixing 
with two parts of distilled water to give a working solution of Oil Red 0. The 
working solution was filtered with Whatman No.I paper an hour before use. 
Oligotex Suspension (supplied with kit) 
Oligotex suspension consisted lO% oligotex particles [w/v], lOmM Tris-HCI, 
I mM EDT A, 0.1% SDS and 0.1% NaN3. 
Paraformaldehyde ( /%) 
A 2 % solution of paraformaldehyde was heated to between 60-70°C until a 
milky solution was formed. At this stage 0.1 M sodium hydroxide was added 
drop wise until clear. This was diluted with 0.2M PBS, pH 7.4 (see below) to 
give a working solution of I% paraformaldehyde. 
0.2M PBS 
Two separate 0.2M solutions were prepared. Solution I was prepared by 
dissolving 35.61 g of dibasic sodium phosphate in I litre of distilled water. 
Solution 2 was prepared by dissolving 31.2lg of monobasic sodium phosphate 
in I litre of water. Solution I (40ml) was mixed with lOrn! of solution 2 to 
give a solution of pH 7.4. 
Phosphate buffered saline (PBS) 
NaCl (8g), KCI (0.2g), I Na2HP04 ( 1.44g) and KH2P04 (0.24g) were dissolved 
in 800ml of deionised water. The pH of the resulting solution was adjusted to 
pH 7.4 with I M HCI. The volume of the final solution was made up to one 
litre before being autoclaved. 
76 
Chapter 2 Methods 
Phorbol 12- myristate 13-acetate [ 50pM} 
A stock solution of 50 11M PMA was prepared by dissolving PMA (lmg) in 
1.62ml of DMSO and subsequently diluting I in 20 with sterile filtered PBS. 
The stock solution was aliquoted into I ml cryogenic vials and stored at -70°C. 
Each vial was thawed and used once. 
Tris borate buffer (5x TBE) 
A 5x stock solution was prepared by dissolving 54g Tris base, 27.5g boric acid 
and 20ml of 0.5M EDT A in one litre of deionised water. The final solution 
adjusted to pH 8.3 using 10M NaOH. 
Tris acetate buffer (SOx TAE) 
A SOx stock solution was prepared by dissolving 242g of Tris base, 57.1ml of 
glacial acetic acid and 100ml of 0.5M EDTA in one litre of water. The 
resulting solution was adjusted to pH 8. 
RNA sample buffer 
RNA sample buffer was prepared by combining I Oml of de ionised formamide, 
3.5ml formaldehyde (37%) and 2ml of 5x MOPS buffer. 
RNA loading buffer 
50% glycerol, lmM EDTA, and 0.4% bromophenol blue in DEPC treated 
water. 
20x sse 
A solution of 20x SSC was prepared by dissolving l75.3g of NaCl and 8.2g of 
sodium citrate in 800ml of deionised water. The pH was adjusted to 7 using 
10M NaOH and the final volume was made up to I litre in deionised water. 
10 o/oSDS 
SDS solution was prepared by dissolving IOOg of SDS in 900ml of deionised 
water at 68°C. The pH was adjusted to 7.2 using I OM HCI and the final 
volume of the solution was made up to I litre using deionised water. 
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TE buffer 
TE buffer consisted of lOmM Tris-HCI and lmM EDTA. The resulting 
solution was adjusted to pH 7.4 and autoclaved. 
2.7 Materials 
All tissue culture plastics were obtained from Falcon/Becton Dickinson 
(Crowley, Oxford, UK) or Griener (Stonehouse, Gloucestershire, UK). 
All inorganic chemicals were of at least AnalaR quality and were obtained 
from Sigma (Poole, Dorset, UK) or BDH chemicals (Poole, Dorset, UK) 
unless otherwise specified. 
All organic solvents were obtained from Sigma (Poole, Dorset, UK) unless 
otherwise specified. 
Molecular Biology enzymes and reagents were obtained from GibcoBRL 
(Paisley, Scotland, UK), Boehringer Mannheim (Lewis, East Sussex, UK) or 
Pharmacia Biotech (Little Chalfont, Buckinghamshire, UK) unless otherwise 
specified. 
Cell culture media and components were obtained from GibcoBRL Life 
Technologies (Paisley, Scotland, UK). 
RNA isolation kits were obtained from Qiagen (Crawley, West Sussex, UK) 
Radioactive material was all obtained from Amersham Life Sciences (Little 
Chalfont, Buckinghamshire, UK). 
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Chapter 3: Foam Cell Formation 
3.1 Introduction 
As discussed in chapter one (section 1.8), one of the major events m 
atherosclerosis is the appearance of lipid-filled foam cells [3]. The accumulation of foam 
cell formation beneath the endothelium leads to the formation of the fatty streak, the 
earliest lesion of atherosclerosis. During the more advanced stages of atherosclerosis, 
foam cell death is thought to contribute to the characteristic lipid core and weakening of 
the thin fibrous cap found in more advanced lesions (section 1.12) [32]. 
Immunohistochemical studies have established that foam cells are predominantly 
monocytic in origin [ 46]. Monocytes attach and enter the intima at sites of endothelial 
injury. Once in the intima they differentiate into macrophages and take up large amounts 
of cholesterol via unregulated scavenger receptors to become foam cells. Modified 
lipoproteins, mainly OxLDL have been implicated as one possible source of cholesterol 
for cholesterol ester storage in foam cells in vivo [ 18]. 
Although most cells can take up lipoproteins, macrophages possess mechanisms 
that allow them to take up, digest and store cholesteryl esters. In addition macrophages 
can secrete cholesteryl esters through SR-B I when cholesterol acceptors such as HDL are 
available [24] 
3.1.1 The Cholesteryl Ester Cycle 
Goldstein and Brown [ 12] were the first to show that acetylation of LDL led to its 
uptake by macrophages and results in foam cell formation in vitro. They found that 
patients with genetic defect FH, had a LDL receptor deficiency, however still 
accumulated large amounts of cholesteryl esters within macrophages of atherosclerotic 
plaques. They subsequently identified the scavenger receptor [ 16], which was found to 
mediate the binding and internalisation of AcLDL through a pathway they termed the 
scavenger pathway. A shift in balance towards cholesteryl ester formation and storage is 
thought to be the mechanism that leads to excessive cholesteryl ester accumulation and 
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foam cell formation within macrophages [71]. Under normal physiological conditions 
macrophages express few receptors for native LDL and these receptors are down 
regulated in the presence of high concentrations of native LDL [ 16]. Modified LDL 
however is taken up by scavenger receptors, which are not subject to down regulation. 
This results in an increase in the amount of cholesterol in the cell. This excess cholesterol 
is subsequently delivered to the lysosome where it is esterified by the ACAT enzyme into 
cholesteryl esters. In the absence of cholesterol acceptors such as HDL, the cholesteryl 
esters are transported to the cytoplasm of the cell for storage where excessive 
accumulation leads to foam cell formation. In the presence of a cholesterol acceptor such 
as HDL, the cholesteryl esters are transported to the liver where they are hydrolysed and 
the free cholesterol excreted is secreted. This cycle in which excess cholesterol is 
esterified and subsequently secreted through an acceptor such as HDL, or retained within 
the cell has been termed the cholesteryl ester cycle [74] 
Although the scavenger receptor has been reported on macrophages from every 
species including human monocyte derived macrophages, the natural ligand for the 
scavenger receptor was unclear since modification by acetylation is not thought to occur 
under physiological conditions. Steinberg et at [ 180] showed that oxidised LDL 
(OxLDL) can also be taken up by the scavenger receptor. Subsequent binding studies 
[181] with both OxLDL and AcLDL concluded that macrophage receptors for modified 
LDL consist of at least three different types, a receptor that recognises AcLDL, a receptor 
that recognises OxLDL and a receptor that recognises both. A number of macrophage cell 
surface proteins have been identified that can specifically bind OxLDL. These include the 
class A and B scavenger receptors, CD36, CD68 and CD32 [22] (see chapter one section 
1.3.4). In particular CD36 has been implicated to be a major receptor for OxLDL on 
human monocyte derived macrophages in vitro [67]. 
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3.1.2 The THP-1 eel/line 
Differentiation of human blood monocytes in vitro has been used extensively as a 
model system for investigating macrophage development [54]. Both primary human 
monocyte-macrophage preparations and differentiated cell lines have been used in vitro 
to study foam cell formation [ 164, 182]. The use of primary macrophage preparations can 
present problems such as donor variability, accessibility, a limited number of cells 
available for study and a finite survival period in culture. The use of a continuous cell 
line can overcome these limitations [ 183]. Commonly used monocytic cell lines include 
J774 cells (mouse), U937 cells and THP-1 cells. Because of the technical limitations 
involved, most studies of lipoprotein metabolism employ the use of cell culture models. 
The human monocytic THP-1 cell line was derived from the blood of a one-year-old 
boy with acute monocytic leukaemia. It is considered to be a more differentiated and 
committed macrophage cell line than other monocytoid lines [184]. In this study the 
THP-1 cell line was used as an in vitro model for foam cell generation instead of human 
monocyte derived macrophages for the following reasons:-
(a) THP-1 cells have been shown to resemble human monocytes in respect to 
morphology, secretory products, oncogene expression, membrane antigens and 
receptors and the expression of genes involved with lipid metabolism [ 183]. 
(b) THP-1 cells take on macrophage like characteristics when stimulated with 
phorbol ester (PMA) [ 160]. 
(c) They are easy to grow in large batches. 
(d) There is less likely to be variation between preparations using THP-1 cells than 
using human monocyte derived macrophages. Thus during experimental 
treatment, differences obtained are more likely to be due to treatment with 
lipoprotein, not due to inter-individual variability. 
3.2 Experimental Design 
In order to study differences in gene expression between macrophages and foam 
cells, a cell culture model of foam cells had to be established. Although it has been 
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reported by many investigators that incubation of THP-1 cells with both acetylated and 
oxidised LDL leads to foam cell formation [ 185,171], this had to be confirmed in the 
hands of the investigator of this study. This was done using a variety of previously 
described techniques that have been used to assess foam cell formation. These techniques 
include:-
I. Staining for lipid droplets using Oil red 0 staining and detection by light 
microscopy. 
2. Staining for lipid droplets using nile red and detection by 
(a) Fluorescence microscopy. 
(b) Flow cytometry. 
3. Measurement of cholesteryl ester accumulation using 14C-oleic acid loading. 
The aim of these experiments was to establish that:-
I. THP-1 cells that had been exposed to PMA changed in morphology from 
monocytes into macrophages. 
2. Differentiated THP-1 macrophages took up modified LDL (either acetylated or 
oxidised LDL) that resulted in cholesteryl ester accumulation and foam cell 
morphology using qualitative analysis 
3. (a) There was cholesteryl ester accumulation in differentiated THP-1 cells 
exposed to native, acetylated and oxidised LDL quantitatively. 
(b) Accumulation was greater in cells exposed to modified LDL than those 
exposed to native LDL at the same concentration. 
82 
Chapter 3 Foam cell j(mnation 
3.3 Modification of LDL 
As discussed before (section 1.8.4), LDL must be modified in order for foam cell 
formation to occur. The uptake of native LDL is tightly controlled by a feedback 
mechanism that does not result in over-accumulation. Modified LDL however is taken up 
by the unregulated scavenger pathway and results in cholesteryl ester accumulation. 
Although AcLDL is not thought to occur in vivo, it is the modification Goldstein and 
Brown used in their discovery of the AcLDL scavenger receptor [ 16]. It is therefore the 
standard used to generate foam cells. OxLDL on the other hand is the most likely in vivo 
candidate involved in foam cell formation and is thus the more physiologically relevant 
ligand. 
In this study LDL was isolated at density 1.063g/ml from normolipaemic subjects 
by ultracentrifugation in potassium bromide gradients. LDL was modified either via 
acetylation by the addition of acetic anhydride or oxidation by the addition of copper 
sulphate as described in the methods (section 2.2.6). To check that modification of LDL 
had been successful native, acetylated and oxidised LDL were subjected to 
electrophoresis on a Beckman agarose LIPO gel as described in the methods (section 
2.2.7) 
83 
Chapter 3 Foam cell formation 
I 
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Figure 3.1 
A Beckman LIPO gel showing migration of native LDL, (lmg/ml; lanes I and 2), 
oxidised LDL, (I mg/ml; lanes 4 and 5) and acetylated LDL (0.5mg/ml; lanes 7 and 8) 
after electrophoresis. Lanes 3 and 6 are blank. 
Modification of LDL by acetylation or oxidation has been shown to abolish the 
positive charges on the lysine residues of LDL [91]. The resultant acetylated or oxidised 
LDL is more negatively charged than native LDL and therefore migrates futther than 
native LDL during electrophoresis as shown in figure 3.1. Rf values were usually 1 for 
native LDL, 1.5 for OxLDL and 2.5 for AcLDL (from the origin). 
Recognition of LDL by the scavenger receptor is dependent on derivatisation of 
the positive lysine residues found in the apolipoprotein B region of LDL [ 186]. It is 
thought that upon modification, apoB undergoes a conformational change in its tertiary 
structure so that there is stelic display of amino acyl groups that are important for 
recognition by the scavenger receptor [ 186]. 
Figure 3.1 also shows that acetylated LDL has greater mobility than oxidised 
LDL. This may be due to the observation that apoB has been shown to be sensitive to 
oxidative damage and that oxidation results in the breakdown of apoB into smaller 
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peptides resulting in a decreased electrophoretic mobility [ 187]. This can be seen on 
agarose gels as a broader lipid band. 
3.4 Differentiation of THP-1 cells 
PMA treatment of THP-1 cells promotes a dramatic changes in cell morphology 
that results in macrophages that have the functional characteristics of tissue macrophages 
[ 159]. PMA is a hydrophobic phorbol ester that acts by binding to the cell membrane acyl 
side chains and activating the protein kinase C signal transduction pathway [ 188]. The 
cells stop proliferating, become adherent and develop an irregular shaped nucleus. In 
addition, the cells form well-developed cell organelles such as phagocytotic vacuoles, 
free ribosomes and golgi apparatus (which are found to be less developed in monocytes) 
[ 159]. The differentiation of monocytes into macrophages is also accompanied by a 
change in their capacity to recognise and accumulate modified LDL. 
Both LDL and scavenger receptors on THP-1 cells have been reported [160,188]. 
Dividing THP-1 cells have been reported to display LDL receptors that disappear when 
the cells differentiate in response to PMA treatment [ 189]. However concomitant with the 
loss of LDL receptors is the appearance of scavenger receptors. PMA treatment of THP-1 
cells has been shown to result in a dramatic induction of scavenger receptor activity 
especially scavenger receptor class All [ 189], via activation of protein kinase C [ 189]. In 
addition treatment of THP-1 cells with PMA also results in the induction of specific 
enzymes and proteins, including tissue lipoprotein lipase and apo E [ 190]. 
Figure 3.2 shows the difference in morphology in THP-1 cells and differentiated 
THP-l cells. THP-1 cells respond to PMA treatment by converting from a suspension cell 
line (figure 3.2A) to one that is adherent and spread (figure 3.2B). 
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Figure 3.2A 
Figure 3.2B 
Figure 3.2 
Photomicrographs showing morphology of dividing THP-1 cells in suspension (figure 
3.2A) and THP-l cells differentiated using PMA (250nM) for seven days (figure 3.2B) 
Cells were differentiated as described in the methods (section 2.1.2). Cells were 
photographed at x320 magnification. 
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3.5 Oil red 0 staining 
A commonly used histological technique for examining lipid stores in tissues and 
cells is Oil red 0 staining. This technique has also been used to examine lipid stores in 
THP-1 derived foam cells [ 160]. For Oil red 0 staining, THP-1 cells were differentiated 
on microscope slides for seven days. Cells were exposed to native or modified lipoprotein 
(0.2mg/ml) for twenty hours. Cells were then fixed and stained with a solution of Oil red 
0 to stain lipid droplets and subsequently counter-stained with Harris Haematoxylin to 
stain the cell nuclei as described in section 2.1.5. THP-1 cells in suspension were 
prepared for staining as described in section 2.1.5. 
THP-1 cells exposed to no lipoprotein and showed no Oil red 0 staining as 
expected (figure 3.3A). When THP-1 cells were differentiated and exposed to native 
LDL, lipid droplets were observed in small numbers in some of the cells (figure 3.3B). 
On exposure to either acetylated or oxidised LDL however, a larger number of lipid 
droplets were found to be present in most of the cells (figure 3.3 C&D). Thus Oil red 0 
staining confirmed that exposure of differentiated THP-1 cells to modified LDL resulted 
in the presence of a larger number of intracellular lipid droplets in comparison to cells 
exposed to native LDL. 
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Figure 3.3 A Figure 3.3 B 
Figure 3.3 C Figure 3.3 D 
Figure 3.3 
THP-1 cells and differentiated THP-1 cells (exposed to lipoprotein) and subsequently 
stained with Oil Red 0 and haematoxylin. Cells were photographed at x320 
magnification. 
Figure 3.3A 
Figure 3.3 B, C and D 
THP-1 cells stained with Oil Red 0 and haematoxylin (as 
described in section 2.15) 
Differentiated THP-1 cells exposed to 0.2mg/ml native, 
acetylated and oxidised LDL for 24 hours respectively. 
Cells were stained with Oil Red 0 and haematoxylin (as 
described in section 2.15). Arrows in 3.3 C&D point to 
cells containing lipid deposits. 
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3.6 Fluorescence microscopy of nile red stained cells 
Fluorescence labelling reagents can be used directly on cells to stain structures 
like DNA and lipids. Fluorescence dyes contain a chromophore structure, made up of 
conjugated bonds and related electronic structures that give the dye its colour [ 191]. 
Fluorescent dyes can produce fluorescence signals through excitation. Dyes can become 
excited by absorbing a photon of light. Once a dye has been excited, the intensity of the 
subsequent fluorescence depends on what happens to the energy of the excited 
chromophore. The excitation energy may be given off as heat, or emitted as a photon 
(fluorescence) or it could be transmitted to another dye molecule [ 191]. 
Greenspan et a/ [ 165] discovered nile red to be an excellent stain for lipid 
droplets. Nile red was found to be present as a minor component of the non-fluorescent 
lipid stain nile blue [ 165]. Nile red is a benzophenoxazone dye that is poorly soluble in 
water. It does, however, dissolve in a wide range of organic solvents including acetone to 
produce an intensely fluorescent solution [ 165]. Figure 3.4 shows the chemical structure 
of nile red. 
Figure 3.4 The chemical structure of nile red 
Treatment of cultured cells with a solution of nile red has been shown to produce 
an intense staining of cytoplasmic contents of cells when viewed by fluorescence 
microscopy [ 163]. To visually examine lipid loading of THP-1 cells, THP-1 cells were 
stained with nile red and examined using fluorescence microscopy. 
THP-1 cells were differentiated using PMA (250nM; as described in section 
2.1.2). After seven days, the cells were exposed to either native or modified LDL 
(0.2mg/ml) for twenty-four hours. Cells were washed well in PBS, stained with nile red 
( 1 OOng/ml) and examined using a Nippon episcopic inverted fluorescence microscope. 
A combination of three elements; an excitation filter, a dichroic mirror and a 
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barrier filter affect excitation techniques in episcopic fluorescence microscopes. Two 
different fluorescent wavelengths, yellow-gold fluorescence (excitation wavelength 450-
490nm) and red fluorescence [excitation wavelength 510-560nm] have been previously 
reported to be used to study nile red staining of macrophages by fluorescence 
microscopy. Thus here, cells were examined using these two different fluorescence 
wavelengths. Yellow-Gold fluorescence has been shown to be good at detecting 
cytoplasmic lipid droplets whereas red fluorescence has been reported not to resolve lipid 
droplets with a sufficient degree of clarity. In addition green fluorescence with a 
wavelength greater than 488nm was also used because nile red has an excitation 
wavelength of 488nm. 
Figure 3.5 shows photographs of fluorescence microscopy of differentiated THP-
1 cells exposed to native or modified LDL (0.2mg/ml for 24 hours), stained with nile red 
and viewed using the above three different fluorescent excitation wavelengths. 
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Figure 3.5 F Figure 3.5 G 
Figure 3.5 
Differentiated THP-1 cells exposed to native LDL (3.5A, 3.50 and 3.5F), AcLDL 
(3.5B) and OxLDL (3.5C, 3.5E and 3.5G) at a concentration of 0.2mg/ml of 
lipoprotein for 24 hours. Cells were stained with nile red (lOOng/ml) and viewed 
by fluorescent microscopy. Cells were photographed at x320magnification. 
Figure 3.5 A-C 
Figure 3.5 D&E 
Figure 3.5 F &G 
Cells viewed using green fluorescence, emission 
wavelength greater than 488nm. 
Cells viewed using yellow-gold fluorescence, emission 
wavelength 450-490nm 
Cells viewed using red fluorescence, emission wavelength 
510-560nm. 
Although fluorescence emjtted was not measured, visually one cou ld can see that 
from figure 3.5, cells exposed to modified LDL, stained with ni le red and viewed using 
green fluorescence (figures 3.5B and 3.5C) or yellow-gold fluorescence (figure 3.5E) 
showed greater fluorescence than cells exposed to native LDL (figures 3.5A and 3.50). 
Although cells exposed to native LDL (figure 3.5A and 3.50) did show fluorescence, the 
intensity of the fluorescence was less than that of cells exposed to modified LDL (figures 
3.5 B, 3.5C and 3.5E) 
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Cells viewed using red fluorescence (figures 3.5F and 3.5G) did show 
fluorescence but the cytoplasmic components of the cells were not resolved and therefore 
the difference in lipid droplets could not be examined. The results of this experiment 
correspond to the work of Greenspan et at. [ 165]. They found better resolution of the 
lipid droplets using yellow gold fluorescence than red fluorescence as is also 
demonstrated in this study. In addition as shown in figure 3.5 A-C green fluorescence 
showed good resolution of lipid droplets. This supports the fact that 488nm is the optimal 
excitation wavelength for nile red. 
3. 7 Flow Cytometry 
Fluorescence activated cell sorting (FACS) is a technique that has had a major 
impact on both basic and clinical research in the last two decades [ 191]. The major 
advantages of FACS are that it allows the rapid collection of quantitative measurements 
on a large number of individual cells and it helps to identify specific cell types from a 
heterogeneous mixture of cells. Fluorescent dyes are used as the means of detection in 
flow cytometry [ 191]. During flow cytometry, cells in suspension are moved through a 
set region of the flow cytometer where they are excited by one or more laser beams. The 
subsequent emissions are collected, separated, processed and recorded in a computer for 
individual cells as they flow one by one past a set region. 
Treatment of macrophages with a dilute aqueous solution of nile red has been 
found to produce an intense fluorescence staining of cytoplasmic lipid components (as 
already shown in figure 3.5). Several investigators including Hassall and Greenspan et al 
[ 163, 165] have thus used nile red in flow cytofluorometric analysis to assess foam cell 
formation. 
For flow cytometric analysis, cells were differentiated using 250nM PMA for 
seven days. After seven days, cells were exposed to varying concentrations (0-0.3mg/ml) 
of native, acetylated and oxidised LDL over different time periods. Cells were fixed in 
paraformaldehyde and stained with nile red (final concentration; I OOng/ml) for 5 minutes. 
Cells were then passed through the flow cytometer and the mean nile red fluorescence of 
emissions representing cholesteryl esters were collected from samples in triplicate. Nile 
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red stained cells were analysed using a Coulter EPIC flow cytometer. For nile red, an 
excitation wavelength of 488nm was used (standard wavelength produced by an argon 
ion laser found in most flow cytometers) and the emission spectra were collected. The 
parameters used in these experiments were based, where possible, on those reported by 
Hassall and Greenspan et at [ 163, 165]. 
The most common display method for flow cytometry data is called a dot plot. 
This is a two-dimensional display, in which two user selected parameters form the x and 
y-axis. Dot plots update the data from the samples in real time. The display data collected 
in these experiments was in two formats; the first display gave the shape (size of cell 
versus granularity of the cell). The second display format gave the fluorescence (cell 
count versus fluorescence). Analysis was performed routinely performed on 10,000 cells. 
Data was expressed as a ratio of forward scatter (size of the cell on the x-axis) and side 
scatter (granularity of the cell on the Y -axis). A gate was placed to include 90% of the 
cell population to prevent the inclusion of outlying data due to cell signal from cell 
debris. 
Fluorescence emission spectra were collected and separated using filters of 
different ranges (given in section 2.1.7) to separate triglycerides and cholesteryl esters 
(which have different emission spectra). Emission spectra representing triglycerides and 
cholesteryl esters were separated using a 590nm dichroic long pass filter. Emission 
spectra were then collected using a 51 0-80nm-band pass filter for triglycerides and a 
600nm long pass filter for cholesteryl esters. All fluorescence data collected was gated on 
forward scatter and the data was expressed as log fluorescence versus count. 
3.7.1 Confirmation of differentiation 
To determine whether PMA treatment resulted in differentiation of THP-1 cells 
from non-adherent cells to adherent cells, THP-1 cells and differentiated THP-1 cells 
were passed through the flow cytometer. Figure 3.6 shows dot plots of THP-1 cells 
(figure 3.6A) and THP-1 cells that have been differentiated into macrophages using PMA 
(figure 3.68). As can be seen from figure 3.6, differentiation of THP-1 cells leads to both 
an increase in size (forward scatter) and an increase in granularity (side scatter). THP-1 
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cells are all si milar in size and granularity whereas differentiated THP-1 cells show a 
much broader range of size and granularity. This result is in agreement with that 
previously reported [ 163]. In addition the changes matched well with the morphological 
changes seen under light microscopy (figure 3.2). 
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Figure 3.6B 
Flow cytometry dot plots of undifferentiated THP-1 cells (figure 3.6 A) and 
differentiated THP-1 cells (figure 3.6 B). The cells are gated on linear forward 
scatter (FS) and linear side scatter (SS) The box labelled A represents the gate 
placed around the cells to prevent inclusion of debris and cell clumps in the 
analysis. 
3. 7.2 Nile red fluorescence staining 
Figure 3.7 shows fluorescence emission profiles of THP-1 cell s that have been 
stained with nile red and unstained THP-1 cells. The emission profiles demonstrate, as 
ex pected, that staining with nile red leads to an increase in fluorescence as shown by the 
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shift to the right of the peak of fluorescence. The fluorescence emission spectra shown 
(FL3) are those corresponding to cholesteryl esters. 
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Figure 3.7B 
Comparison of two fluorescence emission profiles from differentiated THP-1 
cells without nile red (figure 3.7 A) and differentiated THP-1 cells stained with 
nile red (figure 3.7B). Count represents number of cells and FL3 LOG represents 
log fluorescence intensity emissions over 600nm cotTesponding to cholesteryl 
esters. The shift in the peak indicates an increase in fluorescence emissions. The 
lineD is a marker line set at fixed position from which changes can be measured. 
The basis of using nile red was that as levels of cholesteryl esters increase during 
foam cell formation, staining with nile red would be expected to resu lt in a greater 
fluorescence emission (an increase in fluorescence per cell). As cholesteryl esters 
accumulate, the peak of fluorescence emission shown in figure 3.7B would be expected 
to shift to the right. Thus measuring an increase in the mean nile red fluorescence of cells 
would be an indication of increased cholesteryl ester accumulation and foam cell 
formation. 
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3. 7.3 Nile red staining in response to modified WL 
Figure 3.8 shows a dose response curve of mean nile red emissions representing 
cholesteryl esters in differentiated THP-1 cells exposed to 0.05, 0.1, 0.2 and 0.3 mg/ml of 
native, acetylated or oxidised LDL The zero time sample represents lipoprotein depleted 
cells 
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Mean nile red tluroescence of differentiated THP-1 cells exposed 
to varying concentrations of native, acetylated and oxidised LDL 
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Figure 3.8 
Bar chart showing mean nile red fluorescence of differentiated THP-1 
cells exposed to 0, 0.05 , 0.1 , 0.2 and 0.3mg/ml concentrations of native, 
acetylated and oxidised LDL. Bars represent the mean + SO from three 
independent experiments in which each sample was performed in 
triplicate. * indicates significance difference (P= <0.05) between treatment 
(AcLDL or OxLDL) when compared to native sample at the same 
concentration 
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Exposure to native LDL results in an increase in fluorescence. Fluorescence levels 
show a significant increase (P< 0.01) nearly doubling on exposure to 0.05mg.ml of native 
LDL. This is expected as cells were cultured in lipoprotein depleted serum before the 
start of the experiment. With increasing concentration the levels of fluorescence remain 
constant eventually falling at a level of 0.3mg/ml of native LDL. This would be expected 
and would fit in with the model of native LDL uptake sufficient to meet the cells 
requirements before subsequent down-regulation of the LDL receptor. Exposure to 
AcLDL results in a linear increase (correlation coefficient = 0.99) in fluorescence upon 
increasing AcLDL concentration up to 0.2mg/ml with increase being significant between 
concentrations (P <0.002). At a concentration of 0.2mg/ml mean nile red fluorescence is 
significantly greater (P< 0.0002) in cells exposed to AcLDL than native LDL. Compared 
to AcLDL, OxLDL shows a slower increase in mean nile red fluorescence. This may be 
related in some way to the reported cytotoxic effects of OxLDL [ 192]. It can be 
postulated that the cells may have a more stringent control mechanism which limits the 
entry of OxLDL, however when sufficient OxLDL has entered this may override such a 
control mechanism. In addition other receptors may also become involved in the uptake 
of OxLDL. The dose response experiment demonstrated that the greatest mean nile red 
fluorescence was observed using a concentration of 0.2mg/ml AcLDL. To investigate this 
further a time course experiment was performed for up to 72 hours. 
Figure 3.9 shows a time course of mean nile red fluorescence of differentiated 
THP-1 cells exposed to native and modified LDL at a concentration of 0.2mg/ml for 
seventy-two hours. Cells exposed to both native and modified lipoprotein showed a time 
dependent increase in mean nile red fluorescence. Exposure to native LDL resulted in a 
increase in mean nile red fluorescence up to 72 hours, although the increase was not 
significant between any of the increasing time points except 0 and 4 hours (P < 0.001 ). 
Exposure to AcLDL lead to a increase in mean nile red fluorescence, which peaked at 24 
hours after which it began to decline. The 24 hour AcLDL time point showed a 
significant increase (P < 0.0002) in mean nile red fluorescence compared to the 8 hour 
AcLDL time point. In addition at 24 hours and 48 hour times points mean nile red 
fluorescence was significantly higher (P< 0.03) in cells exposed to AcLDL than native 
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LDL. This increase up to 24 hours followed by a decrease confirms the model that the 
cell may stop the uptake of lipoprotein once it has sufficient cholesterol to meet its needs. 
Mean nile red fluorescence of differentiated TIIP-1 cells 
exposed to 0.2mg/ml of native, acetylated and oxidised LDL for 
up to sevety- two hours 
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Bar chart showing mean nile red fluorescence in differentiated THP-cells 
exposed to 0.2mg/ml of either native, acetylated or oxidised LDL for 4, 8, 
24, 48 and 72 hours. Bands represent the mean+ SD of three independent 
experiments with each sample being performed in triplicate. * indicate 
significance difference (P= <0.05) between treatment (AcLDL or OxLDL) 
when compared to native sample at the same time point. 
Exposure to OxLDL leads to a linear increase (correlation coefficient = 0.93) in mean 
nile red fluorescence up to 72 hours. However OxLDL only showed a significantly 
greater mean nile red fluorescence than native LDL at 72 hours ( P < 0.004 ). 
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3.8 14C-oleate loading of differentiated THP-1 cells 
To study foam cell formation, Goldstein and Brown [ 16] demonstrated that mouse 
peritoneal macrophages that were exposed to AcLDL rapidly took up and internalised· 
AcLDL as compared to native LDL. They demonstrated this using cells incubated in the 
presence of 14C-oleate and AcLDL and subsequently measuring the formation of 
cholesteryl 14C-oleate. Thus stimulation of cholesteryl [14C] oleate synthesis is commonly 
used as a functional assay to measure lipoprotein uptake. Lipoprotein uptake leads to 
cholesteryl ester synthesis as part of the cholesteryl ester cycle (see section 1.9). 
Cells were seeded at a density of I x 106 cells/per ml medium as this was the 
density at which maximal uptake of modified LDL has been shown to occur [194]. It has 
been demonstrated by Rodriguez et a! [ 194] that cells plated at high density 
( 4x l06ml/well) took up five times less lipoprotein than cells that were plated at a lower 
density of I x 106 ml/well. 
THP-1 cells were differentiated into macrophages using PMA (250nM; as 
described in section 2.1.2). Although THP-1 cells have been shown to express scavenger 
receptors as early as three days [ 160, 185], cells were routinely maintained for seven days 
as previously reported [ 163] to allow full differentiation and maximal expression of the 
scavenger receptor although this was not measured. After seven days of differentiation, 
cells were exposed to native, acetylated or oxidised LDL at varying concentrations (0-
0.3mg/ml) for a time period for up to 72 hours in the presence of labelled oleate 
(prepared as described in section 2.1.8.1 ). Lipids were subsequently isolated from the 
cells and separated by TLC (as described in section 2.1.8.3). The amount of radioactivity 
in spots representing cholesteryl ester spots was counted in a liquid scintillation counter. 
The readings were corrected for percentage recovery using 3H cholesteryl oleate as an 
internal standard (added during the first step of lipid extraction; see 2.1.8.3). The amount 
of 14C incorporated into cholesteryl esters was then calculated and the results were 
expressed as micromoles of cholesteryl ester accumulation per I xI 06 cells. 
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Figure 3.10 
Bar chart showing accumulation of cholesteryl 14C oleate accumulation in 
differentiated THP-1 cells exposed to 0.05 , 0.1 , 0.2 and 0.3mg/ml of native 
acetylated and oxidised LDL for 24 hours. Results are from three sets of 
independent experiments in which each sample was performed in duplicate. Bars 
represent the mean +SO (standard deviation). * indicates significance difference 
(P< 0.002) between increasing concentrations (0 to 0.05, 0.05 to 0.1, 0.1 to 0.2 
and 0.2 to 0.3) of a particular treatment (native LDL, AcLDL or OxLDL). 
Figure 3.10 shows cholesteryl 14C oleate accumulation in differentiated THP-1 
cells that were exposed to 0.05, 0.1, 0.2 and 0.3mg/ml of native, acetylated or oxidised 
LDL for 24 hours. At concentrations of 0.1 and 0.2 mg/ml there was a significantly 
greater cholesteryl ester accumulation in cells exposed to modified LDL than in cells 
exposed to the equivalent amount of native LDL (P < 0.002). 
As can be seen from figure 3.10, native LDL did show a significant increase (P< 
0.001) in cholesteryl ester accumulation when the concentration of LDL was increased 
from 0.05mg/ml to 0.1 mg/ml , however no significant further increase was observed when 
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the concentration was increased to 0.2mg/ml and 0.3mg/ml. This confirms the data 
observed with native LDL in figure 3.8 (section 3.7.3) and probably reflects the cells 
ptior incubation with lipoprotein depleted medium. 
Although an increase of around two fold in 14C oleate incorporation was observed 
in these experiments with modified LDL, differentiated THP-1 cells have been shown to 
ex hibit up to a four-fold increase in the rate of 14C oleate incorporation into cholesteryl 
esters in response to culture with AcLDL by other investigators [165]. This experi ment 
showed a max imal cholesteryl ester accumulation using concentrations around 0.1 mg/ml 
and 0.2mg/ml of modified LDL. At a concentration of 0.3mg/ml, both AcLDL and 
OxLDL showed a significant decrease in cholesteryl ester accumulation compared to a 
concentration of 0.2 mg/ml (P <0.002). 
To further study the effect of time, cholesteryl ester accumulation was assessed in 
differentiated THP-1 cells exposed to 0.2mg/ml native, acetylated and oxidised LDL for 
24, 48 and 72 hours as shown figure 3. 11 
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Accumulation of cholesteryl 14C-oleate in differentiated THP-1 
cells exposed to 0.2mg/ml of native, acetylated and oxidised LDL 
for up to 72 hours 
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Bar chart showing accumulation of cholesterol 14C-oleate in differentiated 
THP-1 cells exposed to 0.2mg/ml native, acetylated and oxidised LDL for 
24, 48 and 72 hours. Results are from three sets of independent 
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experiments in which each sample was performed in duplicate. Bars 
represent the mean + SO for each experimental condition. * indicate 
significance difference (P= <0.01) between time points for a particular 
treatment (native LDL, AcLDL or OxLDL) 
As can be seen from figure 3.11 there was significantly greater cholesteryl oleate 
accumulation in cells exposed to modified LDL than cells exposed to native LDL at all 
the time points (P< 0.0003). Cells exposed to both AcLDL and OxLDL showed maximal 
accumulation at 24 hours. The accumulation of cholesteryl esters in cells exposed to 
native LDL was limited and showed a significant decrease after 24 hours (P< 0.0002). In 
cells exposed to AcLDL, the level of cholesteryl esters was maintained at approximately 
the same level after 48 hours and 72 hours with no significant difference between the 
time points. 
In cells exposed to OxLDL the cholesteryl ester accumulation decreased 
significantly after 24 hours (P <0.0002). At the 48 and 72 hour time points, the levels of 
cholesteryl ester accumulation was decreased by approximately 25% of the level after 24 
hours. This may be due to some of the cytotoxic effects of OxLDL including lipid 
peroxidation, which prevents the accumulation of cholesterol and results in cell death 
[ 192]. 
3.9 Assay for assessing cell viability 
A 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide MTT) assay for 
cell viability was performed. MTT can be cleaved by mitochondrial enzymes, mainly 
succinate-dehydrogenase, to form a dark blue crystalline product, formazan. This 
cleavage only takes place in living cells. The amount of formazan generated has been 
demonstrated to be directly proportional to the cell number [ 193]. 
Figure 3.12 shows that the percentage cells alive decreases in cells exposed to 
both AcLDL and OxLDL over time, however the decease is greater with OxLDL. This 
indicates there is more cell death on exposure to OxLDL, again consistent with its 
reported cytotoxic effects [ 192]. 
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MIT assay for assessing cell viability 
120 
Q,j 100 
... 
.... 
< 80 
.!a o 0 hr 
~ 
u 60 Q,j 
~ 
s 
= 40 Q,j 
• 24 hr 
• 48 hr 
• 72 hr 
C.l 
'"' Q,j ~ 20 
0 
Control Native illL AcillL Oxl.DL 
Treatment 
Figure 3.12 
Bar graph showing percentage cells alive in differentiated THP-l cells 
exposed to no LDL, native LDL (0.2 mg/ml), AcLDL (0.2mg/ml) and 
OxLDL (0.2mg/ml) for 0, 24, 48 and 72 hours respectively. After 
incubation with lipoprotein, cells were exposed to MTI (0.5mg/ml) for 
three hours at 37°C. The water-insoluble formazan was solubilised by 
adding HCl/Isopropanol(l :24). The OD value of each sample was 
measured using a test wavelength of 570 nm and a reference wavelength 
of 630nm. Results were expressed as %cells alive using the the zero time 
point to represent l 00% 
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3.10 Discussion 
The foam cell is the main constituent of the fatty streak, the earliest recognisable 
lesion of atherosclerosis. It also has been implicated to play a role in plaque stability in 
more advanced plaques and thus may be an appropriate therapeutic target. 
The overall aim of these experiments was to assess foam cell formation in the 
human THP-1 cell line. The human monocytic THP-1 cell line was used because of its 
close homology to human monocytes and because exposure to PMA leads to its 
differentiation into a cell line with human macrophage characteristics [184]. Lipid 
loading of THP- L cells was examined using native, acetylated and oxidised LDL because 
modified LDL is the major contributor of cholesterol for foam cell formation in vivo. The 
purpose of these experiments was to demonstrate that THP-1 cells could be differentiated 
using PMA and that these differentiated THP-1 cells could subsequently take up modified 
LDL and accumulate more cholesteryl esters than native LDL. 
Exposure of THP-1 cells to PMA was shown to result in their differentiation into 
THP-1 macrophages as shown by light microscopy (figure 3.2). Flow cytometry 
demonstrated that differentiation of THP- L cells leads to both an increase in size and 
granularity of the cells (figure 3.6). Thus flow cytometry confirmed the changes observed 
in cell morphology by light microscopy when THP- L cells were differentiated with PM A. 
Subsequently after confirmation of differentiation, four different methods were 
used to assess foam cell formation. Two of the methods; Oil red 0 staining and 
fluorescence microscopy were qualitative. The other two methods, nile red fluorescence 
staining and cholesteryl 14C oleate accumulation were quantitative. 
Oil red 0 staining showed that lipoprotein deficient THP-1 cells had no detectable 
lipid stores (figure 3.3A). In contrast both differentiated THP-1 cells exposed to native 
LDL and modified LDL both showed the presence of lipid droplets (figure 3.3B-3.3D). 
THP- L cells exposed to modified LDL however, visually showed a larger number of cells 
with lipid droplets and a greater number of lipid droplets when compared to cells exposed 
to native LDL. Again visually no detectable difference in lipid stores between the 
different forms of modified LDL used, namely AcLDL and OxLDL was observed. 
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Similarly cells exposed to lipoprotein, stained with nile red and viewed using 
fluorescence microscopy showed increased fluorescence staining in cells exposed to 
modified LDL (figure 3.5 B, C&E) as compared to cells exposed to native LDL (figure 
3.5 A&D). This was only observed in cells viewed for yellow-gold and green 
fluorescence (figure 3.5 A-E), as red fluorescence was found not to resolve the 
cytoplasmic contents of the cells (figure 3.5 F&G). This is in agreement with previously 
reported data [ 163]. 
Flow cytometry of nile red stained cells demonstrated an increase in mean nile red 
fluorescence in cells exposed to increasing concentrations of native and modified LDL 
(figure 3.8). Mean nile red fluorescence was found to be significantly higher in cells 
exposed to AcLDL over native LDL at a concentration of 0.2mg/ml lipoprotein. For 
OxLDL mean nile red fluorescence was found to be higher than native LDL at a 
concentration of 0.3mg/ml of lipoprotein. Time course data demonstrated an increase in 
mean nile red fluorescence in cells exposed to both native and modified LDL for up to 72 
hours (figure 3.9). Cells exposed to AcLDL showed a significantly greater mean nile red 
fluorescence than cells exposed native LDL by 24 hours. OxLDL however did not 
demonstrate this effect until 72 hours. 
Flow cytometry data from nile red stained cells showed that exposure to AcLDL 
lead to cholesteryl accumulation, which was greater than native LDL at a concentration 
of 0.2mg and at 24 hours. It also showed that accumulation of cholesterol esters was 
slower and required longer when OxLDL was used as the modified form of LDL. This 
may be due to the proposed cytotoxic effects of OxLDL that may result in a slower 
uptake of OxLDL by the cells, or in some cell death as demonstrated in figure 3.11. 
Loading with labelled cholesteryl oleate demonstrated a dose dependent increase 
in cholesteryl 14C oleate accumulation in differentiated THP-1 cells exposed to acetylated 
and oxidised LDL as compared to native LDL. However at high concentrations of 
lipoprotein (0.3mg/ml) there was significant decreased accumulation. 
Cholesterol loading data also demonstrated that a concentration of 0.2mg/ml of 
lipoprotein resulted in maximal cholesterol accumulation (in agreement with the flow 
cytometry results). Cholesteryl ester accumulation was lower using OxLDL than 
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equivalent concentrations of AcLDL. This is consistent with previously reported data and 
the possible cytotoxic effects of OxLDL. 
Time course data of cholesteryl oleate accumulation demonstrated maximal 
cholesteryl accumulation by 24 hours (again consistent with flow cytometry results). At 
longer exposure times there was a decrease in cholesteryl ester accumulation again 
possibly due to cytotoxic effects of excess lipoproteins. The cytotoxicity assay data 
suggests that data generated from cells exposed to modified LDL (especially OxLDL) for 
longer than 24 hours should be interpreted with caution. 
Both quantitative and qualitative methods used demonstrated that in our hands 
exposing differentiated THP-1 cells to modified LDL resulted in an increased 
accumulation of cholesteryl esters within the cytoplasm of the cell and foam cell 
formation when compared to native LDL. Furthermore the experimental data presented 
showed that maximal cholesteryl loading occurred at a concentration of 0.2 mg/ml of 
modified lipoprotein and after 24 hours, thus these two parameters were used in 
subsequent experiments aimed at identifying the alteration in gene expression induced by 
lipid loading in macrophages. In addition a 4-hour time point was also included to 
identify genes that are differentially regulated relatively early upon exposure to 
lipoprotein. 
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Chapter 4: Differential Gene Expression 
4.1 Introduction to the concept of gene expression 
The discovery of messenger RNA in the early 1960s led to the deciphering of 
the genetic code and the reporting of the protein synthesis pathway. It was at this time 
that the concept of gene expression was also introduced. RNA has a central role in 
allowing DNA to be translated to protein. As such it has often been seen as only an 
intermediary molecule or 'the servant' to DNA. However the recent discovery of 
RNA interference, has highlighted that RNA may have a more superior role than that 
attributed to it in the past [ 196 ]. 
Regulation of gene expression is a hallmark of many cellular processes [ 197]. 
Gene expression can specify cellular fate and define responses to stimuli [ 197]. 
Inappropriate expression of cellular genes, loss of tumour suppressor genes or 
expression of genes during interactions with pathogens can contribute to disease 
processes [ 197]. 
The theory behind identifying differentially expressed genes in disease 
processes is in fact an attempt to understand the underlying molecular mechanisms 
that may be involved. Identification of differentially expressed genes in experimental 
models could help understand biochemical pathways involved and reveal potential 
therapeutic targets [5]. 
Various methods are currently available for detecting and quantitating gene 
expression levels. The most commonly used include northern blots, differential 
display, quantitative RT-PCR and more recently serial analysis of gene expression 
(SAGE) [ 198] and microarray technology [ 197]. Newer techniques such as 
micorarray technology have largely resulted from the completion of sequencing 
projects which have included sequencing of the human genome [ 199]. As PCR 
revolutionised molecular biology in the late 1980s so array technology has had a 
major impact on molecular biology in the late 1990s and is likely to do so in this 
decade. 
In the early 90's several groups including Southern [200], Lennon [20 I], 
Drmanac [202] and Fodor [203] all simultaneously and independently proposed DNA 
arrays. Foder' s group used an approach similar to that used in the manufacture of 
computer chips. They combined the process of combinatorial chemistry with 
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photolithography and produced high density oligonucleotide microarrays. These 
arrays are manufactured in a series of cycles utilising masks and light directed 
synthesis. Short 25-mer oligonucleotide fragements are synthesised on a silicon wafer 
one nucleotide at a time. Each nucleotide carries a photo-labile protection group 
protecting the oligonucleotide from growing further. This photo labile group can be 
removed and further nucleotides added by illuminating with light [204]. The precise 
location of synthesis is determined by the mask. 
Utilising this approach the Californian based biotechnology company 
Affymetrix built the first commercial DNA array and registered the brand name 
GeneChip®. GeneChip probe arrays can contain as many as 1.3 million different 25-
mer oligonucleotide sequences and are now widely utilised within the scientific 
community. 
Since then, the array technology field has exploded with numerous companies 
and academic institutions providing arrays to the scientific community. In addition to 
oligonucleotide arrays, other variations of arrays have also been produced. These 
include arrays containing eDNA clones and PCR products arrayed on glass slide or 
nylon membranes at high density. Methods other than photolithography to 
manufacture arrays have also been reported. The company Agilent produces arrays 
using an inkjet synthesizer analogous to a inkjet colour printers where the dyes are 
replaced with oligonucleotide bases [205]. Several companies are using digital light 
processors where light is directed through mirrors rather than through a mask [206]. 
The main contributors to filter and glass based array technology have been the 
l.M.A.G.E consortium [207] and Patrick Brown's laboratory at the University of 
Stanford [208]. Others include Jeff Trent (National Human Genome Research 
Institute), Alan Robinson (European Rio-informatics Institute) and Geoff Childs 
(Albert Einstein College of Medicine) and Hans Lehrach (Max Plank Institute). In this 
study nylon membranes containing PCR products gridded at high density were used 
as previously reported [209] and will thus be the main focus. Two major supplements 
'The Chipping Forecast' and 'The Chipping Forecast II' have been published in 
Nature Genetics [210, 211 ]. These provide excellent reading to those unfamiliar with 
the area of microarray technology. 
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4.2 Introduction to array technology and differential gene expression 
Array technology is one of several approaches to comparatively analyse 
genome patterns of mRNA expression. The molecular basis of array technology is 
nucleic acid hybridisation [ 197[. The main advantage of array technology is that it 
allows investigators to study the expression of thousands genes in one experiment 
[ 197]. 
Briefly, messenger RNA is isolated from cells or tissues in the conditions to be 
compared. The isolated RNA is transcribed into eDNA probes and labelled. The 
labelled eDNA probes are subsequently hybridised to arrays containing eDNA 
sequences (either eDNA clones or PCR products) gridded at high density (gridded 
eDNA sequences correspond to genes and ESTs) or oligonucleotide sequences 
corresponding to a transcript of interest. 
There are numerous applications and potential applications of array 
technology including target discovery, pharmacogenomics, toxicogenomics and 
diagnostics [210-212]. Microarray technology has also been utilised for SNP 
discovery [213], resequencing [214[ and studying the role of RNA interference [215]. 
4.3 Designing eDNA arrays 
One of the first steps in the manufacture of a eDNA array is to obtain eDNA 
sequence data in the form of eDNA clones. The most commonly used sources are 
directly from public sequence databases including I.M.A.G.E. Genbank, dbEST or 
Unigene [207 ,216]. Once clones have been obtained, clones or PCR products 
(obtained from amplification of cloned inserts) representing specific genes or EST 
sequences are spotted onto a matrix to produce high-density eDNA arrays. The main 
types of matrix used for producing high-density eDNA arrays are nitrocellulose or 
nylon charged membranes and glass slides [208]. 
Single stranded DNA has been found to bind strongly to nitrocellulose 
membranes. In addition the binding occurs in a way that prevent the DNA strands 
from re-associating with each other but permits hybridisation to complimentary DNA 
[217]. Once the DNA has been arrayed it is usually cross-linked to the matrix by 
ultraviolet irradiation and then rendered single stranded by heat or alkali treatment 
before use [218]. 
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4.4 Experimental probe preparation and hybridisation 
Once eDNA arrays have been prepared, they are hybridised to labelled probes. 
Probes can be generated from either mRNA or total RNA isolated form the samples of 
interest. The purity and quality of the isolated RNA is a critical factor in the process 
1219]. 
Reverse transcription of the RNA is performed using an oligo dT primer, in 
the presence of a label to produced labelled I st strand eDNA [220]. This produces a 
labelled product from the 3'end of the gene, directly complementary to immobilised 
eDNA targets. The probe is then applied to the array for hybridisation to occur. For 
rare samples various amplification procedures can be utilised such as those reported 
by Eberwine eta/ [221 ]. 
4.5 Detection 
Hybridisation can be detected by radioactive methods, although fluorescently 
labelled probes such as Cy 3 and Cy 5 are also commonly used [220]. For radioactive 
detection, 33P dCTP is used as it has been found to produce a more defined spot image 
during phosphor imaging than 32P [209]. 
Hybridisation data of arrays hybridised with radiolabelled probes is captured 
using phosphorimage screens and a Phosphorimager. During analysis, local sampling 
of background is used to specify a threshold above which the signal must exceed. 
Computer software programs are then used to compare arrays from different samples 
and allow identification of differentially expressed genes. This methodology where 
differentially expressed genes between different samples are identified after 
hybridisation to identical eDNA arrays is referred to here as Differential Gene 
Expression (DGE). 
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4.6 Overview of Differential Gene Expression 
This overview will descri be how the eDNA arrays were prepared for the current work 
described in this thesis 
DGE can be splj t into five main stages as shown in Figure 4.1 (stages A-E). 
Figure 4.1 Overview of the steps involved in performi ng a DGE experiment 
B 1. Array containing PCR products 
i 
t 
! 
1 
B3. Send phosphoimagc results to 
database 
4.6.1 Preparation of eDNA Arrays 
t 
E I . Process images. mark position of 
markers and control genes. 
Set DNA loading data 
I 
E2. Compare Images. identi fy spots I 
showing greatest change in signal intensity 
.. 
E3. Send differences to database 
E4. Ident ify eDNA clones of interest 
As discussed above the first stage (Figure I; A l -A4) involves preparation of 
membranes with cDNAs arrayed at high-density (referred to as 'arrays') [209]. The 
arrays used in these experiments were prepared by the DGE group, Glaxo Wellcome. 
The first step in this process involves choosing the eDNA library or libraries 
that you interested in studying (in these experiment a re-arrayed human I.M.A.G.E 
library and a custom atheroma library were used; discussed below). The libraries 
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consisted of vectors that have cloned inserts corresponding to genes or EST 
sequences. The cloned inserts were amplified by PCR in 384-plate well format. The 
PCR products were subsequently gridded onto nylon membranes using a robotic 
arrayer (arrays a large number of PCR products to a very small set area) to produce 
identical arrays. 
All information regarding the library used, PCR conditions and gridding 
information are stored in a database that links every gridded product to an annotation 
giving the Gene/EST sequence information. After arraying, the DNA on the 
membranes is denatured to produce single stranded DNA and cross linked, to fix the 
DNA onto the arrays. 
The arraying of DNA was performed using an arraying robot (Genetix). A 
three axis controlled drive system carries a 384-pin head, which can be positioned at a 
resolution of 5jlm. PCR products can be arrayed in two patterns, a 5x5 pattern or a 
4x4 pattern (depending on the size of the library being used) see figure 4.2. 
Each 5x5 pattern contained a central ink guide dot surrounded by twelve PCR 
products spotted in a duplicate pattern. After hybridisation to experimental probe, the 
guide dot enabled automatic grid finding and subsequent automatic image analysis 
using computer software. When a smaller library was used, PCR products were 
spotted in a 4x4 duplicate pattern. Each 4x4 pattern contained eight PCR products 
arrayed in duplicate. Luciferase eDNA was also gridded at set positions on the array 
to be used as a marker and thus assisting image analysis. The 5x5 pattern and 4x4 
pattern of arraying are shown below. More information about arraying parameters is 
given in appendix 2. 
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4.6.2 11he human I.M.A.G.E collection and the custom atheroma array 
I 
\Gene and EST sequences are commonly deposited in Genbank (a publicly 
available database for sequence information). The human Unigene database [216] is 
an exp~rimental system for automatically assigning Genbank sequences into a set of 
I 
gene-m)ientated clusters. Some ESTs correspond with known genes, others represent 
\ 
partially sequenced novel genes. The aim of the Unigene project is to have one cluster 
corresp~:mding to one gene, however this aim has only been partially successful as 
there is: a large degree of redundancy within the database. 
The Human I.M.A.G.E collection was started by four academic groups with an 
aim to share resources on arrayed eDNA libraries from the Unigene collection and 
make these libraries available in the public domain [207]. The Unigene collection was 
used to create a master array containing a representative eDNA clone for each gene. 
Two separate sets of arrays were used in this study. The first set known as the 
human l.M.A.G.E arrays, represented a subset of the publicly available Human 
114 
Chapter4 Differential Gene Expression 
I.M.A.G.E library. The clones for this library were obtained from the human 
I.M.A.G.E collection and re-arrayed (by the DGE group) to produce a collection of 
clones of interest, representative of the human I.M.A.G.E collection. This was done in 
an attempt to reduce the level of redundancy. The size of this library resulted in this 
library being gridded over three separate membranes. Clones (45,000) were arrayed in 
duplicate in 5x5 patterns on 22cm x 22cm nylon membranes. 
Each human I.M.A.G.E array was also gridded with four commonly used 
housekeeping genes, f3-actin, elongation factor I (EF-1 ), glyceraldehyde phosphate 
dehydrogenase (GAPDH) and ribosomal protein L3 (RL-3) at a range of DNA 
concentrations. These genes were used as controls between arrays. As noted above, 
each PCR product was also gridded in duplicate; this was to enable examination of the 
reproducibility of the results obtained. Using the human I.M.A.G.E library in these 
experiments allowed a significant proportion of the human genome (that had been 
sequenced to date) to be studied. 
A second set of arrays referred to as the 'custom atheroma' arrays were also 
used in this study. The custom atheroma arrays contained a range of 769 genes/EST 
sequences chosen by the Vascular Diseases Unit at GlaxoWellcome as being of 
interest to their studies (a list of these genes is given in appendix 3). These clones 
were again chosen from the human I.M.A.G.E collection. In preparing the custom 
atheroma arrays, all PCR inserts amplified from the I.M.A.G.E clones were also 
sequenced after being gridded onto arrays (a list of genes whose sequence was 
confirmed are given in appendix 3). This was done to produce an array on which all 
the genes gridded had been sequenced to confirm their identity. 
The custom array contained 769 genes that were represented by I 035 clones. 
(Both the custom and I.M.A.G.E arrays contained genes that were represented by 
more than one PCR product). Including luciferase clones (luciferase eDNA was used 
as a marker) and blank controls, the custom atheroma array was represented by 1438 
PCR products. In addition, each PCR product was arrayed in duplicate and the whole 
library was gridded twice onto each membrane. Thus the custom atheroma arrays 
contained 5752 (l438x2x2) PCR products in total, and each PCR product was gridded 
in quadruplicate. The custom atheroma array was gridded in a 4x4-arraying pattern. 
Again control genes were also gridded onto the arrays. 
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4.6.3 Checking for amount of PCR products on arrays 
Stage two (Figure 4.1 B l-B3) involves checking the amount of DNA gridded 
onto the arrays as variation in the amount of PCR product between sets of arrays 
could generate false changes in gene expression. Before hybridisation is performed 
with the experimental probes, all arrays are hybridised with a 33P end labelled 
oligonucleotide specific to the eDNA flanking regions used in the eDNA library. This 
oligonucleotide specifically anneals to all the spotted PCR products on the array via 
complimentary binding to part of the plasmid vector sequence. The oligonucleotide 
used in this case for both the I.M.A.G.E and custom arrays was called M 13F 
(sequence given in section 2.4.3). M 13 F (20 pmoles) was radiolabelled for each set 
of arrays as described in section 2.4.3.1. The amount of label incorporated was 
determined by measuring radioactive emissions (cpm) before and after purification of 
the probe as shown in table 4.1. Although DNA loading probes were prepared 
independently, the probes were pooled and split before being hybridised to each set of 
arrays to provide an equal amount of DNA loading label across all the arrays. 
After hybridisation, the arrays were exposed to phosphorimaging screens and 
the phosphoimage analysis data was captured. This yields a measure of the DNA 
loading for every spot on the array. Therefore any differences in DNA loading can be 
accounted for between different arrays on a spot per spot basis. 
Figure 4.3 shows the phosphoimage of a human I.M.A.G.E array after 
hybridisation with the DNA loading oligonucleotide M 13F whilst figure 4.4 shows 
the phosphoimage of a custom atheroma array after hybridisation with a DNA loading 
oligonucleotide M 13F. After processing, the DNA loading images are assigned 
experiment numbers and stored in the DGE database until required. 
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Table 4.1 
Table showing percentage incorporation of label for DNA loading probes M 13F 
Experiment Counts before Counts after Percentage 
purification purification incorporation 
(cpm) (cpm) (%) 
(A) Control (no LDL) 5220 2705 52 
(B) Control (no LDL) 6820 2928 43 
(C) 24hr Native LDL 6308 3133 50 
(D) 24hr Native LDL 5850 3308 56 
(E) 4hr OxLDL 6189 1677 27 
(F) 4hr OxLDL 5339 1677 31 
(G) 24hr OxLDL 5271 2241 43 
(H) 24hr OxLDL 5965 1577 26 
(J) 4hr AcLDL 5234 1772 34 
(K) 4hr AcLDL 6201 1951 31 
(M) 24hrAcLDL 5157 2121 41 
(N) 24hr AcLDL 6217 2145 35 
117 
Chapter4 Differential Gene Expression 
Figure 4.3 
Phosphoimage of a Human I.M .A.G.E array after hybridisation with DNA 
loading oligonucleotide M L3F (which binds to every arrayed PCR product on 
the array) . Each spot on the array is a PCR product. Arrows points to control 
genes (which are arrayed in a 2-fold decreasing concentration). 
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Figure 4.4 
Phosphoimage of custom atheroma anay after hybridisation of DNA loading 
oligonucleotide Ml3F. Each spot on the anay represents a PCR product. 
Anow indicates control genes (anayed in a 2-fold decreasing concentration). 
4.6.4 Isolation of mRNA 
Stage three (Figure l Cl-C2) involves the preparation of the eDNA probes. 
This involves isolating messenger RNA from the samples of interest. RNA 
preparation from most cell lines is usually a straightforward procedure. Tissue 
samples and micro-dissections can be more difficult [222] . The problems of having 
rare amounts of starting material have been overcome by using strategies such as PCR 
amplification of total eDNA (using random primers) before labelling [223] . In this 
study direct messenger RNA isolation from samples resu lted in a low yield of RNA 
that was of poor qual ity (data not shown). To obtain a good yield of RNA of high 
quality, RNA was isolated in two steps (as described in section 2.4.1). First ly total 
RNA was isolated from the samples and subsequently messenger RNA was isolated 
from the total RNA. 
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After isolation the RNA was quantified by spectrophotometry to determine 
concentration and purity. This was to ensure that equal amounts of mRNA were used 
in eDNA probe preparation. Table 4.2 shows the yields obtained and the A26of A2so 
ratio used as a measure of purity (A26<V A2so ratio greater than 1.8 used as a measure of 
a relatively pure preparation of mRNA). 
Table 4.2 
Table showing RNA spectrophotometer readings at A26o and A2so and estimation of 
RNA concentration and purity. 
Sample A26o A2so A26ofA2so RNA yield Total mRNA 
reading reading ratio Jlg/Jll yield (Jlg) per 
I x 107 cells 
Control 0.586 0.285 2.05 0.47 4.7 
24hr Native LDL 0.580 0.280 2.07 0.46 4.6 
4hr OxLDL 0.926 0.448 2.06 0.74 7.4 
8hr OxLDL 0.606 0.321 1.89 0.49 4.9 
16hr0xLDL 0.490 0.254 1.92 0.39 3.9 
24hrOxLDL 0.387 0.188 2.06 0.31 3.1 
48hrOxLDL 1.117 0.542 2.06 0.89 8.9 
72hr0xLDL 1.773 0.860 2.06 1.42 14.2 
4hr AcLDL 1.253 0.604 2.07 1.00 10.0 
24hr AcLDL 0.385 0.190 2.02 0.31 3.1 
The isolated RNA was also subjected to agarose/formaldehyde electrophoresis 
to check its integrity (as described in section 2.4.1.4). Figure 4.5 shows mRNA 
isolated from differentiated THP-1 cells exposed to native and modified LDL that has 
been subjected to denaturing gel electrophoresis and subsequently stained with Syber 
Gold (as described in section 2.4.1.4.2). The presence of the 18S and 28S ribosomal 
bands confirms its integrity. Degraded RNA would be expected to show a smear 
below the 18S band. Rabbit heart total RNA was used a control marker. 
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Figure 4.5 
Agarose/formaldehyde gel electrophoresis of isolated mRNA showing 18S and 28S 
bands of RNA after staining with Syber Gold (each lane contains 0.5Jlg mRNA, 
except lane II which contains 0.6Jlg total RNA) 
Lane l mRNA isolated from differentiated THP-1 cells exposed to no LDL 
Lane 2 mRNA isolated from differentiated THP-1 cells exposed to native LDL 
Lanes 3-8 mRNA isolated from cells exposed to OxLDL for 4, 8, 16, 24, 48 and 
72 hours respectively 
Lanes 9-10 mRNA isolated from differentiated THP-1 cells exposed to AcLDL for 
4 and 24 hours 
Lane II control human heart total RNA 
4.6.5 Experimental probe preparation 
After mRNA isolation, 2J1g of mRNA (determined by spectrophtometry) from 
each sample was transcribed into radiolabelled eDNA probes as described in section 
2.4.4. The probes were purified and amount of radiolabel incorporated was measured 
by determining radioactive emission before and after purification of the probe. Table 
4.3 shows percentage label incorporated for the experimental probes. 
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Table 4.3 
Table showing percentage incorporation of label in experimental probe samples 
Experimental probe Counts before Counts after Percentage 
purification cpm purification cpm incorporation 
(%) 
Control A (no LDL) 5860 826 68 
Control 8 (no LDL) 6100 3956 65 
24hr Native C 5943 4833 81 
24hr Native D 5947 3731 63 
4hr OxLDL E 15239 7851 52 
4hrOxLDL F 13027 7575 58 
24hrOxLDLG 12784 7905 50 
24hr0xLDL H 14242 10472 73 
4hr AcLDL J 18224 10865 60 
4hr AcLDL K 14573 8954 61 
24hr AcLDL L 24365 14921 61 
24hr AcLDL M 13186 6203 47 
After preparation, the eDNA probes were subjected to formaldehyde gel 
electrophoresis (section 2.4.5) to check that they were intact and their size profile was 
of full length. Figure 4.6 is a phosphoimage of a gel with experimental eDNA probes. 
PCR products of known lengths (800bp, 900bp, 1.3kb and 1.5Kb) were run on the gel 
alongside the samples as markers. As the probes are larger in size (> 1.3Kb) than the 
PCR products they can be confirmed to be of full length. The intensity and location of 
the radioactive signal also indicates that the probes are intact. 
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Figure 4.6 
Phosphoimage of denaturing/formaldehyde gel showing full-length eDNA probes. 
Probe preparation (0.08f.lg mRNA per lane) was loaded in each well of the gel. 
Lane l, 2, 7 and 8 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Control markers; PCR products of size 1.5Kb, 1.3Kb, 
800bp and 900bp respectively (as indicated by arrows) 
4hr OxLDL eDNA probe 
24hr OxLDL eDNA probe 
4hr AcLDL eDNA probe 
24hr AcLDL eDNA probe 
All information regarding amount of mRNA used C211g of messenger RNA for 
each probe), its source (differentiated THP-1 cells) and other relevant information 
such as experimental treatment (native, acetylated or oxidised LDL), name of 
investigator were entered into a database where each probe was automatically 
assigned a unique identity number. 
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4.6.6. Hybridisation 
Stage four involves the actual hybridisation (Figure 4.1 D I). The full-length 
eDNA probes were allowed to hybridise to the arrays for 3 days as described in 
section 2.4.6. 
After hybridisation and washing, arrays were placed between a plastic sheet 
and cling film in developing cassettes and placed next to a phosphorimage screen for 
two days. The data on the phosphorimage screens was then captured using a 
Phosphorimager and edited using a computer software program called Image Quant. 
Unedited and edited files are given different names and stored in the DGE database 
until required. The unedited image files provided a back up should there be problems 
with the edited image files during comparisons. Raw data unedited image files were 
named according to the following convention 
the experimenter's initials (2 characters). 
day and month (4 characters). 
I character (a, b, c, d, etc ... ) for indicating more than one image generated by the 
same person on the same day. 
the last character was an L or H signifying either DNA loading (L) or eDNA 
hybridisation (H) image. 
Files were always named and stored as .gel files. 
4.6.7 Data Analysis 
Stage five involves data analysis (Figure IE). The data captured from the 
phosphorimaging screens were edited and stored as described above. The 
electronically captured data files (for DNA loading or eDNA hybridisation) were 
analysed using DGENT, a PC based piece of software developed by the DGE group at 
Glaxo Wellcome. 
The positions of all the corner spots of a hybridisation image were marked. 
Other parameters such as the position of the luciferase spots were also set (processing 
parameters are given in appendix 2). The DGENT application subsequently identifies 
the location of cell spots present (using the central ink spot and the luciferase marker 
spots) and then predicts where spots would have been present for those that did not 
generate a significant signal. Thus by this method every co-ordinate where a DNA 
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spot was gridded can be located. The intensities of all spot co-ordinates are measured 
and local background is subtracted. The intensities of all the co-ordinates of an image 
are then saved to the DGE database. 
4.7 Analysing DGE results 
Two different hybridisation images of interest were compared using the 
DGENT application (this piece of software also enables comparisons between arrays 
to be performed). Before a comparison was performed, the DNA loading image data 
was associated with the corresponding hybridisation data so that any differences in 
DNA loading are corrected for on a spot to spot basis when the comparison was 
performed. Normalisation was then set using either housekeeping genes, or the 
median array intensity. This ensures standardisation between arrays. Figure 4.7 shows 
DGE Windows software generated image for analysis of the control genes. Figure 4.7 
shows two graphs one for the control genes, elongation factor-! and ~-actin (top 
graph) and one for GAPDH and RL-3 (bottom graph). As can be seen from the 
graphs, EF-1 and ~-actin showed a linear relationship between DNA spot loading and 
eDNA hybridisation whereas GAPDH and RL-3 did not. Thus subsequently EF-1 and 
~-actin were chosen as the control genes for normalisation between arrays. 
Once DNA loading and normalisation steps had been performed within the 
DGE application, the two images of interest could be compared. The DGE software 
presented the results of such a comparison as a table showing the largest differences 
in eDNA hybridisation at the top. In the comparison table image spots were 
subsequently viewed a pair at a time, to verify that there was a clear difference as 
opposed to artefacts on the image. 
Figure 4.8 below shows a comparison between two I.M.A.G.E arrays. The 
table shows the largest differences found between the two arrays. Differences were 
sent to the DGE database where the co-ordinates of clones relating to observed 
differences can be identified. The link between a spot location on an array and the 
plate/well location and identity of the PCR product and eDNA clone it was derived 
from were deciphered using another piece of computer software called filter modules 
(software developed by the DGE group) as shown in Figure 4.9. 
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DGE Windows application image showing processed custom atheroma arrays in the background and graphs for control genes automatically 
generated by the DGE software. Top graph shows the genes elongation factor- I and ~-actin. Bottom graph shows the genes GAPDH and RL-3. 
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Figure 4.8 
DGE application showing two I.M.A.G.E arrays being compared. Two circles indicate spot being compared with top circle a spot present and 
bottom circle showing a spot absent. The software automatically presents the differences found as a table shown at the top. Luciferase marker 
spots are indicated and are clearly visible. 
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Image showing example of software used to interpret array comparison results. Comparison data is given in a table. The software also 
automatically generates a graph of raw intensity data. 
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The software lists the results in both table and graph format. The results were 
presented in table format sorted by the largest fold difference. The table also shows 
the unique database identifier (HGI number) for a eDNA clone, position of the spot 
(X, Y coordinates) in the filter and spot intensities I and 2 (these are uncorrected 
intensities, which are also plotted on a graph automatically generated by the 
software). The HGI number is subsequently used to find the identity of the clone and 
the gene/EST to which it corresponds. For the sequence verified atheroma arrays, the 
gene name could be determined immediately. However for 'hits' identified from the 
Human I.M.A.G.E arrays, it was necessary to identify the clones, prepare the PCR 
products and have them sequenced to determine their identity. 
4.8 DGE database access and features 
All information regarding eDNA library picking and arraying formats of PCR 
products was maintained within a database called the DGE database. The DGE 
database was maintained on a computer in the UK that was a central repository for all 
DGE data collected worldwide for Glaxo Wellcome. Data input into the central DGE 
database was performed through web based modules. These web-based modules were 
of four main types. 
(a) DGENT Image processing 
This was a windows based software package (developed by the DGE group), 
which processes arrays images, allows array comparisons and downloads the 
results to the database. 
(b) Bioinformatics spreadsheets 
These were Excel spreadsheets that are downloaded over the web and used in 
Excel 97. They allow the investigator to look at data in the database relating to 
comparisons, libraries, probes, blast results, arraying and plate/well locations 
of eDNA clones (as shown in Figure 4.9) 
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(c) Acquire on the Web 
These were data input modules that allow the investigator to input data into 
the DGE database including entering probe information, the library used for 
arraying, the name of the experimenter and comparisons performed. 
(d) Expression Profiling 
These link DGE comparisons and raw data to information about the clone, 
including descriptions from Unigene, Genbank and Blast searches. 
4.9 Discussion 
The work presented in this chapter has demonstrated in detail the steps 
involved in performing a DGE experiment. In addition the results obtained at each 
stage of the process have been presented. The results showed that mRNA isolated was 
successfully isolated from differentiated THP-l cells exposed to native, AcLDL and 
OxLDL and was used to synthesize I st strand eDNA probes. These eDNA probes 
were then hybridised to high-density eDNA arrays. Finally the hybridisation data 
obtained was processed and stored in a database for subsequent analysis to identify 
differentially expressed genes. 
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Chapter 5: Gene Regulation in response to native and modified LDL 
5.1 Introduction 
The aim of this study was to compare genes being regulated on exposure of 
differentiated THP-1 cells to native and modified LDL. A relatively new technique, 
referred to here as Differential Gene Expression (DGE) technology (but also referred 
to in the literature by a variety of terms including eDNA array technology and DNA 
chips) was used, rather than other commonly used molecular biology techniques to 
examine gene expression (such as differential display or RT-PCR). DGE technology 
has the advantage of allowing the expression of thousands of genes/EST sequences to 
be analysed simultaneously [ 197]. It should be noted that this technology was still in a 
developmental stage during the course of this thesis. This posed the challenge of using 
a technology that was not fully established. DGE experiments however were 
successfully performed as demonstrated in Chapter 4. In addition, the technology has 
now become widely accepted within the scientific community. 
5.2 Experimental design 
THP-1 cells were differentiated as described in the methods (section 2.1.2) 
Cells were then exposed to medium containing BSA but without FBS. This cleared 
the cells of any exogenous lipoprotein (section 2.1.2). At this stage the cells were 
ready for the addition of lipoprotein. Differentiated THP-1 cells were then exposed to 
native LDL, AcLDL and OxLDL (all at concentration of 0.2 mg/ml) for 24 hours. A 
sample of differentiated THP-1 cells exposed to media only (no lipoprotein) for 
twenty-four hours was used as a control sample. In addition two samples were also 
prepared from differentiated THP-1 cells exposed to AcLDL and OxLDL for four 
hours with the aim of identifying genes that were expressed early on after exposure to 
modified lipoprotein. Messenger RNA was isolated and labelled I 51 strand eDNA 
probes were prepared for the following samples (as described in sections 2.4.1. and 
2.4.4 ): -
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Control sample 
Native sample 
Gene regulation in response to native and modified LDL 
Differentiated THP-1 cells. This sample represented 
lipoprotein-depleted cells (cells were incubated in lipoprotein 
deficient medium; section 2.1.2.) 
Differentiated THP-1 cell exposed to 0.2 mg/ml native LDL for 
24 hours. This sample represented lipoprotein replete cells 
(compared to the control sample) since exposure to native LDL 
results in the availability of cholesterol. 
Acetylated samples Differentiated THP-1 cells exposed to 0.2 mg/ml of AcLDL for 
4 and 24 hours. These samples represented a non physiological 
ligand taken up specifically by scavenger receptors and a mild 
form of lipid loading 
Oxidised samples Differentiated THP-l cells exposed to 0.2 mg/ml of OxLDL for 
and 24 hours. These samples represented a more extreme and 
toxic form of lipid loading. 
The prepared probes were then applied to both custom atheroma arrays and 
human I.M.A.G.E arrays described; section 2.4.6. All mRNA samples were prepared 
from duplicate experiments and applied to duplicate sets of arrays independently as 
shown in figure 5.1 (two identical probes were separately prepared from two 
independently isolated mRNA samples obtained from two identically treated sets of 
cells: the probes were then applied to two separate but identical arrays). Arrays were 
then edited and processed using DGENT software as described (section 2.4.7). After 
processing, DNA loading images were associated with the experimental hybridisation 
images and normalisation set using control genes ~-actin and RL-3. Comparisons 
were then performed using DGENT software. 
Table 5.1 below lists the comparisons performed (for both the l.M.A.G.E and 
custom arrays). For each set of comparisons, samples were compared in both 
directions to determine up-regulated and down-regulated genes. As all samples were 
prepared in duplicate, 4 sets of data lists were generated for each comparison direction 
performed. (For array A being compared against array B there will also be the 
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duplicate samples C and D respectively, therefore comparisons performed will be 
AJC, AJD, B/C and 8/D). 
Figure 5.1 
Diagram showing steps involved in performing array comparisons. 
Differentiated THP-1 cells (sample 2; prepared 
from the same batch of cells as sample 1) 
Isolate mRNA and prepare 
1'1 strand eDNA probe 
Perform comparisons with arrays C and D (identical 
arrays to A and 8 but hybrldised to probes derived from a 
different experimental treatment (example native LDL) to 
analyse genes showing differential expression 
The four li sts of data obtained for each comparison were compared against one 
another and on ly differences that appeared in each of the data sets were identified as 
defin ite differences for that comparison. Thus a fina l comparison list of genes was 
compiled and this final comparison list was assigned a unique comparison 
identificat ion number. A li st of comparisons performed and the comparison 
identification numbers assigned is given in appendix 4. 
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Table showing a list of the comparisons perfonned and the aim of 
performing these comparisons. 
Comparsion 
Native versus control 
24hr OxLDL versus control 
24hr AcLDL versus control 
24hr OxLDL versus native 
24hr AcLDL versus native 
24hr OxLDL versus 
24hr AcLDL 
24hr OxLDL versus 
4hrOxLDL 
24hr AcLDL versus 
4hrAcLDL 
4hr OxLDL versus 4hr 
AcLDL 
To aim to identify 
Genes regulated by native LDL 
(lipid homeostasis) 
Genes regulated by OxLDL 
Genes regulated by AcLDL 
Genes regulated specifically due to OxLDL 
Genes regulated specifically due to AcLDL 
Genes regulated by OxLDL and not AcLDL 
and vice versa 
Genes regulated on early and late exposure to 
OxLDL 
Genes regulated on early and late exposure to 
AcLDL 
Genes regulated on early exposure to by 
OxLDL only and not AcLDL and vice versa 
5.3 Reproducibility of results 
As stated above, each sample used in this experiment was prepared in 
duplicate and applied to two sets of identical arrays (for both l.M.A.G.E and custom 
arrays). For each duplicate sample, the only common source was starting material 
(namely differentiated THP-1 cells) and lipoprotein preparation (native, acetylated 
and OxLDL). Messenger RNA preparation, eDNA probe preparation and 
hybridisation were all performed independently for each of the duplicate samples. 
This meant that each comparison could be performed four times in each direction and 
only those results appearing in every one of the four lists generated for that 
comparison were taken as definite differences for that comparison. 
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All genes on the arrays were gridded in a duplicate pattern (for both the 
custom atheroma and l.M.A.G.E arrays) therefore each gene was gridded at least 
twice. In addition for the custom atheroma array, some genes were gridded up to 
sixteen times (full gridding details given in appendix 3). In general, genes were 
included only when both 'spots' representing the gene were differentially expressed. 
Each array used in these experiments also contained commonly used housekeeping 
genes, ~-actin, GAPDH, RL-3 and EF-1. These housekeeping were used as controls 
between samples so that any variation in expression between arrays was normalised 
using the expression of levels of housekeeping genes. In these experiments, ~-actin 
and EF-1 were used. 
5.4 Sensitivity of detection 
The minimum fold difference used for detecting a change in expression of a 
gene in a particular comparison was 1.5 fold. Although this meant that genes showing 
a smaller fold difference were not detected, genes that were detected were more likely 
to be real changes rather than artefacts on the array. The DGE group has been able to 
detect changes as small as 1.2 fold; routinely however a 1.5 fold difference level was 
used. (The minimum fold change detectable was determined by the DGE group by 
comparing the expression levels of samples containing genes with a known fold 
difference [determined by northern blots and RT-PCR]. Messenger RNA was labelled 
into eDNA probes and hybridised to arrays. Arrays were subsequently analysed to 
determine the minimum fold difference that could be detected). 
During processing of arrays, background noise on the arrays was minimised 
using a threshold signal of 200 pixels. Thus only genes being expressed over the 
threshold value were automatically identified. This had the effect of excluding low 
abundance genes. A gene for example showing a change from 20 to 200 pixels has the 
same fold difference as one showing a change from I 0 to I 00 pixels, however the 
latter would be excluded due to the threshold value used. Using a threshold value 
however has the advantage of excluding background signal generated by the 
hybridisation image and subsequently following through a large number of false 
positives. Using messenger RNA rather than total RNA also increased the sensitivity 
of detection. 
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5.5 Results from custom atheroma array comparisons 
Due to the relatively large amount of data generated from these studies, the 
data obtained is not presented in its entirety in this chapter but has been given in final 
form in appendix 5 and appendix 6 (see attached CD). The data instead has been 
summarised overall in respect to total numbers of genes up- and down-regulated, 
genes showing highest up and down regulation, genes of interest, genes regulated 
specifically by OxLDL and AcLDL and possible function/roles of the genes during 
foam cell formation. The results presented here have focused on the custom atheroma 
arrays. Results from the human I.M.A.G.E arrays have been presented but are not 
discussed in detail. 
The genes on the custom atheroma arrays were chosen by the Vascular 
Diseases Unit at Glaxo Wellcome who were interested in studying gene expression in 
atherosclerotic plaques from patients who had died from myocardial ischemia. Thus, 
although this array was not designed specifically to look at genes thought to be 
regulated during foam cell formation, the array did contain genes with relevance to 
atherosclerosis such as inflammatory molecules, signalling molecules, 
lipoprotein/modified lipoprotein receptors and cytokines. 
As noted in chapter 4 the custom atheroma gird consisted of 769 genes 
represented by 1054 clones. The custom array results tables given in appendix 5 
(Excel workbook; named "appendix 5 custom array results") lists all the genes found 
to be differentially expressed for the comparisons performed. Each table lists the 
comparison, the name of the gene, the mean fold difference (since most of the genes 
on the array were gridded, and therefore detected, more than once), the standard 
deviation of the mean and the comparison number. As noted above, each PCR product 
was gridded at least twice on each array for both the I.M.A.G.E and custom arrays. In 
addition, for the custom atheroma array, most of the PCR products were arrayed 4 or 
8 times. Full arraying details are given in the atheroma array template (Appendix 3 
Excel workbook containing worksheet labelled "array template"; appendix 3.3). 
For the custom atheroma arrays, the arrays hybridised to the 4hr AcLDL probe 
did not produce hybridisation data of sufficient quality that could be processed. The 
reason why the custom arrays hybridised to the 4hr AcLDL probe producing poor 
hybridisation data is unclear, since mRNA was successively isolated and the eDNA 
for AcLDL probes was sufficiently labelled. However the failure could be attributed 
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to a number of other reasons including poor hybridisation of the probe to the array, 
problems with arraying of PCR products onto the membrane or problems with fixing 
and denaturing the DNA on the arrays. The 4hr AcLDL custom arrays were 
subsequently excluded from the comparisons on the basis that no data was produced 
from them. This meant that two of the comparisons that were intended to be 
performed were not performed. These were the AcLDL (24) versus AcLDL (4) and 
OxLDL (4) versus AcLDL (4) comparisons. Note that this only applies to the custom 
atheroma arrays. These comparisons were performed for the human I.M.A.G.E arrays. 
Unfmtunately repeating the experiment for this time point was not within the remit of 
the time slot allocated to perform DGE experiments. 
5.5.1 Total number of regulated genes 
Graph 5.1 below shows the numbers of genes showing up and down regulation 
for each of the comparisons performed using the custom arrays. For example for the 
native versus the control comparison, 54 genes showed a greater expression level on 
the arrays hybridised to the native LDL probe that the arrays hybridised to the control 
probe. Similarly 13 genes showed a greater expression on the arrays hybridised to the 
control probe when compared to the arrays hybridised with the native probe. 
Due to software limitations arrays could only be assessed in one direction, 
namely those that were up regulated (for example it was not possible for the software 
to determine when expression level of genes on arrays exposed to native LDL were 
less than that of genes on arrays exposed to control LDL). To determine these genes, 
one had to compare the level of genes on arrays exposed to control probe showing 
higher expression than genes on arrays exposed to native LDL probe. In other words 
only native > control and control > native comparisons could be performed and not 
native <control or control < native comparisons. 
An important point to note here is that the DGE experiments do not give 
absolute levels of expression; rather they simply compare levels of expression 
between two samples and look for differences between the levels which are then 
presented as a fold difference. Thus although the system detects expression levels (via 
the hybridisation intensities) these are not presented to the end user who receives only 
a fold difference due to software limitations. 
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As can be seen from graph 5.1, of all the comparisons performed, the greatest 
number of genes up-regulated are due to native LDL (when compared to control). The 
greatest number of down-regulated genes were due to AcLDL (24), (when compared 
to native LDL). When OxLDL (24) was compared with AcLDL (24), there were more 
genes up-regulated due to OxLDL (24) than due to AcLDL (24). This could be 
consistent with the fact that OxLDL is thought to be a more potent ligand than 
AcLDL due to the presence of oxysterols in OxLDL. However when compared to 
native LDL both AcLDL (24) and OxLDL (24) showed more genes down-regulated 
than up-regulated. 
The tables below (Table 5.2 - Table 5.9) show the top five up- and down-
regulated genes for each of the comparison performed (where there were less than 
five genes found , all the genes are listed). Gene functions, where known, are given in 
brackets and were derived from the Genecards database (at the internet site 
http://www.nciamty .nci .nih .gov/cards; reference [224]). The tables also give the mean 
fold difference and the standard deviation. Full tables of results in are given in 
appendix 5. 
138 
Chapter 5 Gene regulation in response to nati1•e and modified LDL 
5.6. Genes regulated on exposure to lipoprotein 
5.6.1. Native LDL versus control 
This comparison compared cells exposed to native LDL (the physiological 
form of LDL, found in vivo) with control cells that were depleted of lipoprotein. This 
represents a lipid-depleted and lipid-replete situation where exposure to lipoprotein 
results in the availability of cholesterol and triglyceride to some extent. As would be 
expected in such a situation, this comparison contains a large number of up-regulated 
genes. This comparison showed 53 genes up-regulated (native > control) and 16 
down-regulated (control > native). The top up and down regulated genes are given in 
table 5.2. It is worth nothing that GAPDH, a commonly used housekeeping genes in 
expression studies showed a 4.2 fold change in expression. 
5.6.2. AcLDL (24) versus control 
This comparison compared expression levels of genes in cells exposed to 
AcLDL (at 24 hours) with control cells (lipid-depleted cells). This comparison 
showed 6 genes up-regulated and 17 genes down-regulated on exposure to AcLDL for 
24 hours. Table 5.3 shows the most highly up- and down-regulated genes. The aim of 
this comparison was to identify genes being regulated by AcLDL, however it does not 
take into account that native LDL may also regulate these genes. Genes showing 
expression specifically due to AcLDL are identified through the AcLDL versus native 
comparison (given below). 
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Table 5.2 Table showing up and down-regulated genes when comparing native 
LDL with control 
Comparison: native versus control 
Name of gene Fold Standard 
difference deviation 
up-regulated 
Activator-!, 37kD subunit 8.30 0.99 
Human mRNA for KIAA0201 gene 8.25 2.35 
(human protein; unknown function) 
Homo sapiens GlcNH2-3-0-S04 sulphoT 8.20 0.42 
Human mRNA for XP-C repair complementing 7.45 0.78 
protein (p581HHR23B) 
Human ribosomal protein L37a mRNA sequence 7.35 1.12 
(ribosomal protein) 
down-regulated 
HLA-2 7.35 2.90 
Matrix metalloproteinase 2 (collagenase type IV) 4.85 1.98 
(involved in tissue and ECM degradation) 
Complement component I, S subunit 4.80 0.28 
13 -cantenin 4.20 1.46 
GAPDH 4.15 1.46 
(housekeeping gene) 
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Table 5.3 Table showing up- and down-regulated genes when comparing AcLDL 
(24) with control 
Comparison AcLDL (24) versus control 
Name of Gene Fold Standard 
Difference deviation 
up-regulated 
IL-l~ (inflammatory molecule; chemoattractant 3.73 1.21 
and sustains the inflammatory response) 
Human ribosomal protein L37a 2.70 0.36 
Lymphocyte cytosolic protein 1 (L-plastin) 2.25 0.07 
Human mRNA for translationally controlled tumour 2.02 0.15 
protein (found in healthy and tumor cells) 
Thymosin beta l 0 2 0.00 
(thymic hormone ) 
down-regulated 
MMP-2 (type IV collagenase) 20.10 9.90 
GAPDH 8.05 1.77 
Human alpha enolase mRNA 7.00 0.57 
(glycolysis enzyme) 
Moesin 5.60 2.55 
~ actin mutant 1.75 0.71 
(Ubiquitously expressed gene) 
5.6.3 OxWL (24) and OxWL (4) versus control 
These comparisons compare expression levels of genes in cells exposed to OxLDL (at 
4 and 24 hours with the control (lipid-depleted cells). This comparison showed 13 
genes up-regulated on exposure to OxLDL for 4 hours and a higher number, 18 genes 
up-regulated on exposure to OxLDL for 24 hours. Both time points showed similar 
numbers of genes down-regulated (6 and 7 for the 4 and 24 hour time points 
respectively). Thus although the number of genes regulated by OxLDL is less than 
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those by native LDL it is higher than the number regulated by AcLDL. In addition, as 
would be expected there are more genes up-regulated by OxLDL after 24 hours than 4 
hours. Table 5.4 and 5.5 show the most highly up and down-regulated genes for the 4 
hour and 24 hour OxLDL time points respectively. These comparisons aim to identify 
genes being regulated by OxLDL however similar to the AcLDL versus control 
comparison these comparisons do not take into account that these genes may also be 
regulated by native LDL. Those genes showing expression specifically due to OxLDL 
are identified through the OxLDL versus native comparisons (shown below). 
Table 5.4 
Table showing up- and down-regulated genes when comparing OxLDL (4) with 
control 
Comparison OxLDL (4) versus control 
Name of gene Expression Standard 
level deviation 
Up-regulated 
GAPDH 11.85 9.83 
Epithelin 12 10.50 7.92 
Guanine nucleotide binding protein Rho 6.25 1.20 
Profilin 5.15 0.07 
Urokinase (uPA) 3.75 0.49 
Down-regulated 
Lipocortin II (calcium regulated; involved in 5.15 0.64 
exocytosis, may have an anti-inflammatory 
role) 
Wnt-13 3.45 0.95 
(involved in cell/tissue development) 
p21 homologue 3.35 1.11 
~2 microglobulin gene 2.20 0.14 
23 Kd highly basic protein 2.05 0.07 
(60s ribosomal protein) 
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Table 5.5 
Table showing up- and down-regulated genes when comparing OxLDL (24hr) with 
control 
Comparison: OxLDL (24) versus control 
Name of Gene Fold Standard 
difference deviation 
up-regulated 
Metallothionein 26.2 4.53 
(binds various heavy metals) 
Homo sapiens Wnt-13 rnRNA 10.0 0.88 
Human mRNA for KIAA0312 gene 6.30 1.76 
(human protein; unknown function) 
Human mRNA for lymphocyte function associated 5.55 0.07 
antigen-3 (LFA-3) 
CD36 4.55 0.64 
(macrophage scavenger receptor; binds OxLDL) 
down-regulated 
MMP-2 (collagenase type IV) 6.10 0.57 
~-actin 6.05 0.78 
GAPDH 5.38 3.15 
Human alpha enolase mRNA 4.74 1.67 
Profilin (103191) 3.8 0.14 
5.6.4 Genes regulated specifically by AcWL 
This comparison compared expression levels of genes in cells exposed to 
AcLDL (for 24 hours) with cells exposed to native LDL (for 24 hours) in order to 
identify genes being regulated specifically by AcLDL. This comparison showed only 
I gene up-regulated and 30 genes down regulated on exposure to AcLDL. Table 5.6 
shows the most highly up and down-regulated genes over 24 hours. 
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Table 5.6 Table showing up- and down-regulated genes when comparing AcLDL 
(24) with native LDL (24) 
5.6.5 Genes regulated specifically by OxLDL 
Comparison AcLDL(24) versus native 
Name of gene Expression Standard 
level deviation 
up-regulated 
Interleukin- I~ 1.60 0.00 
down-regulated 
Human mRNA for fibronectin (involved in 6.25 1.71 
cell adhesion, cell motility, wound healing 
and maintaining cell shape) 
14-3-3 protein, theta isoform 5.90 3.25 
CD36 5.80 0.64 
Human RPS3a gene 5.78 0.94 
(ribosomal protein) 
Human cyclophilin like protein mRNA 5.5 2.12 
This comparison compared expression levels of genes in cells exposed to 
OxLDL (at 24 hours) with cells exposed to native LDL in order to identify genes 
specifically regulated specifically by OxLDL. This comparison showed 8 genes up-
regulated and 20 genes down regulated. Table 5.7 shows the top highly up and down-
regulated genes. Note that the 4hr OxLDL was not compared to the native sample as 
the native sample had been prepared by exposing cells to native LDL for 24 hours. (A 
sample of cells exposed to native LDL for 4 hours would be required to perform this 
comparison, which was not prepared for this study due to limitations in the number of 
DGE experiments that could be performed). 
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Table 5.7 
Table showing up- and down-regulated genes when comparing OxLDL (24) with 
native LDL (24) 
Comparison Ox LDL(24) versus native 
Gene name Fold Standard 
difference deviation 
Up-regulated 
Metallothionein 7.30 3.29 
Human c-jun proto oncogene 3.75 1.10 
Homo sapiens mRNA for alpha (I ,2) 2.75 0.07 
fucosyltransferase 
MMP-2 (type IV collagenase) 2.55 0.49 
Proliferation associated gene (pag) 2.25 0.07 
(enhances natural killer cell activity) 
down-regulated 
Fibronectin 7.38 2.04 
Human mRNA for fibronectin precursor 7.18 1.21 
Human Mac-30 mRNA 6.28 1.28 
Myosin regulatory light chain 5.44 0.94 
Profilin 5.00 0.28 
5.6.6 Genes regulated specifically by AcWL and OxLDL 
This comparison compared expression levels of genes in cells exposed to 
OxLDL (24 hours) with cells exposed to AcLDL (24 hours) in order to identify genes 
being regulated specifically by OxLDL or AcLDL. This comparison showed 15 genes 
up-regulated (OxLDL > AcLDL) and I gene down-regulated (AcLDL > OxLDL). 
Table 5.8 shows the most highly up and down-regulated genes over 24 hours. 
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Table 5.8 
Table showing up- and down-regulated genes when comparing OxLDL(24) with 
AcLDL(24) 
Comparison OxLDL(24) versus AcLDL(24) 
Name of gene Expression Standard 
level deviation 
up-regulated 
LFA-3 transmembrane variant 6.55 2.67 
CD36 5.70 1.98 
~- tubulin 4.98 1.71 
Human mRNA for KIAA0312 gene 4.80 0.57 
Wnt-13 4.25 0.21 
Down-regulated 
Interleukin-1 ~ 1.55 0.07 
5.6.7 Genes regulated after early and late exposure to OxLDL 
This comparison compared expression levels of genes in cells exposed to 
OxLDL at 24 hours with cells exposed to OxLDL at 4 hours in order to identify genes 
being regulated early and late after exposure to OxLDL. This comparison showed 4 
genes up-regulated [OxLDL (24) > OxLDL (4)] and 5 genes down-regulated [OxLDL 
(4) > OxLDL (24)]. Table 5.9 shows the most highly up- and down-regulated genes 
over 24 hours. 
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Table 5.9 
Table showing up- and down-regulated genes when comparing OxLDL (24) with 
OxLDL (4) 
Comparison OxLDL(24) versus OxLDL(4) 
Gene Name Expression Standard 
level deviation 
Up-regulated 
~- tubulin 3.35 0.49 
Lymphocyte cytosolic protein I (L-plastin) 3.30 1.41 
Wnt-13 2.25 0.21 
Human B2 microglobulin gene 2.10 0.57 
Vimentin 1.55 0.07 
down-regulated 
lnterleukin-1 ~ 2.10 0.42 
Human collagenase inhibitor mRNA 1.83 0.17 
(inhibitor ofMMPs) 
p53 activated fragement-1 (found in tumours) 1.68 0.18 
Human ribosomal protein L37a mRNA 1.61 0.16 
(ribosomal protein) 
5.6.8 Discussion of results from the custom atheroma arrays 
As can be seen from tables 5.2 - 5.9 and appendix 5 there are some genes that 
appear in more than one of the comparisons performed. Of interest with relevance to 
foam cell formation these genes included CD36, TIMP-1, interleukin-1 ~- CD36 is a 
member of the scavenger receptor family that is a major receptor for OxLDL. TIM P-I 
is an inhibitor of the MMP family. IL-l~ is produced as part of the inflammatory 
response. 
As noted above when a comparison was performed, four lists of genes were 
generated for each direction in which the comparison was performed. Subsequently 
only genes appearing in all four lists were included in the final list of genes for the 
comparison in the direction performed. This did however mean that there was a high 
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'drop out rate' of genes, which were excluded from the final results. In addition it 
meant that in some cases that genes did not appear in comparisons or across all 
comparisons that they would have been expected to appear in. However it does mean 
that the results listed can be taken with high degree of confidence. 
5.7 Genes regulated by native and modified LDL 
5. 7.1 Genes regulated by native WL 
Exposure of lipoprotein-depleted differentiated THP-1 cells to native LDL 
resulted in a larger than expected number of regulated genes (Graph 5.1; when 
compared to AcLDL and OxLDL). This may be attributed to the control used in these 
experiments (differentiated THP-1 cells that were depleted of lipoprotein). Genes up-
regulated on exposure to native LDL included cytokines such as platelet-derived 
growth factor A, interferon y and IL-l~- In addition cytokine receptors such as the 
interleukin-1 receptor and tumour necrosis factor 1 were also found to be up-
regulated. Other genes of interest found to be up-regulated included thrombomodulin, 
fibronectin, stromelysin, collagenase, collagenase inhibitor, protein kinase C inhibitor 
and osteonectin. Genes of interest that were found to be down-regulated on exposure 
to native LDL include alpha enolase, fibronectin receptor beta subunit and MMP-2. 
(all genes up- and down-regulated are listed in appendix 5 atheroma results). Some of 
these genes such as IL-l~ and MMP-2 have been implicated in the atherosclerotic 
process so it was interesting to determine whether subsequent comparisons of the 
native sample with OxLDL and AcLDL samples resulted in an increased or decreased 
level of expression of these genes. In addition the expression of these genes could 
suggest that THP-1 cells (and possibly macrophages in vivo) may (to a certain degree) 
be already sensitised to the subsequent assaults produced by the modified forms of 
LDL (namely AcLDL, the mild fom1 of lipid loading and OxLDL the more toxic form 
of lipid loading). 
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5. 7.2 Genes regulated by modified LDL 
Table 5.10 below lists the genes showing differential expression specifically 
on exposure to AcLDL, OxLDL or both. This list is derived from comparing genes 
regulated in the AcLDL and OxLDL with native LDL comparisons 
Table 5.10 Table showing a list of genes differentially expressed on exposure 
showing specific regulation by either OxLDL/AcLDL or both. 
Genes regulated by 
AcLDL 
Interleukin -1 ~ 
Human RPSA3A gene 
Lipocortin III Annexin II 
Human Ferritin H chain 
Genes regulated by 
OxLDL 
23kd highly basic 
protein 
CD36 
Metallothyonein 
Genes regulated by both 
OxLDL and AcLDL 
TIMP-1 
Nidogen 
Thymosin beta 4 
Proliferation association Alpha enolase 
gene 
Fibronectin 
Wnt-13 
Translationally controlled 
tumour protein 
5. 7.3 Genes regulated specifically by AcWL 
Uptake of modified LDL by macrophages induces the expression of a range of 
growth factors and cytokines many of which have been localised within 
atherosclerotic lesions such MCP-1, TN F-a, MCP-1, IL-8, IL-l and M-CSF [ 114 ]. In 
this study we did not detect any of these cytokines except IL-l~· This could be due to 
a number of reasons; including the fact that in general, cytokines tend to be expressed 
at low levels. Furthermore as these cytokines are involved in the initiating the earliest 
events of atherosclerosis, their expression is likely to occur very early on after 
exposure to lipoprotein. The time point (24 hours) used in this study may thus be too 
late to detect their expression or alternatively the concentration of native LDL used 
(0.2 mg/ml) may be too low or too high to induce their expression at detectable levels. 
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AcLDL also represents a 'pure' ligand with no pathology and simply demonstrates the 
scavenging function of macrophages. 
(a) IL-l~ 
IL-l~ is produced as part of the inflammatory response. It is a chemoattractant 
for T -cells and is known to sustain the inflammatory response. In addition it has also 
been reported to induce the expression of MCP-l from the endothelium [225]. Thus 
IL-l~ plays an important role during the initial stages of atherosclerosis by acting as a 
chemoattractant and during the later stages by sustaining the inflammatory process. 
When comparisons were performed, the AcLDL (24) sample showed an 
increased fold expression in IL-l~ when compared to both the native sample and 
OxLDL (24) samples. A 1.6 (+/- SD 0.00) fold higher expression was found in 
AcLDL (24) sample compared to the native sample. Furthermore when compared 
with the OxLDL (24) sample, there was a 1.6 (+/- SD 0.07) fold higher expression in 
the AcLDL (24) sample compared to the OxLDL (24) sample. IL-l~ was also found 
to show 2.1 ( +/- SD 0.42) fold higher difference in the OxLDL (24) sample when it 
was compared with the OxLDL (4) sample. This indicates that levels of IL-l~ 
increase over time on exposure to OxLDL. 
(b) Annexin II 
Another gene found to be regulated specifically due to exposure to AcLDL 
was annexin II. Annexin II is calcium regulated membrane-binding protein whose 
affinity for calcium is greatly enhanced by anionic phospholipids. It may also cross-
link plasma membrane phospholipids with actin and the cytoskeleton and be involved 
with exocytosis. Furthermore annexins are also thought to play a role in inflammation 
by acting as anti-inflammatory molecules. 
When comparisons were performed, the AcLDL (24) sample showed a 
decreased fold expression of Annexin II when compared to both the native and 
OxLDL (24) samples. A 3.75 (+/- SD 0.86) fold higher expression was found in the 
native sample compared to the AcLDL (24) sample. Similarly when the AcLDL (24) 
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was compared to the OxLDL (24) sample, a 3.10 (+/-SO 0.38) fold higher expression 
was found in the OxLDL (24) sample. These results indicate that exposure of cells to 
AcLDL results in a decrease in annexin when compared to native LDL and OxLDL 
over 24 hours. As noted above, the annexins are thought to act as anti-inflammatory 
molecules thus a decrease in their expression (when compared to native LDL) is not 
surprising since atherosclerosis is known to be an inflammatory process. 
(c) Ferritin 
Another gene also found to be specifically regulated on exposure to AcLDL 
was ferritin. Ferritin is an intracellular molecule that stores iron in a soluble, non-toxic 
readily available form. It is also an acute phase reactant. 
Similar to Annexin II, ferritin also showed a decreased expression in the 
AcLDL (24) sample when compared to the native and OxLDL samples. A 4.10 (+I-
SD 0.57) fold higher expression was found in the native sample compared to the 
AcLDL (24) sample. When the AcLDL (24) was compared to the OxLDL (24) 
sample, a 3.5 (+I- SO 0. 70) fold higher expression was found in the OxLDL (24) 
sample. These results indicate that exposure of cells to AcLDL results in a decrease in 
ferritin when compared to native LDL and OxLDL over 24 hours. 
5. 7.4 Genes regulated specifically by OxLDL 
(a) CD36 
CD36 is a glycoprotein that has been found to be a scavenger receptor for 
OxLDL. It is a member of the scavenger receptor family class B and has been 
reported to be expressed in THP-1 cells [22]. In addition CD36 has been found to be 
significantly expressed in atherosclerotic foam cells from coronary arteries [23]. 
When comparisons were performed, the OxLDL (24) sample showed an increased 
expression in CD36 when compared to both the control sample and AcLDL (24) 
samples. A 4.55 ( +/- SO 0.64) fold higher expression was found in the OxLDL (24) 
sample than the control sample. When compared with the AcLDL (24) sample, there 
was a 5.70 (+/- SO 1.98) fold higher expression in the OxLDL (24) sample. 
Furthermore when the native LDL sample was compared with AcLDL (24), there was 
,_, - --· --· -·~-- _,_,· ___ , __ -· 
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a 5.80 fold (+/-SO 0.64) higher expression found in the native LOL sample. These 
results indicate that exposure of cells to OxLOL leads to a specific increase in C036 
levels when compared to control and AcLOL (24) samples. In addition the native 
versus AcLOL (24) comparison suggests that C036 levels decrease on exposure to 
AcLOL. A possible explanation for the decrease seen in the AcLOL (24) sample 
could be that there is an increase in the expression of other receptors for AcLOL 
resulting in a decrease in C036 expression. 
This result for C036 gives credence to the validity of our model as it suggests 
that foam cell formation has occurred in the experimental system under investigation 
(differentiated THP-1 cells exposed to modified LOL). Furthermore it provides 
confidence that the experimental array technology being used here is capable of 
detecting this change. 
(b)Wnt-13 
Another gene showing increased levels on exposure to OxLOL was Wnt-13. 
The precise role of Wnt-13 is unknown, however it is thought to be involved in 
cell/tissue development. It thought to be a signalling molecule, which affects the 
development of discrete regions of tissues. It may also be associated with the 
extracellular matrix and be involved in normal development or differentiation as well 
as in carcinogenesis. 
When comparisons were performed, the OxLOL (24) sample showed an 
increased fold expression in Wnt-13 when compared to native, AcLOL (24) and 
OxLOL ( 4) samples. A 1.7 ( +1- SO 0.14) fold higher expression was found in the 
OxLOL (24) sample when compared to the native sample. When compared with the 
AcLOL (24) sample, there was a 4.25 ( +1- SO 0.21) fold higher expression in the 
OxLOL (24) sample. Finally when compared to the OxLOL (4) sample there was a 
2.25 ( +1- SO 0.21) higher fold expression in the OxLOL (24) sample. These results 
indicate that exposure of cells to OxLOL (24) leads to an increase in Wnt-13 levels 
when compared to native, AcLOL (24) and OxLOL (4). Since the function of this 
gene has not been fully elucidated it and the results presented here indicate an 
increase in its expression, it would be of interest to perform further in vitro 
experiments with respect to this gene. 
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(c) Metallothionein 
Another gene found to show increased expression in response to OxLDL was 
metallothionein. Metallothioneins have a high content of cysteine residues that bind 
various heavy metals; they are transcriptionally regulated by both heavy metals and 
glucocorticoids. The member of the metallothionein family expressed here binds to 
zinc. 
When comparisons were performed, the OxLDL (24) sample showed an 
increased fold expression in metallothionein when compared to the control and native 
samples. A 26.2 (+/- SD 4.53) higher fold expression was found in the OxLDL (24) 
sample than the control sample. When compared with the native sample, there was a 
7.30 (+/- SD 3.29) fold higher expression in the OxLDL (24) sample. These results 
indicate that exposure of cells to OxLDL (24) leads to an increase levels when 
compared to control and native samples. This result may be expected since the 
OxLDL used here was prepared from native LDL by modification using metal ions 
(copper sulphate solution). 
The gene did not however appear in the OxLDL (24) versus AcLDL (24) 
comparison, indicating that it may be expressed at similar levels in the AcLDL (24) 
sample (If this was the case, then it would be expected to appear up-regulated in the 
AcLDL (24) versus native LDL comparison which it did not). A more likely 
explanation is that it did not confirm in all 4 lists generated for the OxLDL (24) 
versus AcLDL (24) comparison. 
(d) Proliferation associated gene 
Another gene showing increased expression on exposure to OxLDL (24) was 
proliferation associated gene (pag). Pag enhances natural killer cell activity. When 
comparisons were perfonned the OxLDL (24) sample showed an increased expression 
of pag when compared to the control, native and AcLDL (24) samples. A 3.56 (+I-
SD 0.42) fold higher expression was found in the OxLDL (24) sample than the 
control sample. When compared with the native sample, there was a 2.25 ( +1- SD 
0.07) fold higher expression in the OxLDL (24) sample. Furthermore when compared 
to the AcLDL (24) sample, the OxLDL (24) showed a 3.5 (+/- SD 0.00) fold higher 
expression. These results indicate that exposure of cells to OxLDL (24) leads to an 
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increase level of pag when compared to the control, native and AcLDL samples. Its 
expression by OxLDL may reflect the pro-inflammatory nature of atherosclerosis and 
the more toxic effects that OxLDL is thought to have. 
(e) MMP-2 
MMP-2 showed increased expression on exposure to OxLDL(24). MMP-2 is 
also known as 72 Kda type IV collagenase precursor. MMP-2 is involved in the 
cleavage of gelatin type I and collagen types IV, V, VII and X. It cleaves the 
collagen-like sequence pro-gln-gly and requires calcium and zinc for activity. MMP-2 
is a member of the MMP family (discussed in chapter I). MMPs have been implicated 
in determining plaque stability. When comparisons were performed an increase in 
MMP-2 expression was found in the OxLDL (24) sample compared to the native 
sample. A 2.55 ( +1- 0.49) fold higher expression was found in the OxLDL (24) 
sample compared to the native sample indicating an increased level of MMP-2. This 
result is not surprising since MMP-2 has already been shown to be expressed in 
atherosclerotic plaques [147]. Levels of MMP-2 have been reported to be increased in 
shoulder regions of plaques where the majority of macrophages are found [147]. 
Furthermore lipid lowering therapy with pravastatin has been shown to result in a 
decrease in MMP-2 levels in plaques [ 137]. Thus this result is consistent with 
previous observations. 
(f) Fibronectin 
A gene that was found to show decreased levels on exposure to OxLDL was 
fibronectin. Fibronectins binds cell surfaces and various compounds including 
collagen, fibrin, heparin, DNA and actin. Fibronectins are involved cell adhesion, cell 
motility, opsonization, wound healing and maintenance of cell shape. When 
comparisons were perfonned, the OxLDL (24) sample showed a decreased expression 
of fibronectin when compared to native LDL. A 7.38 (+/- SD 2.04) fold higher 
expression was found in the native sample than the OxLDL (24) sample. This result 
indicates that exposure of cells to OxLDL results in a decrease in fibronectin when 
compared to native LDL over 24 hours. 
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5. 7.5 Genes regulated by both OxWL and AcWL 
(a) TIMP-1 
The metalloproteinases and their inhibitors (TIMPs play a central role in tissue 
remodelling (especially in disease states such as cancer. They have also been 
implicated a play a role in plaque rupture. As discussed in chapter one the MMPs are 
a family of structurally related proteases that are capable of degrading the virtually all 
components of the extracellular matrix. The level of MMPs is tightly controlled by the 
MMP: TIMP ratio. In addition to identifying a higher fold expression in MMP-2 in 
the OxLDL (24) sample when compared to the native sample as described above, 
TIMP-1 was also found to be regulated by both forms of modified LDL used in this 
study. 
When comparisons were performed, the native sample showed a higher TIMP-
1 expression when compared to the AcLDL (24) and OxLDL (24) samples. A 2.68 
( +1- SD 0.31) fold higher expression was found in the native LDL sample when 
compared to the OxLDL (24) sample. Furthermore when compared with the AcLDL 
(24) sample, there was a 2.83 ( +/- SO 0.19) fold higher expression in native samples. 
In addition when the OxLDL (24) sample was compared with the OxLDL (4) 
sample there was a 1.83 ( +1- SD 0.17) fold higher expression in the OxLDL (24) 
sample suggesting that levels of TIMP-1 increased over time from 4 to 24 hours on 
exposure to OxLDL (although at the 24 hours the levels still remain less than those 
observed with native LDL at 24 hours as shown by the higher fold difference in the 
native LDL sample when compared to the OxLDL). 
These results suggest that exposure to modified LDL leads to a decrease in 
levels of TIMP-1. When both AcLDL and OxLDL are compared to the native sample, 
the native sample shows a higher expression level of TIMP-1. This may reflect the 
morphological changes taking place within the cell upon lipid loading that result in 
decreased levels of TIMP-1. The OxLDL (24) versus OxLDL (4) comparison 
indicates that there is an increase in TIMP-1 levels between 4 and 24 hours. 
155 
Chapter 5 Gene regulation in response to native and modified LDL 
(b) Alpha enolase 
Another gene that was found to be decreased on exposure to both OxLDL and 
AcLDL was alpha enolase. Alpha enolase catalyses the breakdown of 2-phospho-d-
glycerate into phosphoenolpyruvate and water and is an enzyme of the glycolytix 
pathway. 
When comparisons were performed the native sample was found to show a 
higher expression than both the OxLDL (24) and AcLDL (24) samples. A 3.75 (+I-
SD 1.20) fold higher expression was found in the native sample when compared to the 
OxLDL (24) sample. Similarly a 4.15 (+/- SD 0.58) fold higher expression was found 
in the native sample when compared to the AcLDL (24) sample. These results suggest 
that when OxLDL (24) and AcLDL (24) are compared to the native sample there is a 
decrease in expression of alpha enolase with both OxLDL and AcLDL provoking a 
decrease of similar magnitude. An increase in alpha enolase has been reported in 
mouse macrophages during cholesteryl ester accumulation [226] 
(c) Thymosin beta-4 
Another gene showing decreased expression when comparisons were 
performed was thymosin beta 4. The exact physiological role of thymosin beta-4 is 
not yet known. However it is a thymic hormone that can bind to actin monomers and 
thus inhibit actin polymerisation. It can be induced by alpha-interferon and fibroblast 
growth factors thus it is another gene that merits further investigation in vitro. When 
comparisons were performed the native sample was found to show a higher fold 
expression than both the OxLDL (24) and AcLDL (24) samples. A 1.85 (+/- SD 0.35) 
fold higher expression was found in the native sample when compared to the OxLDL 
(24) sample. When compared to the AcLDL (24) sample a 3.52 (+/- SD 0.84) fold 
higher expression was found in the native sample. Thus the native versus OxLDL 
showed a smaller fold difference than the native versus AcLDL comparison. This 
smaller difference was confirmed in the OxLDL (24) versus AcLDL (24) comparison 
sample where the OxLDL (24) showed a 2.65 (+/- SD 0.35) fold higher expression 
than the AcLDL (24) sample. These results suggest that exposure to modified LDL 
leads to decrease in thymosin beta-4 expression, the decrease being greater on 
exposure to AcLDL that OxLDL. 
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(d) Nidogen 
Another gene showing decreased expression was nidogen. Nidogen is a 
sulphated glycoprotein that is found widely distributed in basement membranes. It is 
found tightly associated with laminin and also binds to collagen and may play a role 
in cell-extracellular matrix interactions. Again a decrease in its expression levels on 
exposure to modified LDL may reflect the morphological changes taking place within 
the cell upon lipid loading. 
When comparisons were performed the native sample was found to show a 
higher fold expression than both the OxLDL (24) and AcLDL (24) samples A 
3.20( +1- SD 0.57) fold higher expression was found in the native sample when 
compared to the OxLDL (24) sample. When compared to the AcLDL (24) sample a 
3.10 ( +1- SD 0.00) fold higher expression was found in the native sample. These 
results suggest that exposure to modified lipoprotein results in a decrease in nidogen 
gene expression. 
5. 7.6 Conclusions from atheroma array results 
The atheroma arrays were much smaller in size than the human I.M.A.G.E 
arrays (in terms of the number of genes/ESTs), however contained what were thought 
to be a more relevant set of genes thought to be involved in cardiovascular disease. 
Surprisingly, the results demonstrated the largest number of genes regulated in 
differentiated THP-1 cells were due to native LDL rather than OxLDL and AcLDL. A 
possible number of explanations for this include 
(a) The control used in this sample was a sample of differentiated THP-1 cells 
that had been exposed to lipoprotein deficient media, therefore exposure to 
native lipoprotein resulted in replete situation and the availability of 
cholesterol. In other words there was a large physical change taking place in 
cells when going from a lipid depleted to lipid repleted situation. 
(b) The genes differentially expressed during foam cell formation (on exposure of 
differentiated THP-1 cells to modified LDL) were not ~~presente~- o?_ the 
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arrays. It is possible other pathways or mechanisms, previously unidentified 
could be involved. 
(c) That other genes were differentially expressed on the arrays but were not 
detected due to the very small changes that may have occurred in their 
expression 
(d) The criteria set for threshold and background values may have excluded these 
genes 
(e) The number of genes regulated on exposure to modified LDL is in fact less 
than the number regulated on exposure to native LDL. As with uptake of 
native LDL, uptake of modified LDL could be considered a 'normal' 
scavenging function of macrophages and may a represent a protective effect 
which macrophages may have evolved to cope with. 
In general, results from the custom atheroma arrays indicate that genes 
regulated on exposure to modified LDL in comparison to native LDL can be split into 
five classes of genes; lipoprotein receptors, inflammatory signalling molecules & 
cytokines, metal binding proteins, ribosomal proteins and cell structure & motility 
proteins as listed below 
Lipoprotein receptor: - CD36 
Inflammatory signalling molecules and cytokines: - IL-l~, translationally 
Metal binding proteins: -
Ribosomal proteins: -
Cell structure and motility proteins: -
Enzymes 
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controlled tumour protein, proliferation 
association gene, annexin II and W nt -13 
metallothionein, ferritin heavy chain 
23KD highly basic protein, RPSA 3A 
Fibronectin, TIMP-1, nidogen, and 
thymosin-beta 4, 
Alpha enolase 
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As noted above, due to the number of genes found to be differentially expressed, the 
results presented above provide a summary of some of the genes found. A few of the 
genes that were found to be specifically expressed by AcLDL, OxLDL and by both 
AcLDL and OxLDL were selected have been discussed above (section 5.6). Further 
experimental work will be necessary to validate and determine the role that these 
genes play in foam cell formation. 
5.8 Results from the human I.M.A.G.E arrays 
The I.M.A.G.E arrays used in these experiments were representative of the 
human I.M.A.G.E collection, which in tum was representative of the human genome 
[207]. Due to the high amount of redundancy that is found in the I.M.A.G.E 
collection, the DGE group at GlaxoWellcome had rearrayed clones from the human 
I.M.A.G.E collection working on basis of representing each gene or EST sequence by 
one or a few clones. 
Comparisons were performed as for the custom atheroma arrays and final 
differences identified in comparisons were sent to the DGE database. For the 
I.M.A.G.E arrays, all genes identified as differentially expressed were sequenced. The 
differentially expressed 'spot' on the array was deciphered to give the plate and well 
location of the clone from which it was derived. Subsequently this clone was repicked 
and grown up. The cloned insert were amplified by PCR and the PCR products were 
sequenced (by the Sequencing Group, Department of Genetics, GlaxoWellcome, 
Stevenage, UK) so as confirm their identity. Due to the large size of the files, the 
results obtained from the I.M.A.GE arrays are given in appendix 6 
Graph 5.2 below shows the number of up- and down- regulated genes found 
for each comparison using the I.M.A.G.E arrays. As for the custom atheroma arrays 
the number of genes up-regulated are highest in the native versus control comparison. 
The highest number of genes down-regulated are found in the AcLDL (24) versus 
AcLDL (4) comparison. There are more genes up-regulated by OxLDL than AcLDL 
after 24 hours, as shown in the OxLDL(24) versus AcLDL (24) comparison. However 
at 4 hours the numbers of genes up- and down-regulated by OxLDL and AcLDL are 
relatively similar. 
In general the human I.M.A.G.E array results indicate that there are more 
genes up-regulated by exposure to modified LDL than are down-regulated. This is in 
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contrast to the results from the custom atheroma arrays that indicate that there are 
more genes down-regulated on exposure to modified lipoprotein than are up-
regulated. This can be explained by the fact that there are more genes on the 
I.M.A.G.E arrays than the custom atheroma arrays. In addition the I.M.A.G.E arrays 
are more representative of the human genome whereas the custom atheroma arrays 
contain a relatively limited number of selected genes with reference to cardiovascular 
di sease. Furthermore the I.M.A.G.E. arrays contained a large number of ESTs. These 
results could suggest that there may be more, as yet undiscovered genes/transcripts 
that play a role during foam cell formation 
Graph 5.2 Graph showing number of genes up regulated and down regulated for 
each comparison performed using the human I.M.A.G.E arrays 
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Results obtained from the IMAGE arrays are given in appendix 6 due to the amount 
of data generated. The first worksheet in appendix 6 entitled 'summary of results' lists 
the tables of genes identified in the comparisons performed. These tables do not 
represent the most highly up- and down-regulated genes (since in many cases, these 
are EST sequences of unknown function) but rather known genes. The number of 
ESTs found to be differentially expressed give another lead to follow in the 
identification of novel genes involved in the process of foam cell formation. 
The tables below (table 5.11-5.21) show five up and down differentially 
regulated genes/EST of interest that are expressed for each comparison perfonned 
using the human I.M.A.G.E arrays. 
Table 5.11 Table showing up and down-regulated genes when comparing native 
LDL with control 
Upregulated Fold difference 
Homo sapiens clone similar to protein phosphatase PP2A, 65Kd 
regulatory subunit, alpha 12.3 
Homo sapiens eDNA clone similar to elongation factor I gamma 
(human) 10.7 
Homo sapiens clone similar to transforming protein RhoA 
(Human) 8.4 
Homo sapiens clone similar to A TP synthase A chain 7.3 
Homo sapiens clone similar to aceyl lactosamine synthase 
(Human) 6.1 
Downregulated Fold difference 
Homo sapiens eDNA clone similar to elongation factor-! gamma 
(human) 3.6 
Human MAP kinase activated protein kinase 2 2.8 
Eukaryotic translation elongation factor -alpha-! (human) 2.4 
Human mRNA for fibronectin (FN precursor) 2.4 
NADH dehydrogenase Fe-S protein 3 2.4 
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Table 5.12 Table showing up- and down-regulated genes when comparing 
OxLDL (24hr) with control 
Upregulated Fold difference 
Homo sapiens eDNA clone similar to RAS-related protein 
RAP-lA (human) mRNA sequence 10.9 
Homo sapiens thyroid receptor interactor protein (TRIP) 8.6 
Cysteine protease l 8.2 
stearoyl-coA desaturase 7.7 
Homo sapiens mRNA for RALDH2-T 7.5 
Down regulated Fold difference 
Homo sapiens eDNA clone similar to elongation factor l alpha-
l (human) 7.1 
Homo sapiens eDNA clone similar to P68 protein (Human) 6.5 
Homo sapiens eDNA clone similar to tubulin alpha- I chain 
(human) 4.9 
Homo sapiens eDNA clone similar to ferritin light chain 4.2 
Homo sapiens eDNA clone similar to heat shock cognate 71 Kd 
protein (Human) 4.2 
Table 5.13 Table showing up- and down-regulated genes when comparing 
AcLDL (24hr) with control 
Upregulated Fold difference 
Homo sapiens eDNA clone similar to prostaglandin E receptor EP l 
subtype (human) 8.6 
Homo sapiens eDNA clone similar to Acetyllactosamine synthase 
(human) 5.7 
Homo sapiens eDNA clone similar to Interleukin !-beta precursor 5.7 
NADH dehydrogenase (ubiquinon l) 4.7 
Homo sapiens eDNA clone similar to NADH-ubiquinone 
oxidoreductase 4.5 
Downregulated Fold difference 
Chloride intracellular channel l 7.1 
Heat shock 70kd protein l 0 6.7 
Transforming growth factor beta stimulated protein (TSC-22) 5.8 
Ferritin, light polypeptide 5 (RNA helicase) 4.5 
Dead/H box polypeptide 5 (RNA helicase) 4.1 
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Table 5.14 Table showing up- and down-regulated genes when comparing 
comparing OxLDL (24 hr) with native LDL (24hr) 
Upregulated Fold difference 
Homo sapiens eDNA clone similar to elongation factor-1-alpha-1 
(human) 5.6 
Human heart mRNA for shock protein 90 5.5 
Transforming protein RhoA (human) 4.5 
Homo sapiens eDNA clone similar to Glia activating factor precursor 
(human) 3.5 
Homo sapiens eDNA clone similar to protein phosphatase PP2A , 
65Kd, regulatory subunit, alpha (human) 3.2 
Downregulated Fold difference 
Human mRNA for fibronectin (FN precursor) 3.7 
EST similar to KIAA 0313 3 
Cathepsin B 2.5 
ATPase family gene AFG-2 1.8 
Nuclear phosphoprotein p 130 1.6 
Table 5.15 Table showing up- and down-regulated genes when comparing 
AcLDL (24hr) with native LDL (24hr) 
Fold 
Upregulated difference 
Homo sapiens eDNA clone similar to laminin alpha- I chain 
precursor 4.5 
Human retinoblastoma susceptibility gene exons 1-27 4.1 
Homo sapiens eDNA clone similar to Cathepsin 0 precursor 3.9 
Homo sapiens eDNA clone similar to aldehyde dehydrogenase 3.8 
Homo sapiens eDNA clone similar to madiamine acetyl transferase 
(human) 3.7 
Fold 
Downregulated difference 
Homo sapiens eDNA clone similar to psoriasis-associated fatty acid 
binding protein homolog (human) 4.6 
Fatty acid binidng protein 5 (psoriasis associated) 4.6 
Human kinase suppressor of ras-1 (KSR l) mRNA 4.2 
Ras homolog gene family, member E 3.8 
Human glucose-6-phosphate dehydrogenase 3.7 
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Table 5.16 Table showing up- and down-regulated genes when comparing 
OxLDL (24hr) with AcLDL (24hr) 
Fold 
Upregulated difference 
Homo sapiens eDNA clone similar to protein phosphatase PP2A 5.2 
Homo sapiens eDNA clone similar to actin, cytoplasmic 2 (Human) 5 
Homo sapiens eDNA clone similar to ferritin light chain (human) 3.9 
Homo sapiens eDNA clone similar to elongation factor 1 -gamma 3.8 
Homo sapiens eDNA clone similar to transducin-like enhancer 
_Qrotein 3 3.5 
Fold 
Downregulated difference 
Homo sapiens mRNA for KIAal372 protein 3.2 
Homo sapiens cystatin B 2.7 
Solute carrier family 2 (facilitated glucose transporter member I) 2.6 
Human mRNA for KIAA 0205 2.6 
Homo sapiens eDNA clone similar to ribosomal protein L26 2.1 
Table 5.17 Table showing up- and down-regulated genes when comparing 
AcLDL (4hr) with control 
Fold 
Upregulated difference 
Homo sapiens eDNA clone similar to transforming protein Rho A 30.3 
Homo sapiens eDNA clone similar to ATP synthase A chain 17.3 
Homo sapiens eDNA clone similar to L-MYCp2 protein (Human) 16.9 
Homo sapiens eDNA clone similar to NADH-ubiquinone 
oxidoreductase KFY 1 subunit precursor 16 
Homo sapiens eDNA clone similar to elongation factor 1 gamma 13 
Fold 
Down regulated difference 
Human ferritin L chain mRNA 6.1 
NADH dehydrogenase (ubiquinone) Fe-S protein-3 (NADH 
coenzyme Q reductase) 2.7 
Annexin AI 2.2 
Homo sapiens retinoldehydrogenase gene 2 2 
Eukaryotic translation elongation factor I alpha I 1.9 
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Table 5.18 Table showing up- and down-regulated genes when comparing 
OxLDL (4hr) with control 
Fold 
Upregulated difference 
Homo sapiens eDNA clone similar to elongation factor 1 gamma 
(human) 22.2 
Homo sapiens eDNA clone similar to PP2A, 65 kd regulaory subunit, 
alpha 18.4 
NADH ubiquinone oxidoreductase KFY 1 subunir precursor 17.8 
Homo sapiens eDNA clone similar to transforming protein Rho A 
(Human) 14.6 
Homo sapiens eDNA clone similar to trans- I ,2, dihydrobenzene 1,2 
diol dehydrogenase (human) II 
Fold 
Down regulated difference 
Human ferritin light chain mRNA 3.9 
NADH-coenzyme Q reductase 3.7 
Eukaryotic translation elongation factor I, alpha I 3.5 
Annexin A1 3.5 
Human MAP kinase activated protein kinase 2 2.8 
Table 5.19 Table showing up- and down-regulated genes when comparing 
OxLDL (4hr) with AcLDL (4hr) 
Fold 
Upregulated difference 
Homo sapiens eDNA clone similar to epidermal growth factor 
receptor 3.8 
Ribosomal protein L25 2.6 
Homo sapiens eDNA clone similar to human cysteine rich protein 2.3 
Homo sapiens mRNA KIAA 0870 protein 1.8 
Homo sapiens eDNA clone similar to ferritin light chain 1.8 
Fold 
Down regulated difference 
Human cis acting sequence 4.4 
Homo sapiens eDNA clone similar to retrovirus -related pol 
polyprotein 3.2 
Ribosomal protein L27a 2.8 
Homo sapiens eDNA clone similar to interleukin-12 beta chain 
precursor 2.7 
EST highly similar to CREB-binding protein 2.7 
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Table 5.20 Table showing up- and down-regulated genes when comparing 
OxLDL (24hr) with OxLDL (4hr) 
Fold 
Upregulated difference 
EST weakly similar to KIAA 0636 protein I (natural resistance 
associated macrophage protein 2 gene) 4.9 
Homo sapiens eDNA clone similar to four and a half LIM domains 2 4.1 
CDW52 antigen (Campath-1 antigen) 3.8 
EST weakly similar nucleo_Il_orin p62 homolog 3.2 
Actin, gamma I 3.2 
Fold 
Downregulated difference 
Homo sapiens eDNA clone similar to human ribosomal protein S 10 3.7 
Human lambda-immunoglobulin constant region complex 3.7 
Homo sapiens eDNA clone similar to 40S ribosomal protein S25 3.6 
Homo sapiens eDNA clone similar to rat cytochrome P450 3.2 
Homo sapiens eDNA clone similar to ribosomal protein L27 3.2 
Table 5.21 Table showing up- and down-regulated genes when comparing 
AcLDL (24hr) with AcLDL (4hr) 
Fold 
Upregulated difference 
EST 2.6 
Ribosomal protein S25 2.5 
Homo sapiens cON A clone similar to putative A TP-dependent 
helicase 1.8 
Human interleukin l beta 1.5 
Fold 
Downregulated difference 
Homo sapiens eDNA clone similar to L-MYC-2 protein 6.6 
Copine I 5.7 
Homo sapiens eDNA clone similar to ATP synthase A chain 5.1 
Chromobox homolog I 5.1 
Eukaryotic translation elongation factor l gamma 5.1 
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5.8.1 Discussion ofresultsfrom human l.M.A.G.E arrays 
As expected there were a larger number of genes regulated using the 
I.M.A.G.E arrays than using the custom arrays. The advantage of using the I.M.A.G.E 
aiTays were that as well as containing known genes representing the human genome, 
the I.M.A.G.E arrays also contained novel EST sequences. This provides an 
opportunity to discover novel EST sequences that play a role in the foam cell 
transformation. 
Table 5.22 below gives some of the genes specifically regulated by AcLDL, 
OxLDL or both AcLDL and OxLDL. This table is derived by comparing genes 
expressed when comparing OxLDL and AcLDL with the native sample. 
Table 5.22 Table showing genes regulated by AcLDL, OxLDL or both using the 
human I.M.A.G.E arrays 
Genes regulated by 
OxLDL AcLDL Both 
Cathepsin B Vitamin 03 receptor Protein phosphatase 2A 
Transforming 
Rho A 
Immunoglobulin 
receptor 
protein Psoriasis-associated fatty Ferrtin light chain 
Heat shock protein 90 
Lysozyme C precursor 
Leukosialin precursor 
acid binding protein 
Fe Interleukin 1 beta Tubulin alpha 1 chain 
Prostaglandin E receptor Elongation factor I gamma 
Macrophage inflammatory Fibronectin 
protein alpha 
Cytokine receptor related 
protein (cytoR4) 
Cathepsin 0 
Glucose transporter, type l 
TIMP-1 
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The results showed that the same genes were not found to be differentially expressed 
from the custom arrays and the I.M.A.G.E arrays. This could be due to a number of 
reasons including:-
[I] Strict criteria were used to ident ify genes being expressed by the custom 
atheroma arrays. As discussed above, a gene had to appear in the all four lists 
of a comparison formed, where it did not this gene was not included in the 
final list. These strict criteria resulted in a large number of genes being 
dropped but ensured that those included in the final list were definite 
differences. 
[2] Both custom and l.M.A.G.E array clones were sequenced after arraying which 
resulted in removal of genes from both comparisons. For example although 
cathepsin B was identified as being differentially regulated by the custom 
atheroma arrays and the I.M.A.G.E arrays. It was not sequence- confirmed on 
the custom arrays and therefore had to be removed from the final results. It 
was however identified as being differentially expressed by the I.M.A.G.E. 
arrays and when sequenced matched its original identity. 
[3] The I.M.A.G.E arrays were derived from a much larger library containing a 
high degree of redundancy. Due to its size this meant that it was more prone to 
errors in picking of cloning 
5.8.2 Genes regulated by native WL using human I.M.A.G.E arrays 
As for the custom atheroma arrays the largest number of genes up-regulated 
were due to native LDL. Of interest these genes include interleukin-1 beta, 
interleukin-12, acyl hydrocarbon receptor, a psoriasis associated fatty acid binding 
protein, a eDNA clone similar to the prostaglandin E receptor and cytokine receptor 
related protein (cyto R4). 
168 
Chapter 5 Gene regulation in response to natil'e and modified LDL 
5.8.3 Genes regulated by AcLDL using human I.M.A.G.E arrays 
As also shown by the results of the custom atheroma arrays, interlukin-1 
expression is increased on exposure to AcLDL. In addition a number of other genes 
including cathepsin 0, psoriasis associated fatty acid binding protein and macrophage 
inflammatory protein I (MIP-1) are regulated on exposure to AcLDL. Of particular 
interest is MIP-1, a chemokine implicated during the progression of CHD [227]. The 
receptor for MIP-1; chemokine motif receptor 5 (CCR5) is found to be expressed on 
macrophages and T lymphocytes [227]. Another gene of potential interest is psoriasis 
associated fatty acid-binding protein. OxLDL has been reported to induce expression 
of an adipocyte lipid binding protein [228] 
5.8.4 Genes regulated by OxWL using human J.M.A.G.E arrays 
Genes specifically regulated by OxLDL include heat shock protein 90, 
transforming protein RhoA, cathepsin B and lysozyme C precursor. Members of the 
cathepsin family (including cathepsin S and K) have been found to be expressed in 
monocyte-derived macrophages [229]. In addition accumulation of oxidised esters has 
been reported in lysosomes [230], which may suggest a role the lysozome C 
precursor. 
5.9 Conclusions from results of human I.M.A.G.E arrays 
As expected a greater number of changes were found using the IMAGE arrays 
when compared to the custom atheroma array. This can mainly be attributed to the 
greater number of sequences represented on these arrays. The genes regulated again 
included some that have been previously implicated in the atherosclerotic process, 
such as onterleukin I~ and macrophage inflammatory protein. In addition several 
members of the cathepsin family including cathepsin B and cathepsin 0 were found to 
be regulated by modified LDL. As other members of the cathepsin family these are 
likely to be involved in remodelling of the extracellular matrix. A number of genes 
were also identified whose function in the atheoroslcerotic process is not yet 
determined but may be of interest. These include heat shock protein 90 (heat shock 
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protein 60 has shown to be induced in monocytes by OxLDL [231 ]), cytokine 
receptor related protein and psoriasis-associated fatty acid binding protein. 
The results from the I.M.A.G.E array of the genes being regulated by modified 
LDL fit into the role of inflammatory molecules and tissue remodelling genes having 
a role in early atherosclerosis. 
5.10 Discussion of array technology 
Technology is now moving so fast that since starting this study, arraying of eDNA 
samples is now more commonly performed on glass slides than nylon membranes 
although both have their own advantages and disadvantages. Filter arrays can be more 
cost effective because they require no special equipment except phosphoimager 
screens [209]. Filters are also useful for rare mRNA; as a smaller amount is required 
than for the preparation of fluorescent probes to glass slides. The major disadvantage 
of filters is that comparison of expression between two samples requires hybridisation 
of each sample to separate duplicate filters [209]. 
It should be noted that this study was performed during the development stages of 
the technology when methodology was constantly being improved. Some 
developmental data has not been shown in this thesis. For example probes were first 
strand eDNA probes were prepared from both messenger RNA and total RNA. The 
results showed that although eDNA probes derived from both mRNA and total RNA 
incorporated similar amounts of label, the hybridisation results obtained were of a 
higher standard in terms of clearer hybridisation to individual spots on the array when 
mRNA was used as the starting material. 
One of the major challenges of using filter arrays has been ensuring clones 
represent the sequences they intend to. Due to the numerous steps involved 
(production of clones, PCR, gridding to arrays) and the large number of clones used, 
the method is highly prone to error. It is therefore essential that workflow is 
performed using strict quality control criteria which should assist in minimising such 
errors. For small labs intending to use limited numbers of arrays it is may be more 
cost effective to buy commercially available arrays or use core micoarray facilities, 
than set up their own microarray facility. For facilities where large number of arrays 
will be used, it is likely to be more cost effective and provide increased flexibility to 
manufacture their own arrays. 
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Chapter 6: Temporal Gene Expression 
6.1. Introduction 
6.1.1 Temporal gene expression 
Although array technology allows biologists to simultaneously study the 
expression of thousands of genes, it has also provided a challenge in the form of the 
amount of data that it has generated. Assigning biological relevance to the changes in 
gene expression observed and organising the data obtained in a functional and 
meaningful manner is still a major hurdle. One approach to finding and displaying 
features of large sets of gene expression data has involved building maps representing 
gene expression data [232]. Making gene expression maps involves two main steps 
(a) The data is firstly organised by a method (usually statistical), which finds 
orderly features within the data. 
(b) The ordered data is then displayed graphically, in a way that allows 
biologists to assimilate the patterns of gene expression. 
6.1.2 Initial work on temporal gene expression 
Early work on large-scale temporal gene expression was reported in two 
biological systems; during spinal cord developments in the rat and in yeast during the 
shift from fermentation to respiration [233, 234]. Somogyi and colleagues [233] produced 
a gene expression map, which contained the expression levels of 112 genes at nine stages 
during rat cervical spinal cord development. They found that that the 112 genes clustered 
into 4 major waves of expression. Each of the four groups was found to have a distinct 
expression profile. De Resi et a/ [234] reported temporal gene expression in yeast 
(Saccharomyces cerevisiae) during the shift from anaerobic (fermentation) to aerobic 
(respiration) metabolism. De Resi' s group used oligonucleotide arrays to look at 
expression across 7 time points. They found several distinct patterns of expression that 
correlated well with 'previously published data· in the same organism [234l.--Genes that 
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showed similar expression profiles were grouped by correlation clustering and five 
distinct temporal patterns of gene expression were observed [234]. 
Thus such clustering approaches demonstrated potential methods to deal with 
large data sets. This therefore also allows one to utilise such approaches in this study with 
some degree of confidence; with the aim of identifying genes or clusters of genes that 
show similar patterns of expression. Clusters can be useful because they can lead to 
associations of poorly characterised genes with genes whose function and regulation are 
better understood [235]. 
6.1.3 Introduction to clustering methodologies for analysing large data sets 
A general overview on current strategies used to analyse microarray data has been 
reported by several authors including John Quackenbush [236] and Donna Slonim 
[237].Two clustering methods are generally taken to analyse large data sets; supervised 
methods and unsupervised methods. A brief overview of these methods is given below. 
Before any clustering method (supervised or unsupervised) is applied on a data 
set, it is essential to perform a dissimilarity measure between two genes [238]. A 
dissimilarity measure indicates the degree of similarity between two genes. The 
subsequent clustering method then uses these dissimilarity measures to create clusters of 
genes with similar patterns. Commonly used dissimilarity measures are Euclidean 
Distance [233] and the Pearson correlation coefficent [235]. These are discussed further 
below 
6.1.3.1 Supen,ised Methods 
The supervised approach aims to identify genes that fit into a predetermined 
pattern. Supervised methods are useful for finding genes with expression levels that are 
significantly different between groups of samples and finding genes that are characteristic 
of a sample. In particular supervised methods have been reported and are useful for 
finding groups of genes that may be able to predict one type of cancer from another 
[232]. Supervised methods include; nearest neighbour analysis, neural networks decision 
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trees and support vector machines. The most popular of these are nearest-neighbour 
analysis and support vector machines. 
6.1.3.1.1 Nearest Neighbours. 
This technique is commonly used in a supervised approach to find genes with 
patterns of expression that are indicative of particular sample. It involves constructing a 
set of genes that show a particular pattern (for example a gene showing low expression in 
a normal state but showing increased expression in a disease state). Subsequently other 
samples can be compared to this pattern of gene expression and ranked by their 
similarity. This method has been successfully used by Golub et al [239] to distinguish 
between two types of childhood leukaemia. 
6.1.3.1.2 Support Vector Machines 
Support vector machines (SVM) are one the most recently reported methods [240] 
and are useful for finding combinations of genes that split sets of biological samples. 
They use a training set of samples in genes in which genes are known to be related to a 
particular class. The training set is used by the SVM to learn to distinguish between a 
members and non-members of a class, based on their expression pattern. Each gene is 
viewed as an expression vector in a multidimensional space. SVM is a classifier that 
attempts to separate the genes into two classes by defining an optimal hyperplane (a N-
dimensional analogy which divides N+1 dimensional space into two). 
6.1.3.2 Unsupervised methods 
The unsupervised approach aims to find relationships or some degree of internal 
structure within a dataset without using any existing prior biological information on 
possible relationships between genes. Within unsupervised methods there are three 
classes of techniques [238] :-
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(a) Feature determination; where genes with interesting properties are identified 
without looking for specific patterns. One such method is principle component 
analysis (PCA). 
(b) Cluster determination; determining groups of genes with specific patterns of 
expression. Such methods include hierarchical clustering, self-organising maps 
(SOMs) and k-means clustering. 
(c) Network determination; determining graphs which represent gene-gene or gene-
phenotype interactions. Such methods include Bayesian networks and relevance 
networks. 
The most common unsupervised techniques are PCA, hierarchical clustering, k-means 
clustering, SOMs and relevance networks. 
6.1.3.2.1 Hierarchical clustering 
Hierarchical clustering is one of the most commonly used methods among 
biologists and has been widely reported [232, 235, 241 ]. The greatest advantage in using 
this method is that it is simple and the number and size of expression patterns can be 
quickly estimated [235]. During hierarchical clustering single expression profiles are 
joined to form groups. These groups are further joined together until all profiles are 
linked forming a single hierarchical tree. Dendograms are subsequently used to visualise 
the results of the hierarchical clustering. Hierarchical clustering is referred to as an 
agglomerative approach as opposed to a divisive method [236]. (The agglomerative 
approach starts with single/few genes per cluster and then links them together. The 
devisive approach begins with all the genes in a single cluster and breaks down this 
single cluster into smaller clusters [236]). One of the disadvantages of hierarchical 
clustering is that it ignores negative correlations even when the dissimilarity measure 
used supports a negative correlation [238]. In addition; genes that are incorrectly linked 
early on in the process cannot later be linked to their correct cluster as the tree is 
constructed. 
174 
Chapter6 Temporal Gene Expression 
6.1.3.2.2 k-means clustering 
In k-means clustering, the user defines the number of clusters (k) and the data is 
subsequently assigned to this number of clusters [242]. The aim being to end up with 
clusters where data within individual clusters is similar but between clusters is dissimilar. 
To achieve this, the data is initially randomly assigned to one of k clusters. An average 
expression vector is then calculated for each cluster and this is used to compute distances 
between clusters. Data is then moved between clusters and intra and inter distances 
between clusters is measured on each move. Data is assigned to a new cluster only if it is 
closer to it than it was in the previous cluster. This shuffling continues until moving any 
more data points would make the clusters more variable. 
6.1.3.2.3 Self-organising maps (SOMs) 
A SOM is a divisive clustering approach where genes are assigned to a series of 
partitions depending on how similar their expression vectors are relative to a reference 
vector (where the reference vector represents a particular partition) [243]. The user 
defines a configuration for the partition (usually a 2-dimensional rectangular grid; such 
as 3x3 giving 9 clusters). A random vector is then assigned to each partition. A gene is 
randomly selected and is assigned to the reference vector closest to it. The reference 
vector is then adjusted so that it is closer to the vector of the assigned gene. At the same 
time other nearby vectors are adjusted so that they are more similar to the vector of the 
assigned gene. The process continues until all the genes are mapped to partitions 
depending on their similarity to a reference vector of a particular partition. With both k-
means clustering and SOMs, it is often useful to use PCA to estimate the number of 
clusters represented within the data before applying the aforementioned techniques. The 
use of SOMs have been successfully reported by Tamayo et a/ for clustering of genes 
from a time series of differentiating haematopoietic cells [244]. 
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6.1.3.2.4 Relevance Networks 
This method allows networks of features to be built, where the features can 
represent not only genes but also factors such as phenotype or clinical measurement 
[245]. The initial part of the technique is similar to hierarchical clustering. For example, 
two genes are compared to each other on a scatter-plot containing all the samples; with 
the expression levels of the two genes being used as coordinates. A correlation coefficient 
is then calculated for the features in the samples. This is compared to a chosen threshold 
value and only features with values greater than the threshold value are kept. They are 
then displayed in graph form where features are nodes joined by lines (of varying size 
and colour) representing the relationship between different nodes. 
The advantage of relevance networks is that features showing negative 
correlations can be visualised [238]. One disadvantage is that at lower thresholds many 
features may be linked in a single network creating a high degree of complexity which is 
difficult to interpret. 
6.1.3.2.5 Principle Component Analysis 
PCA is used largely as a visualisation technique [246]. Genes or samples are 
represented in a multidimensional space as points. Principle components are a set of 
vectors in this multidimensional space that capture the variation seen in these points. As 
the vectors are in the same multidimensional space, the principle components are linear 
combinations of the points [247]. It can be compared to looking at a 3 dimensional cloud 
of data points and rotating the cloud so you can view from different angles [236]. Certain 
views would separate the data better than others. PCA finds those views and gives the 
best separation of the data. Although on its own PCA can make it difficult to define 
accurate boundaries between clusters within data sets; it is a powerful technique when 
used together with k-means clustering or SOMs [236]. 
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6.2 Temporal gene expression in macrophages exposed to OxLDL 
6.2.1 Experimental design 
The initial aim of this work was to identify genes that were differentially 
expressed during exposure of differentiated THP-1 macrophages to modified LDL. 
Results from the previous chapter indicated that time was an important factor to take into 
consideration when looking at differentially expressed genes. Furthermore results from 
the lipid loading experiments in chapter 3 indicated that cholesterol ester accumulation 
occurred at a slower rate in differentiated THP-1 macrophages exposed to OxLDL 
(compared to native and AcLDL), with maximal accumulation occurring at 72 hours. 
Additionally it would be of interest to obtain a 'global picture' of gene expression that 
was taking place within macrophages on exposure to OxLDL to gain an understanding on 
the effects that this ligand has. 
In an attempt to achieve this goal; a time series experiment was performed in 
which differentiated THP-l macrophages were exposed to 0.2 mg/ml of oxidised LDL 
for up to 72 hours. Differentiated THP-l macrophages were exposed to OxLDL for 4, 8, 
16, 24, 48 and 72 hours. A sample of differentiated THP-1 macrophages exposed to no 
OxLDL was used as a zero time control point. 
The temporal expression of genes after treatment was examined with the aim of 
identifying genes showing distinct patterns of expression (for example genes showing 
maximal expression at a particular time point). A further aim was to identify groups of 
genes showing similar patterns of expression (co-expressed genes) over the course of 
exposure to OxLDL. A point to note here is that this part of the study does not eliminate 
that these same genes may also be affected by native LDL; but simply allows genes being 
expressed on exposure to OxLDL to be identified. The identification of genes 
differentially expressed using different forms of LDL was the aim of the DGE 
experiments reported in the previous chapter. 
The study was divided into two parts. The first part of the study was simply to 
identify the genes being expressed at each time point on exposure to OxLDL when 
compared to the control (no OxLDL) sample. The second part of the study used the 
method of hierarchical clustering (discussed above) to group those genes that showed 
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similar patterns of expression into clusters. The clusters were examined to find which 
genes had correlated expression patterns. 
6.2.2 Data collection 
Figure 6.1 below gives an overview of the steps involved performing and 
collecting temporal gene expression data. Differentiated THP-1 macrophages were 
exposed to OxLDL for 4, 8, 16, 24, 48 and 72 hours, with each sample being prepared as 
a biological replicate. Messenger RNA was extracted from the cells and I st strand 
labelled eDNA probes were prepared as described (section 2.4.4.). The probes prepared 
were applied to the custom atheroma arrays only. I.M.A.G.E arrays were not used due to 
several reasons, including limited time, limited resources and subsequent data analysis 
limitations. In addition the genes gridded on the custom atheroma array had been checked 
to confirm their sequence identity (as previously described; see appendix 3). This ensured 
that the analysis of the data was easier because the results obtained did not have to be 
confirmed by sequencing. Hybridisation to atheroma arrays was performed as previously 
described (section 2.4.6) and the data was captured using phosphorimaging. 
6.2.3 Data analysis 
The first step involved processing the phosphorimaging data obtained for each 
array and correcting for DNA loading (amount of DNA gridded onto the arrays) using 
DGEnt software. This produced a hybridisation intensity for every gridded spot on the 
array. As biological samples were prepared and applied to arrays in duplicate, results 
from the duplicate arrays were averaged (mean value was calculated). 
Data was archived and processed in Quanta DGE (a piece of software developed 
by the DGE group, Glaxo Wellcome, UK). Quanta DGE provides data management and 
analysis for gene expression arrays. Quanta DGE was used to provide an average mean 
expression level for each gene at each time point (since each gene was present on the 
array at least four times and two biological replicates were performed per sample, the 
minimum number of data points contributing to the average expression level was 8). 
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Figure 6.1 
Overview of the steps involved in collecting temporal gene expression data 
At this stage the data (which consists of a expression level for each gene at each 
time point) could be exported to a Microsoft Excel workbook. This data, refened to here 
to as 'raw data' is listed in appendix 7 (Excel workbook labelled 'appendix 7', worksheet 
labelled 'data analysis'. This worksheet contains 4 data tables labelled appendix 7.1, 
appendix 7.2, appendix 7.3 and appendix 7.4). The raw data was subsequently conected 
for the mean hybridisation intensity of each anay to correct for variations between arrays 
(appendix 7.2) and background was subtracted (appendix 7.3). This gave a corrected data 
set that gave an expression level for every gene at each time point (appendix 7 .3). This 
data set consisted of 769 genes with expression levels across 7 time points, giving a total 
of 5383 data points. Finally the corrected data set was analysed and genes with 
expression levels below background across all of the time points were removed, as were 
any genes whose sequence was not confirmed. This ensured that all the results obtained 
were for those genes whose sequence had been confirmed. 
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6.3 Results 
6.3.1 Quantitative and qualitative analysis of genes showing temporal expression 
Of 769 genes on the array, 216 genes (28%) showed an expression level (greater 
than background) during at least one time point. These 1512 data points were analysed 
further (appendix 7.4). To make this matrix of expression levels (effectively a table of 
numbers) easier to interpret, the expression level of each gene at each time point was 
colour coded depending on the degree of expression. Genes showing a low expression (0-
1.10) at any given time point were coloured blue, those showing moderate expression 
(1.11-3.86) were coloured green and those showing high expression (3.87-11.33) were 
coloured red as shown below in table 6.1 (and appendix 7.4). This allows one to easily 
visualise the data and select genes showing low, moderate and high levels of expression 
without having to a go through a large list of numbers. The data was coloured using the 
tools function of Microsoft Excel (see methods section 2.4.7.2). 
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Table 6.1 
Table showing the 216 genes identified as expressed during at least one time point in 
differentiated THP-1 macrophages exposed to OxLDL for up to 72 hours. Each cell is 
coloured depending on the degree of expression. Blue corresponds to a low expression 
level (0 - 1.1 0), green to an average expression level ( 1.11 - 3.86) and red to a high 
expression level (3 .87- 11.33). The table is also given in appendix 7.4 
14-3-3 protein, theta isofonn X56468 
14-3-3 protein, theta isofonn X80.536 
14-3-3 protein, zeta isofonn U28964 
23KD hi~y basic protein 
a3integrin Very Late Antigen-3 (VLA-3); collagen 
actinin, alpha non-muscle X5.5187 
activator-1, 37 kD subunit 
alpha 5 integrin (fibronectin rec) 
Annexin I (lipocortin I) 
Annexinll 
b catenin 
b-ACTIN 
Basement membrane 40/SP ARC (secreted protein acidic 
Beta 1 adrener~c receptor 
beta actin mutant 
beta-actin mutant 
Calcineurin B 
CathepsinL 
CathepsinS 
CD106VCAM 
CD1.51 (PET A-3) 
cd29 Fibronectin receptor beta subunit 
CD36 
CD36 antigen (collagen type I receptor, thromb o sp ondin 
CD44 antigen (cell adhesion molecule) 
CD44E 
CD44H 
CD.54ICAM-1 
Cell division cycle 42 (GTP-binding protein, 2.5kD) 
Ceramidase 
CHD036 
Chi (Human class III alcohol dehydrogenase (ADHj) chi 
c-myc binding prot 
C-MYC BINDING PROTEIN MM-1. 
collagenase 
collagenase type IV J03210 
Complement component 1, s subcomponent 
COXl 
CREB-2 
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cyclin D3 (CCND3) 
cyclinG! 
cyclin G1 interacting protein, putative 
cyclin I 
cyclin-dependent kinase 4 (cdk4) 
cyclin-dependent kinase activating kinase 
Cytohesin 
DEFENDER AGAINST CELL DEATH 1 
DNA replication licensing factor 
E2F transcription factor 4, pl07 /pl30-binding 
epithelin 1 2 
FEG-1 
fibrillarin 
fibrone ctin 
Fibronectin 1 
FN Fibronectin 
FN-Rb Fibronectin receptor beta subunit 
fos 
G3PDH 
G9 sialidas e 
GOP-dissociation inhibitor rho X69549 
glutamine synthetrase 
glutathione IJerox:idase 
GRK3 
GTPase-activating protein gap M23612 
guanine nucleotide-binding protein rabl M28209 
guanine nucleotide-binding protein rho XD5026 
H. sapiens home o box protein (HOX-11) mRN A, complete 
H.s~iens mRNA for extracellular matrix protein collagen 
H.sa_piens mRNA for ragA protein 
Heat shock 10 kD protein 1 (chaperonin 10) 
Hexabrachion (tenascin C, cytotactin) 
HLA-1 
Homo sapiens interleukin-1 receptor-associated kinase 
Homo sapiens mRNA for alpha(1 ,2)fucosyltransferase, 
Homo sapiens mRNA for NB thymosin beta, complete 
Hu. 1-8U gene for interpheron ind. 
Human alpha enolase mRNA, complete cds . 
Human alpha-2 collagen type VI mRNA, 3' end 
Human CDK6 inhibitor p18 mRNA, complete cds 
Human collagenase inhibitor mRNA, compte 
Human cyclin-dependent kinase inhibitor p27kipl 
Human ferritin H chain mRNA, complete cd 
Human focal adhesion kinase (F AK) mRN A, complete 
Human HepG2 partial eDNA, clone hmd3ID2m 
Human major histocompatibility class II 
Human MAPKAP kinase (3pK) mRNA, complete cds 
Human mRNA for fibronectin (FN precursor 
Human mRNA for HLA class II DR-beta 1 (D 
Human mRNA for KIAA0120 gene, complete c 
Human mRNA for KIAA0201 gene, complete cds 
Human mRNA for KIAA0233 gene, complete cds 
Human mRNA for KIAA0246 gene, partial cds 
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Human mRNA for lipocortin II, complete c 
Human mRNA for MRP-1. 
Human mRNA for ORF, Xq tenninal portion 
Human mRNA for ornithine decarboxylase antizyme, 
Human mRNA for proteasome subunit z, complete cds 
Human mRNA for protein D123, complete cds 
Human mRNA for protein homologous to elo 
Human mRNA for stromelysin. 
Human mRN A for translation ally c ontrolle 
Human mRNA for Ul small nuclear RNP-specific C 
Human myosin regulatory light chain mRNA, complete 
Human protective protein mRNA, complete 
Human putative protein kinase C inhibitor (PKCI-1) 
Human RHOA proto-oncogene multi-drug-res 
Human Rho-associated, coiled-coil containing protein 
Human ribosomal proteinL37amRNA sequen 
Human RPS3a gene. 
Human sapo sin proteins A-D mRNA, complet 
Human SPARC/osteonectin mRNA, complete c 
hxfl2 t64438 
hxfl3 
IFN gamma R alpha 
IFNgRb 
IL-l beta 
IL-10 
IL-lRa 
IL-2Rg 
IL-4* 
IL-7R 
IL-8 
insulin-like growth factor binding protein 3 X64875 
integrin alpha 3 
lntegrin beta-4 subunit 
integrin-linked kinase (ILK) U40282 
jun 
jun-E protein X51345 
KRAB zinc finger protein {alternative products} 
laminin B2 J03202 
laminin S B3 chain L25541 
LFA-3 GPI-linked variant 
LFA-3 trans-membrane variant 
Lipocortin 
lipocortiniiM14043 
Lymphocyte cytosolic protein 1 (L-plastin) 
lynA 
Matrix metalloproteinase 12 (macrophage elastase) 
Matrix metalloproteinase 2 (gelatinase A; collagenase 
matrix metalloproteinase MMP-18 Y08622 
M-CSF 
metalloprote as e/ disinte grin! cysteine-rich protein 
Metallothyonein 
MIP -1 b Macrophage Inflammtory Protein-1 b 
mitogen-activated protein kinase activated protein kinase 
mitotic feedback control protein madp2 homolog U31278 
moe sin 
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myosin light chain kinase (MLCK) U48959 
myosin regulatory light chain X54304 
nidogen (nid) M30269 
Nip2 
Nip3 
osteopontin 104765 
P21 homolog X64899 
p53 activated fragment-1 
p55CDC U05340 
p85MCM 
pag (proliferation associated gene) 
p axillin Ul4588 
PECAM 
pla2 Phospholipase A2 
Platelet ~ycoprotein IX 
profilin J03191 
prohibitin S85655 
protein kinase p58 M88563 
PROTElN PHOSPHATASE INHIBITOR 2 
prothymosin alpha Ml4483 
proto-oncogene c-myc KD1905 
proto-oncogene c-src tyrosine kinase X59932 
proto-oncogene c-syn Ml4333 
proto-oncogene c-yes-1 Ml5990 
proto-oncogene RHOA, multi-drug-resistance protein 
Radixin 
ras-related GTP-binding protein Krev-1 M22995 
ras-relate d GTP-binding protein rap 1 a Xl2533 
ras-related GTP-binding protein RIT Y07566 
ribosomal protein Sl7 
serine/threonine kinase FAST X86779 
serine/threonine kinase rae, alpha M63167 
serine/threonine phosphatase PP-1 d isolog 090164 
serine/threonine phosphatase PPPIA, alpha subunit 
SHC, p52 isoform X68148 
signal transducer and activator of transcription 6 (Stat6) 
soxl2 
syk B-cell protein tyrosine kinase associated with 
Syndecan2 (heparan sulfate proteoglycan 1, cell surface-
talin isolog X56123 
Thrombin Receptor 
thrombomodulin 
THYMOSIN BET A-10 
TIMP-1 MMP-11 
TIMP-3 
TM4 family : CD9 
TNF-RII 
TNFRtype I 
transcription factor BTF-3 
translationally controlled tumor protein 
Tropomyosin alpha chain (skeletal muscle) 
Tropomyosin beta chain (skeletal muscle) 
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tryptase I Serine protease produced in mast cells 
TUBUUN ALPHA-4 CHAIN 
tubulin, alpha KD0.5.57 
tubulin, beta X79.53.5 
tubulin, gamma M61764 
tymosin beta-4 
tyrosine kinase src-like kinase (srk) M14676 
tyrosine phosphatase hPRL-lN homologU69701 
tyrosine phosphatase hR-PTPu X58288 
tyrosine phosphatase PTPlC X62055 
UBCH.5C (E2 ubiquitin conjugating enzyme) 
u-PAR 
urokinase (uP A) 
vimentin 
VLA-.5 CD49a:Very Late antigen-.5; Fibronectin receptor; 
Wnt-13 Z71621 
zyxin X94991 
Temporal Gene Expression 
As can be seen from table 6.1, the majority of genes show a low level expression. 
However colouring the values does allow one to easily select out those genes showing 
moderate and high level s of expression. Table 6.2 below lists some of the genes taken 
from table 6.1 that show a low to moderate, moderate to high and high level of 
expresston. 
From a biological perspective; genes seen to be switched on by OxLDL again 
seem to be those implicated in inflammatory response (IL-l~ and Annexin), in cell 
structure (fibronectin, thymosin and vimentin) and cell membrane remodelling (MMPs 
and TIMP) . In addition several genes such as p53 and translationally controlled tumour 
protein were also identified which could be due to some of the potentially cytotoxic 
effects of OxLDL. 
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Table 6.2 
Table showing some of the genes found to have low to moderate, moderate to high and 
high levels of expression on exposure of differentiated THP-1 cells exposed to OxLDL 
over 72 hours 
Genes showing a low to Genes showing a moderate Genes showing a high 
moderate expression level to high expression level expression level 
Actinin Annexin II 23Kd highly basic 
protein 
Fi bronectin/fi bronecti n Cathepsin L ~-actin 
receptor 
CD36 Lipocortin II Human collagenase 
inhibitor 
Alpha enolase Human saposin proteins A-D TIMP-1 
MMP-2 L-plastin IL-1~ 
Metallothionein p21 Prothymosin alpha 
Oesteopontin Translationally controlled Thymosin B4 
tumour protein 
Thymosin B 10 P53 activated fragment 1 Vimentin 
6.3.2 Analysis of genes of interest showing temporal expression 
Graph 6.1 shows the expression profile of the annexins (also known as 
lipocortins). Annexins are calcium/phospholipid-binding proteins that are involved in 
membrane fusion and exocytosis. They also play a role in inflammation acting as anti-
inflammatory agents. As can be seen from the graph the Annexin II group shows a much 
higher level of expression than Annexin I. 
There are three eDNA clones representing the annexin II gene, 2 of which 
(annexin II and lipocortin II) show a peak of expression at 24 -hours however the two 
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genes are not strongly correlated (R=0.65). A stronger correlation, however was observed 
between annexin II and human mRNA for lipocortin II; R= 0.81 . The two versions of 
annexin I show a peak of expression at 16 hours; however again the pattern is not highly 
correlated (annexin I and lipocot1in; R= 0.743). The strongest correlation (R = 0.865) 
was observed between Annexin and human mRNA for lipocortin II. This could indicate 
that the clones representing the annexins may not be specific enough to distinguish 
between the two genes. 
Graph 6.1 
Graph showing expression pattern of annexins in differentiated THP-1 macrophages 
exposed to OxLDL for up to 72 hours 
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Graph 6.2 shows the expression pattern of ~-actin . Actins are highly conserved 
proteins that are involved in various types of cell motility and are ubiquitously expressed 
in all eukaryotic cells. The ubiquitous expression of the ~-actin means that it is often used 
as a housekeeping gene. In general it is assumed that the level of a housekeeping gene 
remains relatively constant. As can be seen from the graph however, ~-actin levels in our 
experiments did not remain constant. They show a decreased level at 4 and 24 hours. 
Two of the different clones representing this gene did however show a similar pattern of 
expression (R= 0.94 for the two beta actin mutant clone ). 
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Graph 6.2 
Graph showing express ion pattern of ~-actin in differentiated THP-1 cells exposed to 
OxLDL for 72 hours 
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Graph 6.3 shows expression pattern of myosin light chain. Myosin light chain 
kinase phosphorylates a specific serine in the N-terminus of a myosin light chain. As can 
be seen from the graph all forms of the myosin light chain showed a peak of expression at 
16 hours, decreasing and then showing an increase in expression between 48 and 72 
hours. In addition the pattern of expression was similar with the R value rangi ng from 
0.86 to 0.96 between the different clones. 
Graph 6.4 shows the expression pattern of tubulin. Tubulin is the major 
constituent of microtubules . As can be seen from the graph, the different types of tubulin 
show different patterns of expression . The alpha and beta forms of tubulin show the 
highest levels of expression. Both tubulin alpha and gamma show a peak of expression at 
16 hours whereas tubulin beta shows maximal express ion at 48 hours. However a 
stronger correlation was observed between tubulin alpha-4 chain and tubulin beta (R= 
0.86) compared to tubulin alpha and tubulin gamma (R= 0.73). 
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Graph 6.3 
Graph showing expressiOn pattern of myosin light chain m differentiated THP-1 
macrophages exposed to OxLDL for 72 hours 
Graph 6.4 
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Graph showing expression pattern of the tubulin family of genes in differentiated THP-1 
cells exposed to OxLDL for 72 hours 
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Graph 6.5 shows the expression pattern of the thymosins. The thymosins are 
thymic hormones. Thymosin beta-4 can bind to actin monomers thus inhibiting actin 
polymerisation. It also has an inhibitory effect on the proliferation of haematopoietic 
stem cells. As can be seen from the graph thymosi n beta-4, thymosin beta-1 0 show a 
highly similar pattern of expression (R= 0.96) showing maximal expression at 24 hours. 
Although prothymosin alpha also shows a similar pattern of expression with maximal 
expression at 24 hours, a correlation with either thymosin beta-4 and beta-10 was not 
observed (R <0.45) . 
Graph 6.5 
Graph showing expression pattern of the thymosins of genes in differentiated THP-1 
macrophages exposed to OxLDL for 72 hours 
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Graph 6.6 shows the expression profiles of the CD molecules. CD molecules are 
cluster determinant mo lecules present on the membranes on cells. As already discussed in 
the introduction CD36 is receptor capable of binding OxLDL. CD 151 antigen is an 
integral membrane protein. CD54 is also known as intracellular adhesion molecule-! 
(ICAM- 1 ). ICAM proteins are thought to be involved in the binding of monocytes to the 
endothelium (one of the earliest steps of the atheorsclerotic process . CD29 (also known 
as beta I integri n) associates with different alpha polypeptides to form different receptors 
such as the collagen and laminin receptor. CD44 is the main cell surface receptor for 
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hyaluronate and also for type I and VI collagen. It is involved in matrix adhesion, and 
lymphocyte activation. An epithelial isoform (CD44E) is expressed by cells of the 
epithelium. A haematopoietic isoform (CD44H) is expressed by cells of mesodermal 
origin. As can be seen from the graph most of the CD molecules showed an expression 
pattern peaking at sixteen hours. The exception is CD36, which shows a different 
expression pattern peaking at 48 hours. As CD36 has been shown to be a receptor for 
OxLDL [22] CD36 expression would be expected to increase with time. CD44H shows 
the highest level of expression at 72 hours . This correlates well with the fact that the cells 
used is this study (THP-1 macrophages) are haematopoietic in origin [159]. The two CD 
molecules showing the strongest correlation were observed to be CD49a and CD44E (R= 
0.93). A correlation (R= 0.90) was also observed to occur between CD44E and CD44 
antigen; and also between ICAM-1 and CD44E (R= 0.84). 
Graph 6.6 
Graph showing expression pattern of cluster determinant molecules in differentiated 
THP-1 macrophages exposed to OxLDL for 72 hours 
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Fibronectins bind cell surfaces and vanous compounds including collagens, 
fibrin, heparin, DNA and actin. Fibronectins are thus involved in cell adhesion, cell 
motility, opsonization, wound healing and maintenance of cell shape. As can be seen 
from the graph the different variants of fibronectin and fibronectin receptors all show a 
pattern of expression in which expression levels peak at 16 hours, decrease at 24 hours 
and then showing an increase again between 24 and 72 hours. The fibronectins show a 
very similar pattern to the CD molecules. The strongest correlations were observed for 
the different clones representing fibronectin (R value range 0.77-0.94). The clone 
representing human mRNA for fibronectin precursor also showed a strong correlation 
(R= 0.89) with the fibronectin represented by dark blue in the graph but not with the 
other two fibronectins (represented by pink and yellow in the graph; R< 0.65). Finally a 
strong correlation (R= 0.90) was also observed between clone representing human 
mRNA for the fibronectin precursor and CD49a. 
Graph 6.7 
Graph showing expression pattern of fibronectin in differentiated THP-1 cells exposed to 
OxLDL for 72 hours 
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Graph 6.8 shows the expressiOn pattern of the interleukin family. Interleukin 
molecules are involved as part of the inflammatory response. As can be seen from the 
graph, most of the interleukins show a barely detectable level of expression. However IL-
l~. IL-l receptor a and IL-8 all show a much higher level of expression. IL-l~ shows 
the highest expression level peaking at 16 hours and falling back to near basal level by 72 
hours. IL-l receptor a shows maximal expression between 4 and 48 hours. IL-8 shows a 
peak of expression at 8 hours. 
IL-l~ is produced by activated macrophages and is an important mediator of 
various immunological and inflammatory reactions. It stimulates thymocyte proliferation, 
B cell maturation and proliferation, and fibroblast growth factor activity. IL-8 is a 
chemotactic factor that attracts neutrophils, basophils and T-cells. IL-8 can be produced 
by macrophages. It is also a mitogenic stimulus for smooth muscle cells. IL-8 has 
previously been reported to be increased on exposure of differentiated THP-1 cells to 
OxLDL [247]. This study confirms this result as well as showing an expression pattern 
identical to that already reported [ 118]. In addition the early expression of IL-8 suggests 
it could be involved in the interaction and regulation of other members of the interleukin 
family 
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Graph 6.8 
Graph showing expression pattem of interleukin molecules in differentiated THP- 1 cells 
exposed to OxLDL for 72 hours 
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Graph 6.9 shows the expression pattem of the MMPs. The MMPs as discussed in 
chapter 1 are involved in the remodelling of connective tissue as well as in disease states 
associated with inflammation They have also been implicated in the tumour metastasic 
processes. MMP-2 is involved in the cleavage of gelatin type I and collagen types IV, V, 
Vll and X. Collagenase and MDC9 are both involved in the cleavage of specific types of 
collagen. 
As can be seen from the graph MMP-2, MMP-18 and collagenase show a higher 
expression level than the other MMPs, with MMP-2 showing a higher level of expression 
than MMP-18 than collagenase. No strong correlations were observed in expression 
pattems between members of the MMP family showing the highest levels of expression 
(MMP-2, MMP-18 and collagenase; R< 0.68). 
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Graph 6.9 
Graph showing expression pattern of the MMP family of genes in differentiated THP- 1 
macrophages exposed to OxLDL for 72 hours 
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Graph 6.10 shows the expression pattern of the tissue inhibitors of the MMPs 
(TIMPs). TIMP-1 and TIMP-3 can complex with MMPs and irreversibly inactivate them. 
As can be seen from the graph, TJMP-3 shows a very low level of expression whi lst 
TIMP-1 and collagenase inhibitor show a much higher level of expression peaking at 16 
hours. In addition a correlation (R = 0.83) was observed between TIMP- 1 and the 
collagenase inhibitor. 
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Graph 6.10 
Graph showing expression pattern of the TIMP family of genes in differentiated THP-1 
macrophages exposed to OxLOL for 72 hours 
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Graph 6.11 shows the expression of the cyclins. As can be seen from the graph 
only cyclin 03, cyclin dependent kinase 4 (cdk4), cyclin I and a cyclin dependent kinase 
inhibitor showed an expression level over most of the time points. Cyclin 03 is a 
regulator of progression through the G 1 phase of the cell cycle. Cdk4 is involved in the 
regulation of the G 1 to S phase of the cell cycle. The other cyclins showed very low or no 
expression. Both cyclin 03 and cdk4 showed a similar pattern of expression (R= 0.83) 
showing peaks of expression at 8 and 48 hours, with cyclin 03 showing a higher level of 
expression than cyclin 03. Cyclin I showed a peak of expression after 48 hours but not 
after 8 hours. Of interest, the expression level of these cyclins was minimal at precisely 
the time point (24 hours) where cyclin inhibitor expression was maximal (an inverse 
correlation). 
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Graph 6.11 
Graph showing expression pattern of cyclins and cell cycle molecules in differentiated 
THP-1 macrophages exposed to OxLDL for 72 hours 
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6.3.3 Conclusion from expression patterns of gene families 
The results from this part of the study have shown that members of some gene 
families show correlated patterns of expression whereas others do not. Those with 
members showing simi lar patterns of expression include some of the CD molecules (in 
particular CD44E with ICAM-1 and CD49a), fibronectin, myosin regulatory light chain, 
the thymosin fami ly and some members of the cyclins. Gene families not showing similar 
patterns of expression include the annexin family, the interleukins, the MMPs and 
tubulin. 
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6.3.4 Data analysis of genes of interest 
The next stage in this study was to look at the matrix of genes (table 6. 1) and 
using knowledge of the atherosclerosis field (and those genes showing high levels of 
expression) to analyse the expression of genes that have been implicated in some part of 
the atherosclerotic process. All these genes (around 35) were plotted onto one graph (not 
shown) and visually inspected. From this graph genes that showed similar patterns of 
expression were plotted together as shown in the graphs below. 
Graph 6.12 
Graph showing expression pattern of CD36, STAT 6 and ornithine decarboxylase 
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Graph 6. 12 shows the expression pattern of CD36, STAT 6 and ORF I . As can be 
seen from graph, CD36, STAT 6 and ornithine decarboxylase all show a very similar 
patterns of expression especially between 16 and 72 hours . As already mentioned CD36 
is a major receptor for OxLDL. In addition it is thought to regulate gene expression of 
inflammatory molecules and cytokines through activation of transcription through the 
STAT farnjJy [121]. STAT 6 has a dual role, it is involved in signal transduction and 
activation and it is involved in IL-4 signalling [248] . CD36 showed a con-elation with 
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STAT 6 (R= 0.82) whereas a poor correlation was observed when ornjthine 
decarboxylase was compared to CD36 and STAT 6 (R < 0.63). 
Graph 6.13 
Graph showing expression pattern of alpha enolase, IL-8, u-PAR and thrombomodulin 
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Graph 6.13 shows the expression pattern of alpha enolase, IL-8, urokinase 
plasrrunogen activator receptor and thrombomodulin. All the genes show a sirru lar pattern 
of expression, showing a peak of expression at 8 hours, after which expression levels 
decrease before increasing again after 24 hours. As already mentioned IL-8 is involved as 
part of the inflammatory response and is a chemotactic factor that attracts neutrophils, 
basophils and T-cells. Alpha enolase is involved in the glycolysis pathway. Urokinase 
plasrrunogen activator receptor is a receptor for urokinase plasminogen activator. It plays 
a role in localizing and promoting plasmin formation . Thrombomodulin is a specific cell 
receptor that forms a l : I stoichiometric complex with thrombin . This complex in turn 
reduces the amount of thrombin generated. The basis of a simjlar ex pression pattern 
between these genes is not clear however it can be hypothesized that since lL-8 is 
expressed early on, it may play a role in the activation of the other genes that are 
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expressed at the later time points. Of these genes only IL-8 showed a conelation with 
thrombomodulin (R= 0.85). 
Graph 6.14 
Graph showing expression of expression pattern of TNF-RII , phospholipase A2, platelet 
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Graph 6.14 shows the expression pattern of the TNF receptor, phospholipase A2, 
platelet glycoprotein IX and the IFNy receptor. As can be seen from the graph all the 
genes show a similar pattern of expression showing peak of expression at 16 hours. 
Expression levels then fall for all the genes except phospholipase A2 that shows an 
increase between 24 and 72 hours. Of the genes represented; strong conelations were 
observed between IFNy receptor and platelet glycoprotein IX (R= 0.85) and also between 
TNF receptor and platelet glycoprotein IX (R= 0.92). 
The TNF receptor has high affinity for TNF alpha. Phospholipase A2 catalyses 
hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Platelet glycoprotein IX plays 
a role in platelet adhesion and IFNy is receptor for IFN. The reason why these genes 
show a similar pattern of expression is unclear but the TNF and IFN receptors may have 
some effect on the expression of platelet glycoprotein IX. 
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Graph 6.15 
Graph showing expression pattern of IL-l~ . human collagenase inhibitor and TIMP- I 
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Graph 6.15 shows the expression pattern of IL-L~ . TIMP-1 and collagenase 
inhibitor (effectively TIMP-1) . As can be seen from the graph the genes show a similar 
pattern as well as level of expression showing a peak of expression at 16 hours. IL- L~ 
showed a highly correlated pattern of expression in particular with TIMP-1 (R= 0.96) but 
also with the other form of TIMP-1 represented (collagenase inhibitor; R= 0.86) As 
already noted TIMP-1 is an inhibitor of the MMPs. IL-l is an inflammatory cytokine. 
Cytokines have been reported to have a role in regulating the expression of the MMPs 
and the TIMPs [141]. 
Graph 6.16 shows the expression pattern of IL-l~. IL-8, MMP-2, TIMP-1 and 
CD36. As can be seen from graph 6.17 and as already noted, IL-8 shows the earliest 
expression peaking at 8 hours, this is followed by the expression of IL-l~ . TIMP-1 and 
MMP-2 that all show peak expression at 16 hours. CD36 shows a later expression pattern 
starting to increase after 16 hours and showing peak expression between 24 and 48 hours. 
All these genes have been implicated in atherosclerosis, so one could hypothesize that IL-
8 is the triggering factor, which activates one or more of the genes showing peak 
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expression at 16 hours (IL-l~ . TIMP- 1 and MMP-2) . One or more of these genes could 
in turn activate or affect the expression of CD36. 
Graph 6.16 
Graph showing the expression pattem of lL-1 ~ . lL-8, TIMP- 1, MMP-2 and CD36 
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6.3.5 Conclusion from expression patterns of gene of interest 
The data presented in this section demonstrates that genes of interest such as 
CD36 and TIMP-1 show highly correlated patterns of expression to other genes. 
Furthermore the graphs shown above (section 6.3.5) form a basis for hypothesising 
mechanisms that might be tested further experimentally. However this method of 
analysing the data relies completely on knowledge of genes and processes that may be 
involved during atherosclerosis. It does not allow the identification of other genes that are 
co-expressed unless one simply randomly chooses genes and see how they fit into 
particular expression profiles; this would involve further painstaking examination of 
expression of each gene. To overcome this problem, the method of hierarchical clustering 
was applied to the data matrix (table 6. 1) to further identify genes showing similar 
patterns of expression. 
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6.4 Hierarchical cluster analysis 
6.4.1 Data correlation 
As discussed in the introduction to this chapter a natural basis for organising gene 
expression data is to group together genes with similar patterns of expression. The first 
step in this process is to adopt a mathematical description of similarity and show that a 
degree of correlation exists within the dataset. For any series of measurements, a number 
of measures of similarity in the behaviour of two genes can be used such as Euclidean 
distance, Pearson Correlation Coefficent and Mutual Information. Of these, the Euclidean 
distance and the Pearson Correlation Coeffient are the most commonly used [235, 244]. 
In Euclidean distance, each gene is seen as a point in a multidimensional space, 
with each axis representing a different biological sample and the coordinate on on each 
axis represents the level of gene expression in that sample. Euclidean distance is useful 
for identifying genes that have positive correlations, however it is not useful for 
identifying gene that do not have a positive correlation even though they may be 
correlated in another way (for example inversely correlated genes) [238] .For this reason 
in this study we used the other commonly used dissimilarity measure, the Pearson 
Correlation Coefficient. In addition this method is also sensitive to outliers. 
The Pearson Correlation Coefficient is measured between two genes; where the 
two genes are treated as vectors of measurements. Disadvantages of using the Pearson 
Correlation Coefficient are that firstly it assumes a normal distribution of the 
measurements. Secondly since it uses a linear model, it assumes that genes interact in this 
linear model [238]. 
Figure 2.1 (Chapter 2; section 2.5.1) shows the steps in correlating gene 
expression data, applying hierarchical clustering and analysing the results. The results 
obtained are given in appendix 8. 
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6.4.2 Results of Clusters obtained 
Hierarchical cluster analysis of the 216 genes showing expression during at least 
one time points in differentiated THP-l cells exposed to OxLDL over 72 hours showed 
that the genes could be clustered into nine distinct groups. A nine-cluster solution was 
chosen as it best represented individual clusters 
Graphs 6.17-6.25 show the general shape of the clusters assigned to the 216 genes 
using the Pearson correlation procedure. These graphs for each cluster are derived from 
the average gene expression at each time point of all the genes assigned to that cluster. 
From the graphs given in appendix 8; it can be seen that the nine clusters can be 
classified as follows: -
One cluster showing a peak of expression at 8 hours (cluster 9) 
Four clusters show peak of expression at 16 hours (clusters I, 3, 4 and 5) 
Two clusters show a peak of expression at 24 hours (clusters 2 and 6) 
Two clusters showing maximal peak of expression at 48 hours (clusters 7 and 8) 
The two cluster showing peaks of expression at 48 hours (clusters 7 and 8) were also 
found to show smaller peaks of expression at 8 hours. 
Graph 6.17 
Graph showing average ex pression pattern of genes assigned to Pearson cluster l 
~ 
.... 
~ 
= 0.8 -
--+--average gene 
expression leve l 
(cluster 1) 
Q 
·~ 0.6 
~ c. 0.4 
~ 
~ 0.2 
0 
0 8 16 24 32 40 48 56 64 72 80 
Time (hours) 
Cluster I contains 86 genes all of which showed the general expression pattern 
shown in graph 6.17, with an initial increase in expression which peaked at 16 hours fell 
back by 24 hours and then showed a steady increase in expression from 24 to 72 hours. 
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This cluster contained the largest number of genes 86 out of the 216 (40%) temporally 
expressed genes. Genes of interest in this cluster include some of the fibronectins, MMPs, 
and some of the CD molecules (CD 151, CD 53 CD44; discussed above). Some of the 
fibronectins have already been shown in the graph above (graphs 6.7) to show highly 
correlated patterns of expression, thus it is not surprising that these genes have been 
assigned to one cluster. The three genes showing the highest levels of expression in this 
cluster were MMP-2, alpha enolase and human saposin proteins. 
Genes in cluster 2 showed the general expression pattern shown in graph 6.18. 
The expression level falls approximately 25% between 0 and 8 hours and remains 
constant between 8 and 16 hours. After 16 hours there is a sharp increase in expression 
levels peaking at 24 hours (approximate tripling) before the expression level falls back to 
pre-peak levels at between 48 and 72 hours. This cluster contained 35 out of the 2 16 
genes ( 16%) showing temporal expression and was the third Largest cluster. Genes in this 
cluster included all the thymosin genes, which have already been show to have a similar 
pattern of expression as shown in graph 6.5 above. In addition a member of the lipocortin 
fami ly (lipocortin II) has also been included in this fami ly, as has metallothionein. This 
cluster seems to contain cell morphology related genes, including the thymosins, 
vimentin and ferritin. The three genes showing the highest level of expression in this 
cluster are human ribosomal protein L37, vimentin and thymosin beta 4. 
Graph 6.18 
Graph showing average expression pattern of genes assigned to Pearson cluster 2 
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Genes in cluster 3 showed the general expression pattern shown in graph 6. 19. 
Expression level showed an increase from 4 to 16 hours (approximate 4-fold) peaking 16 
hours before falling back to pre-peak levels by 24 hours and staying at this level between 
24 and 72 hours. This cluster contained 26 out of the 216 genes (12%) showing temporal 
expression. Genes in this cluster included IL-l~ and the TIMPs that have already been 
shown to have a similar pattern of expression as shown above (graph 6.15). Other genes 
in this group some of the CD molecules (CD 106, CD44, CD29) and members of the 
tubu lin family. The three highest expressed genes in this cluster are two forms of the 
TIMP-1 gene and IL-l~· 
Graph 6.19 
Graph showing average expression pattern of genes assigned to Pearson cluster 3 
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Genes in cluster 4 showed the general expression pattern shown in graph 6.20. 
There was an increase in expression between 4 and 16 hours (approx 4 fold) with the 
expression level peaking 16 hours before falling between 16 and 24 hours. The 
expression level then showed a steady increase between 24 and 72 hours. By 72 hours the 
expression level was at approximately the same level as at 16 hours. This cluster 
contained 6 of the 216 genes (3%) showing temporal expression. Genes in this cluster 
included ~-actin, CD44H and the thrombin receptor. The three highest expressed genes 
were~ actin, fibronectin and CD44H. 
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Graph 6.20 
Graph showing average expression pattern of genes assigned to Pearson cluster 4 
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Genes in cluster 5 showed the general expression pattern shown in graph 6.21. 
There was an approximate 4-fold increase in expression between 4 and 16 hours with 
expression levels peaking at t 6 hours. This was followed by a steady decrease in 
expression levels between 16 and 48 hours. Expression levels then increased slightly 
between 48 and 72 hours. This cluster contained 6 out of the 2 16 genes (3%) showing 
temporal expression. Genes in cluster 5 included members of the lipocottin family as well 
as p53 and ribosomal protein S 17. The three genes showing the highest levels of 
expression were p53 activated fragment-!, human mRNA for lipocortin II and ribosomal 
protein. 
Graph 6.21 
Graph showing average expression pattern of genes assigned to Pearson cluster 5 
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Genes in cluster 6 showed the general expression pattern shown in graph 6.22. 
The expression level showed a steady increase between 4 and 24 hours peaking at 24 
hours (approximately 5 fo ld). Expression levels then fell back at 24 hours falling to pre-
peak levels by 48 hours. The expression level then showed an increase (approximately 
doubling) between 48 and 72 hours. This cluster contained 8 out of the 2 L 6 genes ( 4%) 
showing temporal expression. Genes expressed in cluster 6 include a member of the 
lipocortin family (an nexin II) , two cytokine receptors (IL-IR and TNF-R). The three 
most highly expressed genes include annexin II, translationally controlled tumour protein 
and osteopontin. 
Graph 6.22 
Graph showing average expression pattern of genes assigned to Pearson cluster 6 
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Genes in cluster 7 showed the general expression pattern shown in graph 6.23. 
Expression levels increased between 4 and 8 hours, peaking at 8 hours before falling 
between 8 and 24 hours. The expression level again increased between 24 and 48 hours 
peaking at 48 hours (at approximately twice the level of the expression peak at 8 hours). 
The expression level then fell between 48 and 72 hours. This cluster contained 37 out of 
the 2 L 6 genes ( 17%) showing temporal expression, and was the second largest cluster. 
Genes in this cluster included ~-actin, members of the tubulin family (alpha and beta) as 
well as a number of cyclins and kinases. This cluster in general seemed to consist of cell 
cycle and cell regulation genes. The three genes showing the highest levels of expression 
were two genes for ~-actin and a eDNA clone similar to ~-actin. 
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Graph 6.23 
Graph showing average expression pattern of genes assigned to Pearson cluster 7 
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Genes in cluster 8 showed the general expression pattern shown in graph 6.24 
Expression levels showed a zigzag pattern of expression between 0 and 16 hours. 
Expression levels then increased between 16 and 48 hours (approximately tripling) 
peaking at 48 hours before showing a decrease between 48 and 72 hours. This cluster 
contained 6 out of the 216 (3%) genes showing temporal changes in expression. Genes of 
interest in cluster 8 included CD 36, L-plastin and STAT 6 and translationally controlled 
tumour protein. Some of the genes in this cluster such as CD36 and STAT 6 have already 
been shown to have a similar pattern of expression as shown above (graph 6.12). Others 
such as L-plastin, proliferation association gene and translationally controlled tumour 
protein were not. The three genes showing the highest patterns of expression were 
trans lationally controlled tumour protein, L-plastin and ornithine decarboxylase. 
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Graph 6.24 
Graph showing average expression pattern of genes assigned to Pearson cluster 8 
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Genes in cluster 9 showed the general expression pattern shown in graph 6.25 
Expression levels increased between 4 and 8 hours (approximately 8 fold) , peaking at 8 
hours before falling between 8 and 24 hours. The expression level then remained 
relatively low and steady between 24 and 48 hours. This cluster contained 6 out of the 
216 (3%) differentially expressed genes. Genes in this cluster included IL-8 
thrombomodulin and a transcription factor. The three genes showing the highest level of 
expression were IL-8, thrombomodulin and laminin . These early expressed genes are 
interesting because they may the signals that determine or influence the genes switched 
on during the later stages of exposure to OxLDL. Indeed IL-8 has already been reported 
to play a major role as a part of the inflammatory response by acting as a chemo-
attractant for lymphocytes and T-cells, it seems plausible to hypothesize that it may also 
affect/regulate the expression level of other genes. 
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Graph 6.25 Graph showing average expression pattern of genes assigned to Pearson 
cluster nine 
6.5 Discussion 
o.9 r---------;;:::::======~ 
0.8 
~ 0.7 . 
... 
~ 0.6 
= 0.5 
_g 
"' 0.4 
"' 2: 0.3 . 
~ 0.2 
~ 0.1 . 
___._average gene 
expression 
lc vel (cluster 9} 
0 ~~------~--------------------~ 
0 8 16 24 32 40 48 56 64 72 80 
Time (hours) 
Although clustering genes on the basis of their expression IS not a new 
phenomenon, the development of array technology and the subsequently large amount of 
data generated using the technology has made clustering an important tool for the 
interpretation of the results. The obvious advantage in using cluster analysis is that it 
allows some degree of interpretation of large data sets. In particular, cluster analysis of 
results from multiple experiments can help to identify genes that behave similarly. 
The aim of this part of the study was to identify genes showing correlated 
expression in differentiated THP-1 macrophages exposed to OxLDL over 72 hours. This 
time scale was chosen based on lipid loading experiments with OxLDL (chapter 3) that 
indicated cells accumulated OxLDL up to 72 hours. Cells were not exposed for longer 
than 72 hours because of the potentially toxic affects of oxysterols that are present in 
OxLDL. Another aim of performing a temporal gene expression study was to obtain an 
overall or 'global pattern' of gene expression of 769 genes in differentiated THP-1 cells 
exposed to OxLDL and to then look at these genes and identify those showing similar 
patterns of expression. 
Hybridisation experiments were performed using the custom atheroma arrays and 
probes generated at 7 time points; 0, 4, 8, 16, 24, 48, and 72 hours. A final total of 5600 
hybridisation intensities were collected (expression levels of 769 genes at 7 time points). 
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The results showed that 216 genes ( 1512 data points) from 769 genes on the array 
showed an expression level significantly above background at one of the 7 time points 
analysed. This still gave 1512 data points to analyse (of which, 202 data points showed a 
greater than 2 fold change, 58 showed a greater than 5 fold change and 7 showed a 
greater than 10 fold change). On its own this was a table of numbers, which would have 
to be painstakingly analysed. However using previously reported methodology [234], the 
data was represented by colours in a way that was both quantitative and qualitative. This 
allowed easier identification of low, medium and highly expressed genes. Although the 
majority of the 216 genes showed a low level of expression across the time series, some 
genes did show moderate and relatively high levels of expression at one more time points 
(table 6.2). Genes showing high levels of expression included interleukins-1 ~. TIMP-1, 
thymosin beta 4 and vimentin. 
The list of genes was then analysed and gene families were selected and plotted 
on graphs to examine their expression patterns. This demonstrated that some gene 
families such as the fibronectins, thymosins, actins and some of the cyclins showed 
highly similar patterns of expression. However this was not always the case as shown by 
the expression pattern of the interleukins and MMPs. 
Using knowledge of the atherosclerosis field, all relevant genes known or thought 
to be involved in response to OxLDL were selected and plotted to determine if any of 
them showed similar patterns of expression. This demonstrated that some of these genes 
although showing different levels of expression showed highly similar patterns of 
expression over 72 hours. Of particular interest CD36, which is known to be a receptor 
for OxLDL [18], was shown to have a pattern of expression similar to STAT 6, which is 
a transcription factor (graph 6.12). Since OxLDL has also been implicated to affect the 
expression of cytokines and inflammatory molecules this transcription factor may have a 
key role in this process. Two other genes showing a highly similar pattern of expression 
were IL-l~ and TIMP-1 (graph 6.15) both of which have already been shown to play 
important roles in the atherosclerotic process [142, 150]. 
Although looking at genes of interest and those known to have a role in 
atherosclerosis did show genes showing similar patterns of expression, this methodology 
of selecting does not allow analysis of the whole data set of 216 genes to identify if there 
·are any major patterns of expression within the data set. to address this-issue hi~rarchical 
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clustering analysis was performed on the data. The cluster analysis attributed the 216 
genes to nine clusters. The general expression pattern of the clusters showed that they all 
showed a peak of expression at one or more of the time points studied. In particular the 
16 and 24 hour time points were the most prominent points for peaks of expression. 
Analysing the clusters further showed that most of the genes were in 4 clusters (clusters 
1, 2, 3 and 7). These 4 clusters accounted for 184 (85%) of the 216 genes. The remaining 
5 clusters (clusters 4, 5, 6, 8 and 9) accounted for only 32 (15%) of the 216 genes. 
In general the results from the clustering correlated well with the patterns of 
expression observed when genes of interest or genes families were selected and plotted 
on graphs. Although the clustering did cluster gene families together, this was not always 
obvious. For example although the vast majority of fibronectin gene variants were 
assigned to Pearson cluster 1 some forms of fibronectin were assigned to Pearson cluster 
3. This, of course, does not mean that the clustering algorithm is wrong since slightly 
different sequences of the same gene or different sequence regions of the same gene 
could easily show slight differences in expression patterns as indeed is the case if the 
gene graph for fibronectin family is examined further (graph 6.7). Furthermore if one 
examines the two sets of clusters which contain the majority of the fibronectin and CD 
molecules (clusters 1 and 3), one can see that they both show a similar pattern of 
expression, both showing peaks of expression at 16 hours but differing slightly at what 
happens at the other time points. 
Thus it can be concluded that the clustering technique used here (HCA), was able 
to identify clusters of genes showing similar patterns of expression. This database 
provides a valuable tool, which can be used as a starting point for further analysing genes 
showing similar patterns of expression to genes that have already been implicated in the 
atherosclerotic process. The expression levels of these genes can then be analysed under 
different conditions by going back and performing in vitro experiments. 
213 
Chapter 7 Quantitatil'e RT-PCR 
Chapter 7: Quantitative RT -PCR 
7.1 Introduction 
Messenger RNA provides the link between the genetic material, DNA, and the 
biologically functioning material, protein, in a cell. While the genes of an organism are 
relatively fixed, the mRNA population represents how genes are expressed under any set 
of given conditions [161]. RNA synthesis is thus central to the flow of genetic 
information in eukaryotic and prokaryotic cells and isolated mRNA has become the target 
for a diverse array of analytical and diagnostic techniques. The aim of this part of the 
study was to attempt to confirm some of the differentially expressed genes identified by 
the array experiments by other independent means. Due to time limitations however, this 
part of the study was not completed. 
7.1.1 Current methods for analysing mRNA expression 
Current methods for analysing mRNA expression include northern blots, array 
technology, ribonuclease protection assays (RPAs), quantitative RT-PCR and more 
recently the use of RNA interference. 
7 .1.1.1 Northern blots 
Northern blotting is a method in which RNA is transferred to a filter and detected 
by hybridisation to a labelled probe [249]. The RNA of interest is separated according to 
size by electrophoresis, and then immobilized by capillary transfer to sheets of 
nitrocellulose or nylon membranes. The blot is subsequently washed in a buffer 
containing the labelled probe (usually labelled radioactively). The probe selectively 
hybridises to the RNA molecules that are complementary to the nucleotide sequence of 
the probe. The major limitations of using northern blotting is that it is the least sensitive 
of the currently available techniques. In addition it is the technique in which the RNA is 
most vulnerable to degradation. 
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7.1.1.2 Array technology 
As already described (chapters 4 and 5), array based experiments allow the 
simultaneous study of the expression of thousands of genes in a single experiment. This 
technology has now become widely used for analysing mRNA expression and was the 
methodology employed in this study. 
7 .1.1.3 Ribonuclease protection assay (RPA) 
RPA allows the quantitation and detection of specific mRNAs in a complex 
mixture of total cellular RNA. The basis of RP A is solution hybridisation of an antisense 
RNA probe (radiolabelled or non isotopically labelled) to a complex mixture of RNA. 
The reaction can be 10 to 100 fold more sensitive than northern blot analysis [250]. RPA 
is also less sensitive to partial RNA degradation than northern analysis. The main 
disadvantage of RP A is the lack of transcript size information and the lack of probe 
flexibility. Fragment size is determined by the homologous region of the probe, which is 
usually only several hundred nucleotides long. RPA only allows the use of antisense 
RNA probes unlike northern blots, which allow the use of DNA, RNA and 
oligonucleotide probes. 
7 .1.1.4 RNA interference 
RNA interference (RNAi) is thought to be an evolutionary defence mechanism against 
foreign double stranded RNA [196]. Briefly RNAs called small interfering RNA 
(siRNA), which are around 21-23 nucloetides are cleaved from longer dsRNA chains by 
an enzyme called Dicer. The antisense strand of the siRNA is then used by an RNA-
induced silencing complex (RISC) to allow mRNA cleavage, thus resulting in mRNA 
degradation [251]. RNAi is relatively novel technique which aims to identify the function 
of individual genes through gene silencing. The use of RNAi in mammalian cells 
involves the transfection with double stranded siRNAs corresponding to a region of a 
gene of interest. The siRNA then bind specifically to the corresponding cellular RNA 
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leading to the degradation of the mRNA and a subsequent decrease in the levels of the 
corresponding protein. Thus RNAi can specifically downgrade the expression of genes of 
interest. Already RNAi has been used together with microarray technology to identify 
genes involved in diseases such as cancer [215]. 
7.1.1.5 RT-PCR 
The polymerase chain reaction first reported in 1986 [252] is a powerful and 
sensitive technique whereby DNA is quickly and reliably amplified many thousand to 
million fold. A variant of PCR, RT-PCR was subsequently reported and can be used for 
studying gene expression in tissues and cells [253]. There are two main methodologies 
that use RT-PCR for the analysis of gene expression. These are differential display and 
quantitative RT-PCR. 
7.1.1.5.1 Differential Display 
The basis of differential display is to perform RT-PCR using sets of primers, 
which enables the detection of all mRNA species present in the sample [254]. Oligo dT 
primers that anneal to the poly A tails of mRNA present are used. The anchored oligo dT 
primers consists of 11 or 12 Ts plus two additional 3' bases that provide specificity. 
These are used together with a set of random decamer primers. Theoretically the 
combination of all the primer pairs used should ensure that all the mRNA species present 
are transcribed during the reverse transcription reaction and subsequently amplified by 
PCR. 
Typically one of the primers used in the reaction is radioactively labelled and 
PCR products are resolved by denaturing polyacrylamide gel electrophoresis. 
Comparison of relative intensities of PCR products obtained from a control and test 
sample using the same primer pairs helps to reveal sequences that are differentially 
expressed in the test sample. The major disadvantages of differential display are that rare 
mRNA species may not be efficiently displayed. In addition it is a very labour intensive 
method in which there is usually a high frequency of false positives to follow up [255]. 
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7.1.1.5.2 Quantitative RT-PCR 
RT-PCR is the most sensitive of the RNA detection methods. It has been shown 
to be l000-10,000 times more sensitive than the classical methods for analysing gene 
expression (northern blots and RPAs) [256]. The main problem with RT-PCR is the 
difficulty in obtaining quantitative data. This arises from the exponential nature of PCR 
where small changes in amplification efficiency can lead to large changes in the yield of 
product [257]. An additional problem is that during the later stages of PCR, there is a 
plateau effect in which the amount of product generated plateaus due to the limitation of 
necessary components and generation of inhibitors [257]. 
7.1.2 Use of standards 
To correct for variations m amplification efficiency and allow quantitation, 
investigators have used a range of RNA controls. A typical approach has been to co-
amplify a control gene in the same tube and then to correct the experimental sample with 
respect to the control. In general there have commonly been two different types of control 
used; a control RNA already present in the sample or spiking in a synthetic control [258]. 
7 .1.2.1 Use of housekeeping controls 
These are RNA species that are already present within sample [258]. These are 
usually housekeeping genes such as ~-actin and GAPDH, which are ubiquitously and 
constitutively expressed [259]. A second set of primers designed to amplify the mRNA of 
the housekeeping gene are normally used either in the same the same tube or a separate 
tube. However it has been shown that the mRNA levels of these genes do not always 
remain constant [259]. One disadvantage is that multiple sets of primers in the same tube 
often interfere with amplification of target and control gene [259]. 
The ideal control for RT-PCR would be ribosomal RNA since its levels remains 
essentially constant from sample to sample. The major problem however in using rRNA 
is its abundance. Ribosomal RNA tends to be very abundantly expressed thus cannot be 
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used as a control since the endogenous control must be expressed at roughly the same 
level as the RNA under study [258]. 
7.1.2.2 Use of Internal Standards 
An alternative to using housekeeping controls is to use synthetic controls prepared 
by the investigator. These also are referred to as 'competitors' or 'internal standards. The 
advantage of using internal standards is the initial amount of standard added can be more 
accurately determined. Internal standards can be of two types, DNA standards [260] or 
RNA standards [261] and are added to the RT-PCR reaction. DNA standards tend to be 
stable and are easier to construct and quantify, however they do not control for the RT 
step of the RT-PCR reaction since they are added during the PCR step. RNA standards 
control for the RT step but more steps are involved in their construction and they tend to 
be more prone to degradation. Internal standards are designed to share the same primer 
binding sites as the target sequence of interest and have the same intervening sequences 
except for a small insertion, deletion or mutation [262]. This helps to distinguish the 
standard from the target sequence. Once a standard has been prepared it is co-amplified 
with the gene of interest using competitive RT-PCR. 
7.1.3 Competitive PCR 
Competitive RT-PCR is the standard method for quantitative RT-PCR [263]. 
During competitive RT-PCR a dilution series is made of the prepared internal standard 
and is co-amplified in the presence of target [263]. The internal standard competes with 
the target for primers (since it has the same primer binding sites) and also for enzyme. 
When the internal standard is in excess, there is reduced signal from the target. As the 
amount of internal standard decreases, the target signal increases. Quantification is 
performed after competitive amplification of an entire series of dilution reactions. The 
relative amounts of target and internal standard product in each sample are compared. A 
graph is constructed plotting log ratio of internal standard signal/target signal versus the 
log of internal standard added [261 ]. From this graph the amount of initial target RNA 
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can be found at the equivalence point. The initial amounts of target and internal are 
assumed to be equal in those reactions when the ratio is one to one, as then the target 
equals the competitor 
When the ratio of internal standard/target is plotted against the log of the internal 
standard added, a straight line with a slope of one should be the result as shown in graph 
7 .I (adapted from reference 261 ). If the slope is less than I, the target has higher 
efficiency and if the slope is greater than I, the standard has a higher efficiency [261]. 
The linearity of the slope indicates that there is a relationship between the efficiencies 
and that relative levels can be determined. A slope of one indicates that the efficiencies 
are equal and constant [261]. 
Graph 7.1 
Model graph for quantitative competitive RT-PCR showing relationship linear 
relationship between log amount of internal standard added versus log ratio of internal 
standard to target. The equivalence point shown by the arrow is the point at which the 
both target and IS are present in a I : 1 ratio 
Log amount of internal standard added 
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7.2 Experimental Design 
In this study array technology was used to identify for differentially expressed 
genes in differentiated THP-1 cells exposed to native and modified LDL. In an attempt to 
confirm some of these changes by other independent means, the method of quantitative 
competitive RT-PCR was performed. The internal standards chosen were DNA standards 
as they are easier to prepare and are more stable than RNA standards. However it should 
be acknowledged that DNA standards do not control for the RT step as discussed above. 
The initial aim was to successfully set up quantitative RT-PCR for five genes in the THP-
1 foam cell model. Two of the genes selected were normal housekeeping control genes, 
~-actin and HPRT; two of these genes were positive control genes for foam cell 
formation, IL-8 and ACAT (expected increase in levels during foam cell formation). 
Finally lipoprotein lipase was used as negative control gene for foam cell formation 
(expected decrease in levels during foam cell formation). Internal standards were 
prepared for the 5 genes and quantitative experiments were performed. 
7.2.1 Steps involved in performing quantitative RT-PCR 
The main steps involved in performing mRNA quantification include 
(a) Isolation and quantification of RNA 
(b) Preparation of internal standard 
(c) Reverse transcription 
(d) Spiking equal amounts of eDNA with a dilution series of internal standard 
(e) PCR 
(f) Quantitation 
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7.2.1.1 Isolation of RNA 
Total RNA was isolated from differentiated THP-1 cells and differentiated THP-1 
cells exposed to native and modified LDL using a commercially available ready to use 
solution (TRizoi™; as described in the methods section 2.3.2.2). Isolated total RNA was 
then subjected to denaturing agarose gel electrophoresis to visually verify the intensity of 
the RNA by the presence of l8S and 28S ribosomal RNA bands (section 2.4.1.4.1 ). This 
checks that the RNA has not been degraded during the isolation process. Quantitation 
was performed using spectrophotometry (section 2.4.1.3). 
7 .2.1.2 Internal standard preparation 
DNA internal standards can be prepared using primers for the gene of interest and an 
additional composite primer (herewith referred to as the internal standard primer). Primer 
sequences were designed from published sequences obtained from the Genbank database 
and are given in section 2.3.4.2. Figure 7.1 shows a schematic diagram showing steps 
involved in internal standard preparation (adapted from reference 177). These steps 
include 
(I) The forward and reverse primers were used to amplify the target gene of interest. 
The product was then separated on an agarose gel (section 2.3.5) and the product 
isolated from the gel as described in section 2.3.6. PCR conditions are given in 
section 2.3.4.4. 
(2) The isolated product was then amplified using the original forward primer and a 
internal standard primer. The internal standard primer was designed to bind the 
target sequence at an upstream region (of about 40-lOObps) from the original 
reverse primer site. Furthermore the composite primer is designed to contain a tail 
of about l 0 bps that is identical to the first I 0 base pairs of the original reverse 
primer. Again the PCR product obtained was separated on an agarose gel and the 
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product isolated. (Sequence of internal standard primers) are gtven in section 
2.3.4.2; table 2.1) 
(3) During the final amplification step, isolated product from step two was amplified 
with the original forward and reverse primers. The reverse primer binds to the tail 
on the intermediate PCR product from step 2 (since it is complementary). 
(4) This produces a product that is of shorter length that target but which contains the 
same primer binding sites as the target sequence 
A list of product sizes for targets, intermediate products and internal standards are 
given in section 2.3.4.3. A large quantity of each internal standard was prepared for each 
gene using PCR and the products separated on an agarose gel and isolated. Each batch of 
internal standard was aliqouted into smaller amounts and stored at 20°C until required. 
Each time subsequent quantitative experiments were performed; spectophotometric 
measurements were made to determine the concentration of the internal standard. 
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Figure 7.1 
Schematic diagram showing steps involved in internal standard generation (adapted from 
reference 177) 
Step I 5' .. 
.. 3' 
5' 
Step 2 
+-------. ........ 
3' 
5' 
Step 3 
3' 
5' .. 
Step 4 3' 
7.2.1.3 eDNA synthesis 
The initial step in RT-PCR is the production of single stranded 
complementary DNA copy (eDNA). An oligonucleotide dT primer is used to initiate 
eDNA synthesis by annealing to the polyadenylated 3' tail found on mRNA. The mRNA 
is then transcribed through the action of the retroviral enzyme reverse transcriptase. 
Reverse transcription of isolated RNA was performed as described in section 2.3.3. The 
RT step is a enzymatic reaction, there is no amplification and the only variable is the 
amount of RNA, which is converted into eDNA. It can be represented by an equation 
eDNA = RNA x efficiency [261] (where efficiency is measured as the amount of RNA 
transcribed into eDNA). 
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7.2.1.4 PCR 
After preparation and quantitation, dilutions of internal standard were prepared 
and spiked into identical amounts of sample eDNA. The eDNA and internal standard 
were then amplified using the PCR reaction (section 2.3.4.1). PCR is a three-step process 
consisting of denaturation, annealing and elongation. Due to its exponential nature the 
PCR reaction is more complex than the RT step [258]. Theoretically the amount of 
eDNA is doubled after every cycle. This can be represented by P = T ( 1 +E) 11 where P is 
the product (measured after n cycles) and T is the template (amount of eDNA from the 
RT reaction). E is the efficiency (% of eDNA copied in a PCR cycle) and n is the cycle 
number [261]. Small errors in the PCR step can lead to large changes in the amount of 
final product obtained. Use of an internal standard however takes this into account. 
In addition to the use of an internal standard, which can control for amplification 
efficiency during the PCR step, several additional control steps were used during the RT 
and PCR steps to ensure that PCR products obtained were from target genes. Two 
negative controls were included in the RT step. These consisted of a control containing 
no RNA and all other RT reagents except RNA template and a control containing all RT 
reagents except RT enzyme. These ensured that there was no DNA contamination of the 
original and subsequent eDNA preparations. Similarly during PCR, a negative control 
that consisted of all PCR reagents except cON A template was used to ensure that there 
was no eDNA contamination of PCR products. In addition the PCR primers used were 
designed so that they spanned an intron. The idea behind this is that that only products 
from eDNA are likely to amplified. If a product is obtained from the intron containing 
DNA it will give a product of larger size than produced by the corresponding eDNA that 
allows it to be distinguished. 
7.2.1.5 Quantitation 
The final step in the process was the detection and quantitation of the 
amplification products. Reaction products were separated so that the target and internal 
standard could be detected and quantified. This was achieved by electrophoresis through 
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an agarose gel (section 2.3.5) or by polyacrylamide gel electrophoresis as described in 
section 2.3.7.2. Quantitation was initially performed through ethidium bromide staining 
to allow a range of internal standard concentrations where both target and internal 
standard were amplified in approximately equal amounts to be determined. More accurate 
quantitation was achieved through the measurement of incorporated radioactivity using 
labelled primers. 
Both forward and reverse primers were radiolabelled as described in section 
2.3.7.1. The primer showing the most radioactive incorporation was subsequently used 
during PCR reactions. The labelled PCR products were separated on polyacrylamide gel 
and the amount of label in target and internal PCR products was determined by 
phosphorimaging as described in section 2.3.7.2. 
7.3 Results 
7.3.11nternal standard preparation 
As discussed above, one of the initial steps involved the preparation of internal 
standards for genes of interest. Internal standards were prepared for the following genes: 
HPRT, ACAT, interleukin 8, ~-actin and lipoprotein lipase. Internal standards were 
prepared by using a composite primer containing a tail with homology to the reverse 
primer as described above and shown by Figure 7 .l except for ~-actin which was 
prepared according to protocol of reference [264]. Table 7.1 lists the internal standards 
prepared and the size in base pairs of the target gene and corresponding internal standard 
product. 
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Table 7. 1 
Table of internal standards prepared and size of target and internal standard (bp) 
Name of Target Gene Internal Standard 
Target Gene Product Size (bp) Product Size (bp) 
HPRT 351 314 
~-actin 520 320 
Interleukin -8 210 164 
Lipoprotein lipase 227 160 
ACAT 475 407 
Figures 7.2 below shows photographs of ethidium bromide stained gels showing 
the products obtained during internal standard preparation for two of the genes HPRT and 
IL-8. As discussed above (figure 7 .I), three products were obtained, the target product 
(from the gene of interest), an intermediate product (using the composite primer) and the 
internal standard. As can be seen from figure 7 .2, the products although being very 
similar in size (especially the intermediate product and the internal standard) can 
nevertheless be distinguished from one another during agarose gel electrophoresis. 
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Figure 7.2 
Photographs of two ethidium bromide stai ned gels showing products obtained during 
internal standard preparation for HPRT (lanes 2- 4) and IL-8 (lanes 5 - 7) 
600 bp 
100 bp 
M 1 2 3 4 M 5 6 7 M 
(M = IOObp marker) 
Lanes labelled M are marker lanes, each containing 0.5f.lg of I OObp ladder. 
Lanes 1-4 shows products obtained during preparation of the HPRT internal standard. 
Lanes 6-8 show products obtained during preparation of the IL-8 internal standard 
Lane 1 is a negative control for the PCR. Lane 2 is the target HPRT sequence (351 bp ). 
Lane 3 is the intermediary HPRT product (product from lane 2 amplified with 5' forward 
primer and 3' composite HPRT reverse primer; 294bp). Lane 4 is the HPRT internal 
standard (product from lane 3 amplified using the original 5' forward and 3' reverse 
HPRT primers; 314bp). Lane 5 is the target IL-8 sequence (227bp). Lane 6 is the 
intermediary product (product from lane 5 amplified with 5' forward primer and 3' 
composite IL-8 reverse primer; 150bp). Lane 7 is the IL-8 internal standard (product from 
lane 6 amplified using the original 5' forward and 3' reverse IL-8 primers; 160bp). As 
can be seen from figure 7.2 internal standards were successfully prepared for the IL-8 and 
HPRT genes and could be easily distinguished form their target sequences during 
separation by agarose gel electrophoresis. Similarly internal standards were prepared for 
LpL, p actin and ACAT (data not shown). 
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7.3.2 Initial quantitation of internal standards using ethidium bromide staining 
After internal standards had been generated and quantified, a dilution series of 
each internal standard was prepared and added to an equal amount of eDNA. 
Subsequently PCR performed as described in section 2.3.4. The PCR products were 
separated by electrophoresis on an agarose gel, and the gel stained with ethidium bromide 
and photographed under UV light (section 2.3.5). This step was performed in order to 
determine an initial range of concentrations of internal standard, in which the internal 
standard and target sequence competed for PCR reagents. Furthermore so as to determine 
a range of concentrations at which the product and internal standard were amplified at a 
l: l ratio before the procedure was performed radioactively. 
Figure 7.3 below shows a photograph of an ethidium bromide stained agarose gel 
after separation of PCR products obtained after performing competitive PCR using a 
dilution series of the IL-8 internal standard. Similarly figure 7.4 shows a photograph of 
an ethidium bromide stained agarose gel after separation of PCR products using a 
dilution series of the ~-actin internal standard. In both cases an increasing amount of 
internal standard was added to a constant amount of eDNA (section 2.3.4). 
Figure 7.3 
Photograph showing ethidium bromide stained agarose gel after separation of competitive 
PCR products for IL-8. Product sizes are 210 bp for the target sequence and 164 bp for 
the internal standard. (M =marker, IS= internal standard and pg = picograms) 
Target 
210bp 
Internal Standard 
164bp 
M1234 56789M 
Lane l = PCR negative control 
Lane 3 = 80 pg eDNA only 
228 
Lane 2 =DNA 
Lane 4 = 80 pg eDNA + 25pg IS 
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Lane 5 = 80 pg eDNA + 31.25pg IS 
Lane 7= 80 pg eDNA+ l25pg IS 
Lane 9 = 25J..1g IS only 
Figure 7.4 
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Lane 6 = 80 pg eDNA + 62.5pg IS 
Lane 8 = 80 pg eDNA+ 250pg IS 
M=lOObp marker (0.5J..1g) 
Photograph of ethidium bromide agarose gel after separation of competitive PCR 
products for ~-actin . Product sizes are 520 bp for the target sequence and 320 bp for the 
internal standard (M =marker, IS =internal standard and pg = picograms) 
520 bp I ... f!t ... 1-l :: --- -- I .. _ 
-= 
-
320 bp 
M l 2 34567 89lOM 
Lane I = PCR negative control 
Lane 3 = 80 pg of eDNA+ 1.6pg IS 
Lane 5 = 80 pg of eDNA+ 8pg IS 
Lane 7 = 80 pg of eDNA+ 32pg IS 
Lane 8 = 80 pg of eDNA + 960pg IS 
M= l 00 bp marker (0.5J..1g) 
Lane 2 = 80 pg of eDNA only 
Lane 4 = 80 pg of eDNA+ 3.2 pg IS 
Lane 6 = 80 pg of eDNA+ l6pg IS 
Lane 8 = 80 pg of eDNA+ 320pg IS 
Lane lO = 16 Jlg IS only 
As can be seen from figures 7.3 and 7 .4, the range of concentrations used for the 
internal standards resulted in both the target and internal standard competing for PCR 
reagents. As expected at low internal standard concentrations, the amount of target 
amplified was greater than the amount of internal standard amplified. However as the 
concentration of internal standard added was increased, the amount of target amplified 
decreased and the amount of internal standard amplified increased. In addition there were 
low concentrations of internal standard where only target was amplified and vice versa 
higher concentrations of IS where only the internal standard was amplified. Similarly 
229 
Chapter 7 Quantitative RT-PCR 
dilutions were prepared of the internal standards for the other genes (ACAT, LpL and 
HPRT) and competitive RT-PCR was performed to estimate concentration ranges of 
internal standard to use (data not shown). 
7 .3.3 Quantitation using phosphorimaging 
After initial quantitation with ethidium bromide staining that produced only visual 
results, quantitation was performed using phosphorimaging, which allowed a quantitative 
form of measurement (although quantitation using ethidium bromide has been reported, it 
has a poor dynamic range [265]). Both forward and reverse primers were radioactively 
end labelled as described in section 2.3.7.1. Subsequently one of the primers was spiked 
into each tube during competitive PCR. The decision on which primer to use was taken 
by end labelling both primers and assessing which primer incorporated the most label as 
described in section 2.3.7.2. Competitive PCR was then performed in the presence of 32P 
labelled primer. Subsequently PCR products were separated on a denaturing gel as 
described in section 2.3.7 .2. After electrophoresis the gel was dried and exposed to 
photographic film to determine the position of the radiolabelled PCR products (section 
2.3.7.2). This section of the gel was removed and exposed to a phosphor beta-imaging 
screen. The screen was scanned and the relative amounts of products of target and 
internal standard were calculated using BioRad Molecular Analysis software as described 
in section 2.3.7.2. The results were subsequently exported to Microsoft Excel for 
analysis. The ratio of IS target was calculated and graphs were then plotted of log IS 
standard concentration versus log IS: target ratio for the internal standards. 
Figures 7.5 to 7.7 show sections of film of radioactive PCR products obtained 
using competitive PCR in the presence of 32P end labelled primer for the genes HPRT, ~­
actin and IL-8. Quantitation using this method was also performed for ACAT and LpL 
(data not shown). As can be seen from the from the films, at the concentration of internal 
standards used both target and IS competed for PCR which resulted in two products 
corresponding to target and internal standard being formed. In addition, as also shown by 
ethidium bromide staining there were also concentrations of IS used that were too low so 
that only target was amplified and concentrations of IS used that were too high so that 
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only IS was amplified. Graphs 7.2 - 7.4 show plots of log IS standard concentration 
versus log IS : target ratio for each of the internal standards (IL-8, HPRT and ~-actin). As 
can be seen from these graphs, HPRT showed an S-shaped pattern, IL-8 a linear pattern 
and ~-actin a curved pattern. However for each of the graphs there is a region which is 
linear if one selects a specific range of IS concentration added. Thus a region of linearity 
was observed with all the standards as required and shown in the model graph for PCR 
(figure 7. 1 ). The results for all the genes however show that the slope of the graphs is 
greater than one, resulting in the slope not passing through the origin. This means that 
there are different amplification efficiencies between the target and IS at the 
concentrations of IS used. 
Figure 7.5 
Film showing products of competitive PCR between HPRT target and HPRT IS 
2 3 4 5 6 7 8 9 10 
Lane I= 80pg eDNA only Lane 2= 80pg eDNA +41pg IS 
Lane 3= 80pg eDNA +4lpg IS Lane 4= 80pg eDNA +82pg IS 
Lane 5= 80pg eDNA+ l02.5pg IS Lane 6= 80pg eDNA +205pg IS 
Lane 7= 80pg eDNA +0.4IJ.lg IS Lane 8= 80pg eDNA +0.821-lg IS 
Lane 9= 80pg eDNA +8.21-lg IS Lane 10 = 821-lg of IS only 
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Graph 7.2 
Graph showing log internal standard concentration versus log internal standard: target 
ratio of PCR products after competitive PCR for HPRT 
• • 
Log HPRT IS added 
Figure 7.6 
1 
y = 0.7794x + 0.3392 
I• log !S:Target -Linear (log IS:Target) 
Film showing products of competitive PCR between IL-8 target and IL-8 IS 
2 3 4 5 6 7 
Lane I= PCR negative control 
Lane 3= 80pg eDNA+ 0.05ug IS 
Lane 5= 80pg eDNA+ 0.25ug IS 
Lane 7= 80pg eDNA +0.3 1 ug IS 
Lane 9= 80pg eDNA + 0.42ug IS 
Lane II = 80pg eDNA+ 0.63ug IS 
8 
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Lane 2= 80pg eDNA only 
Lane 4= 80pg cON A + 0.13ug IS 
Lane 6= 80pg eDNA + 0.28upg IS 
Lane 8= 80pg eDNA + 0.36ug IS 
Lane 10= 80pg eDNA+ 0.5ug IS 
Lane 12= 80pg cON A + 0 .83ug IS 
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Lane 13= 80pg eDNA+ 1.25ug IS 
Graph 7.3 
Graph showing log internal standard concentration versus log internal standard: target 
ratio of PCR products after competitive PCR for IL-8 
Log IL-8 IS added 
Figure 7.7 
Film showing products of competitive RT-PCR between ~-actin target and ~-actin IS 
2 3 4 5 6 7 
Lane I = PCR negative control 
Lane 3 = 80pg eDNA + I pg IS 
8 9 10 11 12 13 14 15 
Lane 2 = 80pg eDNA only 
Lane 4 = 80pg eDNA+ 1.1 pg IS 
233 
l 
Chapter 7 
Lane 5= 80pg eDNA+ l.3pg IS 
Lane 7 = 80pg eDNA+ l.7pg IS 
Lane 9 = 80pg eDNA+ 2.5pg IS 
Lane l l = 80pg eDNA + 5pg IS 
Lane 13 = 80pg eDNA + 20pg IS 
Lane I 5 = lOflg of IS only 
Graph 7.4 
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Lane 6 = 80pg eDNA+ 1.4pg IS 
Lane 8= 80pg eDNA+ 2pg IS 
Lane 10= 80pg eDNA+ 3.3pg IS 
Lane 12= 80pg eDNA+ lOpg IS 
Lane 14= 80pg eDNA+ lOOpg IS 
Graph showing log internal standard concentration versus log internal standard: target 
ratio of PCR products after competitive PCR for ~-actin 
1.5 
Log ~actin IS added 
234 
y = 0.4688x + 0.9239 
• Log IS:Targetl 
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7.4 Discussion 
Although RT-PCR is a very powerful technique, the sensitivity of the reaction 
means that potential errors can arise at any stage from RNA isolation to PCR therefore it 
is important to use appropriate controls at all steps. It is necessary to prepare controls and 
understand the dynamics of the PCR reaction in the system being studied. However once 
achieved this paves the way for the examination of genes of interest. 
7.4.1 Problems associated with RT-PCR 
A problem associated with RNA isolation is that most techniques used for RNA 
isolation also yield significant amounts of genomic DNA contamination [261]. Thus it is 
important when designing primers for RT-PCR is to design primers that span at least one 
intron. This helps overcome the problems associated with DNA contamination. DNA 
contamination will be identified because the product that will be generated will be of 
larger in size than the product obtained from eDNA. In this study primers were routinely 
designed across an intron. In addition a control DNA sample was included when a new 
set of primers were used. DNA contamination can also be eliminated adding DNase I to 
the reaction. Hung et a! [266] have reported complete inactivation of DNase 1 by heat 
denaturation at 75°C for 5 minutes. Although this step was not included in the protocol 
reported here, it will be included in future experimental work 
An additional problem is that pseudogenes exist in the mammalian genome for 
many genes [267], including the most commonly used housekeeping genes (~actin, 
GAPDH, cyclophilin). Psuedogenes are sequences that arise from the historical 
integration of retroviral sequence into the human genome. As pseudogenes do not have 
introns, the size of a PCR product amplified from a pseudogene may be identical to that 
produced from the eDNA copy. The only way to identify these products is to perform a 
no RT control. The no RT control yields two fragments; one identical in size to the 
expected product and a larger product which can be attributed the pseudogene. In this 
study we routinely performed a no RT control when performing reverse transcription. In 
addition we also included a no RNA control and tested it with primers that amplify DNA 
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to show that there was no contamination of RT reagents. No evidence of pseudogenes 
was found in the experiments performed. 
Another problem that can arise is heteroduplex formation. Although an internal 
standard has the same primer binding sites as the target and is needed so ensure that 
reaction efficiencies of both the target and standard are similar, this similarity can also be 
the source of error [268]. As the PCR reaction proceeds, single strands of the internal 
standard and native amplification products can reanneal to form heteroduplexes. The 
likelihood of hetroduplex formation has been shown to be reduced by using standards 
with a deletion or an insertion but increased when point mutation is used [268]. This is 
thought to be because a deletion or an insertion provides a non-homologous region large 
enough to prevent annealing between the target and standard. In this study internal 
standards were prepared containing a deletion to minimise the risk of heteroduplex 
formation. 
7.4.2 Discussion of results 
In this study high-density eDNA arrays were used to detect changes in gene 
expression during macrophage foam cell formation. To confirm these changes, 
competitive RT-PCR was used in attempt to quantitate these changes independently. 
Unfortunately due to time limitations the method was not fully optimised in the foam cell 
model such that it could be used to quantitate genes found to be regulated by native and 
modified LDL as reported in chapters 5 and 6. 
The major steps towards achieving this goal were however performed. Internal 
standards were successfully prepared for the following genes HPRT, ~actin, lipoprotein 
lipase and interleukin-8. In addition initial set up experiments were also performed. 
Competitive RT-PCR was performed showing standard and target sequences competing 
for the PCR in the presence of a dilution series of internal standard (figures 7.2-7.8). 
Furthermore target and IS products could be easily distinguished from one another by 
agarose gel and denaturing gel electrophoresis. The results for the genes showed 
competitive PCR taking place between the target and internal standard. When graphs 
were plotted for all the genes, at certain concentrations of IS added, a linear relationship 
. -~ 
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was observed between the amount of internal standard added and the ratio of internal 
standard to target. However the slope of the graph was not I as required. In addition, the 
slopes did not pass through the origin. This indicates that there may be a difference in the 
amplification efficiencies of the internal standard and target sequences. This will warrant 
further investigation to determine the effects of the numbers of cycles required at which 
amplification efficiencies are the same. These experiments used 30 PCR cycles at which 
stage the PCR is likely to have reached the plateau stage. Both target and IS are more 
likely to show similar amplification efficiencies during the earlier linear stages of the 
PCR reaction. 
7.4.3 Future Experiments 
Future experiments would first investigate the relative amplification efficiencies 
of the target and internal standard sequence. This could be performed by removing 
aliquots from different cycles of a radioactive competitive PCR reaction between targets 
and IS, separating them on a gel and determining the radioactivity in each aliquot. The 
amount of radioactivity in each sample at different cycle number for IS and target can 
then be compared. Graphs can then be plotted of the cycle number versus radioactive 
incorporation and the two graphs can be compared to ensure that the PCR is only 
performed up to a cycle number that encompasses the linear phase of the reaction before 
the plateau phase occurs. 
Next internal standards would be cloned into a vector with appropriate 
transcription sites and transcribed into RNA standards using an RNA polymerase. This 
would ensure that there is control during the RT step. Subsequently levels of these genes 
can be quantitated in samples of differentiated THP-1 cells exposed to either native or 
modified LDL. In addition specific ELISA assays could be used to measure the protein 
levels of these genes and see if they correlate with the quantitative RT-PCR results. 
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7.4.4 The future of RT-PCR 
Advances in technology have resulted in the development of a new generation of 
thermocyclers. These thermocyclers allow the real time monitoring of PCR products so 
that PCR products can be visualised as they are formed thus offering improved 
quantitation [269]. Such thermocyclers include the ABI 'Taqman' and Roche 
'Lightcycler'. Since multiple fluorescent probes can be used, internal standard and target 
sequences and the DNA melting curves they generate can be differentiated using different 
fluorescent probes. Different types of fluorescent probes have been used for monitoring 
[270]. These include molocular beacons (that form a stem-and-loop structure) hydrolysis 
probes (which take advantage of the 5'- 3' exonuclease activity of Taq), hybridisation 
probes and DNA specific dyes such as SYBR green. 
The advantages of real time monitoring is that a much larger amount of data 
about the PCR is obtained from the data points for each cycle. In addition errors in 
sample manipulation that are involved in end-point quantitation and the time taken are 
minimised. Due to their cost however, these machines are not accessible to everyone and 
are commonly only found in core facilities. 
Changes seen with hybridisation array technologies are commonly reported after 
they have been confirmed using RT-PCR or northern blots [271]. Furthermore 
competitive RT-PCR is still popular method for the quantitative analysis of gene 
expression in those labs that do not yet have access to array technology. In addition when 
only one or a few genes need to be studied, RT-PCR or northern blots are easier to use 
and less expensive. Thus RT-PCR will still remain one of the major methods for the 
analysis of mRNA expression levels. 
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Chapter 8: Discussion 
The overall aim of this study was to gain an insight into gene expression during 
the transformation of macrophages into foam cells in an in vitro model. Information 
regarding which genes are expressed and their pattern of expression during foam cell 
formation will help our understanding of the complex nature of the atherosclerotic 
process. In addition, identification of differentially expressed genes can also help to 
understand the underlying biochemical pathways and may reveal potential therapeutic 
targets. 
The macrophage plays an important role in normal physiology. It is a major cell 
of the inflammatory response involved in the removal of pathogenic organisms [54]. The 
macrophage has also been implicated in a variety of diseases including tuberculosis, 
AIDS, rheumatoid arthritis and atherosclerosis [54]. During the initial stages of 
atherosclerosis, accumulation of foam cells leads to the formation of the fatty streak. 
Although the fatty streak is asymptomatic, it is the precursor lesion that subsequently 
leads to the development of the intermediate and more complicated lesions of 
atherosclerosis. In addition, during the advanced stages of atherosclerosis, macrophages 
are thought to be critical in determining plaque stability through the release of MMPs that 
may weaken the fibrous cap. Studies have described a variety of foam cell responses that 
can contribute to the growth and rupture of atheorsclerotic plaques [114]. These include 
the production of growth factors and cytokines (TGF ~. M-CSF, IL-l and IL-8), 
chemokines (MCP-1), proteins such as the MMPs and tissue factor. 
8.1 Background 
At the start of this study, there were few reports of large-scale gene expression 
studies examining differential expression of genes in the foam cell model. Most of the 
genes that had been reported were single genes identified through the use of traditional 
molecular biology techniques such as differential display or northern blots [249,254]. In 
addition the reporting of these genes were from a variety of different biological models 
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including human and animal cell lines [ 120, 150] in isolated HMDM grown in vitro [ 183], 
and in foam cells isolated from both human and animal plaques [58]. 
The nearest report of an attempt to examine large-scale gene expression study at 
that time was a report by Wang et at [ 118]. These authors studied the expression of 49 
genes in differentiated THP-1 cell line on exposure to AcLDL using a multi-gene assay 
based on northern blotting. The genes they studied included cytokines, growth factors, 
chemokines and adhesion molecules. Their study identified only one gene to be 
differentially expressed namely the cytokine IL-8. 
Therefore in an attempt to identify other differentially regulated genes during 
foam cell formation we attempted to perform a large-scale gene expression study in an in 
vitro model of foam cell formation as the first step of understanding and establishing 
events that may be occurring in vivo. To achieve this goal we used array technology that 
allows the simultaneous study of the expression of thousands of genes. 
8.2 Experimental design 
8.2.1 THP-1 cells -use of an in vitro model for foam eel/formation 
Due to the technical limitations involved, most studies of lipoprotein uptake in 
macrophages use cell culture models. For these experiments the human monocytic cell 
line THP-1 was chosen as the experimental model. THP-1 cells can be easily 
differentiated to macrophages using a phorbol ester and are similar to HMDM in many 
respects [ 184]. The decision to use an in vitro model rather than an ex vivo (HMDM) or 
in vivo model (macrophages isolated from atherosclerotic plaques) was based on practical 
experimental considerations. These included minimising variability of the source of 
sample and the fact that THP-1 cells could be grown in relatively large quantities as 
required with relative ease. The use of an ex vivo model (HMDM) was excluded due to 
the problems associated with variations between individual donors. We wanted to 
minimise variation as when the study was started we were unsure how eDNA array 
technology would perform. The use of in vivo macrophages from plaques was excluded 
due to the limited amount material expected to be obtained and the difficulty in isolating 
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a pure sample of foam cells from the other cell types present in the isolated 
atherosclerotic lesions. 
8.2.2 Use of acetylated and oxidised LDL 
Native LDL is taken up by macrophages via the regulated LDL receptor pathway 
and incubation of macrophages with native LDL does not result in foam cell formation. 
Thus THP-1 cells exposed to native LDL were chosen to represent the physiological 
situation since in vivo macrophages are exposed to the circulating native LDL. 
Modification of LDL is known to result in its uptake by unregulated pathways and foam 
cell formation. Two forms of modified LDL were used in this study, AcLDL and 
OxLDL. AcLDL is not thought to occur in vivo however as shown by Goldstein and 
Brown [ 16] in their discovery of the scavenger receptor, incubation of cells with AcLDL 
results in its uptake, leading to foam cell formation. This form of modified LDL is 
commonly used as an experimental standard for forming foam cells, although the effects 
of AcLDL may not be very representative of in vivo events. 
Modified forms of LDL thought to occur in vivo include oxidation, glycation, 
lipolysis, proteolysis and aggregation. Of these; OxLDL has been implicated as the most 
likely form of LDL that exists in vivo and causes foam cell formation. OxLDL 
represented a more potent form of lipid loading. 
Although aggregated or glycated LDL could have also been used, two extreme 
conditions were chosen. Exposure to AcLDL represented standard lipid loading. 
Exposure to OxLDL was a more extreme form of lipid loading, since OxLDL is not a 
single entity but a heterogeneous mixture consisting of a number of components 
including oxysterols. This can also raise problems when comparing studies between 
different investigators since discrepancies in reported genes may be due to differences in 
techniques used for modification and the concentrations of OxLDL used. 
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8.2.3 Choice of technology to examine differentially regulated genes. 
The original molecular biology method planned to be employed in this study to 
identify differentially regulated genes was differential display (Chapter 7). However as 
this PhD was a part of a collaborative research project with an industrial partner (Glaxo 
Wellcome), the author was given the opportunity to use high density eDNA technology 
that was utilised within the company. 
The decision to proceed with the use of this technology was taken after 
consideration of a number of factors including the time involved in learning a new 
technology, the number of experiments that could be performed, the potential of the 
results that could be obtained using the technology and the risks associated with a method 
still under development. It should be noted that this technology could only be used due to 
the collaborative nature of this study. Such collaborations between industry and academia 
are important for the transfer of scientific knowledge and technological advances 
between the two institutions. Furthermore they play a valuable role in providing students 
work experience in an industrial setting. 
8.3 Results 
8.3.1 Foam cellformation 
Although both AcLDL and OxLDL have been reported to induce foam cell 
formation in macrophages, this had to be achieved by the author of this thesis. To date 
there are no current standard protocols for modifications of LDL and concentrations of 
these modified forms of LDL that induce foam cell formation. Commonly however the 
method reported by Basu et a! [ 172] the standard method used for preparation of 
acetylated LDL and methods of either Steinbrecher et a/ [ 171] and Hammer et a/ [ 175] 
are used for oxidation. 
Due to the nature of experimental work, variations will always exist in the 
experimental procedures used for culturing cells, for isolating and modifying LDL 
between different investigators. Therefore before gene expression between macrophages 
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and foam cells could be assessed, foam cell formation had to be confirmed in 
differentiated THP-1 cells using the experimental conditions used within this study. This 
was achieved using both quantitative and qualitative methods. 
Initially THP-1 cells were differentiated using PMA. PMA stimulates 
differentiation by binding to and activating protein kinase C in cell membranes and 
tissues.Both flow cytometric analysis and light microscopy confirmed that differentiation 
of monocytes to macrophages had occurred (chapter 3) and a change in cell morphology 
was noted. As was expected and reported by other investigators [ 163], cells were found to 
change from a homogenous population of 'round' cells to a more heterogeneous 
population with cells becoming adherent and spread. This is consistent with previously 
reported data that the THP-1 cell line responds to PMA treatment by changes in cell 
morphology with acquisition macrophage like functions including phagocytosis and 
enhanced secretion of lipoprotein lipase and apoE [190]. Exposure of dividing THP-1 
cells to PMA has also been reported to results in loss of LDL receptors and the 
appearance of scavenger receptors [21]. These factors make THP-1 cells suitable for in 
vitro studies of foam cell formation. 
However several disadvantages also exist in using THP-1 cells differentiated with 
PMA. Firstly it does not truly represent the in vivo situation. In addition it has also been 
reported that there is a degree of heterogeneity in expression of macrophage functions 
after PMA treatment. Regardless of length of exposure to PMA, a certain population of 
THP-1 cells remain negative for expression of the scavenger receptor. Another point to 
consider is the length of time required for differentiation. Although some investigators 
have reported differentiation after 24 hours, Via et a/ [ 160] have reported that maximal 
scavenger receptor activity and morphological differentiation were only achieved 
consistently after 72 hours of exposure to PMA (cells in this study were differentiated for 
7 days to ensure full differentiation). PMA itself can activate the transcription of a 
number of genes including LpL, apoE, collagenase and metallothionein. To exclude 
effects of PMA induced genes in this study; cells were exposed to PMA for identical time 
periods for differential gene expression experiments so that the only variable was the 
form of lipoprotein treatment received. 
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Once THP-1 cells had been differentiated using PMA, cells were exposed to 
native, acetylated or OxLDL. Subsequently cholesteryl ester accumulation was assessed 
within the cells to show that differentiated cells exposed to modified LDL accumulated 
more cholesteryl esters than those exposed to native LDL. Cells were exposed at varying 
concentrations (0, 0.05, 0.1, 0.2 and 0.3mg/ml) of LDL and modified LDL over varying 
time periods (0, 24, 48 and 72 hours). Cholesterol accumulation was assessed 
quantitatively by using flow cytometry of nile red stained cells and the 14C oleate loading. 
These methodologies both of which have been previously reported [163,164] for 
assessing foam cell formation indicated that cholesterol ester accumulation using AcLDL 
was greater than native LDL at a concentration of 0.2mg/ml of AcLDL and that this was 
achieved after 24 hours of exposure. Using OxLDL, cholesteryl ester accumulation was 
found to occur at a slower rate and cells did not show accumulation greater than native 
LDL until a concentration of 0.3mg/ml of OxLDL and this was achieved after 72 hours. 
Qualitative methods using Oil red 0 staining and fluorescence microscopy also 
confirmed that differentiated THP-1 cells exposed to modified lipoprotein accumulated 
more cholesterol esters than cells exposed to native LDL as visually observed by the 
presence of increased numbers of lipid droplets and greater fluorescence in cells exposed 
to modified lipoprotein as compared to native lipoprotein. 
Thus an in vitro model of foam cells could be established as previously reported. 
This in vitro model of foam cells could subsequently be used to study differential gene 
expression between cells exposed to native LDL compared to cells exposed to modify 
LDL (foam cells). For gene expression studies, differentiated THP-1 cells were exposed 
to native and modified LDL for 24 hours at concentration of 0.2mg/mllipoprotein. In an 
attempt to study genes showing differential gene expression during early exposure to 
modified LDL, samples of differentiated THP-1 cells exposed to AcLDL and OxLDL 
(0.2 mg/ml) for 4 hours were also prepared. 
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8.3.2 Array Technology 
For array technology experiments two different arrays were used, a custom 
atheroma array with a pre-selected genes thought to be involved in the CHD and arrays 
representative of the human genome (containing genes that had been sequenced to date 
and EST). Both arrays were generated using eDNA clones from the human I.M.A.G.E 
library. 
The custom arrays had the advantage of containing a pre-selected list of genes 
that were relevant to CHD. In addition the all the genes on the array were gridded at least 
4 times and sequenced to determine whether they matched their original given I.M.A.G.E 
identity. This meant post analysis of the data was easier and reproducibility could be 
assessed. In addition it confirmed the high error rate present within the I.M.A.G.E 
collection. Of 769 genes chosen for the custom atheroma array only 579 (75%) matched 
their original assigned I.M.A.G.E identity. 
The I.M.A.G.E arrays had the advantage of containing EST sequences and a much 
larger number of genes. However due to the large error rate and level of redundancy all 
gene differences identified had to be sequence confirmed. This meant that post analysis 
of data took longer since clones corresponding to the genes identified had to be repicked 
from the library and sequenced. In addition as would expected there l.M.A.G.E arrays 
gave a larger number of genes to follow compared to the custom arrays and many of the 
differences identified corresponded to ESTs. 
It has been reported by Botwell et a! [273] that the original Unigene sets (from 
which the I.M.A.G.E collection results) has significant discrepancies between actual and 
designated clone sequence and thus many of the I.M.A.G.E clones (up to 30 %) may be 
assigned incorrect identities. This is consistent with the error rate (25%) found in 
preparing the custom array. 
Another factor to take into consideration for future experiments was the time 
taken to collate all the data from the I.M.A.G.E arrays. Due to the size of the I.M.A.G.E 
library the work involved in processing the arrays, collecting and analysing the data was 
much greater than the custom arrays. In addition the most of the changes identified 
corresponded to ESTs. It is thus arguable whether the I.M.A.G.E arrays should have been 
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used in this study. The results however provide a significant database of subsequent 
genes/EST to follow up and analyse. ln addition the results provide a good starting point 
to follow-up the differential expression of novel genes represented through the ESTs. 
8.3.3 Differential gene expression 
Results of differential gene expression studies showed fewer genes to be regulated 
by experimental treatment (AcLDL and OxLDL) than we had hypothesized and expected. 
Although this result was surprising, reports by other investigators using array technology 
have also showed the number of genes to be regulated to be less than they had expected 
with experimental samples. These results also fit those observed from the completion of 
the sequencing of the human genome project. Although the number of genes expected 
was though to be around I 00,000 before completion of the project, the results have 
suggested around 20,000-30,000 genes [ 199]. This could be due to more splice variants 
of genes being present than previously envisaged. 
In this study we found the largest number of genes found to be regulated were 
found to be in the native versus control sample. The control sample used in this study was 
sample of differentiated THP-1 cells that had been exposed to serum free medium (as had 
all the samples) to remove any exogenous lipoprotein stores, however unlike the other 
samples the cells were not subsequently exposed to any lipoprotein. This sample thus 
represented lipoprotein deficient cells in which essential cellular processes may have 
been switched off completely or slowed down due to lack of lipid availability. In other 
words the control cells may have been in a semi quiescent state and exposure of the cells 
to native LDL resulted in an active state where normal cellular processes may have been 
switched on again, hence the large number of changes observed in this comparison. 
The results from the experimental treatments did however show genes that were 
expected to be involved in this process were differentially expressed. These genes 
included CD36, MMP-2, TIMP-1 and IL-l~ all of which have been reported to play a 
role in the atherosclerotic process [24, 14 7, 150, 225]. These results indicated both that 
foam cell formation had occurred and that the array technology used here was capable of 
detecting these changes. Furthermore in general the genes found to be differentially 
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expressed showed a tendency to be either inflammatory molecules or genes involved in 
cell structure and morphology. Since atherosclerosis is now widely accepted to be an 
inflammatory process [ 4], the results of this study provide further credence to this claim. 
Furthermore lipid loading would be expected to result in changes in cell morphology. 
Although no new novel genes were detected by this study, this is not unexpected 
considering that most of the genes on the custom atheroma arrays were selected due to 
their involvement in CHD and thus most of them have already been reported or studied in 
foam cell models. As the I.M.A.G.E arrays also contained cDNAs representing EST 
clusters, the results from the human I.M.A.G.E arrays did provide potential novel 
transcripts to follow up. 
Comparing AcLDL with OxLDL, more changes were found with OxLDL. This 
was expected since as already noted OxLDL, is not a single entity, but is composed of 
many oxidised lipid components such as oxysterols. In particular exposure to AcLDL 
was found to result in the increased expression of IL-l~. a pro inflammatory cytokine 
which is known to sustain the inflammatory process. Exposure to OxLDL resulted to an 
increase in CD36, a known receptor for OxLDL and also an increase in expression of 
MMP-2. An increase in MMP-2 activity has been reported in foam cells isolated from 
atherosclerotic lesions. MMP-2 is involved in the breakdown of components of the ECM. 
It has also been implicated in SMC migration. Both AcLDL and OxLDL also showed a 
decrease in TIMP-1 expression indicating that active MMPs may play an important role 
during foam cell formation. MMP-1, MMP-2, MMP-3 and MMP-9 have all been 
reported in lesional macrophages. In this study we only detected the expression of MMP-
2 indicating that this may be the one of the MMPs expressed on early exposure to 
modified LDL. It has demonstrated that levels of MMP-2 increase as the plaques from 
fatty streaks to fibrous plaques [274]. 
In hindsight of the large number of changes observed with the native versus 
control samples, it may have been better to expose all cells to native LDL (use the native 
LDL sample as a control). After exposure of all samples to native LDL for 24 hours, cells 
could then have been exposed to native, acetylated and oxidised LDL for 24 hours. This 
may have resulted in the cells being more representative of the in vivo situation where 
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macrophages are exposed to native LDL in the plasma. However this would not have 
been realised had these experiments not been performed in the first place. In addition if 
analysis of the data had been performed for each comparison one at a time this may have 
identified the situation at an earlier stage of the study. Unfortunately this was not possible 
due to time limitations and restricted use of the array technology, which meant that 
experiments had to be performed and analysed in two allocated set time periods. 
8.3.4 Temporal gene expression 
A second part to this study was to examine temporal gene expression of 
differentiated THP-1 cells in response to OxLDL. This was performed so that a global 
picture of the pattern of gene expression taking place upon lipid loading with OxLDL 
could be obtained. Cells were exposed to OxLDL (0.2mg/ml) for 0, 4, 8, 16, 24, 48 and 
72 hours. Probes were prepared and applied to the custom atheroma arrays. This 
generated an expression level for every gene on the custom array at every time point 
studied was obtained. These expression levels were corrected (to take into background) to 
produce a final matrix of data. This showed that 216 genes on the array showed an 
expression level (after normalisation) at one of the time points studied. 
To analyse the data matrix produced by this large number of data points in a 
manner that was meaningful, the data was coloured so that the data was represented in a 
manner that was both quantitative and qualitative. This has been one of the main 
approaches taken to analyse large data sets that are produced by array technology. This 
allowed easier visualisation of the data and allowed the identification of genes showing 
low, moderate and high levels of expression. Furthermore from this data set, genes of 
interest or genes known to be involved in the atherosclerotic process could be selected 
and their patterns of expression compared to identify genes showing similar patterns of 
expression. The results showed that members of gene families showed highly similar 
patterns of expression including members of the annexin, fibronectin and cluster 
determinant families. Other families however; such as the members of the MMPs did not 
show similar patterns of expression. Comparison of expression patterns of genes of 
interest showed that, in particular, two sets of genes showed highly similar patterns of 
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expression. IL-l~ showed a highly similar pattern of expression to TIMP-1. In addition 
CD36 was found to show a highly similar pattern to a transcription factor ST A T6. When 
different variants/subforms of a gene were present and showed differential regulation, the 
different variants were found to show highly similar patterns of expression 
One point to note here is that the results produced by the temporal study do not 
take into account the effect that native LDL has on these genes. This is important since 
when compared to native LDL, the genes may not show up and down regulation. The 
only conclusions that can be drawn from this data set is that the genes identified are 
expressed during their exposure to OxLDL and the pattern of expression these genes 
follow over the time course of exposure to OxLDL over 72 hours. In addition the effects 
of PMA were not controlled for during this part of the study, all cells were compared to a 
zero time sample. However since THP-1 cells were differentiated using PMA for 7 days 
before the time course experiment was started any further changes due to PMA should be 
minimal. This is because PMA should have fully differentiated the cells by this stage. 
Selecting genes known to be involved in the atherosclerotic process or gene 
families did identify genes showing similar patterns of expression. However this method 
relied on knowledge of the atherosclerotic field and did not identify any patterns of 
expression emerging from the full data set of genes showing temporal expression. To 
achieve this, hierarchical cluster analysis was applied to the results produced from the 
temporal study in order to identify groups of genes showing similar patterns of 
expression. The results showed 9 different clusters of genes. 
Hierarchical cluster analysis is a commonly reported clustering method that has 
been applied to data generated using array technology [235]. Hierarchical is an 
unsupervised technique that builds clusters of genes with similar patterns of expression. 
However the method does have some disadvantages. One being that it ignores negatives 
correlations; which may be important in a particular data set. In addition the method is 
inflexible in that genes that are linked together incorrectly early on the process cannot 
latter be assigned to different clusters. Thus the temporal gene results presented here 
show the strength of array technology in terms of number of genes and time points that 
can be analysed. 
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Studies similar to the temporal work performed in this study has been reported. 
An overview of expression profiling in cardiovascular disease has been reported by 
Henriksen et at [ 158]. Andersson et at [275] have reported transcript profiling of 
cholesterol loaded macrophages, however they employed the method of eDNA 
representational difference analysis and shotgun sequencing. Shiffman et at [276] have 
reported the results of a temporal study using THP-1 cells exposed to 0.1 mg/ml OxLDL 
for up to 4 days. However there are some fundamental differences between this study and 
the one reported by Shiffman et al [276]. This means that although the results obtained 
from both studies can be examined they cannot be directly compared. Neither can they 
support or disprove results at an individual level since the experimental conditions used 
in both studies were different. These differences include 
(a) Time allowed for differentiation of THP-1 cells 
Whilst cells in this study were differentiated using PMA for seven day before exposure to 
OxLDL, Shiffman's group only allowed differentiation for 24 hours before exposure to 
OxLDL. However Shiffman's group use a time matched PMA control sample at each 
time point to take into account the effects of PMA. This was not done in this study due to 
limitations of resources and time. 
(b) Concentration of OxLDL used 
The concentration of OxLDL used in this study was 0.2mg/ml, the authors of the above 
study used O.lmg/ml, half the amount used in this study. 
(c) Time course 
Cells in this study were exposed to OxLDL for periods of 4, 8, 16, 24, 48 and 72 hours. 
Shiffmans group exposed cells to OxLDL for 0.5, 2.5, 8, 24, 48 and 96 hours. 
(d) Number of genes assessed 
In this study we assessed 769 genes that were arrayed on nylon membranes. Shiffman et 
at probed a much larger number of genes 9808 human genes. In addition these genes 
were arrayed on glass slides. 
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Both studies however found similar numbers of genes to be differentially 
expressed during exposure. Here we report the expression of 217 genes from 769 genes. 
Shiffman et al repotted the expression 268 genes from 9808 genes. Although we report a 
much higher number of genes in term of the percentage of genes probed, this can be 
accounted for the fact that the genes on the custom arrays used here were pre-selected for 
their involvement in CHD. In addition, similar to the results of the study presented here 
Shiffman's group do not exclude the fact these temporally expressed genes may also be 
regulated by native LDL treatment. 
Although as noted above IL-8 was identified by Wang et a! [ 114] to be expressed 
in differentiated THP-1 cells exposed to AcLDL, we did not identify the gene during 
DGE experiments. However the reason for this became clear when the temporal pattern 
of expression of IL-8 was examined. This showed that IL-8 expression peaked at 8 hours 
and by 24 hours it had returned to basal levels. This is consistent with the work of Wang 
et al [ 114] who despite the fact they used a lower level of OxLDL nevertheless found a 
similar pattern of expression with IL-8 showing a peak of expression at 8 hours. The fact 
that we used a time point of 24 hours explains the reason why the gene was not detected 
during DGE experiments. This highlights the need to perform temporal studies on genes 
of interest since expression patterns can vary greatly even over small time periods. 
8.4 Problems associated with array technology 
As shown by the results presented in this study, array technology has the ability to 
survey a large number of genes and yield large numbers of results. However as with any 
use of any technology in a developmental stage there are many issues, which must be 
addressed. 
8.4.1 Reverse transcription bias 
One of the problems with using technologies that assess mRNA levels via eDNA 
production is that not all mRNA's are not transcribed with the same efficiency [220]. 
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This fact can lead to reverse transcription bias, which can change the relative amounts of 
different cDNAs. Another problem caused by this bias is that some mRNA's may be 
reverse transcribed for only parts of their lengths, making them less likely to bind and 
stay bound to their corresponding sequences on the array. One way of getting around this 
problem is to prime reverse transcription from random starting positions on the mRNA 
rather than always starting from their poly A tails [277]. 
8.4.2 Oligonucleotide versus eDNA arrays 
Two different types of arrays have largely arisen from array technology. 
Oligonucleotide arrays or eDNA clones that are arrayed onto glass slide or nylon 
membranes (as used in this study). Compared to oligonucleotide arrays, eDNA arrays 
have the advantage of potentially improved sensitivity due to the availability of more 
target sequence to which the probe can hybridise [207]. However clone mix-ups between 
sequencing and array creation means that interesting clones must be sequenced again to 
be assured of their identity [273]. Shorter oligonuclotide arrays however have the 
advantage of allowing detection between highly similar genes and alternative splice 
variants [220]. 
The spotting pattern and spot shape of synthesized oligonucleotide arrays are very 
regular [220]. Printed arrays are more likely to have uneven spot morphology and 
irregular spacing caused by the printing method used. Some genomic and eDNA clones 
have repetitive sequences, leading to cross hybridisations on the arrays [220]. Generally 
the use of oligonucleotide arrays is becoming more widespread, however agreement has 
yet to be reached on what the optimal length of oligonucleotide to use (25mer or 60 mer 
oligonucleotides are the currently the most commonly used) [206].1n addition reports 
comparing the different platforms (eDNA arrays versus oligonucleotide arrays) have 
generated conflicting results on whether the data between the 2 platforms is comparable 
[278,279]. 
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8.4.3. Controls for array experiments 
As shown by this study, expression levels of normally used housekeeping genes 
such as GAPDH did not remain constant and were actually found to be differentially 
expressed. Warrington et at [280]have identified only 47 genes out of a total of 7000 
genes studied in 11 different adult and fetal tissues; whose expression remains at similar 
levels making them useful as controls. 
The best controls that have been suggested are genes from different organisms to 
the one being studied, so that when using human samples one should use control genes 
derived from bacteria or plants. This means that the probe should only hybridise to its 
complement sequence on the array and is not present in the sample. If several different 
genes are spiked into the sample at different concentrations, subsequent monitoring of 
these genes can be used as sample to sample normalising factors. 
The results from this study indicated that the levels of normally used 
housekeeping genes between samples did not remain constant during DGE experiments. 
Thus during the temporal gene expression study, housekeeping genes were not used as 
controls, instead the median intensity of the arrays was used. This was considered a 
developmental step in the technology. If the expression levels of housekeeping genes not 
been found to be differentially regulated during DGE experiments; this step could not be 
taken when the temporal gene expression study was performed. 
8.4.4 Background 
Another factor that will affect the results is the background signal of the array and 
subsequent threshold values used to exclude background. This means genes of low 
abundance are likely to be excluded. Quantitation of the intensities of each spot on the 
array can also be affected by noise from surrounding spots. In addition dust on the slide 
and non-specific hybridisation can also affect results. Furthermore detection intensity 
might not be uniform across the array, leading to excessive intensity on one side of the 
array. 
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8.4.5 Glass slides versus nylon membranes 
Arraying of eDNA samples is now more commonly pe1formed on glass slides than 
nylon membranes although both have their own advantages and disadvantages. 
Commercially available filter arrays are cheaper than glass arrays because they require no 
special equipment except phosphorimaging screens [209]. Membranes are also useful for 
scarce mRNA, as a smaller amount of mRNA is required to prepare the probe in 
comparison to the amount required for the preparation of fluorescent probes that are 
applied to glass arrays 
8.4.6 Single versus Dual labelling 
Both Nylon membranes and Affymetrix GeneChip arrays employ a single label 
whereas glass slides use two fluoresecet dyes commonly Cy3 and Cy5 [281]. Use of a 
single dye enables comparison with any subsequent experiments performed; whereas 
when two samples are hybridised on one slide; only that comparison can be performed. 
This means that the experimental design process requires careful thought. In addition 
cross over and gene specific effects of the Cy3 and Cy5 means that dye swapping 
experiments should be performed [220]. On the other hand use of single label requires 
two separate arrays which can cause subsequent image comparison issues if image 
artefacts are present on one of the arrays 
8.4. 7 Technical versus Biological Replicates 
Technical replicates normally indicate identical probes prepared independently 
from the same RNA. Technical replicates are useful to ensure that the procedures and 
equipment being used are working consistently and thus replicates are an important part 
of the set up process. Biological replicates are samples prepared from different 
preparations of RNA isolated from independent samples. Biological replicates are 
important as they provide greater statistical power to the analysis of the data generated. 
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8.4.8. Array technology for the identification of novel genes 
One of the potential downfalls of array technology is that generally only known 
gene/transcripts and EST clusters from the databases such as Unigene are represented on 
arrays. This could result in a lack of novel transcripts on the arrays. In this study, two 
such cases are discussed below. A class of molecules called the disintegrins (MDCs) have 
been identified in atherosclerotic lesions [282]. In particular MDC 15 has been found to 
be present in lesions of atherosclerosis [282]. However when the list of genes on the 
custom array were consulted it was found that only MDC 9 was present on the arrays thus 
even if MDC 15 was differentially expressed on the custom arrays we would not have 
been able to detect it because it was not present on the array. In addition a novel 
scavenger receptor for OxLDL called SR-PSOX (scavenger receptor for phosphatidyl 
serine and oxidised lipoprotein) has been recently reported [283]. Similarly this receptor 
was not represented on the arrays. With sequencing of genomes from the major 
organisms of interest complete, future array experiments can ensure that all the genes in 
the genome of the organism being studied can be represented. 
8.4.9 Data Storage, Sharing and Interpretation 
One of the major problems of array technology has arisen exactly due to the 
strength of the technology, namely the amount of data produced. Undoubtedly the main 
advantage of using array technology in this study has been the amount of data generated. 
For example the time course experiment, which produced 5383 data points would not 
have been possible in the time scale of a PhD project using traditional molecular biology 
methods. Thus the greatest challenges are to have standards which allow data from 
different array platforms to be compared; to allow sharing and storage of data and to be 
able to interpret the data biologically meaningful manner. Major steps have been taken in 
the scientific community over the last few years to address some of these issues. 
The Microarray Gene Expression Data Consortium (MGED) has been formed and 
has set standards for the generation and submission of microarray data [284]. These 
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standards include minimum information about a microarray experiment (MIAME) [285] 
and microarray gene expression markup language (MAGE-ML) [286]. These standards 
have also been adopted by the major scientific journals including Nature, Science and 
The Lancet and microarray data repositories such as Gene Expression Omnibus (GEO; 
discussed below) 
The data from this study and other gene expression studies performed at Glaxo 
Wellcome was stored in a database so that future comparisons and analysis of this data 
with other data sets generated within the company could be performed. However access 
to this database is restricted to Glaxo Wellcome personnel. Unfortunately most academic 
institutions cannot meet the costs of setting up and managing such databases. In addition 
such company databases do not allow data to be made available to the scientific 
community at large. To address these needs, the National Centre for Biotechnology 
Information in the U.S has set up a medium for the deposition for data generated by array 
technology experiments. This database is known as GEO [287]. Other such databases 
include European Bioinformatics Institutes ArrayExpress [288]. 
The results of most microarray experiments results in a list of differentially 
expressed genes. Initially researchers spent huge amounts of time going through such 
lists manually using literature searches and public databases in an attempt to discover 
relevant biological processes and pathways. Recently tools such as NetAffx [289], 
GenMAPP [290], Gene Ontology (GO) [291] and KEGG [292] have been developed to 
assist researchers in this area. As biologists, bioinformations and statisticians continue to 
work together more such tools can be expected. 
8.5 Future work 
Although the results provided here provide a comprehensive view of gene 
expression occurring in during foam cell formation, it should be remembered that this 
experiment was performed in an in vitro cell model. Although this may be highly 
representative of the in vivo model it does still not obviously divert the need for this work 
to be performed in vivo that is ultimately a more complex situation involving other cell 
types all of which interact to contribute to the atherosclerotic process. The first stage in 
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this process would be ultimately to use an ex vivo model, namely HMDM. However due 
to the variability with HMDM from different individuals it would be interesting to use 
array technology to look at the level of HMDM isolated from different individuals. If 
these differences were minimal then the foam cell model could be established within 
these cells and differences in gene expression examined. Further experimentation would 
then look at the in vivo model with macrophages isolated from fatty streaks and advanced 
plaques. However here the problems lie in being able to isolate macrophages from the 
other cellular components present in lesions and the availability of limited material. In 
this respect techniques such as Laser capture microdissection will be important. Recently 
· Trogan et al [293] used this technique to look at gene expression in macrophages from 
atherosclerotic lesions in mice. Whilst they used RT-PCR for looking at gene expression 
because of limited RNA, methods such as linear amplification which decrease the amount 
of RNA required [294] means that microarray analysis is also possible. 
Future experiments will also assess cell viability, since OxLDL has been reported 
by some investigators to be toxic [38]. In this study cell death was noted in differentiated 
THP-1 cells exposed to OxLDL for 72 hours. Shiffman et al [247] have reported 
exposure to OxLDL for up to 4 days with no mention of cell death. In fact their study 
suggested that most up regulation of genes was occurring at this point and that this may 
possibly still represent the early stage of changes that are thought to occur during lipid 
loading. If this is the case, this will also warrant further investigation. 
Although the genes reported here were not confirmed using independent means, 
most of the genes here have already been reported or implicated in the atheorsclerotic 
process. In addition the study by Shiffman et al [247] found that in fact array technology 
was found to under represent the levels of the genes reported. Furthermore they were able 
to confirm the results of genes identified from array technology using quantitative real 
time PCR. In an attempt to confirm some of the genes identified here, the methods of 
quantitative RT-PCR were set up. However due to time limitations the experimentation 
could not be completed. 
When this study was started array technology was limited to industrial 
environments and large academic institutions that could afford the technology. However 
since then the technology has become more widespread as costs of the technology have 
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dropped and the potential of the technology has been exploited. Most institutions have 
now set up core microarray facilities. 
Further developmental progress has also been made with the development of 
tissue arrays and protein arrays. Tissue arrays allow the expression of one gene to be 
assessed over thousands of different tissue samples to be assessed. Although it is more 
difficult to identify proteins that are differentially expressed, protein arrays have been 
utilised successfully [295]. 
8.6 Conclusion 
This study has demonstrated the application of array technology to identify 
expression of genes involved in the macrophage to foam cell formation. The study has 
demonstrated the large amounts of data that such studies can generate and the importance 
of techniques needed to analyse this data. The data presented here should be viewed as an 
ideal database for consultation as knowledge of the atherosclerotic field expands. In 
addition it is a good starting point for designing future experimentation looking at the 
involvement of genes in the foam cell process in the in vitro foam cell model used here. 
As technology progresses to protein arrays, arrays looking at differences in levels 
of mRNA will remain important in establishing how data is correlated between mRNA 
levels and protein levels and establish the importance of post-transcriptional and post-
transcriptional modifications that occur during gene expression. 
The data generated from this study supports the role of inflammation in the 
atherosclerotic process. Advances such as the discovery of statins have had a major 
impact on mortality from CHD over the last couple of decades. As our understanding of 
the atherosclerotic process increases further more such advances are expected. Recently 
Wald et al [296] have suggested work on a polypill which would combine six key 
compounds, aspirin, a statin, folic acid and three blood pressure medications. Such 
treatment if successful could further dramatically decrease mortality from CHD. 
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Appendix I 
Appendix 1 
Density of sod ium bromide solution (g/cm-3) versus index of refraction at 20°C (relative 
to air at a wavelength of 589nm) from reference [ 169]. 
Density Refractive Index 
1.002 1 1.3337 
1.0060 1.3344 
1.01 39 1.3358 
1.02 18 1.3372 
1.0298 1.3386 
1.0380 1.340 1 
1.0462 1.34 15 
1.0546 1.3430 
1.0630 1.3445 
1.0716 1.3460 
1.0803 1.3475 
1.0892 1.349 1 
1.098 1 1.3506 
1.1072 1.3522 
1.1164 1.3538 
1.1945 1.3647 
1.2089 1.3669 
1.2236 1.3691 
1.2385 1.3713 
1.2536 1.3735 
Graph 1. Graph showing relationship between KBr density and 
refractive index 
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Appendix 2: Array Parameters 
Settings used during arraying and subsequent analysis 
(a) Parameters used for arraying 
Arraying pattern 
Spots/cells in X: 4 or 5 
Spots/cells in Y: 4 or 5 
Cells/Field in X: 16 
Cells/Field in Y: 24 
Fields in X: 2 
Fields in Y: 2 
(b) Parameters used for array processing 
General: Spot radius: 0.4 
Spot Finding: Spot search 
Search range 3 
Minimum correlation 0.65 
Minimum covariance 0.16 
Static Phosphoimager: 
Intensity Reading 
Spot reader 1.0 (for eDNA hybridisation) 
0.6 (for DNA loading) 
300 
Spacing 
Spot to spot spacing in X: I 
Spot to spot spacing in Y: I 
Cell to Cell spacing in X: 4.5 
Cell to Cell spacing in Y: 4.5 
Interfield spacing in X: 0.3 
Interfield spacing in Y: 0.5 
Template radius modifier: - 0.8 
Template Parabola Height: - 6 
Background Reading 
Background reader: 
Appendix 2 
Histogram Method: Expand histogram area by 2 for eDNA hybridisation 
Low Fraction Method Background Fraction= 0.1 for DNA loading 
Control defaults 
Spacing in X andY: Spacing in X: 4.5 
Spacing in Y: 0 
Default dilution factor: 2 
Other items 
Duplicates (replicates)= set to 0.9 
Flooding set to 0.5 
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Appendix 3: Atheroma array 
Appendix 3 can be found on the CD enclosed with this thesis. Appendix 3 can be found 
on the CD as a Microsoft Excel worksheet, named appendix 3 'Atheroma Array'. 
The workbook contains three separate worksheets 
(a) Alphabetical gene list. 
The alphabetic gene list contains a list in alphabetical order of the 770 genes 
(identity taken to be as given in the I.M.A.G.E library) arrayed on the array. 
(b) Sequence verified genes 
The sequence verified list contains a list, in alphabetical order of the 579 genes 
that when sequenced matched their original assigned I.M.A.G.E identity. This list 
also contains (where available) the corresponding Genbank and EST accession 
number for each gene. 
(c) Array template 
The array template contains a list of the gene at each X, Y position on the array. 
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Appendix 4 
Appendix 4; list of comparisons performed between samples and identification 
number assigned to the subsequent comparison results tables generated 
custom I.M.A.G.E arrays 
comparison comparison atheroma arrays comparison numbers 
sample I sample 2 comparison /.M.A. G.£ I.M.A.GE /.M.A. G.£ 
numbers I 2 3 
up, down up, down up, down up, down 
(regulated) (regulated) (regulated) (regulated) 
Native Control 2543,2542 2517,2516 2519,2518 2521,2520 
24hrOxLDL Control 2544,2546 2522,2523 2524,2525 2526,2527 
24hrAcLDL Control 2548,2549 2528,2529 2530,2531 2540,2541 
24hrOxLDL Native 2554,2555 2477,2478 2479,0 2480,2481 
24hrAcLDL Native 2552,2553 2482,2483 2484,2485 2486,2487 
24hr0xLDL 24hrAcLDL 2556,2557 0,2489 2490,2491 2492,2493 
4hr AcLDL Control (-) 2534,2535 2536,2537 2538,2539 
4hr OxLDL Control 2560,2561 2510,2511 2512,2513 2514,2515 
4hrOxLDL 4hr AcLDL (-) 0,2494 2495,2496 2497,2498 
24hrOxLDL 4hrOxLDL 2562,2563 0,2499 2501,2500 2503,0 
24hr AcLDL 4hrAcLDL (-) 2505,2504 2507,2506 2509,2508 
Notes to table l 
[ l] The I.M.A.G.E library was gridded over three arrays due to its large size. This is 
denoted by I.M.A.G.E 1, 2 and 3. 
[2] Due to the poor image quality of the arrays obtained from hybridisation of the 4hr 
AcLDL probe to the custom arrays, no comparisons could be performed using 
these images, this is denoted in the table by (-). I.M.A.G.E grids hybridised to 4 
hour AcLDL probe had no problems indicating that gridding of PCR products 
onto the arrays may have been at fault. 
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[3] For each set of comparisons, samples were compared in two directions to 
determine up-regulated and down-regulated genes. This gives two tables of results 
for most of the comparisons, where only one number is given, genes were only 
found to be regulated in one direction. 
[4] As all samples were prepared in duplicate, four sets of results were obtained for 
each comparison performed. The four comparison lists were compared against 
one another and only difference that were common in all lists were identified as 
definite differences and were listed in a new comparison table and assigned a new 
comparison identification number. The comparisons numbers given in the table 
above correspond to these final comparison tables 
[5] Comparison numbers correspond to results in tables given in Appendix 5 Excel 
worksheet. 
Appendix 5 
Appendix 5 can be found on the enclosed CD as an Excel workbook, named 
appendix 5 'atheroma results'. For each comparison table listed, the comparison from 
which the results were derived is listed at the top of the comparison table. The 
comparison tables are arranged by greatest fold difference. The comparison tables list the 
gene name, fold difference, the calculated standard deviation of the gene, its position 
(x,y) on the array (although genes were gridded at more than one position, only one x,y 
position is given; this x,y position corresponds to those given in appendix 3.3; array 
template). The next column contains a unique identification number assigned by the DGE 
group, Glaxo Wellcome, Stevenage, UK. The final column lists the comparison 
identification number; this corresponds to the comparison numbers given in the table in 
appendix 4. 
304 
Appendix 4 -Appendix 8 
Appendix 6 
Appendix 6 can be found on the enclosed CD as an Excel workbook, named 
appendix 6 'I.M.A.G.E results'. 
Appendix 6 I.M.AG.E workbook contains worksheets named by comparison 
numbers, except the first worksheet. The first worksheet is labelled 'summary of results' 
gives a summary of the top up and down regulated genes identified in each the 
comparisons listing the gene name and the fold difference observed. The rest of the 
workbook contains worksheets labelled with comparison identification numbers. These 
comparison numbers correspond to comparisons identification numbers given in the table 
in appendix 4. 
As explained in the text, genes/EST sequences identified from the I.M.A.G.E 
array comparisons as showing differential expression were repicked from the library and 
resequenced. The data provided in these worksheets is the sequencing data obtained. 
Sequencing was performed by the Sequencing group, Department of Genetics, Glaxo 
W ellcome. The worksheets have been modified by the author to provide the data in each 
worksheet by greatest fold difference. 
Appendix 7 
Appendix 7 can be found on the enclosed CD as an Excel workbook, named 
appendix 7 'Data Analysis'. This shows the data obtained from performing the temporal 
gene expression part of this study and the subsequent analysis performed. Appendix 7.4 
lists genes showing expression during at least one time point (listed alphabetically) on 
exposure of differentiated THP-1 cells to OxLDL. 
Appendix 8 
Appendix 8 can be found on the enclosed CD as an Excel workbook, named 
appendix 8 'Pearson Correlation'. The workbook contains separate worksheets, each of 
which represent one of the nine clusters obtained after performing hierarchical clustering. 
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